introduct
pharmacolog
immunomodulatori
intervent
acut
respiratori
distress
syndrom
ard
unsuccess
clinic
trial
despit
promis
result
preclin
studi
use
anim
poor
phenotyp
patient
could
respons
disappoint
result
object
hypothes
ard
patient
cluster
base
concentr
plasma
biomark
biolog
endophenotyp
associ
clinic
outcom
method
patient
screen
presenc
ard
unbias
cluster
analysi
plasma
concentr
biomark
inflamm
coagul
endotheli
activ
diagnosi
ard
provid
endophenotyp
decis
tree
use
predict
cluster
membership
base
restrict
set
biomark
independ
associ
endophenotyp
icu
mortal
studi
multivari
logist
regress
result
three
endophenotyp
ard
identifi
patient
name
impass
n
intermedi
n
reactiv
n
mortal
rate
respect
p
patient
reactiv
endophenotyp
younger
higher
diseas
sever
score
fail
organ
frequent
indirect
caus
ard
patient
impass
intermedi
endophenotyp
reactiv
endophenotyp
independ
confound
associ
icu
mortal
confid
interv
concentr
interleukin
interleukin
matrix
metalloproteinas
suffici
predict
three
endophenotyp
conclus
ard
patient
cluster
three
biolog
endophenotyp
differ
mortal
rate
three
easi
measur
biomark
use
predict
endophenotyp
refer
takeda
pulm
pharmacol
ther
boyl
aj
expert
opin
biol
ther
cepkova
j
intens
care
med
calfe
cs
chest
beitler
jr
chest
grant
acknowledg
studi
support
mar
consortium
publicpriv
partnership
introduct
patient
meet
berlin
definit
criteria
acut
respiratori
distress
syndrom
ard
might
lack
exposur
one
common
risk
factor
patient
might
exhibit
differ
clinic
phenotyp
outcom
other
constitut
individu
subgroup
patient
object
compar
clinic
present
outcom
patient
ard
vs
without
risk
factor
determin
whether
lack
ard
risk
factor
associ
hospit
mortal
identifi
factor
associ
hospit
mortal
subgroup
ard
patient
risk
factor
method
ancillari
studi
intern
multicent
prospect
cohort
studi
lung
safe
studi
patient
meet
ard
criteria
berlin
definit
day
acut
hypoxem
respiratori
failur
onset
includ
studi
categor
common
risk
factor
result
among
patient
present
ard
first
h
patient
ard
risk
factor
identifi
admiss
tabl
show
final
ard
risk
factor
identifi
patient
without
initi
risk
factor
identifi
patient
risk
factor
older
frequent
previous
known
chronic
diseas
present
less
sever
sofa
vs
p
nonpulmonari
vs
p
sofa
score
icu
mortal
lower
ard
patient
risk
factor
other
vs
p
inhospit
mortal
vs
p
lack
ard
risk
factor
associ
hospit
mortal
adjust
p
subgroup
patient
ard
risk
factor
age
sofa
concomit
heart
failur
administr
steroid
within
hour
ard
onset
associ
hospit
mortal
tabl
conclus
almost
ten
percent
patient
ard
risk
factor
identifi
exhibit
differ
clinic
phenotyp
other
futur
research
aim
studi
manag
strategi
subgroup
patient
warrant
refer
bellani
g
et
al
jama
feb
trial
registr
clinicaltrialsgov
grant
acknowledg
lung
safe
studi
support
esicm
introduct
acut
respiratori
distress
syndrom
ard
seriou
complic
follow
major
ard
frequent
complic
oesophagectomi
beta
agonist
lung
injuri
prevent
trial
baltip
provid
larg
cohort
patient
undergon
oesophagectomi
systemat
screen
ard
object
characteris
patient
develop
ard
follow
oesophagectomi
identifi
risk
factor
ard
group
method
data
collect
part
baltip
trial
includ
daili
assess
oxygen
chest
xray
assess
expert
panel
comparison
earli
ard
first
postop
hour
late
ard
hour
undertaken
use
univari
multivari
analysi
differ
outcom
determin
risk
factor
ard
group
identifi
result
case
ard
earli
late
ard
associ
longer
icu
differ
day
confid
interv
hospit
stay
differ
day
ci
fewer
organ
failurefre
day
differ
day
ci
fewer
ventilatorfre
day
differ
day
ci
differ
mortal
qualiti
life
score
late
ard
worst
outcom
earli
ard
associ
increas
age
odd
ratio
ci
p
midoesophag
tumour
ci
p
wherea
gastrooesophag
tumour
protect
ci
p
ard
associ
advers
event
conclus
ard
associ
advers
patient
outcom
increas
healthcar
resourc
utilis
patient
midoesophag
tumour
may
especi
high
risk
investig
aim
reduc
periop
ard
high
risk
ard
follow
oesophagectomi
make
patient
group
use
conduct
trial
prevent
therapi
incid
ard
high
onset
predict
therefor
patient
approach
preoper
refer
singh
gg
chandi
tt
sen
n
incid
outcom
acut
lung
injuri
acut
respiratori
distress
syndrom
surgic
intens
care
unit
indian
j
crit
care
med
perkin
gd
gate
park
et
al
beta
agonist
lung
injuri
trial
prevent
random
control
trial
j
respir
crit
care
med
proudfoot
ag
mcauley
df
griffith
mj
hind
human
model
acut
lung
injuri
di
model
mech
grant
acknowledg
baltiprevent
studi
support
nation
institut
health
research
pah
fund
grant
provid
glaxosmithklin
drt
medic
research
council
gdp
fg
receiv
support
nation
institut
health
research
senior
investig
gdp
dfm
support
director
research
intens
care
foundat
introduct
limit
inform
epidemiolog
recognit
manag
outcom
trauma
patient
acut
hypoxem
respiratori
failur
ahrf
object
assess
demograph
clinician
recognit
ventil
manag
use
adjunct
measur
outcom
trauma
patient
ahrf
enrol
lung
safe
studi
method
lung
safe
intern
multicent
prospect
cohort
studi
patient
undergo
invas
noninvas
ventil
conduct
four
consecut
week
winter
conveni
sampl
icu
countri
across
contin
analysi
compar
data
patient
ahrf
secondari
trauma
gener
ahrf
patient
popul
defin
cohort
group
patient
presenc
trauma
andor
pulmonari
contus
consid
risk
factor
ahrf
result
patient
admit
particip
icu
ahrf
sustain
trauma
andor
pulmonari
contus
tabl
trauma
patient
younger
higher
male
predomin
less
comorbid
lower
ill
sever
compar
gener
ahrf
patient
popul
trauma
patient
develop
ard
clinician
recognit
lower
overal
regard
ventil
manag
tidal
volum
peep
level
compar
seen
gener
ahrf
group
use
noninvas
ventil
lower
neuromuscular
blockad
use
compar
versu
less
use
prone
posit
versu
outcom
trauma
patient
ahrf
better
overal
ahrf
popul
greater
icu
versu
hospit
versu
surviv
compar
gener
ahrf
popul
trauma
independ
associ
reduc
risk
death
multivari
analysi
conclus
trauma
patient
constitut
distinct
cohort
younger
predominantli
male
less
comorbid
improv
outcom
compar
gener
ahrf
cohort
refer
bellani
g
et
al
jama
feb
trial
registr
clinicaltrialsgov
grant
acknowledg
studi
support
esicm
introduct
prognost
patient
ard
improv
patient
reclassifi
hour
use
peep
cutoff
uncertain
could
serv
noninvas
continu
surrog
prognost
ard
patient
hypothes
combin
peep
reliabl
altern
prognost
patient
moder
sever
ard
object
investig
whether
classif
onset
reclassif
hour
use
peep
cutoff
allow
outcom
prognost
patient
moder
sever
ard
accord
berlin
definit
method
secondari
analysi
larg
prospect
observ
studi
mix
intens
care
unit
univers
hospit
netherland
first
relat
determin
patient
assign
four
group
onset
ard
hour
group
peep
cm
group
ii
peep
cm
group
iii
peep
cm
group
iv
peep
cm
primari
outcom
allcaus
inhospit
mortal
secondari
outcom
icu
year
mortal
number
ventilatorfre
day
aliv
day
result
analysi
includ
patient
moder
sever
ard
stay
icu
hour
relat
good
use
predefin
cutoff
peep
prognost
improv
reclassif
hour
tabl
conclus
reliabl
altern
prognost
hour
onset
moder
sever
ard
refer
villar
j
rl
et
al
crit
care
med
bo
ld
cremer
ol
et
al
intens
care
med
rice
tw
wheeler
ap
bernard
gr
et
al
chest
ard
definit
task
forc
jama
grant
acknowledg
research
perform
within
framework
ctmm
center
translat
molecular
medicin
wwwctmmnl
project
mar
grant
introduct
differenti
diagnosi
acut
respiratori
failur
arf
hospit
patient
extens
includ
congest
heart
failur
atelectasi
nosocomi
pneumonia
ard
sepsi
novel
diagnost
test
base
express
four
rna
peripher
blood
septicyt
lab
immunexpress
seatl
wa
may
facilit
discrimin
infecti
noninfecti
caus
set
object
explor
diagnost
prognost
valu
septicyt
lab
arf
patient
admit
icu
hospit
ward
method
enrol
consecut
patient
arf
hospit
hr
requir
prompt
intub
icu
two
dutch
univers
hospit
patient
fulfil
sir
criteria
andor
earli
warn
score
exclud
patient
establish
diagnosi
infect
day
icu
admiss
well
airway
obstruct
circulatori
arrest
pertin
reason
mechan
ventil
blood
sampl
collect
paxgen
tube
rna
extract
upon
icu
admiss
subsequ
analyz
appli
fast
dx
realtim
pcr
instrument
test
result
categor
probabl
band
accord
specif
posthoc
infect
likelihood
sepsi
event
within
day
icu
admiss
base
physician
assess
accord
valid
definit
result
sampl
prepar
process
issu
result
exclus
patient
leav
final
analysi
subject
receiv
antibiot
upon
icu
admiss
wherea
therapi
initi
later
date
addit
patient
test
result
correl
probabl
infect
p
fig
among
patient
test
classifi
sepsi
fals
posit
rate
decreas
higher
probabl
band
patient
test
suggest
infect
unlik
observ
case
confirm
infect
fals
neg
rate
patient
could
categor
certainti
undetermin
formal
calcul
sensit
specif
preclud
septicyt
test
result
affect
age
prior
icu
stay
immun
defici
higher
score
test
indic
increas
sever
diseas
mortal
fig
conclus
septicyt
lab
biomark
assay
may
aid
clinician
separ
infecti
noninfecti
caus
acut
respiratori
failur
hospit
patient
addit
test
may
prognost
util
refer
mchugh
l
et
al
plo
med
klein
klouwenberg
pm
et
al
ccm
grant
acknowledg
thank
immunexpress
kindli
provid
lab
kit
technic
assist
conflict
interest
author
declar
conflict
interest
introduct
recent
intern
consensu
definit
sepsi
septic
shock
launch
accord
guidelin
quick
sequenti
organ
failur
assess
qsofa
score
recommend
clinic
criteria
identifi
sepsi
patient
outsid
icu
emerg
depart
ed
major
sourc
icu
admiss
sepsi
therefor
earli
recognit
sepsi
essenti
applic
bundl
therapi
time
object
want
investig
predict
valu
qsofa
mortal
ed
patient
sepsi
method
patient
suspect
old
definit
sever
sepsi
septic
shock
retrospect
identifi
urban
tertiari
hospit
ed
may
april
demograph
find
initi
vital
sign
glasgow
coma
scale
gc
site
infect
initi
lactat
level
system
inflammatori
respons
syndrom
criteria
sir
qsofa
score
sofa
score
mortal
abstract
area
receiv
oper
characterist
auroc
sir
qsofa
sofa
predict
mortal
compar
diagnost
perform
qsofa
predict
mortal
calcul
result
total
patient
identifi
studi
period
among
patient
exclud
miss
valu
demograph
characterist
describ
tabl
patient
qsofa
less
account
half
enrol
patient
one
third
mortal
case
tabl
auroc
sir
qsofa
sofa
predict
mortal
respect
sir
vs
qsofa
p
qsofa
vs
sofa
p
fig
diagnost
perform
qsofa
predict
mortal
follow
sensit
specif
posit
predict
valu
neg
predict
valu
diagnost
perform
sofa
score
predict
mortal
follow
sensit
specif
posit
predict
valu
neg
predict
valu
conclus
current
clinic
criteria
use
qsofa
better
predict
valu
sir
mortal
ed
patient
sepsi
howev
criteria
qsofa
miss
one
third
mortal
case
therefor
assess
organ
failur
sofa
score
would
help
ed
patient
infect
introduct
new
sepsi
consensu
introduc
quick
sofa
score
qsofa
simpl
screen
tool
earli
detect
patient
infect
risk
wors
outcom
communityacquir
pneumonia
cap
common
infect
respons
sepsi
extern
valid
qsofa
necessari
interest
crb
confus
respiratori
rate
blood
pressur
consolid
score
use
cap
weigh
variabl
use
qsofa
differ
cutoff
object
aim
evalu
perform
qsofa
patient
cap
compar
qsofa
sir
crb
sofa
score
predict
mortal
method
includ
patient
clinic
diagnosi
cap
hospit
clinic
barcelona
hospit
la
fe
valencia
spain
use
variabl
diagnosi
calcul
sir
qsofa
crb
sofa
score
evalu
perform
score
addit
predict
contribut
baselin
risk
model
estim
logist
regress
model
includ
demograph
age
gender
comorbid
variabl
chronic
respiratori
diseas
chronic
neurolog
diseas
liver
diseas
heart
failur
diabet
mellitu
activ
neoplasia
chronic
renal
diseas
hiv
statu
etiolog
diagnosi
primari
outcom
inhospit
mortal
secondari
outcom
inhospit
mortal
andor
day
icu
stay
day
mortal
use
multipl
imput
deal
miss
data
result
evalu
patient
cap
mean
age
inhospit
mortal
patient
discrimin
evalu
area
curv
auc
tabl
sir
criteria
wors
discrimin
perform
compar
qsofa
crb
sofa
calibr
plot
compar
among
score
although
overestim
pronounc
qsofa
sofa
score
ad
score
baselin
risk
model
discrimin
model
sir
chang
although
improv
qsofa
crb
sofa
baselin
model
calibr
improv
similarli
ad
score
use
cutoff
two
point
sensitivityspecif
sir
qsofa
crb
sofa
similar
pattern
observ
secondari
outcom
measur
perform
brier
score
idi
conclus
qsofa
crb
sofa
accur
sir
detect
cap
patient
risk
unfavour
outcom
extern
valid
cutoff
point
qsofa
lower
sensit
expect
screen
tool
crb
outperform
qsofa
sofa
term
calibr
higher
specif
popul
refer
singer
deutschman
cs
et
al
third
intern
consensu
definit
sepsi
septic
shock
jama
prina
e
ranzani
ot
torr
communityacquir
pneumonia
lancet
grant
acknowledg
ceccato
support
longterm
er
fellowship
introduct
previou
studi
link
variou
cytokin
level
clinic
trait
organ
failur
mortal
use
data
cluster
patient
classifi
distinct
endotyp
object
determin
whether
clinic
biomark
defin
endotyp
sepsi
differ
rate
mortal
organ
failur
method
multicent
random
protocolbas
care
earli
septic
shock
process
trial
enrol
patient
septic
shock
show
mortal
use
hierarch
biclust
approach
cluster
patient
use
cytokin
level
earli
trend
baselin
clinic
variabl
featur
cytokin
level
measur
hour
includ
variabl
high
coeffici
variat
signific
univari
logist
regress
pvalu
organ
failur
outcom
includ
candid
cluster
variabl
patient
variabl
standard
differ
cluster
mortal
examin
use
logrank
test
patient
complet
variabl
profil
includ
heat
map
analysi
cluster
perform
associ
cluster
organ
failur
defin
sofa
score
greater
mortal
examin
result
unsupervis
cluster
yield
sever
subgroup
endotyp
interest
increas
potenti
number
subgroup
disclos
emerg
subgroup
distinct
clinic
featur
highest
level
patient
high
cytokinemia
hc
proxim
distinguish
low
cytokinemia
lc
patient
hc
segreg
elev
lactat
hcl
figur
often
higher
averag
platelet
count
although
hc
associ
gener
higher
mof
mortal
hcl
portend
particularli
poor
prognosi
dot
line
move
top
dendrogram
addit
subgroup
appear
patient
acut
kidney
injuri
high
blood
urea
nitrogen
bun
low
urin
output
hyperglycemia
patient
high
systol
blood
pressur
high
temperatur
high
heart
rate
conclus
hierarch
cluster
identifi
endotyp
patient
particularli
high
low
risk
organ
failur
mortal
heat
map
biclust
septic
patient
includ
sever
domain
inform
serum
marker
clinic
featur
promis
method
group
patient
distinct
endotyp
classif
endotyp
act
basi
person
therapi
grant
acknowledg
nih
introduct
new
sepsi
definit
suppos
offer
greater
consist
research
classif
septic
patient
howev
remain
determin
chang
patient
popul
formerli
identifi
criteria
sever
sepsi
septic
shock
object
investig
chang
mortal
length
stay
data
appli
criteria
previou
patient
cohort
identifi
former
sepsi
criteria
method
patient
popul
deriv
previou
prospect
cohort
studi
perform
tertiari
univers
hospit
greifswald
germani
ethic
approv
bb
includ
adult
patient
sepsi
onset
icu
admiss
reanalyz
criteria
appli
patient
previous
classifi
sever
sepsi
septic
shock
consensu
confer
criteria
mortal
rate
length
stay
data
compar
sever
subgroup
defin
former
definit
respect
result
patient
sever
sepsi
septic
shock
includ
appli
criteria
result
subgroup
sepsi
septic
shock
patient
neither
sofa
increas
shock
result
present
fig
conclus
criteria
identifi
patient
higher
risk
mortal
howev
result
signific
investig
need
determin
impact
sepsi
classif
interpret
futur
research
use
care
consid
potenti
chang
compar
result
futur
trial
previou
studi
refer
singer
et
al
jama
bone
r
et
al
chest
introduct
fluid
administr
maintain
organ
perfus
common
practic
critic
ill
patient
reliabl
assess
fluid
respons
difficult
carotid
arteri
flow
easi
measur
bedsid
object
test
hypothesi
chang
carotid
arteri
flow
time
correct
flow
time
ftc
induc
plr
predict
volum
respons
mv
patient
method
prospect
observ
studi
conduct
mv
patient
admit
mix
icu
decemeb
adult
patient
consid
elig
fluid
resuscit
decid
attend
physician
includ
exclus
criteria
pregnant
patient
head
injuri
intraabdomin
hypertens
ampute
rhythm
known
cardiac
abnorm
protocol
linear
transduc
puls
wave
doppler
use
common
carotid
arteri
record
carotid
arteri
ftc
flo
trac
vigileo
edwardlif
sciencestm
monitor
use
detect
chang
stroke
volum
sv
record
taken
baselin
semirecumb
posit
patient
put
supin
minut
plr
done
maximum
sv
plr
record
carotid
ftc
measur
minut
maximum
carotid
ftc
valu
consid
fluid
respons
defin
sv
volum
expans
result
total
patient
taken
studi
mean
age
year
male
femal
bmi
sd
mean
apach
ii
score
sd
mean
mechan
ventil
day
sd
mean
icu
day
diseas
type
respiratori
acut
febril
ill
cn
pancreat
fluid
respons
seen
chang
stroke
volum
chang
carotid
ftc
respons
plr
predict
volum
responsivenesssensit
specif
roc
curv
ci
conclus
carotid
ftc
increas
plr
reliabl
predictor
fluid
respons
mv
patient
refer
monnet
x
rienzo
esophag
doppler
moni
tore
predict
fluid
respons
critic
ill
ventil
patient
intens
care
med
dark
pm
singer
valid
transesophag
doppler
ultrasonographi
measur
cardiac
output
critic
ill
adult
intens
care
med
grant
acknowledg
none
introduct
fluid
resuscit
form
mainstream
amelior
impair
oxygen
deliveri
hemorrhag
shock
howev
doubleedgedsword
underfil
harm
therefor
perform
accord
adequ
physiolog
endpoint
accord
recent
survey
physician
still
use
hypotens
main
target
guid
fluid
resuscit
object
aim
compar
stroke
volum
svi
cardiac
output
ci
mean
arteri
pressur
map
guid
fluid
resuscit
hemorrhag
shockresuscit
experi
perform
vietnames
mini
pig
method
anaesthetis
mechan
ventil
pig
random
svi
n
ci
n
mapgroup
n
instrument
tbsl
anim
bled
till
initi
svi
drop
group
fluid
replac
perform
equival
step
divid
valu
equal
interv
ringer
fundin
rf
solut
reach
baselin
valu
svi
ci
map
respect
invas
hemodynam
measur
blood
ga
analys
undertaken
step
statist
analysi
gener
linear
model
independ
sampl
ttest
mannwhitney
u
test
use
result
similar
amount
blood
drain
group
svi
ci
map
mlkg
signific
differ
among
group
fluidreplac
ratio
svi
ci
map
p
svigroup
variabl
return
baselin
physiolog
valu
anim
cigroup
remain
underresuscit
indic
svi
central
venou
oxygen
satur
global
end
diastol
volum
gedi
ratio
compar
tbsl
svi
vs
vs
gedi
vs
vs
p
respect
mapgroup
hemodynam
variabl
includ
svi
ci
puls
pressur
variat
return
baselin
valu
howev
remain
significantli
lower
tbsl
vs
vs
p
respect
group
experi
termin
volum
replac
exceed
drain
blood
regardless
whether
endpoint
baselin
map
reach
conclus
accord
result
use
svi
goal
resuscit
result
endpoint
closest
physiolog
baselin
valu
whilst
cibas
resuscit
end
mapguid
fluid
replac
caus
overresuscit
experi
henc
physician
still
use
map
guid
resuscit
base
result
practic
care
revis
refer
cecconi
hofer
c
teboul
jl
et
al
fluid
challeng
intens
care
fenic
studi
global
incept
cohort
studi
intens
care
medicin
grant
acknowledg
support
nkfih
introduct
reperfus
injuri
play
major
role
resuscit
hemorrhag
shock
microcirculatori
alter
howev
complet
describ
set
object
character
sublingu
intestin
microcircul
hemorrhag
shock
retransfus
method
perform
progress
bleed
follow
retransfus
anesthet
mechan
ventil
sheep
n
also
studi
sham
group
n
sublingu
intestin
microcircul
quantit
assess
mean
sdfvideomicroscopi
measur
perform
baselin
b
first
last
step
hemorrhag
retransfus
r
result
hemorrhag
shock
microcirculatori
variabl
affect
blood
reinfus
restor
intestin
mucos
total
perfus
vascular
densiti
red
blood
cell
veloc
panel
b
proport
perfus
vessel
microvascular
flow
index
heterogen
flow
index
panel
c
e
f
remain
alter
similar
pattern
observ
sublingu
mucosa
except
red
blood
cell
veloc
reduc
conclus
reperfus
microvascular
injuri
mainli
character
decreas
perfus
veloc
increas
heterogen
contrast
vascular
densiti
preserv
sublingu
microcirculatori
chang
mirror
intestin
mucosa
grant
acknowledg
support
grant
agencia
nacion
de
argentina
introduct
septic
patient
may
requir
larg
amount
intravascular
fluid
initi
resuscit
intravascular
volum
divid
unstress
stress
volum
vs
vs
repres
volum
haemodynam
activ
system
vascular
complianc
csi
quantifi
relationship
chang
volum
per
unit
pressur
complianc
vessel
object
aim
studi
compar
csi
vs
patient
cardiac
surgeri
septic
patient
fluid
challeng
method
patient
admit
intens
care
unit
monitor
invas
arteri
blood
pressur
calibr
lidcoplu
lidco
uk
mean
system
fill
pressur
pmsfarm
measur
use
stopflow
arterialven
equilibrium
method
fluid
challeng
mlkg
solut
perform
minut
csi
calcul
vs
calcul
multipli
csi
time
pmsfarm
end
fluid
challeng
sepsi
defin
presenc
least
system
inflammatori
respons
syndrom
criteria
strong
suspicion
evid
infect
data
present
median
interquartil
rang
compar
use
mannwhitney
u
test
p
valu
less
consid
statist
signific
result
septic
postcardiac
surgeri
patient
includ
studi
csi
septic
patient
mlmmhg
postcardiac
surgic
patient
mlmmhg
u
p
vs
ml
septic
patient
ml
postcardiac
surgic
patient
evid
differ
vs
u
p
septic
postcardiac
surgic
patient
conclus
csi
twice
greater
septic
patient
compar
cardiac
surgic
patient
vs
similar
two
group
refer
aya
hd
rhode
fletcher
n
ground
rm
cecconi
transient
stopflow
arm
arterialven
equilibrium
pressur
measur
determin
precis
techniqu
j
clin
monit
comput
introduct
method
current
avail
predict
effect
fluid
challeng
tissu
perfus
capillari
refil
time
crt
prognost
valu
assess
tissu
perfus
septic
shock
passiv
leg
rais
simul
fluid
load
great
advantag
revers
object
hypothesi
variat
digit
capillari
refil
time
passiv
leg
rais
could
predict
variat
crt
ml
fluid
load
method
hemodynam
variabl
crt
systol
diastol
mean
arteri
pressur
pa
pad
pam
heart
rate
hr
cardiac
index
ci
transpulmonari
thermodilut
record
passiv
leg
rais
ml
fluid
load
capillari
refil
time
record
video
camera
calibr
compress
skin
use
piston
four
crt
acquisit
made
hemodynam
condit
posteriori
analyz
two
reader
mr
mjl
least
signific
chang
measur
consequ
respond
crtr
defin
patient
show
reduct
crt
fluid
load
least
other
defin
crtnr
variat
calcul
passiv
leg
rais
fluid
load
ci
respons
defin
increas
ci
fluid
load
spearman
correl
test
use
mannwhitneywilcoxon
test
use
compar
nonparametr
independ
variabl
roc
curv
build
area
curv
calcul
aucroc
confid
interv
ci
calcul
use
repetit
bootstrap
best
threshold
determin
use
youden
index
result
institut
review
board
de
protect
de
personn
lyon
sudest
iii
approv
studi
protocol
patient
circulatori
failur
recruit
patient
crtr
crtnr
passiv
leg
rais
induc
crt
variat
decreas
crtr
crtnr
p
correl
crt
variat
passiv
leg
rais
fluid
load
r
p
aucroc
ci
best
threshold
sensit
ci
specif
among
patient
diagnos
ci
respons
seven
patient
also
crtr
conclus
method
enabl
precis
reproduc
measur
crt
detect
moder
variat
crt
digit
crt
variat
passiv
leg
rais
predict
crt
variat
fluid
load
method
knowledg
first
predict
effect
fluid
load
tissu
perfus
refer
intens
care
med
j
respir
crit
care
med
jul
introduct
adequ
empir
antimicrobi
therapi
crucial
term
surviv
patient
sever
infect
howev
use
broadspectrum
antimicrobi
treatment
without
drawback
object
aim
studi
evalu
factor
associ
deescal
therapi
cohort
patient
admit
icu
sever
sepsi
method
prospect
observ
studi
patient
admit
icu
sever
sepsi
septic
shock
januari
juli
appropri
cultur
obtain
initi
broad
spectrum
antimicrobi
therapi
support
measur
perform
follow
surviv
sepsi
campaign
guidelin
modif
antimicrobi
regimen
cultur
result
left
decis
physician
charg
patient
follow
variabl
record
demograph
characterist
underli
diseas
sever
ill
admiss
apach
ii
sofa
score
adequaci
empir
antimicrobi
therapi
sofa
score
day
cultur
result
worst
sofa
score
icu
develop
nosocomi
infect
leght
stay
mortal
also
analyz
clinic
characterist
sepsi
sourc
presenc
bacteremia
type
pathogen
use
test
mannwhitney
u
test
chi
squar
appropri
compar
variabl
multivari
analysi
also
perform
control
confound
variabl
order
ass
factor
associ
deescal
result
eight
hundr
fifti
two
patient
enrol
de
escal
therapi
perform
two
hundr
sixti
seven
median
apach
ii
sofa
score
admiss
respectivili
patient
total
cohort
microbiolog
document
multivari
analysi
show
variabl
associ
deescal
therapi
sofa
score
day
cultur
result
ic
previou
antimicrobi
therapi
ic
liver
sofa
score
ic
pulmonar
focu
ic
abdomin
focu
infect
ic
blood
cultur
possit
microbiolog
document
combin
antibiot
therapi
independ
factor
associ
deescal
therapi
conclus
deescal
feasibl
strategi
critic
ill
patient
admit
icu
microbiolog
document
blood
cultur
posit
combin
antibiot
therapi
refer
garnachomontero
j
escorescaortega
et
al
deescal
empir
therapi
associ
lower
mortal
patient
sever
sepsi
septic
shock
intens
care
med
leon
bechi
c
baumstarck
k
et
al
deescal
versu
continu
empir
antimicrobi
treatment
sever
sepsi
multicent
nonblind
random
noninferior
trial
intens
care
med
introduct
data
avail
guid
amikacin
dose
regimen
critic
ill
patient
undergo
continu
renal
replac
aim
studi
describ
amikacin
pharmacokinet
continu
venoven
haemofiltr
cvvh
continu
venoven
haemodiafiltr
cvvhdf
also
use
mont
carlo
simul
determin
optim
dose
regimen
method
patient
receiv
amikacin
undergo
cvvh
cvvhdf
elig
blood
sampl
collect
ten
sampl
time
dose
interv
assay
use
valid
lcmsm
method
popul
pharmacokinet
analysi
mont
carlo
simul
undertaken
use
pmetric
result
sixteen
patient
four
patient
receiv
cvvh
cvvhdf
includ
twenti
sampl
profil
cvvh
cvvhdf
analys
twocompart
linear
model
best
describ
data
patient
weight
covari
associ
drug
clearanc
mean
sd
paramet
estim
l
central
volum
lh
rate
constant
drug
distribut
central
peripher
compart
lh
rate
constant
drug
distribut
peripher
central
compart
lh
haemodiafiltr
clearanc
haemofiltr
clearanc
account
patient
weight
cvvh
cvvhdf
clearanc
lh
lh
p
respect
dose
simul
amikacin
support
use
high
dose
regimen
mgkg
extend
interv
h
patient
achiev
pharmacodynamicspharmacokinet
target
peakmic
efficaci
lowest
probabl
target
attain
pta
minim
concentr
mgl
toxic
conclus
strategi
extendedinterv
high
dose
amikacin
mgkg
associ
therapeut
drug
monitor
tdm
best
approach
aminoglycosid
administr
critic
ill
patient
receiv
continu
renal
replac
therapi
refer
taccon
fs
de
backer
laterr
pf
et
al
pharmacokinet
load
dose
amikacin
septic
patient
undergo
continu
renal
replac
therapi
int
j
antimicrob
agent
grant
acknowledg
nime
univers
hospit
grant
introduct
linezolid
lnz
wide
use
antibiot
critic
ill
patient
treatment
infect
certain
suspect
presenc
gramposit
cocci
methicillin
vancomycin
resist
cgp
mr
object
identifi
clinic
factor
associ
subtherapeut
concentr
lnz
defin
plasma
concentr
cmin
ug
ml
overexposur
defin
plasma
concentr
cmin
ug
ml
method
prospect
observ
descript
studi
one
icu
patient
receiv
intraven
lnz
infus
dose
mg
everi
hour
treatment
suspect
confirm
cgpmr
infect
possibl
obtain
blood
sampl
ml
third
day
steadi
state
determin
cmin
administ
next
dose
includ
patient
renal
replac
therapi
exclud
demograph
variabl
comorbid
sever
admiss
analyt
data
evalu
lnz
quantif
perform
use
high
perform
liquid
chromatographi
techniqu
hplc
differ
group
assess
use
chisquar
categor
variabl
student
ttest
mannwhitney
test
continu
variabl
signific
variabl
univari
analysi
includ
multivari
model
logist
regress
identifi
variabl
relat
subsupratherapeut
level
consid
p
signific
predict
valu
formula
calcul
use
receiv
oper
characterist
curv
roc
area
curv
auc
also
comput
result
total
patient
includ
cmin
ug
ml
cmin
ug
ml
glomerular
filtrat
rate
ci
p
diabet
mellitu
ci
p
independ
variabl
associ
subtherapeut
concentr
discrimin
abil
model
obtain
auc
ci
liver
cirrhosi
ci
p
glomerular
filtrat
rate
ci
p
independ
variabl
associ
supratherapeut
concentr
discrimin
abil
model
obtain
auc
ci
conclus
variabl
relat
sub
supratherapeut
lnz
concentr
critic
ill
patient
admit
icu
identifi
presenc
variabl
would
requir
determin
plasma
level
lnz
glomerular
filtrat
rate
variabl
influenc
group
introduct
multirresist
bacteria
mrb
develop
grow
phenomenon
zero
resist
rz
program
launch
spain
help
prevent
emerg
mrb
critic
ill
patient
one
recommend
complet
checklist
upon
patient
admiss
intens
care
unit
icu
identifi
patient
high
risk
colon
infect
mrb
aim
analys
effect
checklist
risk
factor
rf
propos
rz
project
way
mrb
earli
detect
method
prospect
studi
patient
admit
polyval
icu
gener
hospit
submit
checklist
propos
applic
contact
precaut
cp
strategi
patient
rf
mrb
bacteriolog
swab
nasal
pharyng
axillari
rectal
routin
perform
patient
admit
besid
diagnost
cultur
necessari
furthermor
analys
patholog
variabl
comorbid
diabet
renal
failur
immunosuppress
state
neoplasia
cirrhosi
chronic
obstruct
pulmonari
diseas
copd
organ
transplant
malnutrit
type
admiss
icu
urgent
program
univari
multivari
analysi
rf
mrb
binari
logist
regress
perform
statist
signific
set
ci
result
patient
admit
met
cp
criteria
detect
one
mrb
present
cp
criteria
accord
checklist
met
criteria
met
criteria
met
criteria
accumul
risk
p
mrb
carrier
identifi
rf
checklist
tabl
show
risk
factor
comorbid
signific
ad
risk
mrb
conclus
compar
previou
analysi
seen
increas
sampl
size
almost
rf
includ
rz
checklist
predictor
mrb
despit
could
detect
patient
infect
colon
mrb
consid
factor
predict
presenc
mrb
admit
patient
icu
refer
j
montero
et
al
scientif
expert
committe
zero
resist
project
combat
resist
intens
care
multimod
approach
spanish
icu
zero
resist
program
critic
care
introduct
develop
candidemia
bacteremia
caus
multidrugresist
mdr
pathogen
hospit
patient
significantli
increas
risk
advers
outcom
main
task
antibiot
stewardship
program
asp
reduc
microbi
resist
decreas
incid
infecti
complic
caus
mdr
pathogen
object
estim
etiolog
structur
clinic
outcom
patient
bacteremia
multidisciplinari
hospit
period
implement
asp
method
intervent
studi
histor
control
intervent
asp
includ
group
expert
antimicrobi
therapi
amt
amt
prophylaxi
protocol
infect
control
intern
audit
studi
onset
june
analysi
preintervent
jan
intervent
juli
period
carri
assess
incid
bacteremia
caus
methicillinresist
aureu
mrsa
vancomycinresist
enterococci
vre
esblproduc
enterobacteriacea
mdr
gramneg
nonfer
bacteria
mdrnfgb
incid
candidemia
hospit
length
stay
lo
mortal
patient
bacteremia
secondari
endpoint
result
preintervent
period
blood
sampl
analyz
posit
blood
cultur
patient
obtain
intervent
period
blood
sampl
analyz
posit
blood
cultur
patient
obtain
intervent
period
signific
decreas
incid
bacteremia
caus
mdrnfgb
p
vre
p
incid
candidemia
p
detect
frequenc
bacteremia
caus
esblproduc
enterobacteria
significantli
chang
vs
p
number
mrsa
bacteremia
remain
low
vs
p
signific
reduct
mortal
p
group
patient
bacteremia
lo
chang
significantli
iqi
vs
iqi
p
conclus
implement
asp
multidisciplinari
surgic
hospit
allow
significantli
decreas
incid
candidemia
bacteremia
caus
mdrnfgnb
vre
result
reduct
mortal
patient
bacteremia
refer
bassetti
merelli
ansaldi
f
et
al
clinic
therapeut
aspect
candidemia
five
year
singl
centr
studi
plo
one
tam
v
roger
c
chang
k
et
al
impact
multidrug
resist
pseudomona
aeruginosa
bacteremia
patient
outcom
antimicrob
agent
chemoth
blot
vandewoud
k
colardyn
f
nosocomi
bacteremia
involv
acinetobact
baumannii
critic
ill
patient
match
cohort
studi
intens
care
med
mar
rational
poor
sleep
common
intens
care
unit
icu
patient
environment
factor
contribut
sleep
depriv
alter
sleep
architectur
object
present
studi
evalu
impact
earplug
eye
mask
sleep
architectur
icu
patient
patient
method
singl
center
random
control
trial
icu
patient
conduct
juli
decemb
patient
randomli
assign
sleep
without
earplug
facemask
polysomnographi
perform
first
day
night
follow
inclus
primari
end
point
proport
sleep
stage
secondari
end
point
descriptor
sleep
major
outcom
variabl
result
intervent
group
patient
wear
earplug
night
long
proport
sleep
stage
control
group
protect
group
p
descriptor
sleep
differ
two
group
except
number
long
awak
lower
protect
group
control
group
vs
p
differ
among
two
group
term
sleep
qualiti
occurr
delirium
icu
length
stay
mortal
anxieti
depress
icu
discharg
incid
posttraumat
stress
disord
conclus
icu
patient
earplug
eye
mask
well
accept
patient
increas
proport
sleep
stage
decreas
number
prolong
awaken
impact
outcom
grant
acknowledg
french
ministri
health
phrc
note
abstract
previous
publish
avail
includ
complet
record
abstract
confer
refer
demoul
carreira
lavault
pallanca
morawiec
e
mayaux
j
arnulf
similowski
impact
earplug
eye
mask
sleep
critic
ill
patient
prospect
random
polysomnograph
studi
annal
intens
care
suppl
introduct
postop
pulmonari
dysfunct
cardiac
surgeri
use
cardiopulmonari
bypass
cpb
common
rang
transient
hypoxemia
acut
respiratori
distress
syndrom
ard
trigger
inflammatori
respons
disrupt
coagul
ischemiareperfus
injuri
oxid
stress
howev
nadir
partial
pressur
arteri
oxygen
appear
second
third
postop
day
paramount
import
identifi
patient
risk
earli
stage
determin
progress
hypoxemia
challeng
earli
diagnost
test
exist
hypothes
metobonom
provid
new
insight
pathogenesi
pulmonari
dysfunct
thu
potenti
enabl
identif
specif
biomark
lung
injuri
object
use
human
model
cardiac
surgeri
studi
progress
postop
hypoxemia
mean
blood
metabonom
method
fifti
consecut
patient
undergo
cardiac
surgeri
includ
arteri
blood
sampl
collect
day
surgeri
hour
h
postop
addit
sampl
pulmonari
arteri
left
atrium
collect
seven
differ
time
point
cpb
straight
cpb
h
h
cpb
sampl
analyz
nuclear
magnet
reson
nmr
spectroscopi
statist
method
includ
princip
compon
analysi
pca
partial
leastsquar
regress
pl
discrimin
analysi
plsda
appli
find
metabolit
pattern
relat
surgic
trauma
postop
hypoxemia
venetianblind
crossvalid
permut
test
use
valid
result
patient
normal
preoper
kpa
mean
sd
decreas
kpa
h
kpa
h
respect
twentythre
patient
develop
moder
hypoxemia
kpa
patient
sever
hypoxemia
kpa
nmr
show
major
shift
metabolom
surgeri
differ
metabolit
identifi
differ
timepoint
sever
directli
correl
progress
hypoxemia
plsda
model
predict
postop
hypoxemia
h
sensit
specif
base
blood
sampl
collect
cpb
pl
model
reveal
correl
equal
higher
predict
valu
sensit
specif
achiev
analyz
blood
collect
h
postop
demonstr
abil
metabonom
earli
diagnosi
conclus
found
metabonom
may
contribut
detect
earli
sign
pulmonari
dysfunct
twothre
day
signific
postop
hypoxemia
studi
provid
novel
insight
underli
mechan
trigger
progress
hypoxemia
facilit
new
hypothes
treatment
option
introduct
graviti
play
pivot
role
pathogenesi
ventilatorassoci
pneumonia
vap
previou
laboratori
studi
semilater
trendelenburg
posit
ltp
hinder
gravitydriven
pulmonari
aspir
avoid
vap
object
determin
whether
ltp
vs
semirecumb
posit
srp
would
reduc
incid
microbiolog
confirm
vap
apprais
patient
complianc
safeti
method
conduct
random
singleblind
control
studi
european
center
north
america
total
adult
patient
screen
patient
random
ltp
srp
analyz
intent
treat
approach
patient
ltp
place
semilater
trendelenburg
posit
achiev
orient
sternal
notch
toward
mouth
slightli
horizont
turn
one
side
everi
hour
ltp
encourag
first
day
mechan
ventil
alway
complianc
patient
wish
srp
group
head
bed
elev
primari
outcom
vap
incid
rate
base
quantit
bronchoalveolar
lavag
fluid
cultur
colonyform
unitsml
secondari
outcom
complianc
random
posit
length
intub
durat
intens
care
unit
hospit
stay
mortal
advers
event
result
trial
stop
plan
interim
analysi
achiev
efficaci
endpoint
owe
safeti
concern
patient
ltp
srp
group
kept
random
posit
studi
time
respect
p
yet
first
hour
ltp
patient
kept
random
posit
studi
time
srp
patient
p
ltp
bed
angul
trendelenburg
head
bed
elev
srp
group
incid
rate
microbiolog
confirm
vap
patientday
confid
interv
ci
ltp
group
patientday
ci
srp
p
rel
risk
reduct
ci
statist
signific
differ
observ
durat
mechan
ventil
intens
care
unit
hospit
stay
mortal
vomit
common
ltp
patient
vs
srp
p
conclus
critic
ill
patient
posit
ltp
statist
signific
reduct
incid
vap
compar
posit
srp
comprehens
evalu
potenti
ltp
contraind
warrant
enhanc
safeti
refer
li
bassi
g
et
al
crit
care
med
zanella
et
al
intens
care
med
grant
acknowledg
clinicaltrialsgov
id
studi
endors
eccrnesicm
fund
eccrn
clinic
trial
award
hillrom
introduct
ventil
associ
pneumonia
vap
common
nosocomi
infect
intens
care
unit
icu
increas
length
icu
stay
durat
mechan
ventil
mortal
object
present
studi
use
oral
care
protocol
compar
effect
two
differ
concentr
chlorhexidin
reduct
oropharyng
colon
vap
method
studi
perform
patient
trauma
surgeri
neurosurgeri
gener
icu
randomli
alloc
two
group
oral
care
chlorhexidin
solut
multidisciplinari
team
approv
oral
care
protocol
data
collect
use
demograph
inform
form
apach
iv
form
beck
oral
assess
scale
mucosalplaqu
assess
scale
oropharyng
swab
cultur
result
result
show
signific
reduct
vap
p
oropharyng
colon
p
group
oral
care
chlorhexidin
solut
compar
group
howev
signific
differ
found
two
group
term
oropharyng
advers
effect
p
conclus
oral
decontamin
compar
chlorhexidin
effect
method
prevent
vap
reduct
oropharyng
colon
especi
gramposit
grant
acknowledg
studi
support
grant
grant
vicechancellor
research
shiraz
univers
medic
scienc
introduct
previou
studi
show
presenc
preserv
ventil
interrupt
region
pulmonari
blood
flow
rapidli
lead
sever
ventilationinduc
lung
injuri
vili
data
suggest
tissu
alkalosi
might
multipl
factor
vili
especi
presenc
high
tidal
volum
vt
ventil
andor
preexist
lung
injuri
object
investig
alter
blood
gase
respiratori
mechan
ctscan
imag
anim
model
control
unilater
lobar
pulmonari
arteri
occlus
follow
lung
lavag
high
vt
ventil
method
report
data
pig
weight
kg
anim
randomli
assign
follow
studi
group
five
anim
underw
right
lower
lobar
endovascular
embol
lung
lavag
ml
normal
salin
solut
high
vt
ventil
hour
four
anim
underw
left
lower
lobar
embol
lavag
high
vt
ventil
five
pig
receiv
lung
lavag
high
vt
ventil
three
anim
receiv
right
lower
lobar
embol
low
vt
ventil
three
anim
receiv
low
vt
ventil
group
select
embol
pulmonari
arteri
branch
perfus
lower
lobe
right
left
lung
perform
fluoroscopi
guidanc
expert
radiologist
group
vt
set
mlkg
plateau
pressur
peak
pressur
without
posit
endexpiratori
pressur
peep
respiratori
rate
breathsminut
control
ph
group
vt
mlkg
peep
hour
anim
underw
physiolog
data
collect
chest
ct
scan
zero
peep
ct
imag
analys
offlin
custommad
softwar
data
analys
oneway
anova
tukey
posthoc
test
result
main
paramet
describ
pathophysiolog
characterist
group
hour
report
tabl
lung
lavag
high
vt
ventil
follow
region
embol
led
sever
impair
oxygen
p
especi
left
embol
group
lung
mechan
end
experi
show
similar
trend
plateau
pressur
higher
respiratori
system
complianc
lower
p
embol
lavag
high
vt
group
final
ctscan
reveal
higher
lung
weight
group
p
interestingli
group
nonembol
lung
heavier
embol
trigger
sever
ventilationinduc
lung
oedema
could
develop
mainli
perfus
preserv
conclus
region
block
lung
perfus
might
amplifi
lung
injuri
due
lavag
high
vt
ventil
refer
slutski
n
engl
j
med
kolobow
inter
j
artif
organ
ando
j
int
med
re
grant
acknowledg
department
fund
introduct
acut
kidney
injuri
aki
multifactori
syndrom
knowledg
regard
pathophysiolog
possibl
genet
background
limit
recent
first
hypothesi
free
genet
associ
studi
publish
explor
individu
suscept
aki
object
aim
replic
previou
associ
candid
polymorph
n
develop
aki
use
prospect
collect
cohort
septic
critic
ill
patient
finland
method
includ
septic
patient
genet
sampl
among
finnaki
studi
patient
exclus
patient
due
underli
chronic
kidney
diseas
lack
dna
genotyp
qualiti
remain
sepsi
aki
defin
accord
kdigo
criteria
consid
stage
affect
kdigo
unaffect
genotyp
done
use
assay
agena
bioscienc
genotyp
snp
intron
gene
gene
gene
gene
associ
analys
perform
use
logist
regress
plink
softwar
result
found
signific
associ
snp
p
p
p
p
p
aki
compar
aki
patient
nonaki
patient
tabl
aki
patient
significantli
older
higher
bmi
often
diabet
copd
receiv
often
colloid
admiss
icu
lower
platelet
count
multivari
logist
regress
analysi
adjust
sex
baselin
differ
chang
find
conclus
could
confirm
previous
report
associ
five
snp
develop
aki
kdigo
critic
ill
septic
patient
refer
frank
aj
sheu
cc
zhao
et
al
genet
variant
associ
acut
kidney
injuri
septic
shock
crit
care
med
grant
acknowledg
studi
support
grant
tyh
helsinki
univers
hospit
research
fund
vp
grant
sigrid
juseliu
foundat
vp
introduct
acut
kidney
injuri
aki
sever
complic
critic
ill
often
accompani
vasoconstrict
renal
arteri
microcircul
diagnosi
mainli
base
rise
serum
creatinin
late
phenomenon
renal
resist
index
rri
measur
doppler
ultrasound
repres
new
noninvas
diagnost
tool
assess
flow
resist
renal
circul
earli
admiss
object
determin
whether
rri
measur
intens
care
unit
icu
admiss
earli
predictor
discrimin
aki
develop
sever
develop
within
first
week
icu
admiss
rri
predict
aki
independ
aki
risk
factor
method
prospect
observ
cohort
studi
icu
patient
aki
develop
stage
defin
kdigo
criteria
increas
likelihood
includ
patient
develop
aki
two
cohort
patient
includ
within
h
icu
admiss
patient
shock
without
shock
patient
egfr
mlmin
exclud
besid
routin
icu
measur
includ
risk
factor
develop
aki
three
studi
measur
perform
inclus
rri
sublingu
sidestream
dark
field
imag
sdf
visualis
microcircul
bioelectr
imped
analysi
bia
marker
fluid
statu
uni
multivari
roc
curv
analys
perform
assess
predict
discrimin
valu
rri
variabl
develop
aki
result
includ
patient
mean
age
mean
apach
iii
score
patient
develop
aki
within
first
week
mean
day
inclus
patient
develop
aki
significantli
higher
rri
inclus
vs
p
compar
patient
without
aki
rri
significantli
higher
patient
aki
stage
patient
aki
stage
fig
therefor
chose
aki
stage
endpoint
analysi
univari
analysi
rri
signific
predictor
aki
ci
along
paramet
includ
apach
iii
fluid
balanc
bia
deriv
reactanc
sublingu
microcircul
multivari
analysi
rri
apach
iii
fluid
balanc
remain
signific
auc
rri
aki
stage
ci
composit
auc
multivari
predictor
fig
conclus
observ
studi
rri
icu
admiss
signific
independ
earli
predictor
develop
aki
stage
first
week
aki
stage
evalu
predictor
apach
iii
marker
sever
diseas
fluid
balanc
addit
independ
predictor
aki
suggest
factor
vasoconstrict
contribut
aki
develop
refer
darmon
et
al
intens
care
med
grant
acknowledg
grant
receiv
introduct
postsepsi
syndrom
describ
group
longterm
problem
peopl
sepsi
experi
acut
kidney
injuri
aki
associ
increas
shortterm
mortal
septic
patient
howev
exact
influenc
aki
longterm
mortal
yet
determin
herein
sought
evalu
impact
sepsi
kidney
structur
survivor
method
adult
wistar
rat
g
submit
sepsi
iv
ml
e
coli
cfu
ml
respect
hour
gener
anesthesia
microcircul
renal
cortex
area
monitor
sidestream
dark
field
imag
sdf
videomicroscopi
hour
n
day
n
sepsi
kidney
sampl
evalu
histolog
use
pa
dye
result
sdf
find
fig
show
broadli
distribut
microcircul
dysfunct
outlin
tubul
becam
blur
enlarg
lead
compress
tubular
lumen
peritubular
microvessel
suggest
ongo
obstruct
phenomenon
progress
manner
tubular
wall
edema
heterogen
dysfunct
pattern
dissemin
entir
screen
show
similar
find
howev
intens
histolog
fig
confirm
ongo
obstruct
phenomena
also
show
gener
peritubular
microvessel
congest
multipl
glomerulu
without
mesangi
area
inflammatori
infiltr
connect
tissu
hyalin
degener
suggest
ongo
cellular
dysfunctiondeath
histolog
result
show
similar
pattern
enlarg
epitheli
cell
convolut
tubul
reduc
lumen
compress
dilat
peritubular
microvessel
addit
numer
tubular
epitheli
cell
show
membran
injuri
nuclear
pycnosi
necrosi
although
gener
find
better
compar
earli
phase
sepsi
histolog
find
demonstr
persist
signific
peritubular
glomerular
congest
intens
inflammatori
infiltr
connect
tissu
nucleu
contract
suggest
cell
death
collect
duct
injuri
pa
stain
demonstr
widespread
hyalin
degener
sever
sepsi
group
show
widespread
congest
around
collect
tubul
peritubular
congest
small
larg
vessel
also
observ
glomerulu
without
mesangi
area
intens
congest
hyalin
degener
collect
tubul
cortex
tubul
region
gener
find
ischem
renal
injuri
pattern
find
show
renal
dysfunct
persist
day
sepsi
presenc
patholog
stimuli
may
decay
renal
physiolog
capac
quickli
justifi
fragil
renal
physiolog
patient
surviv
sepsi
grant
acknowledg
fapesp
introduct
remot
ischem
precondit
ripc
demonstr
benefici
effect
acut
kidney
injuri
aki
andor
cardiac
function
coronari
angiographi
ca
high
risk
patient
howev
protect
effect
ripc
may
attenu
diabet
patient
object
purpos
studi
evalu
effect
ripc
myocardi
renal
function
measur
plasma
troponin
probnp
creatinin
cystatin
c
level
earli
marker
glomerular
function
ca
diabet
patient
method
prospect
random
singl
centr
pilot
trial
conduct
univers
hospit
sta
lucia
spain
analyz
diabet
adult
patient
acut
coronari
syndrom
admit
medic
intens
care
unit
diagnosi
diabet
admiss
undergo
standard
ca
establish
two
group
standard
ca
remot
rpic
ripc
group
trough
intermitt
upperarm
ischemia
ca
without
ripc
control
group
record
demograph
clinic
analyt
data
patient
hour
procedur
analyz
qualit
variabl
percentag
categori
squar
chi
quantit
variabl
mean
standard
deviat
student
median
interquartil
rank
u
mann
whitney
regress
depend
statist
distribut
result
patient
receiv
ripc
show
lower
troponin
peak
ngml
compar
control
group
p
ntprobnp
pgml
increas
hour
compar
control
group
p
regard
renal
function
basal
hour
creatinin
cystatinec
plasma
level
similar
group
creatinin
mgdl
increment
hour
ripc
control
p
cystacin
c
mgl
ripc
control
p
calcul
mean
mehran
score
group
present
studi
ripc
group
control
group
thu
determin
present
studi
popul
group
medium
risk
develop
aki
advers
effect
relat
ripc
maneuv
patient
conclus
ripc
maneuv
diabet
patient
ca
demonstr
benefici
cardiac
function
without
affect
renal
paramet
mechan
underli
effect
merit
investig
refer
jensen
rv
et
al
impact
oglcnac
cardioprotect
remot
ischaem
precondit
nondiabet
diabet
patient
cardiovasc
re
p
sivaraman
v
et
al
precondit
diabet
human
myocardium
j
cell
mol
med
p
tsang
et
al
precondit
diabet
heart
import
akt
phosphoryl
diabet
p
introduct
quantit
measur
microcirculatori
tissu
oxygen
concentr
prime
import
experiment
research
noninvas
time
resolv
quench
palladiumporphyrin
phosphoresc
inject
experiment
anim
given
much
fundament
insight
mechan
oxygen
transport
tissu
health
model
diseas
phosphorimet
use
flash
lamp
light
excit
sourc
howev
major
drawback
flash
lamp
plasma
glow
persist
ten
microsecond
primari
discharg
flash
lamp
produc
puls
tail
remain
caus
unwant
excit
initi
puls
phosphor
time
depend
manner
gener
complex
excit
puls
pattern
taken
account
use
deconvolut
analysi
lead
inaccur
read
object
design
calibr
new
ledbas
phosphorimet
ledp
address
previou
drawback
flashlamp
phosphorimet
flp
valid
ledp
vitro
vivo
experiment
studi
method
design
ledp
use
led
differ
colour
blue
green
yellow
red
narrowband
wavelength
nm
provid
excit
light
puls
within
rang
sever
phosphoresc
dye
often
use
experiment
studi
calibr
vitro
devic
use
palladiumporphyrin
phosphoresc
dye
differ
temperatur
adjust
ph
enzymat
reaction
produc
step
step
decreas
oxygen
content
analys
decay
time
phosphoresc
oxygen
content
measur
solidst
polym
optic
fiber
sensor
oxygen
optod
pof
oxymini
world
precis
instrument
usa
vivo
calibr
perform
rat
model
expos
kidney
ventil
anim
differ
hypox
condit
perform
renal
ischemiareperfus
injuri
clamp
renal
arteri
result
ledp
exhibit
block
shape
light
puls
without
afterglow
elimin
need
deconvolut
light
emiss
signal
come
tissu
analysi
perfect
linear
regress
observ
plot
decay
time
ratio
vitro
oxygen
concentr
vivo
ledp
show
similar
kidney
microvascular
compar
previous
publish
work
hypoxia
ischemia
condit
conclus
new
ledp
provid
minimallyinvas
accur
reliabl
measur
microvascular
kidney
without
need
complex
mathemat
deconvolut
light
emiss
signal
come
tissu
led
much
cheaper
smaller
size
simpler
electron
energi
effici
longer
lifetim
ledp
provid
abil
choos
led
enabledis
excit
differ
phosphoresc
dye
within
measur
correspond
z
uz
academ
medic
centr
amsterdam
translat
physiolog
amsterdam
netherland
introduct
system
inflammatori
respons
complic
occur
frequent
cardiac
surgeri
patient
extracorpor
circul
ec
leucocytosi
common
outcom
cardiac
surgeri
due
surgic
trauma
blood
contact
nonendotheli
surfac
ec
endotoxaemia
ischemia
reperfus
injuri
due
aortic
cross
clamp
releas
induc
activ
complement
factor
coagul
pathway
cellular
immun
respons
leucocyt
lc
adhes
endotheli
follow
diapedesi
key
compon
inflammatori
respons
context
cardiac
surgeri
therefor
lc
adhes
expect
especi
follow
releas
cross
clamp
current
direct
method
identifi
behavor
lc
microcircul
studi
describ
use
cytocam
idf
imag
handheld
video
microscop
tool
identifi
quantifi
behavior
lc
sublingu
microcircul
patient
surgeri
object
introduct
applic
algorithm
method
count
noninvas
lc
microcircul
method
prospect
observ
studi
video
sublingu
microcircul
coronari
arteri
bypass
surgeri
ec
record
use
cytocam
braediu
medic
amsterdam
netherland
two
time
point
measur
baselin
induct
anesthesia
cpb
second
time
point
releas
cross
patient
recruit
includ
studi
base
evalu
sublingu
video
imag
use
qualiti
criteria
order
identifi
least
one
post
capillari
venul
pcv
focu
red
blood
cell
primarili
import
patient
group
receiv
blood
transfus
clip
time
point
durat
sec
framessec
differ
spot
captur
identifi
pcv
count
activ
lc
stick
roll
lc
wall
pcv
convert
clip
movi
lower
frame
rate
order
match
veloc
leukocyt
frame
speed
allow
movement
rbc
look
unclear
select
pcv
good
qualiti
clip
least
one
pcv
result
rollingstick
lc
sec
sec
increas
significantli
p
system
leukocyt
surgeri
also
increas
significantli
p
conclus
studi
introduc
bedsid
methodolog
use
cytocam
idf
imag
quantifi
lc
activ
sublingu
microcircul
applic
methodolog
cardiac
surgeri
identifi
increas
microcirculatori
activ
lc
parallel
increas
lc
number
system
circul
refer
akara
et
alcurr
opinion
anaesthesiolog
februari
volum
issu
p
introduct
previous
demonstr
incid
infect
follow
major
abdomin
surgeri
associ
extent
postop
immun
remain
unclear
clinic
avail
immun
stimul
may
best
suit
adjunct
prevent
postop
infect
object
determin
whether
granulocyt
macrophag
colonystimul
factor
gmcsf
interferon
gamma
act
differ
pathway
revers
defect
monocyt
antigen
present
follow
major
abdomin
surgeri
method
serum
collect
patient
undergo
elect
abdomin
surgeri
research
ethic
approv
median
patient
age
year
iqr
median
oper
time
iqr
develop
nosocomi
infect
pool
healthi
peripher
blood
mononuclear
cell
pmbc
incub
media
contain
serum
taken
either
preoper
hr
post
oper
addit
gmcsf
ngml
infg
iuml
monocyt
human
leucocyt
antigendr
mhladr
membran
densiti
geometr
mean
fluoresc
intens
characteris
use
flow
cytometri
follow
incub
cell
sort
bd
fac
aria
iiiu
system
use
posit
select
messeng
rna
mrna
extract
sort
popul
puriti
post
sort
gene
interest
quantifi
use
polymeras
chain
reaction
pcr
use
label
primer
real
time
pcr
abi
flow
cytometri
data
analys
use
flowjo
continu
variabl
analys
use
wilcoxin
signedrank
test
jmp
version
statist
softwar
result
pmbc
incub
postop
serum
demonstr
signific
reduct
mhladr
membran
densiti
fig
p
reduct
mhladr
densiti
prevent
coincub
gmcsf
fig
incub
gmcsf
increas
express
chain
p
cathepsin
ctss
p
suppressor
cytokin
signal
p
march
p
fig
conclus
result
suggest
immun
stimul
gmcsf
exert
effect
monocyt
antigen
present
differ
signal
pathway
increas
gene
express
associ
may
indic
potenti
therapeut
benefit
revers
postop
immun
suppress
refer
torranc
et
al
curr
opin
anaesthesiol
mar
epub
ahead
print
fragkou
et
al
eja
volum
esupplement
pg
june
grant
acknowledg
niaa
bjaroy
colleg
anaesthetist
european
societi
anaesthesiologist
introduct
delirium
critic
ill
patient
associ
increas
mortal
longterm
cognit
declin
recent
pain
agit
delirium
pad
guidelin
includ
recommend
delirium
screen
prevent
manag
may
help
improv
clinic
outcom
reduc
delirium
burden
object
aim
measur
effect
multifacet
implement
program
improv
adher
pad
guidelin
associ
chang
delirium
incid
durat
length
icu
stay
hospit
mortal
method
prospect
multicent
beforeaft
studi
conduct
six
icu
netherland
march
april
intervent
consist
twophas
multifacet
tailor
implement
pad
guidelin
multipl
implement
strategi
appli
chang
clinic
practic
tabl
data
adult
icu
patient
collect
three
fourmonth
period
implement
implement
delirium
screen
andaft
implement
pad
guidelin
differ
adher
clinic
outcom
three
period
assess
random
effect
poisson
logist
regress
random
intercept
patient
outcom
patientday
level
logist
linear
regress
outcom
patient
level
adjust
apach
ii
hospit
age
admiss
type
differ
express
adjust
rate
ratio
arr
odd
ratio
aor
beta
period
refer
result
total
patient
enrol
studi
total
icu
day
adher
pad
guidelin
recommend
improv
significantli
wherea
earli
mobil
reduc
benzodiazepin
sedat
improv
last
period
tabl
incid
delirium
increas
implement
aor
p
wherea
delirium
durat
decreas
day
implement
abeta
p
statist
signific
differ
icu
length
stay
abeta
p
icu
mortal
aor
p
hospit
mortal
aor
p
vs
implement
length
mechan
ventil
increas
half
day
abeta
p
conclus
multifacet
implement
program
effect
improv
adher
multipl
key
pad
guidelin
recommend
delirium
durat
decreas
significantli
spite
increas
incid
probabl
due
improv
screen
observ
differenti
effect
screen
vs
guidelin
implement
howev
improv
adher
guidelin
recommend
translat
measur
improv
shortterm
clinic
outcom
improv
clinic
outcom
futur
investig
pad
guidelin
implement
consid
focus
specif
recommend
target
longterm
outcom
introduct
propofol
infus
syndrom
rare
seriou
advers
effect
commonli
use
drug
high
mortal
rate
symptom
occur
variou
combin
includ
unexplain
metabol
acidosi
arrhythmia
brugada
like
pattern
electrocardiograph
elev
stsegment
covedt
wave
cardiac
andor
renal
failur
rhabdomyolysi
hyperkalaemia
hepatomegali
hyperlipidaemia
mechan
syndrom
still
unknown
experiment
studi
perform
anim
model
clinic
featur
syndrom
suggest
mitochondri
origin
object
hypothes
propofol
decreas
respiratori
chain
capac
inhibit
fatti
acid
oxid
induc
inner
mitochondri
membran
uncoupl
dosedepend
manner
studi
aim
test
hypothesi
vitro
expos
human
skelet
musclederiv
cell
rang
propofol
concentr
day
method
skelet
muscl
cell
isol
biopsi
obtain
patient
n
undergo
hip
replac
surgeri
subsequ
expos
rang
propofol
resembl
clinic
concentr
human
plasma
propofol
infus
lipid
vehicl
il
hour
exposur
mitochondri
metabol
assess
extracellular
flux
analysi
seahors
bioscienc
oxygen
consumpt
rate
ocr
measur
baselin
addit
atpas
inhibitor
mitochondri
uncoupl
complex
iii
inhibitor
inject
agent
enabl
calcul
baselin
ocr
atp
turnov
rate
proton
leak
inner
mitochondri
membran
respiratori
chain
capac
uncoupl
respir
capac
fatti
acid
oxid
measur
etomoxirinhibit
ocr
ad
uncoupl
palmit
valu
present
tabl
express
baselin
ocr
result
human
skelet
muscl
cell
expos
propofol
respiratori
chain
capac
decreas
uncoupl
inner
mitochondri
membran
increas
signific
result
propofolinduc
inhibit
fatti
acid
oxid
respect
baselin
valu
see
tabl
data
present
median
interquartil
rang
statist
signific
result
sign
pvalu
pvalu
conclus
propofol
clinic
relev
concentr
potent
inhibitor
fatti
acid
oxid
induc
chang
function
respiratori
chain
vitro
model
human
skelet
muscl
refer
waldauf
p
f
propofol
infus
syndrom
structur
review
experiment
studi
publish
case
report
crit
care
nov
grant
acknowledg
work
support
grant
gauk
prvouk
introduct
anaemia
affect
patient
admit
critic
care
icu
allogen
red
blood
cell
rbc
transfus
remain
mainstay
treatment
anaemia
associ
costli
patient
may
true
iron
defici
could
benefit
iron
replac
reduc
need
transfus
howev
diagnos
iron
defici
icu
patient
difficult
due
unreli
serum
ferritin
context
coexist
inflamm
object
assess
efficaci
safeti
iron
supplement
rout
anaem
patient
adult
icu
method
search
multipl
databas
central
medlin
embas
rct
compar
iron
rout
placebono
iron
two
investig
independ
assess
elig
extract
data
primari
outcom
rbc
transfus
requir
mean
number
transfus
rbc
mean
haemoglobin
hb
concentr
secondari
outcom
includ
mortal
infect
length
hospit
stay
healthrel
qualiti
life
qol
mean
differ
iron
biomark
eg
ferritin
advers
event
outcom
assess
two
time
point
shortterm
day
ii
midterm
last
measur
time
point
hospit
end
trial
risk
studi
bia
assess
use
cochran
methodolog
metaanalys
perform
revman
use
random
effect
model
continu
variabl
report
mean
differ
md
confid
interv
ci
dichotom
variabl
report
rel
risk
rr
ci
result
five
trial
consist
patient
includ
four
trial
set
surgic
icu
one
mix
icu
one
trial
rate
low
risk
bia
domain
variat
dosag
regim
administr
intraven
iron
daili
oral
iron
day
post
discharg
result
shown
tabl
trial
report
qol
conclus
iron
supplement
reduc
rbc
transfus
requir
adult
icu
patient
larger
welldesign
trial
need
investig
benefit
risk
iron
optim
dose
regim
strategi
identifi
patient
like
benefit
togeth
patientfocus
outcom
qol
discharg
refer
marik
pe
corwin
hl
crit
care
med
pieracci
fm
henderson
p
rodney
jr
et
al
surgic
infect
larchmt
pieracci
fm
stoval
rt
jaouen
b
et
al
crit
care
med
garridomartin
p
nassarmansur
mi
llanaducro
r
et
al
interact
cardiovasc
thorac
surg
van
iperen
ce
gaillard
cajm
kraaijenhagen
rj
et
al
crit
care
med
madijebara
sleilati
gs
achouch
pe
et
al
j
cardiothorac
vasc
anesth
grant
acknowledg
research
support
nh
blood
transplant
introduct
intens
care
lifesav
associ
develop
physic
mental
cognit
problem
survivor
intens
care
aftercar
emerg
help
patient
recoveri
return
normal
life
guidelin
focu
promot
recoveri
improv
qualiti
life
insight
need
mechan
intens
care
recoveri
object
describ
patient
experi
recoveri
longitudin
perspect
analyz
followup
consult
three
timepoint
method
studi
descript
multicent
longitudin
qualit
design
select
strateg
subsampl
consult
patient
random
control
trial
intens
care
recoveri
ten
danish
intens
care
unit
icu
data
prospect
collect
intervent
audiorecord
three
followup
consult
month
patient
photograph
icustay
reflect
sheet
first
consult
focus
patient
narr
icu
support
photograph
aid
memori
second
third
consult
focus
patientcentr
dialog
import
guid
patient
reflect
sheet
themat
analysi
narr
theori
use
explor
mechan
recoveri
intens
care
result
basic
narr
recoveri
toward
trajectori
new
orient
narr
month
describ
mortal
ill
icu
death
door
narr
month
describ
ongo
fear
relaps
still
wood
narr
month
three
potenti
outcom
downhil
detour
road
steadyst
end
road
progress
road
recoveri
new
orient
obtain
steadyst
progress
recoveri
fig
conclus
studi
provid
contemporari
understand
process
intens
care
recoveri
recoveri
evolv
narr
mortal
danger
fear
relaps
differ
type
progress
toward
new
orient
life
nursel
followup
consult
help
patient
obtain
sens
coher
first
year
critic
ill
find
enabl
healthcar
profession
understand
patient
experi
stage
recoveri
offer
dialogu
support
construct
coher
ill
narr
icu
staff
close
rel
share
understand
import
improv
nurs
healthcar
profession
assess
longterm
outcom
manag
patient
intens
care
refer
braun
v
cv
use
themat
analysi
psycholog
qualit
research
psycholog
universiy
west
england
london
http
access
feb
grant
acknowledg
danish
nurs
organ
novo
nordisk
foundat
hospit
univers
copenhagen
dk
introduct
skin
breakdown
caus
adhes
dress
risk
factor
central
lineassoci
bloodstream
infect
clabsi
protect
skin
product
develop
uncertain
whether
use
product
associ
higher
rate
dress
disrupt
also
risk
factor
clabsi
hand
transpar
dress
chlorhexidin
glucon
chg
contain
gel
pad
insert
site
prevent
clabsi
object
compar
transpar
cathet
dress
either
without
applic
protect
skin
ointment
skin
integr
dress
disrupt
dwell
time
addit
assess
rate
cathet
colon
clabsi
transpar
dress
either
without
chgpad
method
conduct
monocentr
openlabel
random
control
trial
compar
transpar
chgdress
use
skin
ointment
creat
polym
protect
film
intervent
group
standard
transpar
dress
without
skin
product
control
group
standard
cathet
care
includ
chg
ethanol
skin
prepar
cvc
insert
maxim
steril
barrier
dress
chang
day
case
full
dress
disrupt
reveal
insert
site
moistur
present
dress
result
sixti
patient
central
venou
cathet
cvc
enrol
account
cvc
total
cvc
day
studi
group
differ
sex
age
insert
site
number
cvc
lumen
comorbid
sever
condit
length
hospit
stay
enrol
concomit
therapi
dress
dwell
time
higher
intervent
group
sd
vs
sd
day
p
tabl
describ
reason
dress
chang
skin
integr
dress
remov
cvc
dwell
time
differ
group
sd
day
intervent
group
sd
day
control
group
p
rate
cvc
colon
differ
cvc
day
intervent
group
vs
cvc
day
control
arm
rel
risk
confid
interv
clabsi
rate
vs
cvc
day
rel
risk
confid
interv
conclus
use
skin
ointment
creat
polym
protect
film
beneath
transpar
dress
result
longer
dress
dwell
time
less
skin
breakdown
applic
skin
product
alter
risk
infect
least
use
combin
chgimpregn
dress
refer
timsit
jf
bouadma
l
ruckli
et
al
dress
disrupt
major
risk
factor
catheterrel
infect
crit
care
med
introduct
icu
program
emerg
promot
psycholog
recoveri
stay
intens
care
unit
icu
scandinavian
countri
patient
discharg
rehabilit
plan
usual
includ
physic
train
seldom
psycholog
rehabilit
address
gap
develop
posticu
recoveri
program
improv
psycholog
health
intens
care
hypothes
nursel
recoveri
program
help
construct
coher
ill
narr
includ
personcent
commun
would
improv
healthrel
qualiti
life
hrqol
sens
coher
soc
reduc
symptom
anxieti
depress
posttraumat
stress
ptsd
first
year
icu
discharg
object
investig
effect
posticu
recoveri
program
compar
standard
care
improv
qualiti
life
first
year
icu
method
randomli
assign
patient
adult
year
survivor
receiv
mechan
ventil
hour
standard
care
sc
plu
recoveri
program
sc
alon
discharg
intens
care
nursel
intervent
consist
patient
photograph
three
followup
consult
reflect
sheet
result
primari
outcom
hrqol
secondari
outcom
soc
anxieti
depress
ptsd
assess
month
intens
care
discharg
use
ttest
supplement
outcom
rehabilit
servic
within
first
year
month
intens
care
hrqol
score
unchang
intervent
mean
differ
mental
compon
summari
score
ci
p
physic
compon
summari
score
ci
p
differ
found
total
score
selfreport
soc
anxieti
depress
ptsd
intervent
show
potenti
effect
rate
anxieti
cutoff
score
appli
complet
analysi
month
howev
patient
receiv
high
level
rehabilit
servic
sc
within
first
year
intens
care
conclus
overal
benefici
detriment
effect
found
either
primari
secondari
outcom
symptom
gener
lower
found
similar
studi
patient
maintain
good
mental
health
strong
sens
coher
ptsd
score
consist
high
high
qualiti
standard
care
danish
icu
might
help
explain
lack
improv
studi
refer
jensen
jf
et
al
impact
followup
consult
icu
survivor
posticu
syndrom
systemat
review
metaanalysi
intens
care
med
egerod
et
al
construct
ill
narr
ground
theori
explor
use
intens
care
diari
crit
care
med
grant
acknowledg
danish
nurs
organ
novo
nordisk
foundat
hospit
univers
copenhagen
dk
introduct
enabl
clinician
prospect
identifi
patient
later
becom
unstabl
would
enabl
target
resourc
patient
need
well
potenti
applic
prevent
care
object
determin
increment
contribut
inform
progress
avail
within
first
hour
sdu
admiss
improv
model
forecast
later
develop
cardiorespiratori
instabl
cri
includ
novel
cri
rel
risk
score
method
continu
noninvas
vital
sign
vs
monitor
data
heart
rate
hr
respiratori
rate
rr
bioimped
oscillometr
blood
pressur
bp
peripher
oximetri
collect
stepdown
unit
sdu
patient
cri
episod
defin
vs
deviat
beyond
stabil
threshold
patient
cri
case
n
never
display
cri
control
n
identifi
comput
minutebyminut
integr
cri
risk
score
base
method
describ
use
featur
comput
vs
data
stream
trail
minut
roll
window
train
random
forest
machin
learn
model
comput
patient
mean
risk
score
aggreg
risk
score
first
hour
sdu
stay
next
built
logist
regress
model
forecast
whether
cri
event
futur
mimic
tempor
avail
data
follow
patient
admiss
first
enter
demograph
avail
patient
admiss
age
gender
charlson
comorbid
index
score
model
initi
vs
averag
continu
vs
data
accru
minut
admiss
final
rel
risk
score
deriv
first
hour
assess
predict
contribut
inform
progress
accru
categori
demograph
initi
vs
risk
score
area
receiv
oper
curv
auc
cross
valid
experi
setup
result
risk
score
deriv
admiss
demograph
alon
yield
auc
forecast
futur
cri
ad
initi
vs
improv
auc
ad
risk
score
auc
becam
conclus
predict
model
incorpor
patient
data
becom
avail
includ
risk
score
deriv
within
first
hour
progress
improv
model
abil
forecast
futur
cri
develop
forecast
inform
could
enabl
clinician
identifi
patient
becom
unstabl
futur
soon
admiss
order
triag
patient
need
closer
surveil
potenti
appli
preemptiv
intervent
refer
chen
l
et
al
model
risk
cardiorespiratori
instabl
heterogen
process
amia
annu
symp
proc
nov
grant
acknowledg
nih
ninr
introduct
physic
activ
rehabilit
form
pivot
aspect
recoveri
critic
ill
studi
demonstr
safe
feasibl
potenti
efficaci
improv
patient
outcom
howev
intern
data
demonstr
low
level
mobilis
occur
icu
current
gap
exist
perceiv
need
actual
practic
implement
physic
activ
across
recoveri
continuum
object
identifi
evalu
synthesis
studi
examin
barrier
enabl
patient
critic
ill
particip
physic
activ
perspect
healthcar
provid
patient
caregiv
method
systemat
review
articl
use
electron
databas
medlin
cinahl
embas
scopu
cochran
quantit
qualit
studi
assess
barrier
enabl
physic
activ
patient
critic
ill
includ
regist
prospero
number
result
studi
includ
studi
includ
primarili
icu
survivor
n
studi
healthcar
provid
n
studi
one
studi
specif
examin
caregiv
patient
barrier
enabl
physic
activ
identifi
major
theme
subthem
patientlevel
barrier
includ
physic
capabl
physiolog
stabil
ill
sever
sedat
weak
delirium
psycholog
influenc
fearmotiv
perceiv
relev
healthcar
provid
barrier
includ
lack
timeknowledg
expertis
commun
concern
line
safeti
environment
barrier
includ
lack
resourc
staf
equip
lower
prioritis
lack
establish
rehabilit
pathway
post
icu
enabl
includ
presenc
mobil
teamsprotocol
design
disciplin
overal
leader
teamwork
develop
daili
care
plan
conclus
systemat
review
identifi
volum
literatur
demonstr
barrier
enabl
physic
activ
multidimension
span
divers
factor
factor
need
consid
develop
rehabilit
intervent
facilit
cultur
chang
rehabilit
practic
across
recoveri
continuum
refer
kayambu
g
r
boot
j
paratz
physic
therapi
critic
ill
icu
systemat
review
metaanalysi
critic
care
medicin
p
morri
pe
et
al
earli
intens
care
unit
mobil
therapi
treatment
acut
respiratori
failur
structur
abstract
critic
care
medicin
berney
et
al
intens
care
unit
mobil
practic
australia
new
zealand
point
preval
studi
critic
care
resuscit
p
nydahl
p
et
al
earli
mobilis
mechan
ventil
patient
one
day
point
preval
studi
germani
critic
care
medicin
p
introduct
literatur
depict
differ
percept
endoflif
eol
decisionmak
dm
nurs
physician
object
examin
percept
nurs
physician
regard
eol
dm
icu
test
hypothesi
wors
eol
dm
climat
greater
discord
nurs
physician
rate
eol
dm
method
percept
eoldm
among
health
care
provid
adult
icu
european
countri
us
measur
aprilmay
use
valid
selfassess
questionnair
questionnair
exist
question
base
appropricu
questionnair
ipeq
instrument
ldbq
questionnair
result
total
nurs
physician
particip
respons
rate
respect
use
factor
analys
cluster
analysi
seven
meaning
factor
physician
leadership
interdisciplinari
reflect
avoid
eol
decis
mutual
respect
within
interdisciplinari
team
involv
nurs
eol
activ
dm
physician
ethic
awar
yield
climat
good
averag
averag
without
involv
nurs
eol
fourth
poor
eoldm
climat
look
overal
percept
seven
factor
signific
differ
p
nurs
physician
physician
consist
perceiv
eoldm
climat
posit
nurs
largest
differ
found
regard
physician
leadership
median
factor
score
nurs
physician
respect
interdisciplinari
reflect
median
avoid
eol
decis
median
look
differ
within
type
eoldm
gener
pattern
found
differ
statist
signific
p
differ
largest
two
lowest
type
eoldm
averag
without
nurs
poor
eoldm
climat
head
nurs
gener
posit
percept
eoldm
climat
compar
nurs
senior
physician
posit
percept
junior
physician
compar
nurs
without
includ
head
nurs
junior
physician
physician
still
significantli
higher
percept
eoldm
except
mutual
respect
within
interdisciplinari
team
p
physician
posit
percept
eoldm
compar
nurs
found
within
particip
countri
within
individu
icu
conclus
poorer
eol
dm
climat
physician
like
overestim
eol
dm
climat
compar
nurs
refer
pier
r
et
al
inappropri
care
european
icu
confront
view
nurs
junior
senior
physician
chest
van
den
bulck
b
et
al
perceiv
qualiti
interprofession
icu
teamwork
singl
centr
intervent
studi
j
interprofession
care
press
introduct
literatur
depict
larg
differ
endoflif
eol
decis
make
dm
countri
icu
object
better
conceptu
eoldm
develop
valid
tool
assess
eoldm
climat
method
percept
eoldm
among
health
care
provid
hcp
adult
icu
european
countri
us
measur
use
selfassess
questionnair
aprilmay
eoldm
climat
questionnair
exist
item
base
appropricu
questionnair
item
concern
eol
care
practic
extend
valid
item
concern
key
condit
provid
good
eol
care
interdisciplinari
collabor
commun
interprofession
practic
educ
qualiti
scale
ipeq
item
leadership
skill
item
exploratori
confirmatori
factor
analysi
follow
cluster
analysi
use
determin
eoldm
climat
result
nurs
doctor
provid
icu
bedsid
care
particip
respect
seven
meaning
factor
identifi
physician
leadership
interdisciplinari
reflect
avoid
eol
decis
mutual
respect
involv
nurs
eol
activ
dm
physician
ethic
awar
yield
eoldm
climat
good
icu
averag
without
involv
nurs
eol
poor
factor
analysi
p
accord
hcp
work
good
climat
leadership
activ
facilit
interdisciplinari
reflect
decisionmak
overal
within
averag
climat
hcp
perceiv
leader
empow
nurs
share
interdisciplinari
decisionmak
eol
mainli
stimul
open
ethic
awar
overal
less
hesit
take
time
eol
decis
could
main
goal
leader
climat
hcp
work
averag
climat
perceiv
leader
hesit
take
import
decis
eol
howev
insuffici
empow
involv
nurs
dm
process
hcp
work
poor
climat
perceiv
need
improv
previou
factor
climat
character
poor
commun
distrust
low
respect
conclus
identifi
seven
key
dimens
meaning
type
icu
eoldm
climat
could
discern
climat
differ
mainli
key
dimens
way
nurs
involv
eol
physician
activ
dm
research
offer
opportun
develop
tailor
icu
team
intervent
refer
pier
r
et
al
inappropri
care
european
icu
confront
view
nurs
junior
senior
physician
van
den
bulck
b
et
al
perceiv
qualiti
interprofession
icu
teamwork
singl
centr
intervent
studi
j
interprofession
care
press
stogdil
rm
coon
ae
ed
leader
behavior
descript
questionnair
oxford
england
ohio
state
univers
introduct
increas
recognit
need
comprehens
expertis
manag
eolc
icu
howev
appear
mani
controversi
profession
regard
optim
provis
object
compon
local
ongo
qualiti
improv
process
area
perform
survey
nurs
percept
aid
obstacl
optim
provis
eolc
method
modifi
previous
valid
survey
anglicis
languag
nurs
ask
rate
size
frequenc
possibl
obstacl
possibl
aid
provid
eolc
use
point
likert
scale
survey
distribut
nurs
staff
one
adult
gener
critic
care
unit
march
confidenti
assur
obstacl
aid
median
interquartil
rang
determin
size
frequenc
determin
effect
size
obstacl
aid
median
size
multipli
median
frequenc
theme
result
sixti
survey
return
repres
return
rate
conclus
studi
highlight
need
proactiv
identifi
famili
liaison
cascad
inform
friend
rel
allow
nurs
concentr
care
deliveri
despit
poor
unit
design
lack
privaci
nurs
feel
provid
dignifi
death
feel
multidisciplinari
agreement
import
part
process
refer
kirchoff
beckstrand
critic
care
percept
obstacl
help
behaviour
provid
endoflif
care
die
patient
j
crit
care
mar
festic
e
wilson
gajic
diverti
gd
rabatin
jt
perspect
physician
nurs
regard
endoflif
care
intens
care
unit
j
intens
care
med
feb
doi
epub
jan
introduct
recogn
healthcar
worker
involv
end
life
eol
decis
may
influenc
cultur
geograph
religi
person
object
investig
possibl
associ
icu
personnel
aspect
person
religi
attitud
toward
eol
method
crosssect
multicent
studi
conduct
nation
level
greec
june
decemb
icu
physician
n
icu
nurs
n
particip
answer
three
questionnair
main
survey
questionnair
investig
eol
eysenck
person
questionnair
epq
spiritu
religi
attitud
questionnair
spreuk
differ
score
epqneurotic
epqpsychotic
spreuktrust
higher
guidanc
record
particip
result
high
particip
rate
record
eightyfour
particip
prefer
character
eol
decis
passiv
euthanasia
refus
futil
care
icu
physician
icu
nurs
p
particip
declar
remov
artifici
ventil
repres
differ
approach
eol
decis
analog
breath
life
physician
nurs
p
particip
acknowledg
fear
litig
major
reason
inform
famili
eol
decis
doctor
nurs
p
statist
analysi
multivari
logist
regress
identifi
attitud
toward
passiv
euthanasia
could
independ
predict
high
neurotic
score
odd
ratio
ci
p
attitud
toward
withdraw
artifici
ventil
trust
higher
guidanc
odd
ratio
ci
p
fear
litig
high
psychotic
score
odd
ratio
ci
p
conclus
result
studi
indic
specif
attitud
toward
eol
decis
may
influenc
aspect
person
religi
icu
personnel
refer
sprung
ch
maia
p
bulow
hh
et
al
import
religi
affili
cultur
end
life
decis
european
intens
care
unit
intens
care
med
ferrand
e
lemair
f
regnier
b
et
al
discrep
percept
physician
nurs
staff
intens
care
unit
endoflif
decis
j
respir
crit
care
med
eysenck
hj
eysenck
sbg
manual
eysenck
person
questionnair
epq
hodder
stoyghton
educ
london
uk
buss
ostermann
matthiessen
pf
et
al
role
religion
spiritu
medic
patient
confirmatori
result
spreuk
questionnair
health
qual
life
outcom
introduct
decis
limit
withdraw
activ
treatment
patient
admit
intens
care
unit
icu
multifactori
prolong
period
organ
support
elderli
frail
patient
may
benefici
resourc
implic
intern
guidelin
suggest
goal
treatment
set
within
hour
admiss
icu
object
aim
identifi
frequenc
endoflif
decisionmak
effect
commun
decis
icu
team
method
prospect
audit
cycl
complet
involv
unplan
icu
admiss
oneweek
period
demograph
inform
apach
ii
score
clinic
frailti
score
cf
limit
treatment
lot
awar
decis
document
reaudit
use
methodolog
conduct
cf
commun
proforma
introduc
unplan
admiss
result
patient
admit
unplan
admiss
first
audit
period
patient
elderli
high
predict
mortal
signific
proport
clinic
frail
cf
mean
length
stay
lo
prolong
level
organ
support
high
result
summaris
tabl
lot
instig
patient
age
apach
ii
score
similar
patient
lot
none
frail
patient
higher
lo
receiv
organ
support
compar
nonfrail
patient
proport
patient
lot
remain
low
despit
increas
lo
commun
team
member
substandard
bedsid
nurs
resid
unawar
decis
reaudit
intervent
demonstr
increas
patient
receiv
lot
higher
proport
frail
patient
repres
patient
also
receiv
less
organ
support
lot
instig
earlier
stay
awar
regard
decis
amongst
staff
improv
feedback
regard
commun
tool
excel
conclus
end
life
care
perform
infrequ
unplan
admiss
icu
instig
knowledg
plan
substandard
introduc
cf
admiss
icu
identifi
patient
unlik
benefit
prolong
organ
support
thu
increas
lot
decis
commun
sheet
improv
team
commun
becom
standard
practic
two
london
icu
refer
le
maguet
et
al
preval
impact
frailti
mortal
elderli
icu
patient
prospect
multicent
observ
studi
intens
care
med
may
delling
rp
et
al
surviv
sepsi
campaign
guidelin
committe
includ
pediatr
subgroup
surviv
sepsi
campaign
intern
guidelin
manag
sever
sepsi
septic
shock
crit
care
med
feb
introduct
tracheostomi
use
manag
around
icu
admiss
increasingli
complex
patient
requir
truli
multidisciplinari
care
reduc
well
describ
prevent
harm
may
occur
global
tracheostomi
qualiti
improv
collabor
gtc
offer
resourc
particip
hospit
site
whilst
individu
element
gtc
programm
shown
benefit
individu
site
implement
packag
resourc
abil
gtc
databas
track
benchmark
healthcar
improv
evalu
object
primari
aim
project
implement
gtc
four
divers
nh
hospit
evalu
impact
safeti
qualiti
care
deliv
hypothesis
systemat
healthcar
improv
would
reduc
sever
harm
result
tracheostomyrel
safeti
incid
improv
surrog
marker
qualiti
patientcentr
outcom
time
first
vocalis
method
part
health
foundat
fund
qualiti
improv
project
introduc
gtc
four
nh
site
manchest
england
august
august
intervent
includ
multidisciplinari
staff
educ
cours
webinar
standardis
protocol
develop
multidisciplinari
tracheostomi
team
local
project
overseen
local
staff
patient
champion
data
collect
use
bespok
gtc
databas
monthli
trend
surrog
patient
safeti
incid
analys
monthli
incid
rate
analys
use
chi
squar
test
linear
trend
result
month
data
collect
period
tracheostomi
patient
admiss
track
across
four
site
similar
demograph
previous
report
nation
data
total
advers
event
identifi
affect
patient
analysi
report
incid
durat
project
show
signific
reduct
sever
harm
month
chi
squar
p
fig
also
signific
trend
toward
lower
harm
categori
incid
durat
project
chi
squar
test
linear
trend
r
p
monthli
analysi
dataset
percutan
tracheostomi
show
nonsignific
trend
toward
earlier
speak
valv
use
vocalis
median
slope
associ
improv
report
patient
satisfact
score
conclus
studi
demonstr
meaning
improv
safeti
qualiti
care
patient
tracheostomi
possibl
use
improv
methodolog
advoc
gtc
divers
nh
trust
refer
right
trach
ncepod
wwwncepodorg
mcgrath
ba
bja
grant
acknowledg
work
support
health
foundat
independ
chariti
commit
bring
better
health
health
care
peopl
uk
introduct
around
tracheostomi
perform
intensivist
critic
ill
patient
england
wale
annual
patient
increasingli
complex
high
qualiti
care
requir
input
wide
rang
multidisciplinari
healthcar
profession
includ
medic
nurs
speech
languag
patholog
specialist
physiotherapi
staff
nation
report
identifi
disjoint
uncoordin
care
lead
delay
progress
care
global
tracheotomi
qualiti
improv
collabor
gtc
bring
togeth
resourc
intern
exemplar
centr
multidisciplinari
tracheostomi
team
mdtt
key
intervent
introduc
gtc
mdtt
resourc
four
divers
nh
site
perform
detail
evalu
impact
object
hypothesis
systemat
healthcar
improv
rais
qualiti
safeti
tracheostomi
servic
would
lead
effici
care
measur
earlier
tracheostomi
decannul
time
reduc
hospit
length
stay
method
introduc
mdtt
four
divers
nh
site
manchest
england
part
health
foundat
fund
project
august
august
measur
outcom
use
gtc
databas
site
set
mdtt
support
resourc
gtc
via
wwwglobaltrachorg
webinar
offer
opportun
question
answer
session
around
obstacl
chang
care
deliveri
overcom
mdtt
review
tracheostomi
patient
weekli
provid
point
contact
educ
bedsid
icu
ward
staff
largest
site
uhsm
kept
detail
mdtt
record
week
four
site
record
individu
patient
metric
via
gtc
databas
length
stay
lo
data
plot
monthli
boxandwhisk
plot
data
point
retain
nonparametr
linear
regress
analysi
result
uhsm
mdtt
undertook
review
make
intervent
signific
monthbymonth
trend
toward
reduc
lo
across
site
patient
median
hospit
lo
reduc
day
month
project
ci
newli
insert
tracheostomi
nonsignific
trend
toward
reduc
tracheostomi
time
median
slope
icu
lo
reduc
significantli
durat
project
median
slope
equat
reduct
day
per
patient
conclus
introduc
mdtt
coordin
improv
qualiti
safeti
care
provid
icu
ward
tracheostomi
patient
improv
reflect
reduct
icu
hospit
lo
refer
mcgrath
ba
otolaryngologyhead
neck
surgeri
mcgrath
b
clin
otolaryngol
hettig
r
bjic
autumn
grant
acknowledg
fund
health
foundat
independ
chariti
commit
bring
better
health
health
care
peopl
uk
introduct
previou
studi
show
low
nurs
staf
level
associ
poor
outcom
increas
occurr
advers
event
howev
nation
data
scarc
regard
relationship
nurs
staf
ratio
pediatr
patient
outcom
object
investig
associ
nurs
staf
level
outcom
pediatr
patient
korean
intens
care
unit
icu
method
retrospect
cohort
studi
use
data
nation
health
insur
claim
includ
patient
year
old
admit
icu
neonat
icu
august
septemb
icu
nurs
staf
grade
nine
level
accord
total
bed
nurs
ratio
hospit
nation
health
insur
polici
lowest
highest
bedtonurs
ratio
respect
inspect
differ
overal
patient
mortal
nurs
staff
grade
discharg
also
analyz
mortal
patient
underw
mechan
ventil
care
hour
accord
nurs
staff
grade
result
studi
period
medic
surgic
pediatr
patient
admit
icu
mechan
ventil
administ
patient
median
interquartil
rang
icu
length
stay
day
overal
hospit
mortal
rate
mortal
rate
mechan
ventil
patient
half
patient
receiv
highest
grade
icu
treatment
overal
mortal
rate
increas
higher
bedtonurs
ratio
ie
lower
nurs
staf
level
howev
trend
toward
increas
mortal
observ
mechan
ventil
patient
bedtonurs
ratio
increas
mortal
mechan
ventil
patient
bedtonurs
ratio
ratio
ratio
ratio
conclus
nurs
staff
bed
ratio
may
associ
overal
mortal
pediatr
patient
discharg
howev
low
nurs
staff
level
associ
higher
mortal
pediatr
patient
requir
mechan
ventil
introduct
exposur
keratopathi
ek
clinic
syndrom
characteris
incomplet
eyelid
closur
corneal
wet
lead
corneal
damag
variabl
sever
extent
incid
critic
ill
patient
object
studi
aim
determin
rate
ek
patient
admit
critic
care
icu
identifi
risk
factor
develop
ek
use
identifi
risk
factor
experi
first
part
studi
develop
eyecar
protocol
final
studi
effect
protocol
prevent
ek
method
undertook
twophas
prospect
cohort
singlecentr
studi
novemb
august
gener
adult
icu
unit
kingdom
first
phase
studi
observ
second
phase
studi
eyecar
protocol
introduc
ethic
approv
waiv
trust
ethic
committe
inclus
criteria
patient
admit
icu
exclus
criteria
age
known
eye
diseas
patient
agit
refus
particip
patient
remain
studi
icu
discharg
withdraw
activ
therapi
eyecar
protocol
develop
incorpor
electron
patient
recordal
data
collect
singl
investig
data
apach
ii
score
daili
sofa
mechan
ventil
richmond
agitationsed
scale
level
eye
care
ophthalm
assess
examin
extern
eye
eyelid
ocular
surfac
use
portabl
slit
lamp
pre
postfluorescein
dye
instil
statist
test
twotail
student
ttest
use
continu
data
fisher
exact
test
binari
data
logist
regress
use
analys
relationship
ek
independ
variabl
rel
risk
rr
odd
ratio
calcul
confid
interv
result
studi
patient
overal
rate
ek
among
mechan
ventil
patient
rate
compar
patient
receiv
noninvas
ventilatori
support
rr
p
develop
ek
p
mechan
ventil
p
lagophthalmo
sofa
associ
ek
p
found
independ
effect
age
sedat
apach
ii
score
follow
introduct
protocol
second
phase
studi
rate
ek
reduc
case
rr
p
associ
mechan
ventil
lagophthalmo
remain
complianc
protocol
conclus
ek
common
critic
ill
patient
associ
mechan
ventil
lagophthalmo
simpl
protocol
substanti
reduc
incid
ek
easili
achiev
clinic
practic
refer
kuruvilla
peter
j
david
et
al
j
crit
care
grant
acknowledg
none
receiv
introduct
loss
muscl
mass
critic
ill
caus
mismatch
synthesi
degrad
synthesi
nearnorm
degrad
enhanc
result
neg
protein
balanc
muscl
mass
loss
per
week
report
studi
support
mechan
almost
exclus
patient
initi
two
week
critic
ill
object
investig
mechan
valid
also
longer
time
perspect
studi
critic
ill
patient
day
icu
stay
method
critic
ill
patient
mechan
ventil
n
includ
multipl
time
possibl
total
measur
muscl
protein
turnov
perform
employ
model
techniqu
constant
infus
leg
blood
flow
measur
biopsi
determin
tissu
enrich
result
net
protein
balanc
leg
mix
muscl
show
pattern
becom
less
neg
time
regress
analys
pattern
total
attribut
increas
protein
synthesi
rate
protein
breakdown
rate
although
higher
healthi
subject
complet
unalt
time
net
protein
balanc
day
nmol
g
muscl
lower
p
ttest
day
nmol
g
muscl
conclus
tempor
pattern
protein
turnov
leg
muscl
show
pattern
diminish
protein
loss
time
surviv
patient
stay
icu
pattern
relat
nutrit
mobil
pharmacolog
remain
establish
introduct
critic
ill
patient
exhibit
high
degre
vitamin
c
defici
icu
admiss
plasma
concentr
decreas
even
follow
day
high
intraven
iv
dose
vitamin
c
requir
increas
plasma
concentr
normal
supranorm
rang
optim
dosag
regim
popul
remain
unclear
prolong
vitamin
c
administr
may
associ
oxal
kidney
stone
format
effect
shortterm
highdos
supplement
urinari
oxal
excret
unknown
studi
design
object
conduct
prospect
random
control
trial
determin
pharmacokinet
four
high
dose
regim
iv
vitamin
c
critic
ill
patient
measur
oxal
excret
patient
adult
patient
admit
icu
sepsi
sir
nonneurolog
sequenti
organ
failur
assess
sofa
score
expect
length
icu
stay
hour
intervent
patient
random
either
g
g
vitamin
c
twice
daili
bolu
infus
g
g
daili
continu
infus
vitamin
c
administr
continu
hour
patient
receiv
total
dose
either
g
g
vitamin
c
measur
concentr
vitamin
c
determin
plasma
hour
urin
vitamin
c
oxal
concentr
determin
first
last
hour
vitamin
c
administr
nonmem
use
pharmacokinet
analysi
result
fourteen
patient
includ
patient
receiv
g
vitamin
c
patient
g
vitamin
c
iv
twice
daili
two
day
two
patient
receiv
gday
vitamin
c
patient
receiv
gday
continu
infus
two
day
tabl
four
patient
vitamin
c
defici
admiss
twocompart
pharmacokinet
model
best
describ
data
fig
model
paramet
shown
urinari
excret
vitamin
c
oxal
shown
tabl
conclus
normal
vitamin
c
plasma
level
attain
either
g
iv
twice
daili
g
continu
infus
bolu
infus
need
rapid
achiev
highnorm
plasma
concentr
highdos
regim
produc
supranorm
plasma
concentr
continu
infus
urinari
vitamin
c
loss
lower
higher
proport
remain
bodi
urinari
excret
oxal
acid
increas
higher
vitamin
c
dose
refer
schorah
et
al
total
vitamin
c
ascorb
acid
dehydroascorb
acid
concentr
plasma
critic
ill
patient
j
clin
nutr
long
et
al
ascorb
acid
dynam
serious
ill
injur
j
surg
re
introduct
effect
glucocorticoid
therapi
septic
shock
patient
subject
mani
studi
follow
studi
annan
et
al
shown
patient
develop
critic
ill
relat
adren
insuffici
earli
cours
sepsi
chang
adren
function
sepsi
gain
attent
recent
report
adren
function
may
decreas
cours
critic
ill
condit
often
overlook
howev
preval
adren
exhaust
critic
ill
medic
patient
associ
factor
unknown
object
object
studi
determin
preval
adren
exhaust
medic
patient
prolong
critic
ill
factor
associ
method
observ
studi
perform
medic
intens
care
unit
icu
univers
hospit
admiss
cortisol
level
measur
septic
shock
patient
initi
unrespons
fluid
resuscit
vasopressor
consequ
patient
initi
cortisol
level
follow
cortisol
test
repeat
patient
ongo
vasopressor
depend
underli
caus
result
total
septic
shock
patient
screen
icu
admiss
patient
cortisol
level
underw
cortisol
retest
ongo
vasopressor
need
icu
admiss
eleven
serum
cortisol
level
mean
age
year
apacheii
sequenti
organ
failur
assess
score
icu
admiss
respect
age
gender
apacheii
sofa
score
serum
albumin
protein
crp
procalcitonin
level
similar
group
howev
time
cortisol
retest
patient
lower
cortisol
level
significantli
longer
length
icu
stay
p
time
interv
two
cortisol
sampl
median
iqr
day
time
interv
higher
lower
cortisol
group
reach
statist
signific
glucocorticoid
therapi
begun
lower
cortisol
group
vasopressor
wean
within
hour
vasopressor
wean
longer
vari
higher
cortisol
group
conclus
adren
respons
dynam
process
cours
critic
ill
organ
adren
failur
may
develop
find
adren
exhaust
seem
complic
prolong
critic
ill
suggest
prolong
vasopressor
depend
prompt
search
adren
exhaust
even
initi
cortisol
test
result
within
normal
limit
identifi
patient
could
benefit
corticosteroid
therapi
may
lifesav
measur
refer
jorg
guzman
md
et
aladren
exhaust
septic
patient
vasopressor
depend
j
cri
care
wu
jy
hsu
sc
et
aladren
insuffici
prolong
critic
ill
crit
care
grant
acknowledg
none
introduct
earli
suffici
enter
intak
associ
reduc
icu
morbid
mortal
limit
data
suggest
use
nursedriven
feed
protocol
defin
target
may
facilit
nutrit
improv
outcom
object
investig
whether
implement
nursedriven
feed
protocol
result
increas
enter
calor
intak
critic
ill
patient
first
week
icu
method
perform
uncontrol
beforeandaft
studi
data
consecut
adult
patient
readmiss
exclud
treat
least
day
gener
icu
tartu
univers
hospit
extract
exist
databas
nursedriven
feed
protocol
institut
depart
analyz
outcom
implement
patient
treat
includ
patient
group
result
patient
includ
group
respect
group
compar
regard
demograph
casemix
sever
ill
instal
feed
protocol
result
significantli
higher
cumul
amount
enter
provid
calori
day
kcal
vs
kcal
group
median
iqr
p
less
calori
given
parenter
vs
kcal
p
cumul
proport
patient
receiv
enter
feed
significantli
smaller
group
fig
percentag
enter
receiv
calori
calor
need
significantli
higher
group
fig
preval
gi
symptom
intraabdomin
hypertens
differ
group
icu
length
stay
significantli
shorter
group
vs
day
respect
p
differ
note
durat
mechan
ventil
icu
mortal
conclus
use
nursedriven
feed
protocol
icu
patient
associ
improv
enter
nutrit
without
increas
gi
complic
refer
kuslapuu
k
starkopf
j
reintam
blaser
reason
insuffici
enter
feed
intens
care
unit
prospect
observ
studi
intens
crit
care
nur
oct
grant
acknowledg
ministri
educ
research
estonia
introduct
enter
nutrit
essenti
compon
critic
care
adequ
nutrit
essenti
recoveri
critic
ill
malnutrit
associ
poor
patient
outcom
intens
care
unit
object
estim
adequaci
nutrit
mechan
ventil
patient
effect
patient
outcom
method
prospect
observ
studi
done
period
one
year
jandec
adult
patient
mechan
ventil
hour
includ
studi
patient
start
protocol
driven
continu
enter
nutrit
target
achiev
kcalkgday
energi
gmkgday
protein
data
collect
demographi
admiss
sever
ill
hemodynam
subject
global
nutrit
assess
sga
lead
time
initi
achiev
full
feed
adequaci
energi
protein
suppli
reason
feed
interrupt
complic
enter
nutrit
data
nutrit
collect
till
patient
stay
ventil
primari
outcom
time
achiev
full
feed
secondari
endpoint
time
initi
feed
reason
interrupt
feed
result
patient
fit
inclus
criteria
major
male
mean
age
patient
year
bmi
apach
ii
sofa
score
high
patient
malnourish
nutrit
screen
sga
respiratori
failur
common
reason
intub
follow
neurolog
deterior
major
patient
medic
patient
two
patient
nasogastr
tube
malposit
xray
requir
reinsert
receiv
enter
feed
receiv
parenter
nutrit
receiv
feed
time
initi
enter
feed
hour
median
iqr
hour
rang
hour
patient
receiv
target
calori
hour
patient
achiev
target
calori
interrupt
feed
occur
patient
enter
fed
common
reason
interrupt
wean
follow
airway
relat
procedur
patient
restart
feed
hour
follow
interrupt
feed
patient
receiv
kcal
prescrib
calori
ventil
day
mortal
rate
icu
alo
ventil
day
day
respect
conclus
protocol
driven
enter
nutrit
allow
earli
feed
minimum
interrupt
feed
mechan
ventil
patient
still
room
improv
refer
keng
f
yip
vineya
rai
kang
k
wongevalu
deliveri
enter
nutrit
mechan
ventil
malaysian
icu
patient
bmc
anesthesiolog
introduct
recent
random
control
decstrial
demonstr
highdos
dexamethason
cardiac
surgeri
cardiopulmonari
bypass
decreas
icu
length
stay
center
mani
patient
undergo
offpump
cardiac
surgeri
dexamethason
administ
postop
cortisol
level
might
associ
outcom
studi
prospect
measur
cortisol
level
cardiothorac
surgeri
relat
outcom
patient
receiv
dexamethason
method
prospect
collect
postop
cortisol
level
obtain
first
morn
cardiothorac
surgeri
cortisol
determin
serum
chemiluminisc
assay
use
dexamethason
mgkg
record
well
icu
hospit
length
stay
hospit
longterm
mortal
observ
period
least
year
patient
divid
low
high
cortisol
accord
median
cortisol
measur
dexamethason
control
patient
result
includ
patient
male
mean
sd
age
year
cardiopulmonari
bypass
use
highdos
dexamethason
administ
oper
icu
hospit
length
stay
day
respect
hospit
longterm
mortal
respect
median
iqr
cortisol
first
day
postsurgeri
nmoll
ugdl
median
cortisol
level
lower
dexa
group
control
group
p
patient
dexa
group
median
iqr
cortisol
divid
lowcortisol
high
cortisol
group
cortisol
nmoll
respect
likewis
control
patient
median
cortisol
divid
nmoll
group
signific
differ
length
stay
mortal
observ
patient
low
high
cortisol
level
within
dexa
control
group
conclus
cortisol
level
obtain
one
day
cardiac
surgeri
far
lower
dexamethason
treat
patient
control
dexamethasonetr
patient
lower
cortisol
level
associ
wors
outcom
refer
dieleman
jm
nierich
ap
rosseel
pm
et
al
intraop
highdos
dexamethason
cardiac
surgeri
random
control
trial
jama
venkatesh
b
cohen
j
cooper
ten
fals
belief
cortisol
critic
ill
patient
intens
care
med
henzen
c
kobza
r
schwallerprotzmann
b
et
al
adren
function
coronari
arteri
bypass
graft
eur
j
endocrinol
introduct
plasma
albumin
concentr
low
critic
ill
patient
despit
higher
normal
synthesi
rate
demonstr
capillari
escap
rate
albumin
increas
relat
enhanc
capillari
leakag
return
plasma
lymphat
system
character
nevertheless
necessari
postul
enhanc
degrad
rate
increas
volum
distribut
explain
find
object
explor
differ
techniqu
assess
albumin
turnov
degrad
method
healthi
volunt
n
studi
day
first
day
albumin
synthesi
rate
measur
postabsorpt
state
vivo
incorpor
dose
given
assess
albumin
degrad
degrad
rate
measur
calcul
decay
radioact
way
urin
collect
hour
separ
day
plasma
repeatedli
day
result
basal
albumin
synthesi
rate
mgkgday
equal
degrad
rate
steadi
state
catabol
rate
urin
sampl
mgkgday
p
v
basal
plasma
mgkgday
p
v
basal
conclus
differ
calcul
turnov
rate
may
correspond
effect
feed
differ
halfliv
exogen
endogen
albumin
exact
explan
need
investig
introduct
low
plasma
glutamin
concentr
icu
admitt
associ
unfavor
outcom
number
studi
shown
benefici
effect
exogen
glutamin
supplement
unselect
critic
ill
patient
howev
recent
harm
report
pharmacolog
dose
exogen
glutamin
given
underf
unselect
icu
patient
organ
failur
mechan
behind
find
understood
specif
reason
low
level
known
object
relat
plasma
glutamin
concentr
glutamin
product
rate
method
critic
ill
patient
n
normal
low
plasma
glutamin
concentr
studi
glutamin
rate
appear
reflect
glutamin
product
rate
determin
employ
bolu
dose
techniqu
decay
curv
fit
singl
pool
model
result
glutamin
rate
appear
rang
umolkgmin
icu
patient
plasma
concentr
umol
statist
signific
p
relat
coeffici
determin
low
also
correl
model
statist
signific
p
coeffici
determin
intermediari
conclus
understand
result
recent
glutamin
supplement
studi
critic
ill
relev
plasma
glutamin
level
must
stood
healthi
volunt
high
concord
model
calcul
rate
appear
lower
agreement
icu
patient
indic
extens
model
may
necessari
introduct
preval
malnutrit
icu
estim
major
critic
ill
patient
requir
nutrit
support
tradit
teach
suggest
earli
enter
feed
mechan
ventil
septic
patient
superior
parenter
feed
due
lower
complic
rate
neither
form
support
without
risk
object
studi
compar
outcom
mechan
ventil
septic
icu
patient
receiv
enter
versu
parenter
nutrit
method
singl
centr
studi
patient
admit
bed
univers
hospit
icu
period
three
year
demograph
sever
ill
score
apach
sofa
bmi
must
measur
upon
admiss
daili
nutrit
requir
calcul
patient
patient
random
enter
en
parenter
nutrit
pn
group
within
hour
intub
admiss
unit
durat
mechan
ventil
icu
hospit
length
stay
lo
mortal
rate
record
result
total
patient
men
mechan
ventil
septic
patient
mean
age
year
studi
patient
met
consensu
criteria
sepsi
baselin
characterist
similar
two
group
apach
ii
sofa
studi
entri
respect
mean
bmi
seventi
seven
patient
receiv
en
sixti
nine
receiv
pn
differ
two
group
age
sex
bmi
score
icu
hospit
lo
similar
group
icu
mortal
rate
pn
group
vs
en
group
indic
signific
differ
hospit
mortal
similar
group
well
pn
fed
group
howev
durat
mechan
ventil
longer
p
feed
goal
attain
earlier
p
conclus
mechan
ventil
septic
icu
patient
icu
lo
hospit
lo
well
icu
hospit
mortal
rate
patient
receiv
pn
significantli
differ
patient
receiv
en
furthermor
feed
goal
attain
much
easier
pn
durat
mechan
ventil
howev
appear
longer
patient
receiv
pn
introduct
adipokin
hormon
play
import
role
regul
insulin
metabol
bodi
fat
distribut
regul
appetit
satieti
adipokin
hormon
effect
inflamm
insulin
resist
relat
hormon
critic
ill
rout
nutrit
known
object
aim
studi
determin
associ
nutrit
rout
adipokin
hormon
level
critic
ill
patient
method
studi
perform
prospect
medic
surgic
icu
erciy
univers
patient
expect
stay
icu
least
hour
receiv
either
parenter
enter
nutrit
includ
studi
result
total
patient
includ
studi
male
mean
age
year
total
patient
fed
via
enter
rout
patient
receiv
parenter
nutrit
mean
apach
ii
score
resistin
level
lower
enter
nutrit
group
p
hour
p
compar
parenter
nutrit
group
baselin
hour
hour
level
found
higher
enter
nutrit
group
parenter
nutrit
group
p
p
p
respect
adiponectin
level
significantli
higher
enter
nutrit
group
compar
parenter
nutrit
group
hour
p
conclus
studi
show
enter
nutrit
help
revers
abnorm
process
critic
ill
patient
increas
adiponectin
level
decreas
resistin
level
refer
kwon
h
pessin
je
adipokin
mediat
inflamm
insulin
resist
frontier
endocrinolog
vassiliadi
da
tzanela
kotanid
orfano
se
nikita
n
armaganidi
et
al
serial
chang
adiponectin
resistin
critic
ill
patient
sepsi
associ
sepsi
phase
sever
circul
cytokin
level
journal
critic
care
introduct
switch
carbohydr
fat
util
hallmark
system
inflamm
adapt
respons
occur
quickli
allow
anim
surviv
restrict
food
suppli
condit
markedli
affect
cell
metabol
object
elucid
molecular
mechan
underli
substrat
switch
carbohydr
fat
differ
organ
studi
earli
alter
phosphoryl
enzym
involv
energi
metabol
amp
kinas
ampk
acetylcoa
carboxylas
acc
pyruv
dehydrogenas
pdk
hormon
sensit
lipas
hsl
ii
express
mitochondri
uncoupl
protein
soleu
gastrocnemiu
skelet
muscl
liver
kidney
heart
shamoper
septic
rat
h
wellcharacter
h
fluidresuscit
rat
model
faecal
periton
method
awak
instrument
yet
fulli
mobil
male
wistar
rat
g
receiv
ip
inject
faecal
slurri
fluid
resuscit
mix
mlkgh
commenc
h
control
anim
treat
ident
except
slurri
inject
h
echomeasur
heart
rate
cutoff
bpm
use
classifi
anim
predict
survivor
sr
nonsurvivor
nsr
anim
kill
organ
immedi
collect
liquid
nitrogen
alter
protein
phosphoryl
express
studi
western
blot
normal
perform
load
control
actin
pfk
result
present
mean
se
analyz
use
student
ttest
consid
statist
signific
p
result
h
postsepsi
differ
seen
renal
hepat
phosphoryl
ampk
acc
pdh
hsl
sham
septic
anim
cardiac
acc
phosphoryl
strongli
increas
septic
rat
ampk
phosphoryl
differ
suggest
acc
phosphoryl
mediat
ampk
rather
via
glucagonpka
pathway
biggest
chang
observ
skelet
muscl
ampk
phosphoryl
increas
gastrocnemiu
even
soleu
septic
rat
accompani
correspond
increas
acc
phosphoryl
muscl
pdh
phosphoryl
markedli
increas
pdh
fell
suggest
fall
pyruv
oxid
decarboxyl
glucos
usag
fuel
hsl
phosphoryl
strongli
increas
soleu
nonsurvivor
level
alter
organ
tabl
conclus
organ
program
switch
carbohydr
fat
metabol
consequ
chang
develop
organ
dysfunct
merit
investig
may
lead
novel
direct
therapeut
refer
rudig
et
al
clin
sci
grant
acknowledg
esicm
basic
scienc
award
intens
care
foundat
uk
young
investig
award
nihr
introduct
albeit
practic
implement
remain
concern
indirect
calorimetri
ic
first
choic
techniqu
estim
energi
requir
critic
ill
patient
method
adult
mainli
surgic
intens
care
unit
icu
retrospect
assess
patient
util
practic
aspect
estim
daili
energi
requir
determin
energi
requir
ic
quark
cosm
compar
estim
calcul
measur
alon
use
ventil
evita
xl
draeger
use
formula
base
bodi
mass
bodi
mass
index
result
studi
popul
found
averag
bodi
mass
kg
accord
ic
energi
requir
kcalday
averag
correl
found
estim
ic
compar
estim
base
bodi
mass
alon
howev
use
adjust
mass
base
hight
assum
bodi
mass
index
correl
improv
base
estim
energi
requir
weakli
correl
ic
weak
correl
explain
assum
fix
respiratori
coeffici
ventil
base
energi
estim
well
imperfect
correl
estim
report
calorimet
ventil
conclus
bodi
paramet
hight
mass
nt
suit
predict
patient
energi
need
albeit
promis
simpl
estim
energi
requir
base
ventil
deriv
also
fail
precis
whether
technic
improv
ventil
calcul
render
suit
daili
praxi
determin
futur
studi
introduct
extracorpor
membran
oxygen
ecmo
advanc
treatment
support
critic
ill
patient
cardiac
andor
sever
respiratori
failur
suggest
ecmo
patient
risk
splanchnic
ischemia
thu
enter
feed
poorli
toler
need
nasojejun
feed
potenti
unsaf
studi
aim
investig
nutrit
adequaci
patient
group
object
establish
feed
toler
calor
protein
intak
initi
day
feed
method
retrospect
review
patient
receiv
ecmo
conduct
tertiari
critic
care
unitecmo
referr
centr
patient
fed
per
unit
feed
protocol
recommend
earli
enter
feed
instead
parenter
delay
enter
nutrit
result
data
review
patient
initi
feed
day
report
mean
sd
averag
durat
ecmo
day
sixtyf
patient
receiv
venoven
ecmo
respiratori
failur
whilst
remaind
receiv
venoarteri
ecmo
cardiac
failur
patient
age
bodi
mass
index
bmi
sofa
score
respect
enter
feed
start
hr
reach
target
within
hr
overal
patient
good
toler
feed
mean
gastric
residu
volum
grv
hr
day
feed
intoler
defin
grv
ml
observ
everi
day
episod
day
accordingli
diarrhoea
observ
patient
mainli
day
fortytwo
patient
need
prokinect
metoclopramid
eight
also
erythromycin
eight
patient
parenter
nutrit
supplement
inadequ
enter
feed
overal
patient
receiv
day
onward
patient
nasogastr
feed
nasojejun
feed
necessari
conclus
enter
nutrit
well
toler
patient
receiv
ecmo
whether
venoven
venoarteri
mode
seriou
advers
event
attribut
enter
nutrit
patient
introduct
nowaday
hospit
acquir
infect
widespread
phenomena
among
critic
ill
patient
prophylaxi
gastric
stress
ulcer
acidsuppress
therapi
increas
risk
ventil
associ
pneumonia
vap
critic
ill
patient
two
meta
analys
compar
ppi
term
prophylact
effect
gastric
stress
ulcer
critic
patient
show
appar
differ
group
regard
upper
gastric
ulcer
prophylaxi
pneumonia
mortal
patient
admit
icu
object
prophylaxi
stress
ulcer
mechan
ventil
patient
consid
culprit
develop
ventil
associ
pneumonia
vap
retrospect
studi
test
hypothesi
mix
medicalsurg
adult
icu
design
random
clinic
pilot
studi
determin
necessari
sampl
size
compar
effect
intraven
ranitidin
pentoprazol
incid
vap
method
patient
least
hour
expect
mechan
ventil
alloc
randomli
receiv
either
mg
ranitidin
r
everi
hour
mg
pentoprazol
p
everi
hour
intraven
admiss
till
hour
extub
vap
diagnosi
accord
clinic
pneumonia
infect
score
posit
cultur
endotrach
tube
aspir
result
recruit
patient
month
period
preliminari
analysi
studi
termin
due
low
differ
vap
incid
r
p
group
p
valu
odd
ratio
confid
interv
statist
signific
differ
observ
term
gastrointestin
bleed
icu
hospit
length
stay
mortal
two
group
conclus
vap
incid
hardli
relat
type
stress
ulcer
prophylaxi
agent
icu
set
high
rate
vap
low
util
vap
prophylaxi
bundl
find
effect
huge
number
patient
need
recruit
larg
random
clinic
trial
refer
prescott
hc
jm
prevent
ventilatorassoci
pneumonia
adult
medicin
report
lin
pc
chang
ch
hsu
pi
tseng
pl
huang
yb
efficaci
safeti
proton
pump
inhibitor
vs
receptor
antagonist
stress
ulcer
bleed
prophylaxi
among
critic
care
patient
metaanalysi
critic
care
medicin
alhazzani
w
alenezi
f
jaeschk
rz
moayyedi
p
cook
dj
proton
pump
inhibitor
versu
histamin
receptor
antagonist
stress
ulcer
prophylaxi
critic
ill
patient
systemat
review
metaanalysi
critic
care
medicin
grant
acknowledg
studi
fund
grant
number
vicechancelleri
research
technolog
shiraz
univers
medic
scienc
shiraz
iran
rational
pneumonia
lead
risk
factor
acut
respiratori
distress
syndrom
ard
critic
ill
patient
pneumonia
coinfect
higher
mortal
longer
length
stay
intens
care
unit
icu
littl
known
impact
coinfect
outcom
pneumoniainduc
ard
patient
object
evalu
role
coinfect
bronchoalveolar
lavag
bal
examin
outcom
pneumoniainduc
ard
method
perform
prospect
observ
studi
adult
icu
chang
gung
memori
hospit
octob
may
patient
includ
met
berlin
definit
ard
bal
indic
pneumoniainduc
ard
suspect
clinic
definit
microbi
indentifi
tracheal
aspir
bal
specimen
sent
comprehens
microbiolog
studi
includ
bacteria
fungi
viru
demograph
baselin
clinic
characterist
collect
enrol
final
pathogen
identifi
result
clinic
outcom
analyz
result
total
receiv
invas
mechan
ventil
patient
admit
icu
mmhg
screen
patient
fulfil
berlin
definit
ard
ard
patient
patient
pneumoniainduc
ard
bal
pathogen
survey
includ
analysi
one
hundr
forti
two
patient
identifi
microbiolog
pathogen
accord
identifi
viru
pathogen
patient
divid
viru
identifi
group
n
viru
identifi
group
n
coinfect
pathogen
group
n
distribut
ard
sever
signific
differ
group
patient
p
coinfect
group
significantli
higher
hospit
mortal
rate
viru
group
viru
group
vs
p
conclus
coinfect
viru
pathogen
bal
associ
increas
mortal
pneumoniainduc
ard
patient
introduct
cap
potenti
life
threaten
disord
despit
advent
potent
antibiot
commonli
caus
acut
respiratori
failur
high
diseas
sever
predict
outcom
essenti
appropri
alloc
health
care
resourc
optim
treatment
kallistatin
endogen
tissu
kallikrein
inhibitor
protect
inflamm
fibrosi
oxid
stress
may
involv
cap
pathogenesi
antiinflammatori
object
determin
whether
kallistatin
level
prognost
valu
sever
cap
correl
biomark
crp
apach
ii
sofa
score
pneumonia
sever
index
psi
method
plasma
sampl
clinic
data
prospect
collect
patient
admit
critic
care
depart
sever
cap
accord
idsaat
serum
kallistatin
level
collect
day
icu
admiss
correl
apach
ii
sofa
score
psi
admiss
also
ratio
crp
day
result
lower
kallistatin
level
day
show
strong
trend
toward
increas
mortal
pvalu
respect
level
neg
correl
apach
ii
sofa
score
psi
pvalu
respect
show
posit
linear
correl
ratio
day
pvalu
respect
also
show
neg
correl
crp
day
pvalu
level
day
icu
admiss
significantli
decreas
patient
develop
septic
shock
pvalu
respect
ard
requir
mechan
ventil
pvalu
respect
kallistatin
cutoff
valu
predict
mortal
determin
roc
curv
ml
sensit
specif
pvalu
day
sensit
specif
pvalu
conclus
kallistatin
may
serv
promis
novel
marker
prognosi
sever
cap
may
involv
pathogenesi
refer
restrepo
mi
mortensen
em
velez
ja
et
al
compar
studi
communityacquir
pneumonia
patient
admit
ward
icu
chest
lim
ws
van
der
eerden
mm
la
r
boersma
et
al
defin
commun
acquir
pneumonia
sever
present
hospit
intern
deriv
valid
studi
thorax
weichieh
lin
shioul
lu
chioufeng
lin
et
al
plasma
kallistatin
level
patient
sever
communityacquir
pneumoniacrit
care
mandel
la
wunderink
rg
anzueto
et
al
infecti
diseas
societi
americaamerican
thorac
societi
consensu
guidelin
manag
communityacquir
pneumonia
adult
clin
infect
di
suppl
object
assess
clinic
development
implic
delay
diagnosi
communityacquir
influenza
infect
critic
ill
patient
admit
icu
method
prospect
observ
multicent
studi
spanish
icu
data
obtain
getgag
semicyuc
patient
infect
influenza
confirm
rtpcr
first
week
hospit
stay
includ
viral
communityacquir
pneumonia
patient
classifi
accord
moment
flu
diagnosi
earli
first
two
day
hospit
late
day
admiss
demograph
temporari
variabl
comorbid
sever
icu
admiss
treatment
mortal
evalu
intraicu
logist
regress
use
identifi
relat
factor
late
diagnosi
cox
regress
determin
whether
late
diagnosi
independ
variabl
associ
mortal
result
present
odd
ratio
confid
interv
ci
consid
p
signific
result
icu
patient
diagnos
first
day
hospit
stay
evalu
earli
diagnos
late
diagnos
independ
variabl
associ
late
diagnosi
day
hospit
stay
icu
admiss
ci
p
mechan
ventil
ci
p
need
renal
replac
ci
p
clinic
present
viral
pneumonia
protect
variabl
relat
delay
ci
p
patient
late
diagnosi
present
higher
icu
vs
p
hospit
day
stay
vs
p
well
higher
intraicu
mortal
vs
p
diagnosi
delay
independ
variabl
associ
mortal
multivari
analysi
ci
conclus
influenza
diagnosi
delay
critic
ill
patient
admit
icu
associ
delay
icu
admiss
increas
respiratori
failur
acut
renal
failur
increas
mortal
delay
diagnosi
independ
variabl
associ
mortal
introduct
influenza
virus
one
main
caus
sever
acut
respiratori
infect
sari
know
clinic
featur
prognosi
factor
essenti
manag
outcom
object
determin
incid
mortal
patient
sari
influenza
infect
admit
icu
identifi
common
symptom
comorbid
among
patient
affect
sari
influenza
infect
method
prospect
observ
studi
perform
includ
patient
sari
admit
icu
tertiari
care
hospit
novemb
march
influenza
infect
diagnos
rtpcr
demograph
clinic
radiolog
featur
outcom
record
pearson
chisquar
fisher
mann
whitney
u
test
logist
regress
use
statist
analysi
data
express
frequenc
percentag
median
interquartil
rang
result
studi
period
patient
admit
icu
seventyf
includ
sari
male
median
age
year
old
apach
ii
sofa
icu
lo
day
day
symptom
onset
hospit
admiss
main
comorbid
lung
diseas
patient
cardiovascular
diseas
patient
seventeen
patient
present
influenza
infect
one
present
viral
pneumonia
cough
short
breath
muscl
pain
common
symptom
influenza
patient
respect
influenzalik
ill
frequent
influenza
patient
vs
p
furthermor
patient
influenza
infect
diagnos
influenza
epidem
period
vs
p
patient
influenza
infect
treat
oseltamivir
highflow
oxygen
therapi
requir
sari
patient
noninvas
mechan
ventil
invas
mechan
ventil
inotrop
drug
renal
replac
therapi
influenza
patient
present
similar
distribut
overal
sari
mortal
one
influenza
infect
vs
p
apach
ii
vs
p
sofa
score
vs
p
show
good
predictor
mortal
icu
admiss
also
delay
admiss
icu
vs
p
renal
replac
therapi
vs
p
associ
increas
mortal
previou
renal
diseas
ci
p
oncolog
diseas
ci
p
independ
associ
mortal
conclus
nonsignific
decreas
mortal
observ
patient
influenza
infect
earli
icu
admiss
could
improv
sari
prognosi
introduct
influenza
caus
selflimit
lifethreaten
ill
triag
patient
requir
hospit
admiss
safe
discharg
difficult
pandem
situat
exist
triag
tool
focu
predict
hospit
admiss
assess
abil
routin
clinic
marker
predict
earli
discharg
patient
confirm
influenza
object
assess
abil
routin
clinic
laboratori
variabl
predict
patient
could
safe
discharg
home
within
hour
compar
predict
valu
clinic
variabl
triag
tool
stss
sofa
qsofa
criteria
method
review
exist
databas
patient
present
royal
liverpool
univers
hospit
inclus
criteria
patient
confirm
revers
transcriptas
polymeras
chain
reaction
year
age
exclus
criteria
unconfirm
case
patient
seen
hospit
miss
case
note
differ
clinic
paramet
patient
discharg
within
hour
medic
assess
admit
hospit
analys
chest
xray
score
system
also
employ
assess
abil
radiograph
find
predict
likelihood
discharg
result
eightysix
patient
elig
studi
patient
discharg
earli
patient
admit
hospit
pf
ratio
crp
predict
discharg
area
receiv
oper
characterist
roc
curv
ci
ci
respect
higher
triag
bedsid
tool
chest
radiograph
score
tool
predict
patient
discharg
p
demonstr
good
interrat
reliabl
cohen
kappa
statist
conclus
pf
ratio
crp
predict
discharg
better
clinic
paramet
superior
specif
triag
tool
describ
literatur
pf
ratio
simpl
effect
method
determin
oxygen
exchang
recommend
tool
assess
patient
influenza
pandem
guid
manag
decis
futur
work
would
involv
valid
prospect
cohort
refer
singanayagam
et
al
factor
associ
sever
ill
pandem
influenza
infect
implic
triag
primari
secondari
care
j
infect
singer
et
al
third
intern
consensu
definit
sepsi
septic
shock
jama
taylor
e
chest
radiograph
score
system
patient
sever
acut
respiratori
infect
valid
studi
bmc
med
imag
introduct
ventilatorassoci
pneumonia
vap
common
icuacquir
infect
recent
incid
extendedspectrum
betalactamas
produc
enterobacteriacea
esbl
substanti
increas
critic
ill
patient
identifi
patient
risk
vap
relat
esbl
could
help
improv
rate
appropri
initi
antibiot
treatment
reduc
unnecessari
exposur
carbapenem
object
primari
object
identifi
risk
factor
vap
relat
esbl
secondari
object
determin
impact
esbl
outcom
vap
patient
method
retrospect
studi
conduct
singl
mix
icu
period
patient
confirm
vap
includ
vap
defin
use
clinic
radiolog
quantit
microbiolog
data
vap
first
episod
prospect
identifi
use
continu
surveil
data
exposur
differ
risk
factor
taken
account
diagnosi
esbl
vap
icu
discharg
patient
esbl
vap
vap
relat
bacteria
respect
patient
routin
screen
esbl
rectal
swab
perform
icu
admiss
week
patient
esbl
vap
compar
vap
relat
bacteria
use
univari
analysi
signific
factor
includ
multivari
logist
regress
model
result
among
patient
vap
esbl
vap
patient
polymicrobi
vap
vap
relat
multidrug
resist
bacteria
follow
factor
significantli
associ
higher
rate
esbl
vap
univari
analysi
femal
gender
medic
admiss
ard
shock
infect
admiss
antibiot
treatment
day
preced
icu
admiss
largespectrum
antibiot
treatment
icu
stay
digest
tract
colon
relat
esbl
acut
exacerb
copd
icu
admiss
significantli
associ
lower
rate
esbl
vap
univari
analysi
multivari
analysi
identifi
prior
esbl
colon
digest
tract
independ
risk
factor
esbl
vap
ci
p
whilst
posit
predict
valu
esbl
digest
colon
low
neg
predict
valu
excel
predict
esbl
vap
durat
mechan
ventil
median
iqr
vs
p
length
icu
stay
vs
p
mortal
rate
vs
p
similar
esbl
vap
compar
vap
relat
bacteria
conclus
digest
tract
colon
relat
esbl
independ
associ
esbl
vap
excel
neg
predict
valu
suggest
patient
without
esbl
colon
receiv
carbapenem
part
initi
empir
antibiot
treatment
cover
esbl
introduct
sever
acut
respiratori
syndrom
sar
influenza
infect
activ
interest
surveil
patient
sever
acut
respiratori
infect
sari
object
investig
local
epidemiolog
pattern
infect
sever
outcom
patient
admit
intens
care
unit
icu
result
sever
acut
respiratori
infect
sari
method
prospect
observ
studi
patient
admit
icu
octob
march
screen
studi
demograph
characterist
underli
condit
clinic
present
therapeut
intervent
outcom
sari
defin
acut
respiratori
ill
recent
onset
within
day
includ
fever
cough
dyspnea
requir
overnight
hospit
result
patient
screen
studi
period
median
iqr
age
year
male
median
iqr
sap
ii
sofa
score
underli
diseas
symptom
onset
occur
median
iqr
day
admiss
icu
chest
xray
display
alveolar
consolid
admiss
icu
gramposit
gramneg
bacteria
found
sari
patient
rare
atyp
bacteria
virus
present
patient
influenza
requir
invas
mechan
ventil
vasopressor
corticosteroid
antimicrobi
therapi
none
treat
antivir
agent
organ
failur
occur
patient
respiratori
hemodynam
renal
median
iqr
length
stay
day
durat
mechan
ventil
day
icu
mortal
rate
patient
sari
overal
sever
prolong
hypoxemia
refractori
shock
univari
analysi
identifi
respiratori
chronic
failur
greater
sever
score
icu
admiss
associ
increas
risk
icu
death
conclus
sinc
pandem
influenza
proport
viral
infect
decreas
whatev
admiss
icu
sari
remain
associ
high
morbid
mortal
rate
refer
rello
j
al
semicyuc
work
group
intens
care
adult
patient
sever
respiratori
failur
caus
influenza
spain
crit
care
sakr
ferrer
r
reinhart
k
beal
r
rhode
moreno
r
et
al
intens
care
global
studi
sever
acut
respiratori
infect
icglossari
multicent
multin
incept
cohort
studi
intens
care
medicin
introduct
epidem
flu
predominantli
influenza
caus
chaotic
situat
health
care
facil
taiwan
includ
emerg
depart
overcrowd
difficult
patient
find
bed
emerg
room
icu
shortag
respiratori
ventil
well
extracorpor
membran
oxygen
ecmo
machin
death
toll
continu
rise
recordbreak
reason
mani
patient
suffer
sever
influenza
requir
intens
care
unclear
studi
emphas
import
aspergillu
infect
sever
influenza
attack
object
show
correl
activ
aspergillosi
influenza
infect
method
confirm
influenza
case
defin
least
one
posit
assay
test
influenza
includ
influenza
b
rapid
antigen
real
time
polymeras
chain
reaction
pcr
viral
isol
identif
specimen
nasopharyng
swab
andor
lower
respiratori
tract
aspir
detect
aspergillu
galactomannan
gm
antigen
platelia
aspergillu
ag
assay
human
serum
bronchoalveolar
lavag
fluid
use
aid
assess
patient
suspect
aspergillosi
gm
index
defin
posit
aspergillu
antigenemia
decis
test
aspergillu
antigen
made
attend
physician
mostli
patient
worsen
pneumonia
oseltamivir
andor
routin
antibiot
therapi
result
total
hospit
medic
icu
patient
identifi
observ
period
includ
patient
diagnosi
sever
influenza
patient
posit
aspergillu
gm
antigen
test
meanwhil
patient
sever
influenza
worsen
pneumonia
aspergillu
antigenemia
howev
influenza
patient
test
aspergillu
gm
antigen
physiciandepend
patient
select
bia
result
accuraci
incid
patient
influenza
andor
posit
aspergillu
antigenemia
medic
icu
patient
significantli
increas
februari
comparison
previou
month
hospit
conclus
medic
imag
serum
galactomannan
antigen
current
constitut
basi
screen
approach
invas
pulmonari
aspergillosi
presenc
aspergillu
antigenemia
might
repres
true
invas
aspergillu
infect
prompt
diagnost
workup
encourag
patient
suffer
lifethreaten
ard
clinic
impact
invas
aspergillosi
sever
influenza
may
import
previou
thought
conclus
studi
reveal
possibl
link
invas
aspergillosi
sever
influenza
patient
recognit
potenti
might
help
physician
initi
prompt
diagnost
workup
incorpor
strategi
prepared
epidem
crisi
object
assess
prognost
implic
hospit
acquisit
influenza
viru
popul
critic
ill
patient
admit
icu
method
prospect
observ
multicent
studi
spanish
icu
data
obtain
getgag
semicyuc
registri
patient
infect
influenza
confirm
rtpcr
includ
patient
classifi
two
group
depend
day
diagnosi
flu
communityacquir
first
h
hospit
admiss
nosocomi
infect
day
admiss
without
treatment
oseltamivir
demograph
temporari
variabl
comorbid
sever
admiss
treatment
mortal
evalu
differ
group
assess
use
chisquar
categor
variabl
student
ttest
mannwhitney
test
continu
variabl
signific
variabl
univari
analysi
includ
multivari
model
logist
regress
consid
p
signific
result
patient
influenza
includ
evalu
classifi
influenza
communityacquir
infect
nosocomi
infect
couldnt
classifi
either
group
patient
patient
nosocomi
pneumonia
present
older
age
vs
p
higher
rate
sever
admiss
apach
ii
vs
p
sofa
vs
p
immunosuppress
hematolog
diseas
vs
p
vs
p
requir
invas
mechan
ventilatil
vs
p
day
mechan
ventil
vs
p
icu
stay
vs
p
hospit
stay
vs
p
mortal
vs
p
also
increas
significantli
group
nosocomi
infect
furthermor
hospit
acquisit
influenza
ic
p
apacheii
ic
p
hematolog
diseas
ic
p
need
renal
replac
ic
p
mechan
ventil
ic
p
independ
variabl
associ
mortal
multivari
analysi
conclus
patient
nosocomi
influenza
admit
icu
serious
ill
requir
resourc
consumpt
hospit
acquisit
influenza
critic
ill
patient
need
admit
icu
associ
increas
mortal
introduct
describ
first
pandem
xxi
centuri
caus
influenza
viru
viru
affect
patient
extrem
age
life
signific
comorbid
also
affect
young
immunocompet
patient
antigen
variat
virus
suffer
caus
season
outbreak
differ
extens
object
describ
characterist
patient
diagnos
influenza
requir
admiss
intens
care
unit
icu
methodolog
descript
analysi
includ
patient
diagnos
influenza
admit
octob
april
icu
referr
hospit
popul
inhabit
diagnosi
obtain
pcr
nasal
pharyng
swab
sputum
tracheal
aspir
epidemiolog
variabl
risk
factor
sever
admiss
administ
treatment
life
support
therapi
mortal
collect
result
period
patient
influenza
admit
averag
per
year
mean
age
year
men
mean
apach
ii
mean
sofa
patient
vaccin
influenza
identifi
case
influenza
comorbid
present
patient
copd
hematolog
diseas
diabet
mellitu
obes
pregnanc
radiolog
affect
observ
patient
admiss
patient
requir
vasoact
drug
requir
renal
replac
patient
move
prone
posit
appli
center
sinc
patient
receiv
oseltamivir
averag
day
day
averag
onset
symptom
first
dose
receiv
empir
antibiot
therapi
respiratori
coinfect
case
pneumonia
ventilatorassoci
pneumonia
observ
patient
patient
requir
mechan
ventil
mv
initi
patient
receiv
noninvas
mechan
ventil
nimv
invas
mechan
ventil
imv
nimv
failur
occur
patient
connect
imv
patient
requir
ventilatori
support
mean
icu
stay
day
total
patient
die
hospit
stay
icu
group
mean
apach
ii
mean
sofa
day
onset
symptom
administr
first
dose
oseltamivir
averag
conclus
influenza
identifi
patient
nonsurvivor
subgroup
present
higher
rate
immunosuppress
increas
sever
admiss
longer
period
time
onset
symptom
administr
first
dose
oseltamivir
introduct
mortal
patient
communityacquir
pneumonia
cap
remain
high
despit
improv
treatment
object
determin
immunoglobulin
level
patient
cap
impact
diseas
sever
mortal
method
observ
studi
hospit
patient
cap
follow
level
immunoglobulin
g
igg
subclass
immunoglobulin
iga
immunoglobulin
igm
measur
serum
first
hour
cap
diagnosi
result
patient
cap
wardtreat
icutr
enrol
icutr
patient
significantli
lower
valu
subclass
iga
wardtreat
patient
patient
die
day
level
significantli
lower
nonsurvivor
survivor
p
level
mgdl
associ
poorer
surviv
accord
bivari
hr
p
multivari
hr
p
analys
conclus
patient
cap
level
mgdl
poorer
prognosi
higher
risk
death
studi
suggest
util
predict
evolut
cap
increas
support
measur
addit
treatment
introduct
ventilatorassoci
pneumonia
vap
one
frequent
nosocomi
infect
icu
result
increas
mortal
prolong
hospit
stay
greater
healthcar
cost
object
analyz
frequenc
risk
factor
antimicrobi
resist
pattern
microbiolog
agent
respons
vap
patient
admit
icu
sagrada
method
retrospect
cohort
patient
mechan
ventil
h
data
collect
icu
admiss
day
death
vap
diagnosi
defin
accord
cdc
requir
microbiolog
confirm
analyz
associ
risk
factor
occurr
vap
result
mechan
ventil
util
ratio
incid
vap
episod
per
day
mechan
ventil
case
vap
late
onset
vap
reintub
ci
identifi
independ
risk
factor
vap
vap
associ
attribut
mortal
icu
day
mortal
p
vs
p
relat
threefold
increas
durat
mechan
ventil
p
increas
hospit
stay
p
gramneg
bacteria
common
agent
icu
conclus
know
close
monitor
incid
vap
microbiolog
agent
associ
antimicrobi
resist
pattern
key
adopt
specif
standard
icu
rule
refer
alp
e
voss
annal
clinic
microbiolog
antimicrobi
rosenth
v
maki
g
mehta
leblebicioglu
h
memish
z
al
mousa
h
h
apisarnthanarak
american
journal
infect
introduct
ventil
associ
pneumonia
vap
common
hospit
acquir
infect
requir
mechan
ventil
associ
prolong
length
stay
icu
poorer
outcom
increas
current
gold
standard
definit
high
clinic
suspicion
often
enough
begin
treatment
diagnosi
complic
sign
seen
vap
uncommon
critic
ill
itu
potenti
delay
object
aim
project
establish
signific
differ
trigger
predict
vap
vap
trigger
oppos
trigger
predict
vap
non
vap
trigger
group
trigger
alert
method
data
intens
care
unit
electron
record
system
icip
phillip
queri
extract
vap
alert
trigger
june
march
time
period
vap
trigger
nonvap
case
look
acknowledg
time
differ
valu
order
index
paramet
vap
trigger
non
vap
trigger
look
differ
suggest
earli
predictor
posit
microbiolog
radiolog
microsoft
excel
use
manipul
data
analysi
spss
statist
use
calcul
summari
statist
gener
tabl
perform
student
ttest
analysi
produc
graph
student
ttest
use
analys
statist
signific
group
result
quantit
variabl
measur
statist
signific
differ
confirm
vap
case
nonvap
case
apart
temperatur
nonvap
case
higher
averag
temperatur
compar
confirm
vap
notwithstand
note
lower
mean
crectiv
protein
crp
higher
oxygen
requir
lower
white
cell
count
wcc
confirm
vap
case
would
expect
vap
group
secret
commonli
describ
creami
moder
copiou
amount
term
trigger
order
confirm
vap
case
secret
amount
common
first
second
trigger
vap
alert
follow
nonspecif
inflammatori
marker
wbc
crp
temperatur
non
vap
group
temperatur
oxygen
requir
wbc
common
first
trigger
factor
conclus
conclus
earli
secret
quantiti
descript
predict
posit
microbiolog
radiolog
compar
paramet
temperatur
wbc
crp
refer
valencia
torr
l
ventilatorassoci
pneumonia
curr
opin
crit
care
feb
hunter
jd
ventil
associ
pneumonia
bmj
may
grant
acknowledg
fund
declar
introduct
surviv
predictor
optim
mechan
ventil
mv
set
patient
sever
acut
respiratori
distress
syndrom
ard
undergo
extracorpor
membran
oxygen
ecmo
uncertain
object
evalu
influenc
clinic
variabl
mv
set
intens
care
unit
icu
mortal
sever
ard
patient
treat
ecmo
method
retrospect
review
sever
ard
patient
receiv
ecmo
due
refractori
hypoxemia
may
octob
serial
mv
set
ecmo
factor
associ
icu
mortal
analyz
result
total
sever
ard
patient
receiv
ecmo
analyz
overal
icu
mortal
ecmo
initi
nonsurvivor
significantli
higher
peak
inspiratori
pressur
drive
pressur
survivor
day
day
day
vs
vs
vs
cm
p
vs
vs
vs
cm
p
multivari
analysi
mean
drive
pressur
cm
first
day
ecmo
independ
associ
higher
death
odd
ratio
confid
interv
p
factor
independ
associ
icu
mortal
includ
ard
durat
ecmo
odd
ratio
confid
interv
p
acut
physiolog
chronic
health
evalu
ii
score
ecmo
initi
odd
ratio
confid
interv
p
conclus
drive
pressur
first
day
ecmo
support
sever
ard
independ
associ
icu
mortal
level
cm
relat
higher
death
larg
multicent
prospect
random
control
trial
warrant
confirm
find
introduct
acut
respiratori
distress
syndrom
ard
sever
acut
inflammatori
lung
injuri
still
high
mortal
despit
current
lung
protect
ventilatori
strategi
rescu
therapi
venoven
extracorpor
membran
oxygen
vvecmo
ard
immun
system
inflammatori
pathway
strongli
activ
result
system
microparticl
mp
tini
cellderiv
vescicl
releas
varieti
activ
apoptot
cell
play
role
sever
diseas
howev
mp
role
vvecmo
describ
yet
object
assess
presenc
origin
circul
microparticl
patient
sever
ard
treat
vvecmo
relat
clinic
cours
method
consecut
patient
admit
icu
sever
ard
requir
vvecmo
enrol
immedi
day
placement
remov
vvecmo
arteri
platelet
free
plasma
collect
analys
flow
cytometri
evalu
endotheli
emp
plateletderiv
pmp
leucocytederiv
lmp
tissu
factorbear
tfmp
microparticl
level
comparison
drawn
differ
time
point
survivor
n
non
survivor
n
analysi
twoway
anova
p
valu
consid
significantli
differ
result
found
progress
signific
reduct
circul
emp
median
iqr
median
iqr
mpsml
p
lmp
median
iqr
iqr
mpsml
p
start
ecmo
support
soon
decannul
shown
fig
survivor
show
higer
level
lmp
p
compar
non
survivor
almost
significantli
higher
level
emp
p
standard
laboratori
test
ie
crp
pct
wbc
show
signific
differ
time
point
differ
outcom
correl
level
kind
mp
heparin
dose
bleed
episod
mortal
conclus
patient
sever
ard
treat
vvecmo
plasma
level
emp
lmp
significantli
elev
ecmo
support
gradual
reduc
treatment
decannul
moreov
blood
passag
ecmo
circuit
seem
gener
procoagul
endotheli
leucocytederiv
plateletderiv
mp
compar
baselin
refer
bellani
g
jama
fujishima
journal
intens
care
mcvey
et
al
j
physiol
lung
cell
mol
physiol
introduct
use
extracorpor
membran
oxygen
ecmo
acut
respiratori
distress
syndrom
ard
unrespons
convent
ventilatori
manag
increas
rapidli
therefor
april
establish
new
ecmo
program
japanes
health
care
system
without
region
object
studi
aim
determin
whether
outcom
ecmo
program
associ
interhospit
transfer
patient
method
clinic
data
patient
treat
ecmo
april
march
collect
analyz
retrospect
clinic
data
patient
transfer
hospit
transfer
group
nontransf
group
compar
venoven
vv
ecmo
treatment
result
studi
period
patient
treat
vvecmo
median
age
patient
year
median
durat
mechan
ventil
prior
introduc
ecmo
day
median
durat
vvecmo
day
total
durat
intens
care
unit
stay
day
twelv
patient
success
wean
ecmo
patient
surviv
discharg
howev
median
respiratori
ecmo
surviv
predict
resp
score
indic
estim
surviv
rate
low
moreov
patient
transfer
hospit
result
show
surviv
rate
higher
transfer
group
nontransf
group
vs
p
proport
immunocompromis
patient
transfer
group
lower
nontransf
group
vs
p
vvecmo
treatment
durat
mechan
ventil
transfer
group
shorter
nontransf
group
vs
p
moreov
resp
score
transfer
group
lower
nontransf
group
vs
p
treatment
vvecmo
durat
ecmo
support
transfer
group
longer
nontransf
group
vs
p
conclus
clinic
outcom
program
inferior
advanc
ecmo
center
europ
north
america
improv
outcom
ecmo
ard
japan
result
suggest
region
employ
ard
patient
better
resp
score
transfer
ecmo
center
refer
comb
brodi
bartlett
r
et
al
posit
paper
organ
extracorpor
membran
oxygenationprogram
acut
respiratori
failur
adult
patient
j
respir
crit
care
med
sep
introduct
influenza
pandem
determin
event
develop
modern
extracorpor
life
support
techniqu
still
repres
frequent
caus
convent
respiratori
support
failur
usual
present
rapidli
evolv
critic
hypoxemia
demand
extracorpor
oxygen
ecmo
rescu
treatment
object
identifi
characterist
patient
sever
form
ard
order
promot
earli
identif
patient
put
need
ecmo
treatment
comparison
ecmo
popul
ecmo
treat
popul
ard
caus
term
physiolog
function
biomechan
ventil
paramet
rule
prognosi
predict
method
retrospect
review
prospect
collect
data
protocoldriven
ecmo
referr
centr
interhospit
patient
rescu
capabl
elso
regist
activ
result
sixti
one
patient
treat
ecmo
support
sever
acut
respiratori
distress
syndrom
quadrox
hl
pl
oxygen
system
maquet
patient
ard
patient
ard
caus
two
patient
exclud
insuffici
data
compar
non
similar
age
vs
p
sap
ii
vs
p
preecmo
mechan
ventil
durat
vs
day
p
hypoxemia
degre
vs
mmhg
p
static
lung
complianc
day
vs
p
averag
ecmo
run
durat
vs
day
p
patient
higher
bodi
mass
index
vs
p
higher
murray
score
diffus
lung
involv
vs
p
lower
level
vs
mmhg
p
higher
level
ph
vs
p
translat
less
sever
alveolar
ventil
compromis
global
surviv
differ
group
prognosi
predict
score
also
similar
ecmonet
vs
p
lip
vs
p
conclus
patient
sever
ard
present
predominantli
hypoxem
respiratori
failur
diffus
bilater
lung
diseas
higher
murray
score
less
effect
ventil
compromis
characterist
result
wors
outcom
compar
patient
sever
ard
caus
object
patient
moder
sever
ard
respiratori
acidosi
introduc
enabl
protect
ventil
ultraprotect
ventil
nt
know
result
obtain
introduct
popul
ard
respiratori
acidosisth
object
studi
describ
time
improv
blood
ph
allow
ultraprotect
ventil
method
retrospect
includ
patient
receiv
ard
respiratori
acidosi
august
march
icu
perform
devic
membran
sweep
ga
oxygen
lmin
vascular
access
f
dual
light
cathet
femor
posit
blood
flow
membran
around
lmin
introduc
patient
ratio
acidosi
patient
ventil
control
ventil
mlkg
pbw
tidal
volum
vt
respiratori
rate
rr
patient
sedat
midazolam
sufentanyl
necessari
use
neuromuscular
block
agent
necessari
clinician
charg
patient
perform
prone
posit
session
collect
ph
vt
rr
peeptot
drive
pressur
h
initi
compar
paramet
repeat
measur
anova
test
result
includ
patient
male
femal
averag
age
year
bmi
caus
ard
pneumonia
patient
cellul
patient
septicemia
last
patient
eleven
patient
perform
least
one
prone
posit
session
hour
averag
durat
treatment
day
mortal
none
patient
die
complic
nt
hemorrhag
complic
cathet
evolut
paramet
tabl
conclus
ard
patient
respiratori
acidosi
help
normal
ph
decreas
vt
rr
make
ultraprotect
ventil
decreas
drive
pressur
type
ard
sever
hypercapnia
other
studi
necessari
know
kind
procedur
improv
mortal
patient
introduct
critic
ill
patient
evid
suggest
conserv
transfus
strategi
paper
question
standard
use
hb
mgdl
trigger
consid
comorbid
clinic
pictur
threshold
transfus
prbc
ecmo
still
matter
debat
prbc
given
increas
act
critic
point
patient
ard
consumpt
coagulopathi
bleed
frequent
ecmo
elso
guidelin
suggest
keep
hb
normal
valu
gdl
frequent
prbc
unit
transfus
daili
also
set
report
lower
hb
trigger
transfus
object
describ
transfus
practic
vvecmo
sever
ard
berlin
definit
ismett
method
blood
manag
strategi
base
hb
level
accord
metabol
perfus
datatransfus
use
antileukocyt
filterslow
dose
anticoagul
heparin
aptt
rang
anticoagul
stop
case
bleedingautotransfus
blood
circuit
decannul
possibl
retrospect
observ
analysi
electron
medic
chart
data
manag
perform
stata
result
result
report
mean
valu
standard
deviat
total
number
percentag
case
high
variabl
median
interquartil
rang
report
mark
select
period
run
ecmo
sever
ard
due
bacteri
pneumonia
politrauma
postpneumonectomi
pneumocysti
pneumonia
lung
graft
failur
pneumonia
complic
pleural
empyema
chemic
pneumonia
main
result
ecmo
wean
icu
discharg
conclus
transfus
practic
institut
definit
trigger
sinc
sever
year
abandon
suggest
hb
valu
tack
account
function
data
possibl
thank
high
blood
flow
reach
high
effici
oxygen
decis
left
care
team
consid
actual
hemodynam
paramet
lactat
comorbid
sepsi
circuit
function
reach
wean
ecmo
elso
registri
main
result
patient
without
transfus
median
rate
prbc
transfus
mlday
ecmo
support
higher
report
use
lower
hb
trigger
probabl
quit
restrict
consid
sever
patient
support
relat
transfus
strategi
report
bleed
need
treatment
stop
anticoagul
surgicalendoscop
patient
need
ffp
need
plt
refer
lelubr
c
et
al
red
blood
transfus
strategi
critic
ill
patient
lesson
recent
random
clinic
studi
minerva
anestesiol
jan
epub
agerstrand
cl
et
al
blood
conserv
extracorpor
membran
oxygen
acut
respiratori
distress
syndrom
ann
thorac
surg
introduct
indic
extracorpor
membran
oxygen
ecmo
use
lung
transplant
lt
bridg
transplant
intraop
extracorpor
respiratori
andor
circulatori
support
treatment
primari
graft
dysfunct
pgd
postop
period
sever
mortal
risk
factor
preecmo
initi
investig
prealbumin
bodi
mass
index
bmi
predictor
mortal
critic
ill
patient
object
estim
nutrit
state
begin
ecmo
associ
mortal
method
retrospect
observ
studi
januari
march
bed
intens
care
unit
icu
tertiari
hospit
center
inclus
criteria
ecmo
entri
patient
list
lt
bridg
transplant
intraop
extracorpor
respiratori
andor
circulatori
support
pgd
ecmo
system
centrifug
pump
polymethylpenten
membran
oxygen
coat
circuit
cannula
demograph
data
includ
bmi
level
prealbumin
time
mechan
ventil
mv
collect
time
ecmo
initi
ecmo
indic
type
ecmo
support
icu
mortal
also
record
prealbumin
level
bmi
compar
survivor
nonsurvivor
continu
variabl
report
mean
standard
deviat
sd
median
rang
compar
use
student
ttest
categor
variabl
compar
use
test
analysi
perform
use
spss
ver
valu
p
consid
statist
signific
result
patient
p
male
femal
includ
median
age
year
sd
interv
median
simplifi
acut
physiolog
score
sap
ii
pulmonari
fibrosi
frequent
diagnosi
p
p
mv
start
ecmo
support
median
hour
interv
intraop
support
use
p
p
respiratori
p
cardiac
p
support
bridg
lt
p
p
respiratori
p
cardiac
p
support
pgd
indic
p
p
ecmo
place
cardiopulmonari
bypass
type
ecmo
support
peripher
venousarteri
p
central
venou
arteri
p
venousven
p
icu
mortal
median
bmi
survivor
nonsurvivor
median
prealbumin
level
survivor
nonsurvivor
statist
signific
observ
bmi
prealbumin
level
survivor
nonsurvivor
conclus
review
ecmo
patient
lt
statist
signific
differ
prealbumin
level
bmi
survivor
nonsurvivor
time
ecmo
initi
refer
wagner
k
risn
abdelnoor
karlsen
hm
svennevig
jl
possibl
predict
outcom
pulmonari
ecmo
analysi
preoper
risk
factor
perfus
introduct
venoven
ecmo
vvecmo
rescu
therapi
refractori
ard
despit
technolog
progress
enhanc
biocompat
anticoagul
unfraction
heparin
remain
often
use
recommend
bleed
complic
remain
main
caus
increas
morbid
mortal
patient
vvecmo
object
aim
studi
effect
dosag
unfraction
heparin
caw
heparin
antixa
patient
vvecmo
ard
method
perform
retrospect
observ
studi
first
quarter
patient
baselin
characterist
dose
ufh
anticoagul
biolog
data
anticoagul
aptt
antixa
hemochron
act
atiii
fibrinogen
collect
studi
incid
haemorrag
thromboembol
event
ufh
anticoagul
result
patient
ard
requir
vvecmo
includ
major
men
vs
p
mean
age
year
year
case
doublelumen
cannula
use
mean
diamet
other
cannul
averag
diamet
femor
vein
ufh
anticoagul
use
patient
patient
ufh
instal
vvecmo
averag
valu
aptt
second
antixa
averag
hemochron
sec
valu
ufh
administ
averag
iu
h
ivs
bleed
complic
note
case
none
patient
ecmo
thrombosi
cannula
oxygen
patient
posit
patient
chang
anticoagul
conclus
anticoagul
use
studi
appear
lower
recommend
without
increas
thromboembol
complic
persist
high
rate
bleed
complic
without
direct
connect
ecmo
result
reinforc
idea
lower
anticoagul
ratio
patient
vvecmo
note
abstract
previous
publish
avail
includ
complet
record
abstract
confer
refer
extracorpor
life
support
patient
acut
respiratori
distress
syndrom
report
consensu
confer
ann
intens
care
may
zogheib
e
nader
j
villeret
l
guilbart
pesserv
p
cau
dupont
h
vvecmo
ard
toward
lower
coagul
ration
ann
intens
care
suppl
grant
acknowledg
ecmo
introduct
low
flow
extracorpor
venoven
remov
therapi
addit
mechan
ventil
use
remov
allow
protect
ventil
pv
ard
howev
techniqu
requir
anticoagul
may
induc
sever
bleed
critic
ill
patient
altern
method
consist
use
citrat
anticoagul
object
aim
studi
assess
effect
citrat
anticoagul
extract
method
studi
conduct
experiment
model
sever
hypercapn
acidosi
perform
group
pig
first
group
heparin
group
pig
anticoagul
standard
protocol
unfraction
heparin
citrat
use
devic
anticoagul
second
group
citrat
group
sedat
analgesia
endotrach
intub
via
cervic
tracheostomi
pig
connect
volumecycl
ventil
tidal
volum
mlkg
respiratori
rate
peep
sever
hypercapn
acidosi
obtain
reduc
tidal
volum
half
start
group
arteri
ph
lower
pump
assist
lung
protect
palp
maquet
germani
system
use
two
small
cannula
remov
blood
flow
palp
success
set
mlmin
set
last
minut
sweep
ga
flow
set
lmin
extract
arteri
ph
well
system
pulmonari
pressur
continu
follow
result
extract
depict
graph
mean
arteri
ph
normal
extracorpor
blood
flow
mlmin
come
arteri
ph
significantli
chang
citrat
group
compar
heparin
group
conclus
use
citrat
anticoagul
feasibl
trend
toward
better
extract
observ
citrat
group
statist
signific
compar
heparin
group
refer
kluge
et
al
intens
care
medicin
avoid
invas
mechan
ventil
extracorpor
carbon
dioxid
remov
patient
fail
noninvas
ventil
grant
acknowledg
leon
fredericq
foundat
univers
belgium
introduct
extracorpor
membran
oxygen
ecmo
one
rescu
therapi
sever
acut
respiratori
distress
syndrom
ard
need
anticoagul
activ
clot
cascad
caus
ecmo
circuit
put
patient
risk
bleed
thrombosi
convent
coagul
test
fail
fulli
describ
complic
process
use
point
care
poc
method
like
thromboelastometri
platelet
aggregometri
may
provid
addit
inform
clot
develop
lysi
platelet
activ
howev
role
poc
test
venoven
vv
ecmo
ard
still
remain
object
assess
associ
poc
test
episod
hemorrhag
ecmo
method
blood
sampl
rotat
thromboelastometri
aggregometri
collect
immedi
start
ecmo
everi
day
first
day
hour
remov
circuit
prothrombin
time
pt
activ
partial
thromboplastin
time
aptt
platelet
count
plt
antixa
activ
plasma
fibrinogen
level
activ
clot
time
act
record
bleed
episod
defin
sever
associ
administr
least
unit
pack
red
blood
cell
rbc
result
enrol
sever
ard
patient
requir
vvecmo
ecmo
median
durat
interquartil
rang
day
mortal
found
strong
correl
maximum
clot
firm
mcf
amplitud
curv
minut
rotem
test
rho
p
patient
least
one
episod
bleed
hemorrhag
sever
plt
lower
bleed
compar
nonbleed
group
p
among
rotem
test
heparinas
modifi
thromboelastometri
clot
time
clot
format
time
heptem
ct
cft
significantli
higher
bleed
group
p
fig
poc
test
evalu
intrins
extrins
coagul
pathway
well
thrombin
receptor
activ
test
trapauc
assess
platelet
aggregometri
differ
group
even
though
statist
signific
fig
differ
pt
aptt
antixa
activ
fibrinogen
act
group
conclus
rotem
strongli
correl
mcf
provid
fast
coagul
assess
ecmo
bleed
episod
predict
use
convent
laboratori
coagul
test
except
plt
found
associ
heptem
ct
cft
hemorrhag
increas
sampl
size
might
identifi
poc
test
use
predict
monitor
hemorrhag
thrombot
complic
refer
anz
ecmo
influenza
investig
extracorpor
membran
oxygen
influenza
acut
respiratori
distress
syndrom
jama
bollig
et
al
pointofcar
coagul
manag
algorithm
ecmo
support
yet
minerva
anestesiol
mar
introduct
noninvas
ventil
niv
routin
use
hypercapn
patient
acut
exacerb
copd
extracorpor
remov
techniqu
evalu
patient
niv
failur
feasibl
techniqu
late
niv
failur
hour
unknown
object
tri
assess
feasibl
singl
site
system
hypercapn
patient
acut
exacerb
copd
late
niv
failur
method
five
hypercapn
copd
patient
admit
icu
acut
exacerb
whose
respiratori
acidosi
improv
despit
hour
niv
enrol
singl
center
prospect
feasibl
trial
low
flow
singl
site
system
alung
technolog
pittsburgh
pa
use
primari
endpoint
time
normal
arteri
blood
ga
ph
level
data
express
median
percentil
result
ph
level
icu
admiss
mmhg
respect
ph
level
initi
mmhg
respect
start
hour
niv
treatment
arteri
blood
ga
ph
level
came
normal
rang
hour
treatment
one
patient
stop
due
clot
circuit
complic
observ
regard
use
system
conclus
system
altern
copd
patient
late
niv
failur
system
seem
safe
due
low
flow
characterist
clot
complic
must
kept
mind
studi
need
emphas
result
also
test
impact
procedur
outcom
like
ventil
free
day
durat
icu
stay
cost
mortal
refer
burki
nk
mani
rk
herth
fj
schmidt
w
teschler
h
bonin
f
becker
h
randerath
wj
stieglitz
hagmey
l
priegnitz
c
pfeifer
blaa
sh
putensen
c
theuerkauf
n
quintel
moerer
novel
extracorpor
co
remov
system
result
pilot
studi
hypercapn
respiratori
failur
patient
copd
chest
mar
doi
kluge
braun
sa
engel
nierhau
fring
ebelt
h
uhrig
metschk
wegscheid
k
suttorp
n
rousseau
avoid
invas
mechan
ventil
extracorpor
carbon
dioxid
remov
patient
fail
noninvas
ventil
intens
care
med
oct
introduct
sever
acut
respiratori
distress
syndrom
ard
associ
mortal
current
low
tidal
volum
ventil
proven
reduc
mortal
patient
ard
frequent
difficult
achiev
presenc
hypercapnia
decreas
ventilatori
drive
pressur
strongli
associ
icu
surviv
hypothesis
ventil
combin
reduc
tidal
volum
extracorpor
carbon
dioxid
remov
eccor
may
result
improv
mortal
prospect
randomis
trial
plan
object
assess
patient
sever
ard
acidosi
secondari
hypercapnia
use
venoveno
eccor
normalis
ph
reduct
peak
airway
pressur
secondari
outcom
surviv
hospit
discharg
complic
therapi
method
data
ventilatori
arteri
blood
ga
paramet
therapi
prospect
collect
enter
extracorpor
life
support
organis
elso
registri
line
nation
guidanc
hemolung
ra
lung
technolog
use
provid
eccor
result
patient
receiv
eccor
use
hemolung
patient
improv
degre
acidosi
mean
hydrogen
ion
concentr
fall
nm
ph
nm
ph
first
hour
mean
fall
kpa
kpa
peak
airway
pressur
drop
time
period
direct
complic
therapi
patient
surviv
hospit
discharg
discuss
use
eccor
local
patient
sever
ard
possibl
lower
hydrogen
ion
concentr
improv
degre
acidosi
correspond
trend
lower
peak
airway
pressur
small
case
seri
reach
statist
signific
complic
therapi
mortal
shown
lower
quot
ard
trial
refer
bellani
et
al
epidemiolog
pattern
care
mortal
patient
acut
respiratori
distress
syndrom
intens
care
unit
countri
jama
ard
network
ventil
lower
tidal
volum
compar
tradit
tidal
volum
acut
lung
injuri
acut
respiratori
distress
syndrom
new
england
journal
medicin
amato
et
al
drive
pressur
surviv
acut
respiratori
distress
syndrom
new
england
journal
medicin
bein
et
al
lower
tidal
volum
strategi
mlkg
combin
extracorpor
remov
versu
convent
protect
ventil
mlkg
sever
ard
intens
care
med
protect
ventil
venoven
lung
assist
respiratori
failur
http
access
http
access
introduct
would
like
present
experi
use
arterioven
extracorpor
membran
carbon
dioxid
remov
devic
novalung
ila
district
gener
hospit
set
object
analys
data
review
practic
use
respiratori
failur
method
period
year
use
arterioven
devic
novalung
ila
patient
overal
mortal
analys
retrospect
patient
due
lack
complet
document
patient
survivor
result
review
sampl
patient
three
patient
surviv
common
diagnosi
popul
pneumonia
other
ard
post
cardiac
arrest
refractori
asthma
compar
patient
group
survivor
nonsurvivor
mean
age
survivor
vs
nonsurvivor
mean
apach
score
vs
two
three
survivor
singl
organ
failur
one
requir
crrt
aki
patient
nonsurviv
group
multiorgan
failur
mean
time
initi
support
post
itu
admiss
vs
hour
vs
hour
patient
mean
initi
kpa
first
hour
kpa
hour
kpa
devic
associ
complic
survivor
dgroup
one
limb
ischaemia
nonsurvivor
group
conclus
analysi
show
use
devic
significantli
improv
elimin
patient
allow
us
use
lung
protect
ventil
strategi
surviv
small
group
clearli
influenc
select
patient
tri
identifi
group
patient
would
like
benefit
invas
intervent
small
group
patient
earli
initi
lower
apach
score
singl
organ
failur
young
age
factor
predict
good
outcom
continu
audit
use
devic
unit
current
use
venoven
devic
elimin
risk
signific
complic
av
limb
ischaemia
introduct
metaanalys
suggest
levosimendan
superior
tradit
inotrop
decreas
postop
morbid
improv
hemodynam
function
decreas
myocardi
injuri
time
compar
balloon
counterpuls
method
observ
prospect
admit
patient
ariam
registri
septemb
public
privat
hospit
ccv
retrospect
compar
patient
underw
cabg
treat
iabp
surgeri
receiv
levosimendan
surgeri
immedi
surgeri
analys
clinic
epidemiolog
data
group
well
complic
hospit
stay
mortal
use
mann
whitney
u
test
exact
test
alpha
maximum
comparison
variabl
accord
necess
result
patient
involv
cabg
time
period
studi
patient
treat
bciao
surgeri
receiv
levosimendan
differ
age
comorbid
two
group
analys
extracorpor
circul
time
p
howev
function
statu
time
surgeri
wors
group
bciao
nyha
iii
iv
p
risk
score
use
euroscor
p
patient
postop
complic
similar
group
differ
hospit
stay
mortal
group
group
patient
treat
levosimendan
develop
lower
rate
heart
failur
renal
failur
creat
mg
dl
prolong
mechan
ventil
group
receiv
bciao
p
howev
levosimendan
group
requir
patient
necessari
group
conclus
levosimendan
heart
coronari
arteri
bypass
surgeri
decreas
postop
morbid
heart
failur
renal
failur
prolong
mechan
ventil
increas
need
crrt
differ
found
mortal
hospit
stay
refer
levosimendan
versu
intraaort
balloon
pump
adult
cardiac
surgeri
patient
jctva
wessex
cardiothorac
centr
univers
southampton
southampton
gener
hospit
southampton
unit
kingdom
calcium
sensit
levosimendan
give
superior
result
dobutamin
postop
low
cardiac
output
syndrom
r
l
levina
et
al
servicio
de
cardiovascular
hospit
universitario
de
la
universidad
abierta
interamericana
del
hospit
bueno
air
argentina
introduct
fluid
overload
associ
wors
outcom
critic
ill
patient
object
aim
studi
investig
impact
fluid
overload
fo
initi
renal
replac
therapi
rrt
critic
ill
patient
acut
kidney
injuri
aki
method
perform
retrospect
analysi
patient
treat
rrt
aki
multidisciplinari
intens
care
unit
icu
univers
hospit
london
uk
cumul
fluid
balanc
day
initi
rrt
use
describ
fluid
accumul
estim
baselin
bodi
weight
bw
fo
defin
fluid
accumul
greater
bw
collect
data
relat
patient
demograph
anthropometr
sofa
score
outcom
hospit
mortal
length
stay
icu
result
patient
receiv
rrt
aki
die
hospit
signific
differ
cumul
fluid
balanc
initi
rrt
hospit
survivor
nonsurvivor
fig
patient
fo
significantli
higher
hospit
mortal
p
longer
stay
icu
day
versu
p
also
higher
sofa
score
compar
patient
fo
tabl
conclus
critic
ill
patient
aki
fluid
overload
initi
rrt
associ
significantli
higher
mortal
longer
stay
icu
grant
acknowledg
research
sole
support
european
renal
associationeuropean
dialysi
transplant
associ
eraedta
shortterm
young
fellowship
grant
introduct
aki
complic
acut
ill
signific
implic
volum
resuscit
seen
integr
manag
much
recent
debat
regard
overal
volum
balanc
import
treatment
object
decid
examin
relationship
fluid
prescript
patient
outcom
patient
aki
method
premier
databas
identifi
studi
popul
hospit
patient
admit
icu
aki
first
day
hospitalis
receiv
least
l
day
fluid
surviv
day
multivari
model
built
predict
mortal
casemix
adjust
model
appli
data
set
order
adjust
sever
ill
togeth
premorbid
assess
result
mean
age
year
male
emerg
diabet
ckd
mean
lo
day
day
icu
averag
day
fluid
l
median
l
lowest
without
pressor
l
highest
mv
septic
shock
l
hospit
mortal
day
survivor
vari
mv
pressor
nmnp
among
mv
pressor
mvap
signific
associ
volum
day
fluid
hospit
surviv
seen
overal
mortal
receiv
l
fluid
l
fluid
l
respectivelyfor
nmnp
case
actual
expect
mortal
rate
decreas
increas
fluid
volum
l
l
patient
receiv
pressor
mv
exhibit
minim
variat
expect
mortal
present
decreas
mortal
low
middl
rang
l
l
increas
mortal
middl
high
rang
l
l
highest
sever
group
exhibit
chang
actual
expect
mortal
fluid
administr
septic
shock
requir
mv
case
variat
mortal
across
lower
group
day
fluid
use
l
l
howev
higher
rang
l
group
increas
actual
mortal
rate
l
l
higher
predict
conclus
potenti
resuscit
resuscit
observ
patient
aki
receiv
treatment
vasopressor
requir
pressor
mv
support
clear
associ
exist
volum
excess
outcom
emphas
need
better
understand
individu
fluid
need
import
popul
refer
waikar
ss
liu
kd
chertow
gm
incid
prognost
signific
acut
kidney
injuri
current
opinion
nephrolog
hypertens
kdigo
clinic
practic
guidelin
acut
kidney
injuri
kidney
int
suppl
ostermann
straaten
hm
forni
lg
fluid
overload
acut
kidney
injuri
caus
consequ
critic
care
introduct
laparoscop
abdomin
surgeri
wide
use
reduc
length
stay
complic
open
abdomin
surgeri
oper
pneumoperitoneum
need
creat
better
visual
oper
field
follow
decreas
urin
output
result
acut
kidney
injuri
howev
know
effect
pneumoperitoneum
factor
induc
acut
kidney
injuri
aki
object
aim
show
incid
aki
patient
undergon
laparoscop
abdomin
surgeri
propos
set
risk
factor
associ
develop
aki
follow
laparoscop
abdomin
surgeri
method
patient
underw
laparoscop
abdomin
surgeri
king
chulalongkorn
memori
hospit
bangkok
thailand
prospect
enrol
n
two
exclud
due
preexist
chronic
kidney
diseas
nsaid
use
previou
week
baselin
characterist
laboratori
result
introp
data
prospect
record
case
record
form
urin
neutrophil
gelatinaseassoci
lipokalin
ngal
measur
surrog
marker
aki
identifi
kdigo
criteria
characterist
analyz
ttest
nonparametr
test
factor
associ
aki
identifi
use
logist
regress
area
receiv
oper
characterist
curv
auc
result
patient
receiv
laparoscop
abdomin
surgeri
develop
postop
aki
mean
age
initi
blood
pressur
initi
glomerular
filtrat
rate
differ
aki
nonaki
group
peak
serum
creatinin
seen
hour
postop
aki
patient
significantli
increas
urin
ngal
level
hour
postop
compar
nonaki
p
mean
oper
time
inflat
time
exposur
index
defin
product
inflat
time
intraabdomin
pressur
significantli
higher
aki
compar
nonaki
patient
p
durat
intraop
hypotens
amount
blood
loss
intraven
fluid
differ
group
multivari
analysi
exposur
index
significantli
associ
postop
aki
adjust
odd
ratio
ci
auc
inflat
time
oper
time
exposur
index
respect
p
conclus
postop
aki
occur
patient
undergon
laparoscop
abdomin
surgeri
larger
cohort
requir
confirm
find
refer
chiu
aw
chang
ls
birkett
dh
et
al
impact
pneumoperitoneum
pneumoretroperitoneum
gasless
laparoscopi
system
renal
hemodynam
j
coll
surg
nov
grant
acknowledg
none
introduct
incid
acut
kidney
injuri
aki
critic
ill
patient
approxim
odd
ratio
death
high
patient
aki
often
impair
excret
salt
water
hand
intraven
fluid
part
manag
aki
increas
risk
fluid
overload
patient
object
examin
associ
fluid
overload
outcom
icu
patient
aki
method
retrospect
cohort
studi
adult
icupati
two
univers
hospit
denmark
admit
jan
dec
case
aki
identifi
accord
creatinin
criteria
kdigo
definit
fluid
data
miss
patient
exclud
analysi
associ
cumul
fluid
balanc
risk
deathren
recoveri
day
estim
joint
model
techniqu
cumul
fluid
balanc
dichotom
cutoff
admiss
bodi
weight
day
first
five
day
admiss
longitudin
submodel
fit
use
mix
effect
logist
regress
surviv
submodel
cox
model
adjust
age
gender
sever
diseas
sap
ii
kdigo
grade
use
life
support
norepinephrin
mechan
ventil
dialysi
studi
approv
nation
board
health
waiv
need
consent
result
screen
patient
identifi
aki
fig
develop
fluid
overload
respect
bodywieght
bw
first
day
icu
fig
day
aki
patient
renal
recoveri
die
tabl
fluid
overload
bw
day
first
day
icu
associ
hazard
ratio
hr
death
p
bw
fluid
overload
hr
death
p
contrast
associ
fluid
accumul
renal
recoveri
conclus
cohort
patient
aki
develop
fluid
overload
bw
first
day
icu
fluid
overload
even
bw
associ
increas
mortal
adjust
risk
factor
fluid
overload
associ
renal
recoveri
refer
host
eaj
bagshaw
sm
et
al
epidemiolog
acut
kidney
injuri
critic
ill
patient
multin
akiepi
studi
intens
care
med
bellomo
r
kellum
j
ronco
c
acut
kidney
injuri
lancet
rizopoulo
joint
model
longitudin
timetoev
data
ed
london
chapman
hallcrc
biostatist
seri
grant
acknowledg
studi
fund
depart
anaesthesiolog
hospit
introduct
subtl
worsen
renal
function
associ
advers
outcom
pediatr
patient
pt
heart
failur
cardioren
syndrom
cr
recent
coin
term
underscor
coexist
cardiac
renal
dysfunct
stress
bidirect
natur
heartkidney
interact
well
defin
adult
popul
avail
pediatr
data
scarc
acut
kidney
injuri
aki
consensu
definit
could
offer
standard
approach
cr
definit
could
help
stratifi
patient
object
appli
three
consensu
definit
aki
previous
valid
heterogen
pediatr
popul
pediatr
risk
injuri
failur
prifl
acut
kidney
injuri
network
akin
kidney
diseas
improv
global
outcom
kdigo
assess
cr
burden
associ
outcom
method
retrospect
studi
pt
admit
acut
decompens
heart
failur
adhf
failur
medic
therapi
defin
mechan
support
transplant
death
cr
defin
admiss
adhf
concomit
aki
accord
kdigo
akin
prifl
creatinin
criteria
result
pt
male
year
iqr
includ
hospit
lo
day
pt
prior
diagnosi
heart
failur
baselin
creatinin
fmt
happen
pt
mortal
akin
kdigo
ident
diagnos
stage
cr
kdigo
data
present
cr
admiss
present
prifl
vs
kdigo
p
prifl
identifi
addit
pt
cr
admiss
compar
kdigo
r
f
cr
admiss
either
prifl
kdigo
good
predict
fmt
auc
vs
respect
similar
stage
cr
reach
admiss
either
definit
auc
prifl
stage
vs
kdigo
stage
wherea
peak
cr
stage
reach
admiss
good
predict
abil
fmt
auc
pt
still
fulfil
cr
criteria
prifl
kdigo
respect
discharg
prifl
kdigo
admiss
cr
pt
persist
cr
discharg
kdigo
stage
cr
discharg
associ
readmiss
p
prifl
stage
p
auc
kdigo
vs
prifl
readmiss
conclus
cr
common
pediatr
pt
adh
persist
discharg
renal
function
discharg
predict
readmiss
peak
kdigo
stage
predict
composit
outcom
death
transplant
mechan
support
discharg
kdigo
stage
predict
readmiss
kdigo
stage
outperform
prifl
stage
outcom
predict
pediatr
cr
find
need
valid
prospect
multicent
studi
introduct
microcirculatori
dysfunct
import
trigger
event
organ
dysfunct
sepsi
fluid
therapi
essenti
improv
hemodynam
ideal
fluid
strategi
sepsi
develop
yet
aggressivefluid
therapi
controversi
consequ
kidney
dysfunct
littl
known
studi
investig
effect
earli
phase
aggressivefluid
therapi
kidney
microcircul
tubular
structur
method
adult
wistar
rat
g
submit
sepsi
iv
ml
e
coli
cfuml
hour
sepsi
ringer
lactat
infus
min
minut
sepsi
challeng
gener
anesthesia
microcircul
renal
cortic
area
monitor
sidestream
dark
field
imag
sdf
videomicroscopi
hour
n
day
n
sepsi
tissu
sampl
evalu
histolog
pa
stain
result
conclus
sdf
show
broadli
distribut
microcircul
tissu
dysfunct
group
fig
outlin
tubul
becam
blur
enlarg
compress
tubular
lumen
peritubular
microvessel
suggest
obstruct
phenomenon
cellular
edema
histolog
hour
sepsi
anim
treat
aggress
fluid
infusionshow
less
peritubular
congest
preserv
mesangi
space
lower
area
hyalin
degener
better
preserv
tubular
lumen
compar
sepsi
without
aggress
overhydr
pa
stain
show
slight
hyalin
degener
better
preserv
tissu
architectur
lower
occurr
cellular
death
suggest
aggress
fluid
therapi
earli
stage
sepsi
minim
sever
vascular
tissu
injuri
kidney
live
anim
treat
aggress
fluid
show
less
peritubularmicrovesselscongest
compar
better
preserv
mesangi
space
minor
hyalin
degener
less
cell
death
deeper
region
cortexaft
month
recoveri
howev
gener
appear
show
kidney
limit
venou
blood
drainag
clearli
aggressivefluid
therapi
attenu
renal
damag
compar
result
suggest
anim
treat
aggress
fluid
therapi
earli
stage
sepsi
better
condit
respond
new
harm
challeng
kidney
besid
recov
process
sepsi
seem
partial
justifi
occurr
postsepsi
syndrom
grant
acknowledg
fapesp
introduct
electr
cardiometri
allow
measur
fluid
statu
use
thorac
fluid
content
tfc
cardiac
output
cardiac
index
system
vascular
resist
index
could
ideal
noninvas
hemodynam
monitor
patient
undergo
hemodialysi
hd
object
investig
relat
chang
tfc
amount
fluid
remov
hd
session
monitor
hemodynam
parametersto
avoid
episod
hemodynam
compromis
hd
session
method
thirti
critic
ill
patient
hd
enrolledclin
assess
volum
overload
hemodynam
bp
map
cvp
monitor
electr
cardiometri
hd
session
result
studi
patient
male
repres
n
mean
age
yearsther
posit
correl
ufvolum
tfc
r
p
studi
hemodynam
stabl
vs
hypotens
repres
non
respond
group
lower
tfc
compar
hemodunam
stabl
group
vs
p
valu
indic
hypovolem
studi
congest
vs
remain
persist
congest
accomplish
hd
session
significantli
higher
tfc
compar
get
red
congest
vs
p
valu
indic
still
hypervolem
use
analysi
roc
curv
tfc
significantli
predictor
hypotens
p
also
tfc
cutoff
valu
predict
persist
congest
p
conclus
electr
cardiometri
evolv
noninvas
tool
adjust
fluid
statu
critic
ill
patient
rrt
use
thorac
fluid
content
indic
fluid
statu
could
use
avoid
hemodynam
instabl
persist
volum
overload
congest
hd
session
refer
palmer
bfand
henrich
wl
recent
advanc
prevent
manag
intradialyt
hypotensionj
soc
rosner
mhand
ronco
c
techniqu
assess
volum
statu
patient
end
stage
renal
diseasesemin
malik
v
subramanian
et
al
correl
electr
cardiometri
continu
thermodilut
cardiac
output
monitor
systemsworld
journal
cardiovascular
wynn
jl
ovadj
lo
et
al
imped
cardiographi
potenti
monitor
hemodialysisj
surg
osypka
mj
introduct
electr
cardiometri
cao
compani
editor
de
nicola
sucr
mj
imped
cardiographi
estim
hemodynam
fluid
statu
coma
patient
continu
venoven
hemodiafiltr
critic
van
de
water
jm
mount
et
al
tfc
thorac
fluid
content
new
paramet
assess
chang
chest
fluid
volumeam
introduct
acut
kidney
injuri
aki
believ
carri
good
prognosi
recent
report
rais
concern
longterm
outcom
assess
renal
function
reserv
aki
aid
ascertain
recoveri
kidney
function
object
develop
method
estim
renal
reserv
critic
care
set
method
exploratori
studi
select
patient
menwomen
year
without
known
previou
renal
diseas
develop
aki
icu
stay
patient
receiv
drug
could
interfer
renal
function
stabl
alreadi
recov
initi
problem
still
bladder
cathet
iv
line
nasogastr
tube
enter
feed
administr
load
gr
protein
enter
rout
creatinin
clearanc
crcl
calcul
next
hour
time
collect
urin
sampl
serum
creatinin
end
everi
period
analysi
perform
umannwhitney
kruskalw
nonparametr
test
data
mean
mean
error
standard
median
percentil
result
age
year
men
base
crcl
mlmin
median
percentag
chang
base
maximum
crcl
pick
detect
four
hour
protein
load
analys
two
hour
togeth
find
median
chang
chang
first
third
hour
signific
either
absolut
valu
p
p
hourli
chang
crcl
present
fig
conclus
protein
load
enter
rout
follow
earli
rise
creatinin
clearanc
profil
respons
let
us
propos
creatinin
clearanc
hour
load
gr
protein
quick
easi
way
estim
renal
reserv
next
goal
defin
profil
respons
differ
kind
patient
degre
renal
dysfunct
introduct
evid
establish
strong
link
acut
kidney
injuri
aki
progress
chronic
kidney
diseas
ckd
end
stage
renal
failur
esrf
aki
permen
loss
kidney
function
dialysi
depend
post
hospit
discharg
renal
followup
recommend
patient
aki
whilst
critic
ill
object
assess
whether
patient
receiv
renal
replac
therapi
rrt
icu
nephrolog
follow
determin
need
serviceto
assess
differ
mortal
group
method
perform
retrospect
longitudin
cohort
studi
analysi
patient
receiv
rrt
aki
greater
glasgow
clyde
hospit
one
year
renal
function
month
preadmiss
post
discharg
examin
compar
urea
creatinin
egfr
valu
nephrolog
follow
statu
also
investig
exclud
patient
renal
baselin
month
periodpair
ttest
analysi
use
analyz
preadmiss
vs
post
discharg
renal
baselin
normal
egfr
patient
result
sampl
admiss
patient
surviv
discharg
icu
patient
nephrolog
followup
remain
patient
follow
patient
abnorm
egfr
month
follow
patient
die
group
conclus
renal
follow
rate
rrt
critic
care
low
despit
abnorm
egfr
effici
followup
servic
requir
refer
uchino
kellum
ja
bellomo
r
et
al
acut
renal
failur
critic
ill
patient
multin
multicent
studi
jama
acut
kidney
injuri
lead
chronic
kidney
diseas
longterm
outcom
acut
kidney
injuri
best
opportun
mitig
acut
kidney
injuri
contrib
nephrol
kirwan
cj
blunden
mj
dobbi
h
jame
nedungadi
prowl
jr
critic
ill
patient
requir
acut
renal
replac
therapi
increas
risk
longterm
renal
dysfunct
rare
receiv
specialist
nephrolog
followup
nephron
introduct
risk
chronic
kidney
diseas
increas
time
evolut
type
diabet
chronic
metabol
control
peopl
year
occur
progress
loss
glomerular
filtrat
rate
correspond
ml
per
year
associ
progress
deterior
renal
tissu
replac
fibrou
tissu
involv
progress
glomeruroesclerosi
tubulointerstiti
fibrosi
nephrosclerosi
object
determin
evolut
time
diabet
preval
stage
chronic
kidney
diseas
materi
method
crosssect
descript
studi
done
patient
diabet
type
includ
year
evolut
diabet
type
sampl
calcul
averag
formula
finit
popul
select
simpl
random
sociodemograph
variabl
health
variabl
studi
stage
chronic
kidney
diseas
estim
cockcroftgault
equat
statist
analysi
includ
averag
percentag
confid
interv
method
cross
section
descript
observ
retrospect
studi
conduct
includ
adult
patient
year
older
year
diabet
mellitu
type
diagnosi
without
complic
mention
nephrolog
unit
hospit
gener
de
mexico
mexico
citi
result
regard
studi
popul
femal
averag
age
year
mean
glucos
mg
dl
time
evolut
diabet
patient
stage
year
patient
stage
year
averag
creatinin
clearanc
stage
ml
min
stage
ml
min
popul
stage
similar
percentag
stage
time
evolut
stage
stage
year
stage
year
conclus
chronic
kidney
diseas
public
health
problem
affect
health
system
around
world
today
studio
prefer
focus
popul
undergo
dialysi
treatment
variou
form
lie
stage
howev
comprehens
approach
chronic
kidney
diseas
stage
necessari
inform
condit
henc
import
studi
time
evolut
diabet
popul
analyz
stage
chronic
kidney
diseas
diabet
patient
chronic
kidney
diseas
flatter
distinguish
short
evolut
time
stage
high
popul
percentag
stage
refer
wild
roglic
g
green
sicre
r
king
h
globla
preval
diabet
estim
year
project
diabet
care
eknoyan
g
lameir
n
eckardku
kasisk
bl
et
al
kdigo
clinic
practic
guidelin
evalu
manag
chronic
kidney
diseas
introduct
approxim
patient
intens
care
unit
requir
renal
replac
therapi
rrt
admiss
though
figur
rang
depend
particular
hospit
previou
studi
suggest
patient
requir
rrt
icu
inhospit
mortal
rate
compar
overal
mortal
rate
patient
admit
icu
object
aim
studi
compar
demograph
physiolog
characterist
patient
requir
rrt
icu
requir
investig
impact
receiv
rrt
length
unit
stay
mortal
ultim
hospit
discharg
method
studi
multicentr
retrospect
observ
cohort
studi
use
data
januari
decemb
three
teach
hospit
intens
care
unit
combin
bed
associ
tertiari
referr
renal
servic
glasgow
data
use
collect
prospect
wardwatch
servic
demograph
detail
sever
score
physiolog
paramet
inform
length
unit
stay
inhospit
mortal
gather
standardis
mortal
ratio
smr
calcul
use
apach
ii
predict
mortal
score
denomin
result
data
total
patient
collect
receiv
rrt
admiss
mean
durat
rrt
standardis
mortal
ratio
two
group
compar
rrt
group
non
rrt
group
result
two
group
shown
conclus
patient
receiv
rrt
mortal
rate
ultim
hospit
discharg
roughli
line
previou
studi
nearli
twice
rate
requir
rrt
patient
also
stay
icu
twice
mani
day
requir
rrt
interest
note
howev
smr
actual
margin
lower
receiv
rrt
patient
requir
rrt
point
icu
stay
also
significantli
derang
physiolog
first
admiss
evidenc
urin
output
potassium
urea
creatinin
valu
two
group
refer
uchino
kellum
ja
acut
renal
failur
critic
ill
patient
multin
multicent
studi
scottish
intens
care
societi
audit
group
audit
critic
care
scotland
report
edinburgh
uk
nh
nation
servic
scotland
introduct
approxim
patient
intens
care
unit
icu
requir
renal
replac
therapi
rrt
admiss
though
figur
rang
depend
particular
hospit
studi
suggest
patient
requir
rrt
icu
roughli
inhospit
mortal
rate
compar
overal
mortal
rate
patient
admit
icu
object
aim
studi
compar
demograph
physiolog
characterist
patient
requir
rrt
icu
requir
investig
impact
receiv
rrt
length
unit
stay
mortal
ultim
hospit
discharg
method
studi
multicentr
retrospect
observ
cohort
studi
use
data
januari
decemb
three
intens
care
unit
icu
base
teach
hospit
bed
combin
associ
tertiari
renal
servic
data
use
collect
prospect
servic
demograph
detail
sever
score
physiolog
paramet
inform
length
unit
stay
inhospit
mortal
gather
standardis
mortal
ratio
smr
calcul
use
apach
ii
predict
mortal
score
denomin
result
data
total
patient
collect
receiv
rrt
admiss
mean
durat
rrt
day
result
two
group
shown
conclus
patient
receiv
rrt
mortal
rate
ultim
hospit
discharg
roughli
line
previou
studi
nearli
twice
rate
requir
rrt
patient
also
stay
icu
twice
mani
day
requir
rrt
interest
note
howev
smr
actual
lower
receiv
rrt
patient
requir
rrt
point
icu
stay
also
significantli
derang
physiolog
first
hour
admiss
evidenc
urin
output
potassium
urea
creatinin
valu
two
group
refer
uchino
kellum
ja
bellomo
r
doig
gs
morimatsu
h
morgera
et
al
acut
renal
failur
critic
ill
patient
multin
multicent
studi
jama
aug
scottish
intens
care
societi
audit
group
audit
critic
care
scotland
report
edinburgh
uk
nh
nation
servic
scotland
introduct
acut
kidney
injuri
aki
sever
complic
shock
pathophysiolog
pathway
includ
renal
vasoconstrict
endotheli
damag
microvessel
therebi
impair
micro
macrovascular
flow
microvascular
flow
measur
sublingu
sidestream
dark
field
imag
renal
macrocircul
assess
renal
resist
index
rri
peak
systol
flow
veloc
end
diastol
flow
veloc
peak
systol
veloc
use
doppler
ultrasound
obtain
intraren
arcuat
interlobar
arteri
high
rri
predictor
persist
aki
whether
rri
reflect
system
circul
renal
microcircul
well
known
object
determin
whether
rri
elev
patient
shock
relat
rri
concomit
marker
system
circul
sublingu
microcircul
hydrat
state
renal
function
method
perform
prospect
observ
cohort
studi
critic
ill
patient
admit
icu
august
februari
patient
shock
patient
without
shock
includ
icu
admiss
shock
defin
persist
hypotens
low
cardiac
index
lmin
despit
adequ
fluid
resuscit
need
vasopressor
defer
consent
obtain
inclus
three
studi
measur
perform
rri
sdf
bioelectr
imped
analysi
bia
assess
fluid
statu
resist
membran
integr
reactanc
uni
multivari
analys
comput
determin
relat
potenti
determin
rri
result
forti
patient
shock
without
shock
includ
patient
egfr
mlmin
exclud
mean
age
vs
yr
apach
iii
score
vs
p
shock
patient
higher
rri
patient
without
shock
median
vs
p
fig
univari
analysi
high
age
apach
iii
score
vasopressor
support
puls
pressur
index
ppi
systolicdiastol
systol
blood
pressur
central
venou
pressur
posit
fluid
balanc
low
mean
arteri
pressur
map
reactancem
creatinin
clearanc
marker
significantli
associ
high
rri
p
marker
microcircul
multivari
analysi
vasopressor
support
higher
ppi
lower
map
lower
xcm
remain
independ
determin
rri
n
adj
conclus
critic
ill
patient
shock
higher
rri
patient
without
shock
high
rri
associ
renal
dysfunct
one
hand
disturb
system
circul
vasopressor
support
high
ppi
low
map
poor
cellular
membran
resist
marker
microcircul
find
support
concept
shockinduc
aki
associ
renal
vasoconstrict
cellular
damag
refer
darmon
icm
introduct
sever
sepsi
state
constitut
worlwid
public
health
problem
thu
ssc
edict
recommend
improv
manag
patholog
author
express
reserv
implement
recommend
low
incom
countri
object
evalu
faisabl
impact
recommend
ssc
adult
septic
shock
univers
hospit
kinshasa
method
conduct
quasiexperiment
prospect
studi
twelv
month
februari
februari
studi
divid
phase
month
protocol
preprotocol
phase
protocol
postprotocol
phase
adult
year
old
septic
shock
within
period
includ
preprotocol
group
treat
usual
establish
local
protocol
base
ssc
recommend
postprotocol
group
receiv
earlier
hour
intraven
fluid
vasopressor
blood
transfus
larg
broad
spectrum
antibiot
next
hour
devot
failur
manag
endpoint
complianc
accord
ssc
recommend
mortal
group
result
patient
includ
first
phase
second
phase
patient
characterist
similar
group
infect
site
respons
septic
shock
mainli
pulmonari
cutan
urinari
abdomin
postprotocol
group
receiv
intraven
fluid
ml
catecholamin
well
blood
transfus
preprotocol
group
also
like
achiev
target
mean
arteri
pressur
versu
receiv
appropri
antibiot
versu
complianc
ssc
bundl
significantli
improv
pass
protocol
protocol
also
observ
signific
decreas
mortal
month
conclus
ssc
recommend
appli
countri
subsaharan
africa
signific
reduct
mortal
refer
alberti
c
brunbuisson
c
burchardi
h
al
epidemiolog
sepsi
infect
icu
patient
intern
multicentr
cohort
studi
intens
care
med
angu
dc
lindezwirbl
wt
lidick
j
clermont
g
al
epidemiolog
sever
sepsi
unit
state
analysi
incid
outcom
associ
cost
care
crit
care
med
delling
rp
levi
mm
rhode
al
surviv
sepsi
campaign
intern
guidelin
manag
sever
sepsi
septic
shock
crit
care
med
feb
baelani
l
jochberg
laimer
al
availibilityof
critic
care
resourc
treat
patient
sever
sepsi
septic
shock
africa
selfreport
contin
wide
survey
anaesthesia
providerscrit
introduct
venoven
vv
extracorpor
membran
oxygen
ecmo
becom
wide
accept
treatment
option
lifethreaten
acut
respiratori
failur
date
nosocomi
infect
bloodstream
infect
occur
ecmo
support
report
studi
relat
infect
directli
attribut
ecmo
devic
object
evalu
infect
colon
rate
relat
ecmo
devic
vvecmo
adult
patient
method
prospect
includ
consecut
adult
patient
treat
vvecmo
least
hour
referr
region
ecmo
center
time
ecmo
remov
systemat
perform
blood
cultur
swab
cultur
insert
cannula
site
femor
jugular
intravascular
cannula
extrem
cultur
classifi
ecmo
support
accord
infecti
statu
three
group
uninfecteduncolon
ecmo
devic
ecmo
devic
colon
ecmo
devic
infect
impact
outcom
assess
result
ninetynin
patient
underw
one
hundr
three
vvecmo
repres
ecmoday
ecmo
devic
infect
rate
per
ecmoday
event
ecmo
support
includ
ecmo
devicerel
bloodstream
infect
per
ecmoday
ecmo
devic
colon
rate
per
ecmoday
event
ecmo
support
coagulas
neg
staphylococcu
frequent
organ
respons
ecmo
devic
infect
ecmo
devic
colon
differ
observ
three
group
regard
day
mechan
ventil
icu
length
stay
mortal
hospit
mortal
observ
longer
ecmo
durat
ecmodevic
colon
group
compar
uninfecteduncolon
ecmodevic
group
day
day
versu
day
day
respect
p
conclus
time
ecmo
devic
remov
report
low
incid
infect
relat
devic
studi
need
evalu
benefit
systemat
strategi
use
chlorhexidineimpregn
dress
reduc
rate
colon
refer
brodi
bacchetta
extracorpor
membran
oxygen
ard
adult
n
engl
j
med
schmidt
n
hariri
et
al
nosocomi
infect
adult
cardiogen
shock
patient
support
venoarteri
extracorpor
membran
oxygen
clin
infect
di
publ
infect
di
soc
bizzarro
mj
conrad
sa
kaufman
da
et
al
infect
acquir
extracorpor
membran
oxygen
neonat
children
adult
pediatr
crit
care
med
j
soc
crit
care
med
world
fed
pediatr
intens
crit
care
soc
introduct
sever
necrot
soft
tissu
infect
nsti
life
threaten
bacteri
diseas
spread
quickli
cuti
subcuti
fascia
estim
mortal
incid
denmark
case
per
year
sweden
fulmin
cours
nsti
progress
matter
hour
requir
immedi
diagnosi
treatment
save
live
limb
littl
known
human
cost
diseas
patient
famili
short
long
object
object
explor
live
experi
famili
acut
stage
nsti
use
diari
written
close
famili
member
method
studi
multicent
binat
qualit
explor
design
use
diari
written
close
famili
member
n
acut
stage
trajectori
start
intens
care
unit
icu
hospit
nsti
central
denmark
sweden
famili
defin
broadest
term
spous
partner
bloodrel
neighbor
friend
qualit
content
analysi
investig
triangul
use
studi
part
pinfectstudi
investig
patient
famili
experi
nsti
differ
perspect
patient
famili
involv
appli
construct
studi
result
mean
age
patient
year
rang
mean
length
stay
icu
day
rang
day
main
theme
identifi
trajectori
ii
treatment
iii
patient
famili
first
theme
led
descript
typic
cours
nsti
trajectori
model
second
theme
focus
inform
need
famili
third
theme
identifi
issu
import
close
famili
close
patient
worst
famili
fear
relaps
network
travel
reflect
life
death
conclus
nsti
gener
unknown
patient
famili
come
shock
patient
sampl
receiv
rapid
treatment
icu
worst
consequ
avoid
nevertheless
close
famili
includ
spous
face
sudden
risk
disfigur
death
patient
cope
ambival
sever
place
lack
sleep
lack
certainti
recommend
provis
systemat
inform
acut
stage
includ
knowledg
expect
refer
et
al
prognost
factor
necrot
softtissu
infect
nsti
cohort
studi
jamacaddermatol
et
al
move
beyond
surviv
measur
success
understand
patient
experi
necrot
softtissu
infect
jsurgr
grant
acknowledg
lundbeck
foundat
introduct
give
seriou
underli
condit
follow
need
invas
procedur
icupati
highli
risk
develop
icuacquir
infect
repres
addit
mortal
factor
object
estim
incid
icuacquir
infect
tunisian
medic
intens
care
unit
method
prospect
studi
conduct
septemb
span
year
consecut
icu
patient
icu
length
stay
h
includ
surveil
till
discharg
death
data
collect
patient
characterist
initi
diagnosi
sap
ii
ventil
modal
condit
invas
cathet
insert
peripher
venou
cathet
central
venou
cathet
urinari
cathet
infect
declar
diagnosi
retain
accord
center
diseas
control
prevent
nation
healthcar
safeti
network
cdcnhsn
definit
type
infect
result
one
hundr
patient
includ
period
year
mean
age
histori
includ
diabet
mellitu
copd
immunocompromis
antibiot
admiss
mean
sap
ii
mechan
ventil
central
venou
cathet
insert
case
mean
length
stay
day
mean
durat
invas
mechan
ventil
day
patient
develop
icuacquir
infect
overal
icuacquir
infect
densiti
incid
day
develop
icuacquir
pneumonia
icuacquir
pneumonia
densiti
incid
day
patient
diagnos
central
line
relat
infect
densiti
incid
line
day
patient
develop
peripher
cathet
relat
infect
acinetobact
baumannii
isol
tracheal
aspir
icuacquir
pneumonia
case
overal
mortal
patient
develop
icuacquir
infect
conclusioncommentari
compar
intern
nosocomi
infect
control
consortium
inicc
report
present
studi
show
similar
rate
icuacquir
pneumonia
vs
day
howev
central
lineassoci
infect
rate
higher
vs
line
day
refer
rosenth
v
maki
mehta
leblebicioglu
h
memish
z
almousa
h
et
al
intern
nosocomi
infect
control
consortium
inicc
report
data
summari
countri
deviceassoci
modul
american
journal
infect
control
object
studi
design
investig
clinic
microbiolog
characterist
infect
surgic
intens
care
unit
sicu
univers
hospit
iran
method
retrospect
studi
patient
develop
infect
icu
year
period
januari
decemb
result
total
consecut
patient
admit
icu
period
among
develop
infect
mean
age
patient
year
patient
women
infect
ventilatorassoci
pneumonia
bloodstream
surgic
site
central
venou
cathet
urinari
tract
infect
microorgan
found
order
frequenc
acinetobact
baumannii
enterobacteriacea
klebsiella
pneumonia
candida
albican
pseudomona
aeruginosa
staphylococcu
aureu
microorgan
highli
resist
antibiot
case
complic
mortal
rate
conclus
infect
one
lead
caus
morbid
mortal
sicu
due
high
incid
drug
resist
rate
associ
complic
ventilatorassoci
pneumonia
lead
caus
icu
infect
studi
acinetobact
baumannii
frequent
found
organ
patient
introduct
variou
icd
code
abstract
strategi
use
identifi
sever
sepsi
case
administr
data
reliabl
data
valid
scarc
object
assess
accuraci
sever
sepsi
code
valid
trough
clinic
chart
review
identifi
reason
wrong
noncod
method
random
sampl
patient
stratifi
hospit
length
stay
icu
admiss
statu
admit
academ
medic
center
germani
select
sever
sepsi
patient
identifi
follow
abstract
strategi
appli
patient
primari
secondari
discharg
diagnos
clinic
sepsi
code
r
code
explicit
approach
microbiolog
clinic
sepsi
code
r
code
andimplicit
approach
infect
organ
dysfunct
code
gold
standard
diagnosi
sepsi
accord
accpsccm
consensu
criteria
base
review
full
patient
chart
four
independ
physician
predict
accuraci
abstract
strategi
compar
correct
stratifi
sampl
use
sampl
weight
follow
analysi
fals
neg
fals
posit
review
determin
reason
misclassif
result
chart
adult
patient
access
full
patient
sever
sepsissept
shock
sensit
specif
posit
neg
predict
valu
shown
tab
overal
explicit
code
strategi
limit
sensit
better
posit
predict
implicit
code
strategi
identif
strategi
base
clinic
andor
microbiolog
sepsi
code
risk
underestim
true
sepsi
incid
wherea
indirect
code
strategi
carri
risk
overestim
explicitli
identifi
case
code
fals
posit
n
organ
dysfunct
caus
infect
infect
organ
dysfunct
document
chart
patient
meet
two
sir
criteria
implicit
approach
falseposit
n
result
concurr
infect
organ
dysfunct
without
causal
infect
organ
dysfunct
identifi
retrospect
chart
review
meet
sir
criteria
implicitli
falseneg
n
organ
dysfunct
infect
code
case
respect
conclus
exist
icd
code
strategi
differ
accuraci
identifi
septic
patient
hospit
discharg
databas
thu
may
underestim
true
sepsi
incid
standard
valid
code
strategi
sever
sepsi
need
ensur
compar
epidemiolog
intervent
studi
base
administr
data
grant
acknowledg
cscc
fund
german
feder
ministri
educ
research
germani
fkz
introduct
level
healthcar
worker
knowledg
hospit
acquir
infect
hai
intern
recommend
strongli
influenc
increas
object
describ
level
knowledg
icu
doctor
nurs
physiotherapist
sagrada
clinic
hai
intern
recommend
method
appli
icu
doctor
nurs
physiotherapist
questionnair
use
evid
studi
includ
comprehens
question
concern
bloodstream
infect
catheterassoci
infect
ventilatorassoci
pneumonia
urinari
catheterassoci
infect
surgic
site
infect
hand
wash
gener
knowledg
hai
valid
number
correct
answer
rate
staff
good
medium
enough
poor
result
healthcar
worker
invit
particip
receiv
analyz
total
complet
questionnair
respons
rate
doctor
nurs
physiotherapist
overal
mean
age
standard
deviat
doctor
nurs
physiotherapist
particip
femal
mean
number
year
work
icu
doctor
nurs
physiotherapist
fourteen
healthcar
worker
receiv
train
hai
past
three
year
ten
attend
train
four
omit
mean
correct
answer
wrong
answer
p
healthcar
worker
rate
good
three
rate
medium
doctor
eight
enough
three
doctor
five
nurs
seventeen
poor
two
doctor
ten
nurs
four
physiotherapist
compar
result
found
signific
differ
doctor
nurs
p
doctor
physiotherapist
p
differ
nurs
physiotherapist
p
conclus
healthcar
worker
show
studi
good
knowledg
hospit
acquir
infect
intern
recommend
refer
iren
ocran
daniel
nii
arye
tago
asian
pac
j
trop
di
introduct
sepsi
one
lead
caus
mortal
amongst
icu
patient
howev
pauciti
inform
variabl
could
advis
physician
predict
mortal
object
identifi
risk
factor
associ
poor
prognosi
patient
sepsi
critic
care
unit
method
retrospect
observ
studi
perform
tertiari
referr
univers
hospit
month
septemb
septemb
inclus
patient
admit
icu
diagnosi
sepsi
code
audit
team
exclus
age
less
year
patient
admit
end
life
care
plan
data
collect
case
note
review
follow
detail
record
predesign
data
collect
sheet
demograph
profil
admiss
diagnosi
apach
ii
score
antibiot
comorbid
surviv
length
stay
ethic
approv
sought
studi
consid
servic
evalu
result
includ
patient
n
mortal
rate
demograph
detail
patient
seen
tabl
note
age
apach
ii
score
admiss
significantli
associ
high
mortal
mortal
increas
proportion
time
administr
antibiot
although
significantli
note
common
sourc
infect
respiratori
system
demonstr
graph
common
antibiot
use
piperacillintazobactam
mortal
higher
patient
respiratori
soft
tissuebon
sourc
infect
lowest
mortal
seen
infect
nervou
system
conclus
studi
demonstr
increas
age
high
apach
ii
score
delay
administr
antibiot
associ
higher
mortal
sepsi
relat
admiss
icu
aim
develop
score
system
identifi
differ
variabl
contribut
inform
decis
make
sepsi
relat
admiss
refer
vincent
jl
akr
sprung
cl
et
al
sepsi
european
intens
care
unit
result
soap
studi
crit
care
med
feb
introduct
sepsi
lead
caus
icu
admiss
associ
high
mortal
indian
data
avail
identifi
incid
sever
sepsi
septic
shock
outcom
object
identifi
incid
risk
factor
outcom
patient
sever
sepsissept
shock
method
prospect
observ
studi
done
multidisciplinari
icu
period
month
includ
adult
patient
admit
icu
featur
sever
sepsissept
shock
per
sccmaccp
guidelin
data
collect
done
demographi
coexist
ill
paramet
assess
acut
physiolog
chronic
health
evalu
apach
ii
sequenti
organ
failur
assess
sofa
score
relev
lab
data
includ
vital
paramet
data
concern
sourc
infect
obtain
organ
failur
support
measur
taken
captur
primari
outcom
data
mortal
collect
secondari
outcom
data
ventil
day
icu
length
stay
alo
ventil
free
day
captur
result
patient
screen
patient
sever
sepsi
incid
sever
sepsi
mortal
rate
admiss
apach
ii
sofa
score
high
common
sourc
infect
respiratori
tract
follow
urinari
tract
intraabdomin
infect
patient
requir
ventil
support
patient
requir
vasopressor
support
despit
adequ
fluid
resuscit
one
third
patient
requir
renal
replac
therapi
hematocrit
total
leucocyt
count
serum
bilirubin
sofa
score
significantli
higher
among
nonsurvivor
conclus
incid
sever
sepsi
high
associ
poor
patient
outcom
refer
angu
dc
lindezwirbl
wt
lidick
j
et
al
epidemiolog
sever
sepsi
unit
state
analysi
incid
outcom
associ
cost
care
crit
care
med
delling
rp
cardiovascular
manag
septic
shock
crit
care
med
martin
gs
mannino
dm
eaton
et
al
epidemiolog
sepsi
unit
state
n
engl
j
med
lindezwirbl
wt
angu
dc
sever
sepsi
epidemiolog
sampl
select
societi
crit
care
dombrovskiy
vy
martin
aa
sunderram
j
et
al
rapid
increas
hospit
mortal
rate
sever
sepsi
unit
state
trend
analysi
crit
care
med
introduct
inadequ
icu
bed
concurr
clean
associ
increas
risk
nosocomi
infect
critic
ill
patient
healthcar
provid
train
continu
educ
associ
better
outcom
sever
set
object
evalu
microbiolog
impact
train
critic
care
staff
concurr
clean
icu
bed
method
design
beforeandaft
studi
intervent
train
program
concurr
clean
critic
care
healthcar
provid
period
set
januari
octob
mix
privat
icu
pretest
questionnair
appli
particip
nurs
assess
initi
knowledg
concurr
clean
train
new
test
appli
particip
nurs
deem
approv
answer
correctli
least
question
microbiolog
burden
evalu
train
day
quantit
atp
essay
icu
bed
consid
clean
quantit
assay
result
less
equal
url
quantit
essay
result
higher
url
icu
bed
consid
contamin
new
clean
process
initi
microbiolog
burden
evalu
includ
three
differ
moment
follow
patient
admiss
six
hour
admiss
hour
admiss
result
total
icu
bed
includ
train
train
includ
train
critic
care
healthcar
provid
pre
posttest
answer
particip
provid
answer
correctli
question
respect
microbiolog
quantit
result
train
url
url
url
admiss
six
hour
admiss
hour
admiss
respect
thirti
day
train
result
url
url
url
admiss
six
hour
admiss
hour
admiss
respect
microbiolog
burden
significantli
reduc
train
admiss
p
six
hour
admiss
p
hour
admiss
p
conclus
train
program
concurr
clean
critic
care
healthcar
provid
effect
reduc
burden
microbiolog
specimen
icu
bed
refer
avila
mag
bocchi
scm
telephon
confirm
intent
present
elect
surgeri
strategi
reduc
absente
rev
esc
enferm
usp
rapparini
c
saraceni
v
lauria
lm
barroso
pf
vellozo
v
cruz
et
al
occup
exposur
bloodborn
pathogen
among
healthcar
worker
rio
de
janeiro
brazil
j
hosp
infect
grant
acknowledg
none
introduct
prevent
hospit
acquir
infect
among
intric
problem
critic
care
set
object
studi
sought
assess
effect
multidimension
approach
develop
team
reduct
cathet
relat
hospit
acquir
infect
crhai
rate
patient
hospit
adult
intens
care
unit
aicu
inicc
member
hospit
shiraz
iran
method
studi
divid
two
period
baselin
period
conduct
activ
prospect
surveil
vap
vae
clabsi
cauti
use
cdc
nhsn
definit
inicc
method
intervent
period
implement
multidimension
approach
vap
vae
clabsi
cauti
addit
perform
activ
surveil
multidimension
approach
includ
bundl
infect
control
intervent
includ
hand
hygien
activ
screen
contact
precaut
environment
clean
baselin
rate
crhai
compar
rate
obtain
intervent
analyz
impact
intervent
z
score
result
two
year
studi
period
divid
epoch
sixmonth
durat
patient
admit
icu
bed
day
central
line
util
ratio
percentth
rate
clabsi
reduc
per
thousand
cathet
day
p
incid
vap
plu
vae
decreas
per
thousand
mechan
ventil
day
p
ventil
util
ratio
percent
rate
cauti
also
decreas
per
thousand
cathet
day
p
conclus
implement
multidimension
approach
crhai
associ
signific
reduct
clabsi
vap
plu
vae
cauti
rate
particip
aicu
introduct
salford
royal
foundat
trust
srft
hcai
involv
infect
methicillin
resist
staph
aureu
mrsa
clostridium
difficil
c
diff
fulli
investig
use
process
recommend
nation
patient
safeti
agenc
includ
use
root
caus
analysi
rca
event
surround
infect
fulli
describ
compar
accept
practic
share
outcom
investig
essenti
part
process
unless
result
dissemin
lesson
learnt
staff
involv
nh
nation
patient
safeti
agenc
describ
seven
stage
process
patient
safeti
outlin
process
object
assess
effect
result
investig
infect
mrsa
cdiff
dissemin
staff
work
ccu
srft
method
ccu
staff
duti
ask
complet
questionnair
without
refer
addit
sourc
inform
eg
noticeboard
colleagu
websit
survey
ask
particip
follow
question
long
ago
last
cdiffmrsa
infect
ccu
know
rca
infect
show
particip
ask
addit
comment
includ
heard
result
investig
idea
inform
could
effect
share
result
member
staff
particip
studi
group
mdt
repres
staff
awar
time
sinc
recent
infect
seen
tabl
perhap
even
worryingli
fewer
one
third
particip
awar
investig
either
hcai
shown
conclus
day
survey
recent
case
mrsa
cdiff
fulli
investig
result
rca
event
publish
despit
complet
investig
survey
show
learn
point
rais
share
small
percentag
critic
care
team
limit
impact
investig
work
result
work
intend
involv
member
mdt
rca
chang
way
result
investig
commun
critic
care
team
ensur
lesson
learnt
wider
group
individu
refer
seven
step
patient
safeti
overview
guid
nh
staff
london
nation
patient
safeti
agenc
edit
april
introduct
icu
infect
increas
icu
mortal
length
hospit
stay
extend
microorgansim
caus
infect
intens
care
vari
accord
countri
type
intens
care
object
aim
studi
determin
intens
care
infect
ici
preval
derinc
koca
educ
hospit
ascertain
risk
factor
describ
pathogen
associ
intens
care
infect
method
studi
aim
identifi
infecti
agent
retrospect
pointpreval
survey
march
concern
patient
intens
care
unit
least
hour
retrospect
analysi
patient
underw
icu
therapi
march
perform
primari
outcom
studi
aim
identifi
infecti
agent
retrospect
secondari
outcom
studi
identifi
area
infect
intens
care
result
patient
undergo
enfect
screen
infecti
agent
respect
pseudomona
aeroginosa
acinetobact
baumania
klebsiella
pneumonia
area
infect
respect
lower
respiratori
tract
urinari
tract
blood
circul
case
admit
icu
icu
infecti
agent
per
cent
respect
pseudomona
auroginosa
acinetobact
baumania
klebsiella
pneumonia
conclus
think
appropri
profil
factor
intens
care
infect
intens
care
turkey
end
studi
resist
acinetobact
colistin
risk
factor
associ
infect
longer
hospit
stay
precenc
comorbid
mulitrauma
still
turkey
first
intens
care
unit
locat
gram
neg
factor
refer
year
review
intens
care
medicin
ii
pneumonia
infect
sepsi
coagul
hemodynam
cardiovascular
microcircul
critic
care
organ
imag
ethic
legal
issu
massimo
antonelli
marc
bonten
maurizio
cecconi
jean
chastr
giusepp
citerio
giorgio
conti
j
randal
curti
goran
hedenstierna
michael
joannidi
duncan
macra
salvator
maggior
jordi
mancebo
alexandr
mebazaa
jeancharl
preiser
patricia
rocco
timsit
jan
wernerman
haibo
zhang
intens
care
med
march
publish
onlin
januari
doi
introduct
plasmapheresi
therapeut
plasma
exchang
tpe
establish
treatment
option
therapi
syndrom
gb
random
control
trial
establish
effici
far
recommend
number
tpe
session
four
optimum
tpe
protocol
number
exchang
volum
exchang
remain
establish
also
role
tpe
patient
gb
fail
respond
therapi
relaps
therapi
remain
determin
tpe
expect
logic
therapeut
option
diseas
pathogenesi
link
biolog
substanc
rel
high
molecular
weight
slow
rate
format
distribut
vascular
space
tpe
use
treatment
diseas
pathogenesi
associ
abnorm
circul
pathogen
autoantibodi
role
antibodi
gangliosid
gb
establish
miller
fisher
variant
type
gb
role
antibodi
still
remain
determin
optimum
tpe
protocol
especi
patient
fail
respond
therapi
patien
relaps
standard
tpe
protocol
determin
question
whether
patient
role
antibodi
consid
number
tpe
session
individu
adapt
result
object
want
determin
relationship
antibodi
gangliosid
patient
gb
tpe
influenc
tpe
protocol
method
prospect
screen
patient
gb
treat
tpe
antibodi
gangliosid
tpe
seri
adapt
number
tpe
neurolog
statu
result
antibodi
result
unexpect
number
gb
patient
icu
patient
admit
icu
period
monthsin
patient
chose
tpe
initi
therapi
test
patient
antibodi
gangliosid
tpe
protocol
adapt
number
tpe
clinic
cours
diseas
result
antibodi
gangliosid
patient
posit
antibodi
remain
neurolog
deffici
relaps
repeat
seri
tpe
conclus
studi
tpe
protocol
gb
year
old
optim
tpe
protocol
remain
establish
question
whether
efficaci
tpe
least
patient
sever
neurolog
symptom
patient
fail
respond
standard
tpe
protocol
individualis
accord
result
antibodi
gangliosid
refer
cortes
chaudhri
v
et
al
evidencebas
guidelin
updat
plasmapheresi
neurolog
disord
neurolog
jan
william
balogun
ra
principl
separ
indic
therapeut
target
plasma
exchangeclin
j
soc
nephrol
jan
introduct
traumat
brain
injuri
tbi
common
caus
morbid
europ
manag
rais
intracrani
pressur
icp
barbitur
coma
final
option
medic
interact
thiopenton
potassium
attribut
mortal
icu
object
review
frequenc
complic
contribut
factor
loss
potassium
homeostasi
thiopenton
infus
method
patient
prescrib
thiopenton
infus
march
select
serum
potassium
record
baselin
hourli
hour
infus
stop
follow
cessat
potassium
level
record
hourli
hour
unless
death
occur
potassium
replac
hour
use
insulin
note
complic
follow
infus
review
result
total
patient
prescrib
thiopenton
eight
receiv
bolu
three
indic
patient
durat
hour
exclud
thirtysix
patient
review
patient
die
infus
patient
characterist
shown
tabl
hypokalaemia
potassium
develop
patient
infus
mean
lowest
hour
fig
subsequ
patient
develop
hyperkalaemia
potassium
mean
peak
hour
three
patient
die
due
cardiac
arrest
hyperkalaemia
follow
infus
patient
requir
filtrat
control
potassium
insulin
use
durat
infus
weight
potassium
replac
presenc
hypokalaemia
statist
signific
relat
loss
regul
tabl
conclus
fatal
attribut
hyperkalaemia
post
barbitur
coma
aim
assess
occurr
contribut
factor
case
highlight
potassium
replac
signific
variabl
shown
possibl
due
restrict
replac
patient
infus
find
earlier
fall
potassium
follow
start
infus
earlier
peak
cessat
variabl
show
signific
suggest
lack
understand
caus
dysregul
studi
limit
sampl
size
like
due
limit
barbitur
coma
final
attempt
icp
control
larg
trial
may
requir
identifi
variabl
predict
hyperkalaemia
overal
littl
indic
patient
develop
hyperkalaemia
icu
staff
bewar
potenti
fatal
complic
refer
brain
trauma
foundat
american
associ
neurolog
surgeon
congress
neurolog
surgeon
et
al
guidelin
manag
sever
traumat
brain
injuri
introduct
j
neurotrauma
suppl
ng
sy
chin
kj
kwek
tk
dyskalaemia
associ
thiopenton
barbitur
coma
refractori
intracrani
hypertens
case
seri
intens
care
med
introduct
inflamm
key
player
brain
damag
increas
product
proinflammatori
lower
level
antiinflammatori
cytokin
peripheri
blood
cerebrospin
fluid
csf
associ
poorer
clinic
outcom
primari
intraventricular
hemorrhag
ivh
object
aim
studi
investig
chang
concentr
interleukin
il
transform
growth
factor
tgf
css
patient
ivh
extern
ventricular
drainag
treat
catheterbas
clot
lysi
lowdos
tissu
plasminogen
activ
tpa
method
thirti
adult
patient
ivh
enrol
prospect
studi
patient
divid
two
group
group
treat
h
tpa
pt
age
male
control
group
b
placebo
pt
age
male
intracerebr
hemorrhag
score
admiss
equal
group
ich
concentr
tgf
csf
determin
hour
day
day
start
clot
lysi
result
patient
group
concentr
il
significantli
lower
day
vs
p
day
vs
p
significantli
lower
day
vs
p
concentr
tgf
significantli
higher
day
vs
p
day
vs
p
significantli
higher
day
vs
p
conclus
intraventricular
clot
lysi
lowdos
tpa
probabl
amplifi
initi
antiinflammatori
respons
diminish
inflammatori
respons
later
stage
introduct
bone
marrow
suppress
leucopenia
infecti
complic
report
use
barbitur
coma
therapi
bct
refractori
intracrani
hypertens
howev
studi
mainli
involv
small
sampl
size
thu
although
effect
lower
intracrani
pressur
barbituratemedi
infect
may
sever
limit
potenti
life
save
util
bct
object
method
conduct
retrospect
cohort
studi
patient
n
receiv
thiopenton
bct
control
refractori
intracrani
hypertens
neurosurg
intens
care
unit
year
collect
data
includ
chang
cell
count
procalcitonin
level
incid
clinic
diagnos
infect
microbiolog
profil
organ
isol
antibiot
prescrib
also
analys
result
mean
preinduct
wbc
count
x
l
patient
experienc
decreas
wbc
count
induct
mean
maxim
decreas
white
cell
count
x
l
incid
leucopenia
neutropenia
respect
procalcitonin
level
gener
rais
earli
first
day
bct
incid
clinic
infect
pneumonia
n
blood
stream
infect
n
account
major
infect
main
caus
organ
caus
pneumonia
klebsiella
pneumonia
n
staphyloccu
aureu
n
pseudomona
aeruginosa
n
main
cultur
organ
blood
stream
infect
pseudomona
aeruginosia
n
klebsiella
pneumonia
n
enterococcu
cloaca
n
acinetobact
baumannii
staphyloccu
aureu
n
posit
cultur
klebsiella
pneumonia
n
multiresist
staphyloccu
aureu
n
methicillinresist
constitut
commonest
bacteria
isol
conclus
leucopenia
infect
predominantli
pneumonia
common
complic
patient
bct
refractori
intracrani
hypertens
refer
frenett
perreault
lam
williamson
thiopentalinduc
neutropenia
two
patient
sever
head
trauma
pharmacotherapi
stover
j
stocker
r
barbitur
coma
may
promot
revers
bone
marrow
suppress
patient
sever
isol
traumat
brain
injuri
eur
j
clin
pharmacol
introduct
stroke
diseas
high
morbid
mortal
constitut
main
medic
caus
perman
disabl
adulthood
spain
one
lead
caus
death
intraven
thrombolysi
approv
treatment
select
patient
new
recomend
group
could
bigger
advanc
imag
studi
acut
ischem
stroke
larg
due
develop
new
efficaci
treatment
carri
acut
phase
comput
tomographi
ct
perfus
studi
ct
angiographi
facilit
select
patient
like
benefit
appropri
earli
treatment
object
analyz
impact
new
recomend
acut
ischem
stroke
treatment
select
patient
treatment
outcom
patient
atend
polyval
icu
last
year
first
trimest
year
method
consecut
registri
patient
seen
last
year
first
trimest
year
suffer
acut
stroke
icu
univers
hospit
descript
analyz
registri
period
result
approach
suffer
acut
stroke
patient
women
men
medium
age
yo
treat
thrombolysi
patient
treatment
consider
efect
patient
report
case
bleed
ct
control
patient
thrombolysi
appli
caus
thrombolysi
contraind
case
indic
thrombolysi
case
improv
disabl
case
first
trimest
year
patient
women
men
medium
age
yo
thrombolysi
apppli
patient
efect
treatment
case
one
case
bleed
ct
control
patient
thrombolysi
appli
caus
thrombolysi
contraind
indic
thrombolysi
case
everi
group
improv
disabl
consider
caus
thrombolysi
conclus
new
recomend
acut
ischem
stroke
advanc
neuroradiolog
allow
better
approach
patient
increas
patient
benefit
treatment
effect
seem
increas
way
advers
result
seem
remain
low
case
introduct
acut
ischem
stroke
leader
term
mortal
disabl
earli
rehabilit
significantli
improv
outcom
treatment
one
effect
method
earli
rehabilit
passiv
vertic
aim
prevent
elimin
complic
associ
longstay
patient
supin
posit
one
rel
contraind
vertic
carri
mechan
ventil
av
object
assess
effect
earli
passiv
vertic
conduct
background
mechan
ventil
patient
ischem
stroke
method
analysi
medic
histori
patient
diagnosi
ischem
stroke
form
two
group
addit
vertic
group
person
without
vertic
group
peopl
patient
treat
accord
recommend
aha
asa
patient
underw
mechan
ventil
respir
hamilton
switzerland
vertic
carri
vertic
tabl
beka
hospit
germani
patient
conduct
sever
rate
scale
sofa
nihh
cg
admiss
first
stage
assess
respiratori
statu
result
group
assess
result
present
tabl
start
ventil
patient
group
requir
differ
time
substanti
averag
eighth
day
group
diagnos
pneumoniath
frequenc
hemodynam
disturb
durat
inotrop
support
compar
group
mortal
rate
group
significantli
lower
group
explain
increas
period
mechan
ventil
stay
patient
icu
hospit
analysi
go
surviv
patient
show
signific
differ
introduct
postcraniotomi
pain
report
moder
sever
manag
postcraniotomi
pain
inadequ
mani
case
yet
limit
side
effect
opioid
codein
mainstay
treatment
postcraniotomi
pain
institut
due
safer
side
effect
profil
compar
potent
opioid
howev
effect
may
limit
due
need
demethyl
analges
effect
process
subject
interindividu
variabl
object
primari
object
determin
differ
mean
pain
va
score
oxycodon
codein
group
hour
secondari
object
compar
pain
va
score
hour
compar
incid
excess
sedat
depress
respiratori
rate
gc
method
random
doubl
blind
control
trial
use
evalu
efficaci
oral
oxycodon
versu
oral
codein
patient
random
control
group
codein
n
experiment
group
receiv
oxycodon
n
addit
regular
oral
paracetamol
group
patient
analgesia
administ
accord
strict
protocol
patient
review
blind
assessor
close
day
subsequ
day
hour
postop
result
total
patient
analys
patient
drop
due
postsurg
complic
mean
pain
score
hour
p
codein
oxycodon
group
respect
also
statist
signific
differ
sedat
score
respiratori
rate
gc
score
conclus
oral
oxycodon
effect
oral
codein
manag
postcraniotomi
pain
local
popul
also
seemingli
mild
pain
craniotomi
mean
pain
va
score
compar
report
literatur
one
deduct
compar
western
popul
popul
probabl
minim
genet
variabl
abil
metabolis
codein
popul
may
effici
metabolis
thu
allow
codein
effect
oxycodon
also
patient
gener
mild
pain
codein
may
adequ
analgesia
differ
advers
effect
oxycodon
may
also
safe
codein
bioequival
dose
henc
oxycodon
consid
effect
altern
codein
introduct
ischem
stroke
still
constitut
major
caus
death
portug
widespread
invest
inform
popul
creation
net
refer
hospit
establish
protocol
intraven
fibrinolysi
endovascular
treatment
mortal
morbid
declin
object
object
studi
character
popul
undergo
intraven
fibrinolysi
alteplas
intens
care
unit
research
hospit
verifi
earli
hour
mortal
admiss
identifi
caus
death
method
observ
retrospect
studi
base
inform
acquir
clinic
record
patient
admit
intens
care
unit
intraven
thrombolysi
januari
decemb
statist
analysi
result
among
total
patient
includ
n
male
averag
year
oldth
averag
admiss
nation
institut
health
stroke
scale
nihss
score
averag
symptomstoneedl
time
minut
total
death
first
h
admiss
death
hour
day
post
admiss
earli
death
due
intracerebr
hemorrhag
account
progress
ischem
diseas
unrespons
thrombolysi
highest
caus
death
day
aspir
pneumonia
follow
progress
ischem
diseas
intracerebr
hemorrhag
septic
shock
prehospit
death
refer
caus
death
clinic
record
averag
nihss
score
twelv
hour
patient
die
hour
day
conclus
applic
adequ
guidelin
evalu
patient
propos
fibrinolysi
earli
death
account
total
death
attribut
non
effect
fibrinolyt
therapi
hemorrhag
complic
death
occur
day
post
admiss
occur
patient
higher
nihss
score
reveal
import
neurolog
dysfunct
frequent
caus
death
aspir
pneumonia
import
appli
prevent
measur
patient
icu
hospit
stay
order
reduc
aspir
pneumonia
incid
allow
patient
start
physiotherapi
soon
possibl
regain
lost
function
patient
suffer
stroke
evalu
multidisciplinari
team
involv
neurolog
intern
medicin
physiotherapi
regular
period
adequ
assist
resum
live
refer
h
et
al
stroke
e
golestanian
crit
care
med
dec
introduct
propofol
midazolam
known
excel
drug
sedat
intens
care
unit
object
studi
aim
compar
sed
analges
effect
recoveri
profil
propofol
midazolam
rat
model
conduct
motor
coordin
test
rotarodaccelerod
test
evalu
analges
respons
time
conduct
hot
plate
tail
flick
test
method
rat
randomli
divid
follow
group
basi
treatment
receiv
first
group
receiv
propofol
second
midazolam
third
morphin
fourth
control
group
rat
place
rotat
rod
test
first
slowest
speed
rpm
follow
speed
rpm
speed
increment
speed
rpm
speed
set
increas
rpm
within
min
accelerod
test
pain
reflex
respons
thermal
stimulu
measur
min
drug
inject
use
hot
plate
tail
flick
test
neurobehavior
statu
includ
sensori
motor
function
assess
everi
min
normal
function
resum
investig
blind
group
result
test
speed
midazolaminject
rat
remain
rotarod
longer
propofolinject
rat
furthermor
min
accelerod
test
midazolaminject
rat
remain
longer
durat
propofolinject
rat
latenc
time
hot
plate
test
significantli
higher
min
propofol
group
midazolam
group
min
latenc
time
greater
propofol
group
midazolam
group
latenc
time
min
tail
flick
test
greater
propofol
group
midazolam
group
propofol
enhanc
sensori
blockad
greater
extent
min
midazolam
correspond
time
point
durat
complet
motor
blockad
significantli
greater
propofol
group
midazolam
group
conclus
achiev
longterm
analges
benefit
propofol
treatment
may
effect
midazolam
treatment
propofol
may
prefer
sedat
applic
intens
care
unit
afford
faster
onset
recoveri
motor
coordin
perform
refer
bhana
n
goa
kl
mcclellan
kj
dexmedetomidin
drug
bittner
b
rc
isel
h
flament
c
impact
solutol
hs
pharmacokinet
behavior
midazolam
upon
intraven
administr
male
wistar
rat
eur
j
pharm
biopharm
introduct
ranolazin
rn
drug
use
treatment
chronic
angina
pectori
propos
manag
epilept
disord
abil
decreas
neuron
excit
block
late
inward
sodium
current
late
ina
central
nervou
system
recent
demonstr
primari
cultur
rn
could
act
neuroprotect
drug
promot
astrocyt
viabil
prevent
necrosi
apoptosi
inhibit
inflammatori
phenomena
induc
antiinflammatori
antioxid
agent
peptid
protein
involv
pathogenesi
diseas
produc
glial
activ
inflammatori
respons
oxid
stress
lead
neuron
death
object
hypothesi
ranolazin
act
neuroprotect
drug
present
studi
focus
effect
ranolazin
astrocyt
expos
toxic
peptid
method
incub
rat
astrocyt
primari
cultur
hour
rn
rn
cell
viabil
prolifer
measur
use
mtt
convers
assay
ldh
releas
assay
apoptosi
determin
caspas
activ
assay
result
cultur
astrocyt
rn
significantli
increas
cell
viabil
prolifer
concentr
test
decreas
ldh
leakag
caspas
activ
indic
less
cell
death
significantli
decreas
cell
viabil
compar
control
astrocyt
incub
rn
prevent
decreas
cell
viabil
induc
rn
decreas
ldh
releas
medium
rn
rn
toxic
peptid
increas
ldh
releas
incub
rn
lower
ldh
level
indic
protect
effect
conclus
ranolazin
increas
cell
viabil
prevent
necrosi
apoptosi
induc
suggest
rn
could
act
neuroprotect
drug
situat
associ
oxid
stress
inflamm
refer
belardinelli
l
et
al
j
pharmacol
exp
ther
park
yy
et
al
j
neurophysiol
peter
ch
et
al
br
j
pharmacol
sl
et
al
age
cell
aldasoro
et
al
plo
one
mar
introduct
delay
cerebr
ischaemia
dci
first
caus
morbid
subarachnoid
haemorrhag
sah
eicosanoid
found
cerebrospin
fluid
csf
patient
dci
potent
vasoconstrictor
induc
platelet
aggreg
mediat
inflamm
thromboxaneprostaglandin
tp
receptor
bind
object
aim
studi
first
estim
occurr
dci
proinflammatori
state
use
high
omega
polyunsatur
fatti
acid
diet
secondli
evalu
effici
terutroban
ter
tp
receptor
inhibitor
method
nineti
wistar
rat
g
randomli
assign
one
group
doubl
intracistern
inject
autolog
arteri
blood
sah
group
artifici
csf
csf
group
perform
induc
proinflammatori
state
anim
fat
week
sah
procedur
ter
ter
administ
mgkgday
day
follow
sah
sah
ter
group
evalu
uptak
radiolabel
agent
achiev
use
microspectct
imag
hmpao
cerebr
perfus
quantif
dtpa
blood
brain
barrier
bbb
integr
studi
annexinv
apoptot
activ
studi
anova
follow
student
test
result
hmpao
uptak
analysi
show
signific
decreas
sah
group
figur
dtpa
annexinv
uptak
also
significantli
increas
sah
group
compar
csf
group
proinflammatori
state
sah
dramat
decreas
hmpao
uptak
figur
increas
dtpa
vs
p
annexinv
vs
p
ter
significantli
counteract
decreas
hmpao
uptak
figur
increas
dtpa
uptak
p
annexinv
uptak
p
induc
sah
conclus
first
time
proinflammatori
sah
rat
model
dci
describ
microspect
studi
show
proinflammatori
diet
dramat
increas
apoptosi
dci
ter
improv
hypoperfus
bbb
disrupt
apoptosi
tp
receptor
antagonist
could
promis
treatment
sah
refer
vergouwen
et
al
cerebr
infarct
subarachnoid
hemorrhag
contribut
poor
outcom
vasospasmdepend
independ
effect
stroke
et
al
thromboxaneendoperoxid
receptor
tp
common
villain
j
cardiovasc
pharmacol
dusick
j
r
et
al
minimallyinvas
rat
model
subarachnoid
hemorrhag
delay
ischem
injuri
surg
neurol
int
grant
acknowledg
author
grate
acknowledg
use
servic
facil
nort
laboratori
inserm
inra
introduct
brain
injur
critic
ill
patient
often
impair
airway
reflex
requir
longterm
mechan
ventil
tracheostomi
standard
care
mani
issu
still
remain
unclear
exampl
optim
time
earli
versu
late
better
techniqu
effect
icp
brain
injur
patient
object
describ
approach
systemicintracrani
effect
tracheostomi
sever
brain
injur
patient
neurocrit
intens
care
unit
san
gerardo
hospit
monza
itali
method
consecut
adult
patient
undergon
tracheostomi
includ
retrospect
analysi
prospectivelycollect
data
retriev
digit
pdm
system
perform
demograph
procedur
characterist
blood
ga
analys
intracrani
pressur
icp
mean
arteri
pressur
map
cerebr
perfus
pressur
cpp
data
report
median
interquartil
rang
prior
toduringaft
tracheostomi
repeat
measur
analysi
varianc
util
assess
effect
tracheostomi
result
preliminari
data
base
patient
male
femal
year
old
gc
admiss
admit
intracrani
hemorrhag
subarachnoid
hemorrhag
trauma
stroke
tracheostomi
perform
day
admiss
compromis
neurolog
statu
gc
tracheostomi
direct
laryngoscopi
translaryng
techniqu
tlt
percutwist
surgic
standard
tlt
dolphin
use
case
ent
specialist
intenstivist
perform
tracheostomi
respect
deleteri
effect
record
paramet
detect
see
tabl
four
lesion
tracheal
ring
document
conclus
larg
cohort
braininjur
patient
tracheostomi
perform
one
week
initi
insult
safe
introduct
paradigm
treatment
ischem
stroke
hyperacut
chang
recent
year
introduct
thrombolyt
alteplas
rtpa
efficaci
directli
relat
time
interv
onset
symptom
drug
administr
hospit
moys
deutsch
southern
citi
paulo
indic
use
rtpa
intraven
patient
ischem
stroke
frame
accord
protocol
establish
servic
sinc
necessari
ask
neurolog
evalu
distanc
trough
hospit
israelita
albert
einstein
telemedicin
object
demonstr
experi
use
intraven
alteplas
clinic
practic
neurologist
telemedecin
support
check
effici
procedur
safeti
method
retrospect
studi
case
ischem
stroke
receiv
intraven
alteplas
decemb
februari
protocol
indic
use
alteplas
patient
inclus
criteria
period
onset
symptom
hospit
admiss
hour
contraind
use
thrombolyt
nihss
nation
institut
health
scale
cours
calcul
admiss
hour
thrombolysi
comput
tomographi
ct
admiss
hour
solicit
evalu
requir
neurolog
telemedicin
hospit
israelita
albert
einstein
shortli
conclus
tc
cranio
rtpa
dose
mg
kg
remain
bolu
dose
continu
infus
hour
maximum
dose
mg
result
alteplas
use
patient
diagnosi
stroke
ischem
evalu
neurolog
telemedicin
trough
trigger
case
time
onset
symptom
drug
administr
patient
less
minut
minut
patient
minut
averag
nihss
admiss
patient
show
reduct
point
nihss
score
within
first
hour
patient
nonsymptomat
intracrani
hemorrhag
symptomat
intracrani
hemorrhag
death
period
conclus
patient
receiv
alteplas
recommend
time
interv
underw
ct
cranio
control
case
trigger
evalu
neurolog
telemedicin
improv
nihss
score
similar
percentag
observ
refer
studi
protocol
implement
adequ
excel
support
telemdicina
neurolog
team
good
profit
time
therapeut
efficaci
mortal
correl
sever
patient
nihss
admiss
data
ratifi
safeti
intraven
alteplas
use
treatment
ischaem
stroke
refer
ecass
iii
trial
decemb
meyer
bc
raman
r
hemmen
et
al
efficaci
siteindepend
telemedicin
stroke
doc
trial
randomis
blind
prospect
studylancet
neurol
grant
acknowledg
conflict
concern
introduct
system
inflammatori
respons
syndrom
sir
lead
pronounc
tissu
damag
frequent
caus
multiorgan
failur
mortal
intens
care
sir
elicit
varieti
insult
sepsi
trauma
major
surgeri
specif
therapi
current
routin
use
newli
develop
synthet
linear
tetrapeptid
deriv
chorion
gonadotropin
hormon
shown
promis
antiinflammatori
tissueprotect
effect
anim
object
investig
toler
safeti
immunomodulatori
effect
human
method
conduct
doubl
blind
placebo
control
doseescal
random
clinic
trial
healthi
volunt
studi
carri
two
phase
first
phase
n
safeti
toler
establish
escal
dose
mgkg
second
phase
n
dose
use
assess
effect
system
inflamm
experiment
human
endotoxemia
hour
ngkg
e
coli
endotoxin
administ
iv
follow
continu
iv
infus
placebo
level
circul
cytokin
adhes
molecul
well
bodi
temperatur
flulik
symptom
assess
furthermor
effect
renal
function
investig
use
plasma
clearanc
iohexol
result
well
toler
show
excel
safeti
profil
treatment
highest
dose
lower
dose
result
signific
attenu
endotoxininduc
increas
plasma
level
shown
fig
b
c
adhes
molecul
fig
furthermor
highest
dose
reduc
fever
flulik
symptom
fig
endotoxemia
result
mark
increas
gfr
differ
group
observ
conclus
administr
safe
result
attenu
system
inflammatori
respons
human
promis
result
pave
way
phase
iib
clinic
trial
assess
antiinflammatori
tissueprotect
effect
patient
refer
vincent
jl
sakr
sprung
cl
et
al
sepsi
european
intens
care
unit
result
soap
studi
critic
care
medicin
khan
na
benner
r
human
chorion
gonadotropin
model
molecul
oligopeptidebas
drug
discoveri
endocrin
metabol
immun
disord
drug
target
van
den
berg
hr
khan
na
van
der
zee
et
al
synthet
oligopeptid
relat
beta
subunit
human
chorion
gonadotropin
attenu
inflamm
liver
damag
trauma
hemorrhag
shock
resuscit
shock
introduct
mortal
sepsi
septic
shock
remain
high
result
trial
intraven
immunoglobulin
ivig
adjunct
therapi
sepsi
show
controversi
object
aim
studi
identifi
factor
predict
prognosi
patient
sever
sepsi
ss
septic
shock
ssh
accord
quartil
immunoglobulin
g
igg
concentr
method
cohort
studi
critic
ill
adult
admit
polival
intens
care
unit
univers
hospit
demograph
data
clinic
paramet
igg
level
determin
within
hour
ss
ssh
onset
defin
accord
surviv
sepsi
campaign
ssc
criteria
patient
divid
four
group
quartil
base
percentil
initi
level
igg
test
differ
baselin
characterist
igg
interv
use
kruskalw
test
continu
data
chi
squar
test
categor
data
report
median
interquartil
rang
logist
regress
model
adjust
potenti
confound
age
apach
ii
score
sofa
score
number
organ
failur
nof
presenc
shock
admiss
statist
analysi
perform
use
spss
window
spss
inc
chicago
il
usa
result
analyz
consecut
episod
ss
sh
admit
icu
median
age
studi
sampl
interquartil
rang
year
old
male
main
sourc
infect
respiratori
tract
intraabdomen
medic
patholog
mortal
quartil
serum
igg
concentr
quartil
mgdl
less
quartil
mgdl
quartil
mgdl
quartil
mgdl
greater
median
igg
concentr
quartil
mgdl
mgdl
mgdl
mgdl
p
differ
quartil
shown
signific
differ
apach
ii
sofa
score
number
organ
failur
nof
neither
daymort
surprisingli
patient
higher
mortal
compar
quartil
ci
p
follow
patient
conclus
studi
show
prognost
valu
low
level
serum
igg
within
hour
ss
ssh
onset
high
level
igg
within
hour
ss
ssh
may
risk
factor
increas
daymort
septic
patient
investig
field
refer
alejandria
mm
lansang
mad
dan
lf
mantar
iii
jb
intraven
immunoglobulin
treat
sepsi
sever
sepsi
septic
shock
review
cochran
librari
issu
introduct
lymphocyt
play
fundament
role
immunolog
respons
sepsi
cell
new
subset
lymphocyt
repres
small
popul
immun
cell
exhibit
featur
innat
adapt
immun
play
indispens
role
host
defens
immun
surveil
homeostasi
recent
studi
found
massiv
loss
gamma
delta
cell
patient
sepsi
howev
littl
know
function
chang
role
patholog
statu
object
studi
design
evalu
phenotyp
function
peripher
cell
patient
sever
sepsi
septic
shock
associ
prognosi
method
prospect
observ
studi
conduct
three
icu
univers
hospit
total
patient
consecut
admit
diagnos
sever
sepsi
septic
shock
exclud
previou
immunosuppress
healthi
control
enrol
surfac
marker
intracellular
cytokin
cell
isol
peripher
blood
analyz
flow
cytometri
result
also
correl
clinic
outcom
result
septic
patient
display
decreas
percentag
cell
express
increas
pro
antiinflammatori
intracellular
cytokin
compar
healthi
control
stimul
cell
vitro
pamidron
pam
phorbolmyrist
acet
pma
plu
ionomycin
express
secret
significantli
reduc
septic
patient
compar
healthi
control
vs
vs
respect
p
importantli
decreas
express
pronounc
nonsurvivor
compar
survivor
use
multiregress
logist
method
adjust
factor
impact
patient
outcom
secret
stimul
sofa
score
independ
risk
factor
associ
patient
death
ci
ci
respect
p
conclus
result
show
pronounc
chang
cell
phenotyp
function
septic
patient
find
provid
novel
insight
role
cell
sepsi
refer
andreuballest
jc
tormocalandin
c
garciaballestero
c
et
al
associ
gammadelta
cell
diseas
sever
mortal
septic
patient
clin
vaccin
immunol
matsushima
ogura
h
fujita
k
et
al
earli
activ
lymphocyt
patient
sever
system
inflammatori
respons
syndrom
shock
grant
acknowledg
work
support
nation
natur
scienc
foundat
china
introduct
hallmark
sepsi
sever
includ
loss
vascular
immunolog
homeostasi
import
vasodilat
loss
may
contribut
impair
microcircul
moreov
involv
protein
modif
regul
transcript
factor
product
superoxid
anion
larginin
larg
substrat
produc
synthas
no
homolog
lhomoarginin
harg
competit
substrat
asymmetr
dimethylarginin
adma
endogen
no
inhibitor
see
refer
object
therefor
sought
investig
whether
larg
harg
adma
alter
septic
patient
addit
analyz
mrna
express
level
dimethlyarginindimethylaminohydrolas
adma
degrad
enzym
peripher
blood
monocyt
pbmc
sepsi
patient
method
blood
sepsi
patient
healthi
control
drawn
analyz
larg
harg
adma
concentr
measur
mass
spectrometri
peripher
blood
monocyt
mrna
express
measur
quantit
pcr
qpcr
paramet
correl
sequenti
organ
failur
assess
score
sofa
score
sepsi
sever
result
observ
differ
no
substrat
larg
control
patient
contrast
concentr
harg
blood
signific
decreas
patient
p
wherea
adma
concentr
increas
patient
p
harg
adma
concentr
associ
diseas
sever
spearmanrank
analysi
reveal
posit
associ
sofa
score
blood
level
adma
rho
p
neg
associ
harg
sofa
score
determin
howev
signific
roc
analysi
adma
emerg
power
indic
organ
dysfunct
follow
sofa
score
wherebi
paramet
yield
almost
ident
auc
furthermor
pbmc
express
decreas
patient
signific
lower
patient
sepsi
relat
organ
dysfunct
p
conclus
blood
septic
patient
found
increas
concentr
endogen
no
inhibitor
adma
togeth
decreas
mrna
express
pbmc
measur
may
influenc
system
intracellular
level
patient
sepsi
may
contribut
septic
phenotyp
microcirculatori
immunolog
collaps
sepsi
decreas
concentr
harg
competit
substrat
no
may
reaction
restor
equilibrium
sepsi
prospect
studi
need
confirm
result
larger
cohort
nonsept
patient
control
refer
bogdan
c
nat
immunol
oct
leiper
j
arterioscl
thromb
vasc
biol
jun
lupp
c
crit
care
may
grant
acknowledg
none
introduct
antimicrobi
resist
threaten
undermin
treatment
sever
infect
new
therapeut
strategi
urgent
need
augment
passiv
immunotherapi
peptid
novel
therapeut
strategi
increas
phagocyt
activ
vitro
rescu
moribund
septic
mice
object
aim
determin
ex
vivo
activ
target
popul
patient
admit
critic
care
sever
infect
method
prospect
recruit
uk
critic
care
unit
patient
sever
sepsi
observ
clinic
cours
month
post
discharg
blood
sampl
taken
earli
hr
postdiagnosi
n
latent
seven
day
postdiagnosi
n
convalesc
month
postdiagnosi
n
phase
diseas
primari
outcom
measur
kill
opsonis
spneumonia
neutrophil
without
peptid
stimul
also
use
flow
cytometr
whole
blood
phagocytosi
assay
determin
phagocyt
associ
oxid
intraphagosom
report
bead
result
peptid
increas
neutrophil
kill
opsonis
pneumococci
ci
p
phase
sepsi
independ
infect
sourc
microbiolog
statu
repres
increas
bacteri
kill
compar
unstimul
neutrophil
earli
phase
sampl
similarli
peptid
treatment
significantli
increas
neutrophil
monocyt
intraphagosom
report
bead
associ
oxid
independ
infect
sourc
conclus
extend
vitro
mice
model
work
demonstr
peptid
significantli
increas
phagocytosi
bacteri
kill
sampl
target
patient
popul
sever
sepsi
studi
support
rational
augment
passiv
immunotherapi
therapeut
strategi
sever
sepsi
grant
acknowledg
work
support
medic
research
council
uk
confid
concept
award
introduct
wellknown
bacteri
sepsi
induc
immunosuppress
state
impair
host
abil
clear
primari
infect
increas
vulner
secondari
bacteri
fungal
infect
howev
whether
bacteri
sepsi
affect
subsequ
respons
influenza
infect
unknown
safeti
administr
live
attenu
influenza
vaccin
laiv
immunosuppress
patient
experiment
human
endotoxemia
induc
system
inflamm
mimic
bacteri
sepsi
subsequ
develop
immun
suppres
object
investig
effect
human
endotoxemia
immun
respons
elicit
subsequ
challeng
laiv
fluenz
surrog
influenza
infect
method
random
placebocontrol
studi
healthi
male
subject
receiv
intraven
placebo
nacl
n
endotoxin
e
coli
lp
ngkg
n
follow
administr
quadrival
fluenz
day
subject
nasal
wash
sampl
obtain
measur
viral
shed
inflammatori
mediat
symptom
record
daili
use
onlin
symptom
diari
result
lp
administr
result
typic
increas
plasma
level
cytokin
absent
placebo
group
fig
follow
fluenz
challeng
viral
shed
least
one
four
influenza
strain
present
vaccin
lpsfluenz
group
compar
placebofluenz
group
increas
viral
shed
influenza
b
strain
similar
group
fig
upper
panel
likewis
fluenzinduc
increas
level
chemokin
nasal
wash
well
local
symptom
differ
lpsfluenz
placebofluenz
group
fig
lower
panel
conclus
human
endotoxemia
attenu
inflammatori
respons
second
challeng
endotoxin
approxim
influenc
fluenzinduc
local
immun
respons
viral
shed
data
suggest
immun
respons
bacteri
compound
alter
respons
subsequ
viral
infect
refer
hotchkiss
rs
monneret
g
payen
immunosuppress
sepsi
novel
understand
disord
new
therapeut
approach
lancet
infecti
diseas
leentjen
j
kox
koch
rm
preijer
f
joosten
la
van
der
hoeven
jg
netea
mg
pickker
p
revers
immunoparalysi
human
vivo
doubleblind
placebocontrol
random
pilot
studi
j
respir
crit
care
med
carter
nj
curran
mp
live
attenu
influenza
vaccin
flumist
r
fluenz
review
use
prevent
season
influenza
children
adult
drug
grant
acknowledg
work
part
immunoforc
project
support
efro
grant
introduct
sepsi
sever
infect
hyperinflammatori
respons
mediat
cytokin
induc
acut
lung
injuri
multiorgan
dysfunct
common
caus
death
intens
care
unit
current
specif
drug
treatment
diseas
new
therapeut
altern
essenti
methotrex
mtx
immunosuppress
current
use
autoimmun
diseas
act
decreas
lymphocyt
prolifer
cytokin
object
aim
studi
evalu
effect
mtx
inflamm
caus
sepsi
focus
system
lung
injuri
main
hypothesi
treatment
mtx
reduc
damag
control
inflammatori
respons
lung
system
level
method
sepsi
induc
cecal
ligat
punctur
clp
spraguedawley
rat
g
hour
later
surgic
sourc
control
administ
antibiot
fluid
analges
addit
administ
one
group
mtx
ip
mgkg
h
later
anim
sacrif
sampl
lung
tissu
bronchoalveolar
lavag
blood
collect
group
shamsham
mtxclpclp
mtx
surviv
bodi
weight
lung
weight
mesur
neutrophil
macrophag
lymphocyt
protein
concentr
bronchoalveolar
lavag
quantifi
differ
cell
subset
blood
analys
molecular
marker
relat
inflamm
infiltr
damag
evalu
qrtpcr
lung
tissu
result
result
show
decreas
circul
lymphocyt
treg
lymphocyt
lung
weight
group
treat
mtx
compar
septic
group
fig
cellular
content
alveolu
clp
mtx
group
show
decreas
cell
infiltr
polimorfonuclear
cell
lymphocyt
compar
clp
group
number
alveolar
macrophag
alter
differ
group
fig
express
inflammatori
cell
recruit
matrix
remodel
proinflmatori
marker
show
increas
septic
rat
mtx
treatment
exhibit
reduct
final
mtx
caus
increas
express
antiinflammatori
cytokin
fig
conclus
mtx
administr
anim
model
sepsi
reduc
system
lung
injuri
caus
sepsi
drug
inhibit
cytokin
cascad
recruit
proinflammatori
cell
lung
refer
lb
koyama
zhao
z
janz
dr
wickersham
n
bernard
gr
may
ak
calfe
cs
matthay
biomark
lung
epitheli
injuri
inflamm
distinguish
sever
sepsi
patient
acut
respiratori
distress
syndrom
crit
care
oct
h
cronstein
bn
understand
mechan
action
methotrex
implic
treatment
rheumatoid
arthriti
bull
nyu
hosp
jt
di
grant
acknowledg
parc
ciber
introduct
neutrophil
key
effector
immun
respons
sepsi
excess
stimul
dysregul
function
neutrophil
consid
respons
pathogenesi
sepsi
object
report
neutrophil
autophagi
prime
neutrophil
increas
neutrophil
extracellular
trap
net
format
respons
host
surviv
sepsi
method
studi
patient
communityacquir
pneumonia
admit
intens
care
unit
investig
hypothesi
isol
neutrophil
communityacquir
pneumonia
patient
day
day
determin
ro
gener
net
format
surfac
express
granul
marker
result
neutrophil
isol
septic
patient
express
high
level
autophagyspecif
protein
prime
neutrophil
net
format
respons
subsequ
phorbol
pma
stimul
neutrophil
show
decreas
mean
lobe
count
distinct
chang
surfac
marker
express
contrast
neutrophil
isol
nonsurviv
septic
patient
show
dysregul
autophagi
decreas
respons
pma
stimul
mous
model
sepsi
autophagi
augment
improv
surviv
via
netdepend
mechan
studi
provid
import
insight
role
autophagi
neutrophil
sepsi
conclus
neutrophil
autophagi
could
attract
therapeut
target
treatment
sepsi
refer
r
hotchkiss
g
monneret
payen
sepsisinduc
immunosuppress
cellular
dysfunct
immunotherapi
nat
rev
immunol
jl
vincent
opal
j
c
marshal
k
j
tracey
sepsi
definit
time
chang
lancet
r
hotchkiss
e
karl
pathophysiolog
treatment
sepsi
n
engl
j
med
r
hotchkiss
e
r
sherwood
immunolog
get
sepsi
therapi
right
scienc
weiss
weinrauch
zychlinski
neutrophil
extracellular
trap
kill
bacteria
scienc
introduct
septic
shock
acut
kidney
injuri
common
critic
ill
patient
apelinerg
system
improv
cardiac
function
decreas
vascular
tone
exhibit
diuret
properti
effect
held
two
distinct
endogen
peptid
domin
bioactiv
fragment
apelin
famili
mainli
express
cardiovascular
system
elabela
ela
recent
discov
ligand
apjr
describ
regul
cardiovascular
develop
mainli
express
kidney
tissu
object
elabela
vs
sepsisinduc
cardioren
syndrom
method
sepsi
induc
cecal
ligatur
punctur
clp
adult
rat
myocardi
impact
ela
vs
healthi
septic
isolatedheart
assess
langendorff
apparatu
ex
vivo
peptid
fluid
resuscit
intraven
infus
osmot
andor
syring
pump
healthi
vs
clp
rat
vivo
monitor
myocardi
function
echocardiographi
vivo
left
ventricular
lv
hemodynam
pressurevolum
probe
h
clp
induct
water
intak
urin
output
record
heart
kidney
blood
collect
subsequ
biolog
assay
result
ela
well
stimul
left
ventricular
ino
lusitropi
healthi
septic
heart
ex
vivo
sepsi
dpdtmax
baselin
ela
ela
also
improv
surviv
significantli
h
sepsi
induct
surviv
clp
clp
p
vs
clp
clp
ela
p
vs
clp
clpinduc
myocardi
dysfunct
vivo
counteract
ela
infus
shown
higher
cardiac
index
ci
sham
g
clp
p
vs
sham
clp
p
vs
clp
clp
ela
p
vs
clp
improv
left
ventricular
pressurevolum
relationship
nonetheless
elatr
clp
rat
onesi
display
signific
improv
lv
fill
shown
increas
ewav
veloc
sham
clp
clp
clp
ela
p
vs
clp
lv
enddiastol
volum
sham
clp
clp
clp
ela
p
vs
clp
ii
exhibit
higher
plasma
volum
sham
clp
clp
clp
ela
p
vs
clp
andiii
limit
clpinduc
drop
urin
output
limit
free
water
clearanc
moreov
ela
improv
creatinin
clearanc
reduc
microalbuminuria
clp
rat
conclus
modul
apelinerg
system
exogen
ela
infus
improv
surviv
cardiovascular
dysfunct
sepsi
induct
recent
discov
ela
display
addedvalu
improv
hemodynam
limit
kidney
dysfunct
injuri
elabela
potenti
new
therapeut
drug
support
cardioren
dysfunct
sepsi
refer
murza
et
al
j
med
chem
grant
acknowledg
heart
stroke
foundat
merckdhom
fmss
grant
crsng
sep
mitac
introduct
major
sourc
bodi
heat
product
muscular
activ
oxid
food
uncoupl
mitochondri
respir
due
proton
leak
caus
fever
sepsi
unknown
particularli
sedat
ventil
patient
neither
perform
much
voluntari
skelet
muscl
activ
shiver
often
fed
acut
earli
phase
furthermor
usual
vasodil
state
impli
increas
heat
loss
must
exceed
heat
gener
gener
pyrexia
object
determin
associ
fever
uncoupl
mitochondri
respir
compar
effect
exogen
uncoupl
dinitrophenol
sham
septic
rat
method
awak
male
wistar
rat
approx
g
bodi
weight
previous
instrument
tunnel
carotid
jugular
line
place
metabol
cage
continu
monitor
whole
bodi
oxygen
consumpt
core
temperatur
measur
intermitt
rectal
probe
sepsi
induc
ip
inject
faecal
slurri
sham
anim
receiv
ip
salin
intraven
fluid
resuscit
mlkgh
crystalloid
start
h
h
anim
receiv
mitochondri
uncoupl
dinitrophenol
dnp
mgkg
given
h
statist
differ
compar
pre
postdnp
assess
use
pair
ttest
p
valu
consid
statist
signific
result
sham
anim
eutherm
h
similar
baselin
valu
dnp
produc
signific
rise
respect
temperatur
timepoint
p
contrast
septic
anim
febril
prednp
h
p
h
dnp
induc
small
nonsignific
rise
temperatur
chang
seen
either
timepoint
conclus
wherea
sham
anim
gener
appropri
rise
temperatur
respons
mitochondri
uncoupl
dnp
septic
rat
could
gener
small
rise
temperatur
minim
respons
impli
mitochondri
uncoupl
alreadi
increas
septic
rat
thu
explain
pyrexia
could
increas
exogen
uncoupl
also
possibl
upstream
inhibit
electron
transport
chain
may
prevent
respons
dnp
seen
septic
anim
possibl
investig
refer
rolf
df
brown
gc
physiol
rev
introduct
critic
ill
acquir
myopathi
rat
character
homogen
muscl
atrophi
convers
histolog
abnorm
heterogen
among
muscl
type
oxid
muscl
show
patchi
alter
myofasc
necrosi
glycolyt
type
demonstr
normal
pattern
activ
ubiquitinproteasom
system
up
respons
myofibrillar
protein
breakdown
skelet
muscl
whether
up
activ
depend
oxid
glycolyt
muscl
type
critic
ill
unknown
object
character
up
activ
skelet
muscl
type
longterm
periton
model
method
male
wistar
rat
follow
week
intraperiton
inject
yeast
cell
wall
constitu
zymosan
nsalin
soleu
oxid
slow
twitch
muscl
gastrocnemiu
mix
glycolyticoxid
fast
twitch
muscl
harvest
zymosan
control
group
day
insult
caspas
trypsin
chemotrypsinlik
activ
proteasom
measur
enzymat
assay
protein
express
activ
musclespecif
ubiquitin
ligas
mafbx
polyubiquitin
protein
assess
western
blot
time
point
protein
express
specif
fragment
myofibrillar
actin
assess
day
result
weight
loss
statist
differ
soleu
versu
gastrocnemiu
zymosan
group
versu
p
day
catalyt
activ
proteasom
increas
day
soleu
day
gastrocnemiu
soleu
display
upregul
day
gastrocnemiu
display
activ
mafbx
day
activ
polyubiquitin
protein
increas
day
soleu
gastrocnemiu
specif
fragment
myofibrillar
actin
increas
soleu
gastrocnemiu
result
summar
tabl
conclus
rodent
model
longterm
periton
oxid
glycolyt
muscl
show
similar
eg
upregul
ubiquitin
ligas
earli
proteasom
activ
also
mark
differ
caspas
activ
polyubiquitin
durat
proteasom
activ
refer
hill
ne
et
al
detail
character
longterm
rodent
model
critic
ill
recoveri
crit
care
med
introduct
mesenchym
stem
cell
msc
applic
candid
prevent
organ
dysfunct
sepsi
treatment
algorithm
object
studi
aim
investig
effect
intraven
applic
dental
follicul
deriv
mesenchym
stem
cell
dfmsc
cytokin
balanc
regul
level
ileal
tissu
histopatholog
method
spragu
dawley
male
rat
seper
five
group
igroup
control
ii
group
healti
dfmsc
administr
iii
group
cecal
ligationperfor
clp
iv
group
clp
administr
dfmsc
zero
hour
v
group
clp
administr
dfmsc
fourth
hour
hour
treg
level
lymphocyt
prolifer
cytokin
level
analyz
spleen
sacrif
rat
histopatholog
evalu
ileal
tissu
done
use
chiu
score
result
migrat
green
fluoresc
protein
mark
msc
gfp
dfmsc
damag
ileocec
epithelium
shown
vivo
imag
system
ivi
studi
lympocyt
prolifer
greater
lymphocyt
level
lower
vs
p
group
iii
iv
v
compar
control
one
vs
lymphocyt
prolifer
cytokin
lymphocyt
level
differ
group
iii
iv
treg
level
higher
vs
level
lower
vs
p
group
v
compar
group
iii
addit
tnfalfa
level
tendenc
decreas
group
v
ileal
damag
group
v
lesser
group
iii
accord
chiu
score
igroup
control
normal
ileal
mucosa
chiu
iigroup
clp
pb
nake
lamina
propria
due
denud
surfac
epithelium
chiu
iiigroup
clp
msc
disintegr
surfac
epithelium
chiu
ivgroup
clp
mc
subepietheli
space
format
apex
villi
chiu
conclus
known
data
literatur
human
deriv
dfmsc
treatment
sepsi
experiment
model
result
suggest
intraven
applic
dfmsc
result
migrat
stem
cell
damag
ileocec
tissu
function
protect
integr
ileal
tissu
find
show
immunomodul
ensur
supress
proinflamatori
tnf
alpha
antiinflammatori
cytokin
togeth
increas
treg
ratio
might
new
therapeut
approach
treat
sepsi
relat
organ
dysfunct
refer
chao
yh
et
al
increas
regulatori
cell
administr
umbil
cordderiv
mesenchym
stem
cell
sepsi
plo
one
p
sung
ph
et
al
apoptot
adiposederiv
mesenchym
stem
cell
therapyprotect
lung
kidney
injuri
sepsi
syndrom
caus
cecal
ligat
punctur
rat
stem
cell
re
ther
p
introduct
increas
evid
present
suggest
modul
mitochondri
bioenerget
may
play
key
role
appar
paradox
clinic
biochem
present
acut
kidney
injuri
aki
observ
sepsi
lack
cell
death
mainten
tissu
oxygen
eventu
furthermor
evid
vitro
studi
indic
humor
mediat
carri
circul
may
play
role
mitochondri
dysfunct
observ
sepsi
result
organ
dysfunct
unrel
haemodynam
object
determin
exposur
septic
serum
modul
mitochondri
function
live
kidney
slice
mitochondri
function
probe
mitochondri
membran
potenti
mmp
redox
state
reactiv
oxygen
speci
ro
gener
method
live
kidney
slice
thick
expos
serum
hour
sham
oper
septic
rat
minut
imag
confoc
microscop
use
fluoresc
dye
detect
dynam
chang
mitochondri
function
fig
tetramethylrhodamin
methyl
ester
tmrm
indic
mmp
whose
signal
decreas
mmp
depolaris
dihydroethidium
het
indic
ro
whose
signal
increas
increas
ro
nadh
constitut
fluoresc
use
marker
redox
state
result
septic
serum
caus
decreas
mmp
increas
ro
chang
nadh
minut
exposur
compar
baselin
fig
sham
serum
caus
chang
baselin
compar
slice
expos
physiolog
salin
solut
conclus
decreas
mmp
seen
exposur
septic
serum
could
indic
either
increas
uncoupl
decreas
electron
transport
chain
activ
first
case
one
would
expect
parallel
decreas
nadh
signal
second
one
would
expect
increas
nadh
studi
nadh
chang
septic
expos
slice
clear
two
propos
scenario
like
mitochondria
establish
sourc
cellular
ro
exvivo
model
ro
increas
significantli
follow
exposur
septic
serum
ro
may
mediat
consequ
mitochondri
dysfunct
relationship
two
explor
studi
suggest
humor
factor
within
septic
serum
capabl
caus
mitochondri
dysfunct
exvivo
kidney
slice
model
refer
singer
role
mitochondri
dysfunct
sepsisinduc
multiorgan
failur
virul
pathak
e
macmillancrow
l
mayeux
p
r
role
mitochondri
oxid
vitro
model
sepsisinduc
renal
injuri
j
pharmacol
exp
ther
grant
acknowledg
ucl
medic
school
mbphd
programm
astor
foundat
scholarship
introduct
incid
icuacquir
infect
follow
major
trauma
greater
hyperacut
increas
well
reduct
monocyt
hladr
mhladr
express
document
follow
injuri
associ
develop
late
nosocomi
infect
object
evalu
role
mediat
pathway
posttraumat
immun
suppress
assess
revers
phenomenon
method
serum
collect
consecut
patient
suffer
sever
blunt
polytrauma
admiss
hour
age
sex
match
healthi
volunt
serv
control
pool
peripher
blood
mononuclear
cell
pmbc
healthi
volunt
incub
hr
media
contain
serum
either
trauma
patient
healthi
volunt
cultur
presenc
absenc
granulocytemacrophag
colonystimul
factor
gmcsf
ngml
interferon
gamma
intern
unit
neutralis
antibodi
ngml
monocyt
hladr
mhladr
membran
densiti
geometr
mean
floresc
intens
gmfi
characteris
bd
fac
aria
iiiu
flow
cytomet
data
display
median
interquartil
rang
iqr
analys
nonparametr
statist
result
ten
polytrauma
patient
median
injuri
sever
score
iss
iqr
recruit
cohort
male
median
age
iqr
decreas
antigen
densiti
mhladr
healthi
donor
pbmc
incub
admiss
p
p
polytrauma
serum
compar
incub
serum
age
sex
match
control
fig
cultur
presenc
p
gmcsf
p
prevent
decreas
antigen
densiti
fig
preincub
neutralis
antibodi
partial
revers
detriment
effect
incub
polytrauma
trauma
serum
p
fig
conclus
serum
obtain
polytrauma
patient
induc
immunosuppress
respons
depend
pathway
revers
gmcsf
treatment
refer
torranc
hd
et
al
ann
surg
torranc
hd
et
al
crit
care
suppl
cheron
et
al
crit
care
grant
acknowledg
royal
colleg
surgeon
england
bart
london
chariti
introduct
prolong
use
intraven
iv
drug
intens
care
unit
icu
sedat
associ
accumul
difficulti
control
new
volatil
anesthet
conserv
devic
acd
introduc
use
volatil
anesthet
agent
sedat
icu
emerg
though
mani
trial
shown
effect
sedat
use
volatil
agent
sever
aspect
studi
small
identifi
signific
effect
object
access
overal
efficaci
volatil
sedat
compar
iv
sedat
icu
patient
method
review
public
pubm
embas
cochran
databas
icu
sedat
compar
volatil
anesthet
sevofluran
isofluran
use
acd
iv
agent
propofol
midazolam
remifentanil
perform
metaanalysi
elig
studi
two
review
independ
assess
studi
inclus
extract
data
cochran
collabor
methodolog
use
standard
mean
differ
smd
confid
interv
ci
estim
result
sixteen
trial
patient
includ
metaanalysi
extub
time
termin
sedat
compar
volatil
intraven
sed
significantli
shorter
volatil
sedat
group
iv
sedat
group
smd
ci
p
addit
icu
length
stay
lo
significantli
shorter
volatil
sedat
group
iv
sedat
group
smd
ci
p
conclus
found
evid
icu
sedat
volatil
acd
provid
shorter
extub
time
termin
sedat
icu
lo
refer
misra
koshi
review
practic
sedat
inhal
anaesthet
intens
care
unit
anaconda
r
devic
indian
j
anaesth
soukup
j
scharff
k
kubosch
k
pohl
c
bomplitz
kompardt
j
state
art
sedat
concept
volatil
anesthet
critic
ill
patient
journal
critic
care
grant
acknowledg
author
thank
ha
yan
kim
medic
statistician
yonsei
univers
colleg
medicin
seoul
korea
help
statist
analysi
introduct
clinic
practic
guidelin
manag
agit
american
colleg
critic
care
medicin
suggest
either
propofol
dexmedetomidin
may
prefer
sedat
benzodiazepin
improv
clinic
outcom
critic
ill
intub
patientsrec
studi
reveal
dexmedetomidin
reduc
incid
shorten
durat
postop
deliriumit
remain
unknown
whether
side
effect
bradycardia
hypotens
dexmedetomidin
may
affect
cardiac
output
stroke
volum
critic
ill
patient
object
aim
studi
compar
hemodynam
effect
dexmedetomidin
propofol
postop
sedat
patient
abdomin
surgeri
method
random
control
clinic
trial
clinicaltrialsgov
id
patient
undergo
abdomin
tumor
surgeri
enrol
studi
randomli
alloc
propofol
group
dexmedetomidin
group
cardiac
index
stroke
volum
index
measur
continu
noninvas
cardiac
output
monitor
use
bioreactancebas
techniqu
opioid
requir
urin
output
length
icu
stay
hospit
stay
compar
two
group
result
baselin
heart
rate
mean
arteri
pressur
significantli
differ
two
group
treatment
period
heart
rate
mean
arteri
pressur
significantli
lower
dexmedetomidin
group
propofol
group
sever
bradycardia
hypotens
note
group
cardiac
index
stroke
volum
index
significantli
differ
two
group
mean
length
hospit
stay
shorter
dexmedetomidin
group
propofol
group
vs
day
p
conclus
result
support
cardiac
output
stoke
volum
significantli
differ
sedat
dexmedetomidin
propofol
found
postop
sedat
dexmedetomidin
shorten
length
hospit
stay
patient
abdomin
surgeri
refer
barr
j
fraser
gl
puntillo
k
et
al
clinic
practic
guidelin
manag
pain
agit
delirium
adult
patient
intens
care
unit
crit
care
med
djaiani
g
silverton
n
fedorko
l
et
al
dexmedetomidin
versu
propofol
sedat
reduc
delirium
cardiac
surgeri
random
control
trial
anesthesiolog
grant
acknowledg
support
part
research
grant
nation
taiwan
univers
hospit
introduct
delirium
common
critic
ill
import
independ
predictor
mortal
abl
accur
manag
delirium
screen
presenc
confus
assess
method
intens
care
unit
camicu
intens
care
delirium
screen
checklist
icdsc
essenti
object
assess
impact
delirium
screen
valid
screen
tool
tool
use
camicu
versu
icdsc
prognost
valu
delirium
hospit
mortal
method
prospect
multicent
beforeaft
implement
intervent
studi
conduct
six
icu
march
april
netherland
intervent
consist
multifacet
implement
pain
agit
delirium
guidelin
subanalysi
consecut
adult
patient
admit
icu
exclud
primari
neurolog
diagnos
includ
three
period
discern
beforeperiod
routin
daili
delirium
screen
camicu
icdsc
delirium
consid
present
note
medic
nurs
chart
antipsychot
given
afterperiod
multifacet
implement
daili
delirium
screen
three
hospit
use
camicu
three
icdsc
primari
outcom
associ
delirium
assess
without
screen
icdsc
camicu
hospit
mortal
multivari
logist
regress
analysi
use
adjust
covari
age
apach
ii
admiss
type
medic
electiveemerg
surgeri
hospit
vs
afterperiod
analysi
interact
covari
test
assess
primari
outcom
vs
afterperiod
screen
afterperiod
screen
assess
camicu
versu
icdsc
enter
covari
regress
model
result
patient
includ
afterperiod
patient
patient
miss
data
covari
delirium
independ
associ
hospit
mortal
crude
analysi
p
tabl
signific
interact
apach
ii
delirium
p
adjust
delirium
effect
much
stronger
patient
higher
apach
ii
score
median
valu
p
versu
p
mortal
risk
delirium
afterperiod
compar
beforeperiod
camicu
versu
icdsc
afterperiod
differ
versu
afterperiod
p
icdsc
versu
camicu
p
conclus
larg
multicentr
prospect
studi
confirm
independ
associ
icu
delirium
hospit
mortal
found
signific
interact
apach
ii
screen
instrument
use
camicu
versu
icdsc
influenc
deliriumassoci
risk
inhospit
death
introduct
level
analgesia
sedat
tradit
evalu
clinic
sign
increas
heart
rate
hr
blood
pressur
lacrim
defens
movement
howev
patient
analges
level
sedat
hard
determin
intens
care
set
clinic
sign
specif
recent
assess
anti
nocicept
balanc
differ
monitor
devic
describ
analgesia
nocicept
index
ani
metrodolori
lill
franc
deriv
hr
variabl
provid
index
nocicept
analgesia
surgic
pleth
index
spi
ge
healthcar
helsinki
finland
deriv
hr
puls
wave
amplitud
measur
photoplethysmographi
display
parasympathet
tone
index
pupillari
reflex
dilat
prd
follow
noxiou
event
measur
video
record
algiscan
idm
marseil
franc
object
prospect
observ
clinic
studi
design
evalu
diagnost
accuraci
analges
indic
assess
level
analgesia
sedat
compar
clinic
sign
method
obtain
ethic
approv
inform
consent
surgic
patient
anaesthet
preoper
propofol
bispectr
index
bi
laryng
mask
insert
remifentanil
increas
stepwis
dose
ensur
steadyst
period
two
differ
standard
pain
stimuli
appli
tetan
stimul
sec
common
use
noxiou
event
clinic
studi
compar
bromm
pain
model
direct
intracutan
stimul
sec
cfibr
stimul
accompani
record
spi
ani
prd
hr
mean
arteri
pressur
map
bi
sensit
specif
detect
pain
stimulu
compar
calcul
area
curv
auc
receiv
oper
characterist
curv
result
propofol
sedat
sensit
specif
ani
auc
spi
auc
prd
auc
detect
pain
stimuli
high
compar
hr
map
bi
auc
resp
fig
b
likewis
propofol
sedat
remifentanil
mcgkgmin
sensit
specif
ani
auc
spi
auc
prd
auc
detect
pain
stimuli
higher
compar
hr
map
bi
auc
resp
fig
conclus
three
analges
indic
superior
detect
pain
stimuli
sedat
compar
clinic
sign
bi
marker
sedat
confirm
marker
analges
level
refer
bromm
et
al
neurophysiolog
evalu
pain
electroencephalogr
clin
neurophysiol
grant
acknowledg
none
introduct
use
sevofluran
icu
possibl
system
properti
could
interest
procedur
sedat
repetit
dress
burn
patient
icu
object
evalu
pharmacokinet
sevofluran
administr
procedur
sedat
popul
burn
patient
compar
standard
popul
critic
ill
patient
method
burn
patient
bodi
surfac
area
burn
bsab
degre
requir
procedur
sedat
control
patient
enrol
sevofluran
administ
expir
fraction
target
plasma
concentr
sevofluran
hexafluoroisopropanolol
hfip
free
fluorid
ion
record
differ
time
kinet
pro
wgroup
franc
use
pharmacokinet
analysi
result
twelv
burn
patient
bsab
control
mean
age
year
respect
vs
year
p
mean
bodi
mass
index
vs
kg
p
includ
averag
plasma
concentr
sevofluran
mg
l
burn
patient
mg
l
control
end
sedat
p
slower
decreas
burn
p
discontinu
sedat
volum
distribut
higher
l
l
halflif
longer
hour
h
burn
patient
hfip
free
rate
higher
burn
patient
mg
l
vs
mg
ml
minut
discontinu
sedat
p
remain
mg
ml
averag
plasma
fluorid
differ
day
mmol
l
vs
mmol
l
p
mmol
l
vs
mmol
l
p
valu
urea
plasma
creatinin
remain
stabl
conclus
studi
pharmacokinet
administr
sevofluran
system
burn
highlight
increas
volum
distribut
slower
elimin
time
washin
washout
correct
conserv
maneuver
introduct
sleep
wake
strong
interconnect
stage
regul
complex
mechan
basal
brain
disturb
sleep
impair
function
nervou
immun
system
metabol
much
focu
sleep
icu
recent
year
disturb
sleep
caus
prolong
stay
icu
increas
morbid
includ
delirium
mortal
sever
studi
reveal
patholog
sleep
pattern
critic
ill
patient
critic
ill
patient
busi
environ
icu
expos
rang
differ
disturb
high
level
nois
light
procedur
mechan
ventil
medic
critic
ill
itselfpolysomnographi
psg
never
use
studi
critic
ill
patient
icu
test
whether
environment
chang
improv
sleep
patient
group
object
hypothesis
improv
intens
care
environ
would
lead
better
sleep
qualiti
critic
ill
mechan
ventil
patient
method
studi
conduct
gener
icu
vejl
hospit
denmark
nightintervent
routin
protocol
plan
bundl
procedur
direct
toward
improv
icu
environ
pm
nois
level
control
intervent
night
record
control
intervent
adult
patient
relev
contact
mechan
ventil
random
inform
consent
intervent
either
first
second
night
studi
monitor
sleep
psg
standard
american
academi
sleep
medicin
aasm
sleep
score
criteria
insuffici
assess
polysomnogram
psg
accordingli
aasm
classif
extend
supplement
criteria
sleep
score
critic
ill
patient
suggest
watson
et
al
psg
assess
expert
sleep
medicin
blind
intervent
result
patient
includ
studi
two
patient
exclud
due
deteriorationsound
level
analysi
show
insignific
effect
intervent
nois
reduct
p
analysi
psg
accord
watson
classif
reveal
patient
exhibit
characterist
normal
sleep
patient
patholog
pattern
conclus
unpredict
factor
relat
critic
ill
patient
statu
hinder
implement
environment
intervent
result
insignific
nois
reduct
found
patient
characterist
normal
sleep
presenc
normal
sleep
characterist
associ
environment
intervent
refer
watson
et
al
atyp
sleep
ventil
patient
empir
electroencephalographi
find
path
toward
revis
icu
sleep
score
criteria
critic
care
medicin
grant
acknowledg
region
southern
denmark
introduct
pressur
ulcer
increas
patient
risk
seriou
infect
associ
higher
mortal
critic
ill
patient
often
sedat
lead
sustain
period
immobl
clinic
experi
suggest
nonsed
patient
easier
mobil
chang
posit
bed
often
therefor
hypothes
nonsed
might
prevent
pressur
ulcer
object
assess
whether
nonsed
associ
fewer
pressur
ulcer
method
retrospect
data
patient
includ
multicent
nonseda
trial
kold
trial
site
dk
per
march
patient
particip
randomis
either
standard
care
sedat
daili
wake
nonsed
mechan
ventil
possibl
blind
whether
patient
sedat
howev
icunurs
perform
clinic
assess
registr
unawar
investig
incid
pressur
ulcer
clinic
data
extract
interpret
princip
investig
patient
random
statu
reveal
encount
difficulti
ascertain
whether
ulcer
acquir
icu
alreadi
present
admiss
assum
ulcer
icuacquir
avoid
risk
underestim
primari
outcom
total
number
pressur
ulcer
acquir
icu
describ
grade
iiv
local
result
icuacquir
assum
icuacquir
pressur
ulcer
identifi
signific
differ
group
regard
sex
age
bmi
apach
ii
sap
ii
grade
pressur
ulcer
sedat
nonsed
grade
ulcer
sedat
nonsed
grade
ulcer
sedat
nonsed
signific
differ
group
concern
local
result
group
three
sacrum
heel
caus
equip
exampl
nostril
oxygen
cathet
wrist
arteri
line
local
ulcer
significantli
differ
p
sacrum
sedat
nonsed
heel
sedat
nonsed
equip
sedat
nonsed
conclus
signific
differ
incid
pressur
ulcer
two
group
interest
differ
local
pressur
ulcer
found
sedat
patient
mainli
ulcer
classic
local
name
sacrum
heel
wherea
nonsed
mainli
ulcer
relat
equip
divers
local
face
limb
genitalia
consid
longterm
prognosi
ulcer
deriv
equip
easier
reliev
must
expect
heel
faster
refer
cooper
l
et
al
prevent
manag
pressur
ulcer
summari
updat
nice
guidanc
j
wound
care
cox
j
predictor
pressur
ulcer
adult
critic
care
patient
j
crit
care
introduct
delirium
acut
confusion
state
common
intens
care
unit
icu
mani
critic
ill
patient
treat
icu
experi
sleep
disrupt
disrupt
sleep
icu
propos
potenti
risk
factor
delirium
evid
spars
object
studi
undertaken
identifi
sleep
statu
develop
delirium
nonsed
critic
ill
patient
method
prospect
studi
conduct
medic
icu
tertiari
referr
hospit
polysomnographi
record
perform
hour
assess
quantiti
qualiti
sleep
delirium
measur
daili
use
confus
assess
method
icu
result
total
patient
enrol
median
apapch
ii
score
iqr
median
total
sleep
time
hh
mm
iqr
major
sleep
stage
median
scant
stage
median
rem
median
absent
stage
delirium
develop
patient
multivari
analysi
durat
icu
stay
day
independ
associ
delirium
incid
p
also
found
patient
stay
day
icu
show
signific
reduct
night
sleep
time
compar
patient
stay
less
day
vs
p
despit
similar
total
sleep
time
conclus
quantiti
qualiti
sleep
critic
ill
patient
poor
long
durat
icu
stay
disrupt
circadian
rhythm
might
contribut
develop
delirium
critic
ill
patient
introduct
mechan
ventil
patient
frequent
receiv
analgesia
sedat
manag
pain
agit
intens
care
unit
icu
current
clinic
practic
guidelin
advoc
mainten
light
target
level
sedat
along
use
structur
sedat
protocol
daili
sedat
interrupt
sedat
protocol
therefor
develop
implement
medic
intens
care
unit
micu
tertiari
hospit
standard
manag
analgesia
sedat
mechan
ventil
patient
object
evalu
impact
sedat
protocol
patient
outcom
mechan
ventil
patient
method
observ
beforeaft
studi
conduct
micu
nation
univers
hospit
nuh
singapor
septemb
march
sedat
protocol
incorpor
daili
sedat
interrupt
routin
object
assess
pain
agit
delirium
nurs
advoc
titrat
analgesia
sedat
maintain
target
richmond
agit
sedat
scale
rass
rang
data
collect
retrospect
electron
patient
record
primari
outcom
durat
mechan
ventil
main
secondari
outcom
includ
number
ventilatorfre
day
day
icu
length
stay
icu
mortal
mortal
result
studi
includ
patient
protocol
implement
respect
signific
improv
percentag
icu
day
daili
sedat
interrupt
postimplement
period
vs
p
trend
decreas
durat
mechan
ventil
implement
day
vs
day
respect
adjust
effect
estim
ci
p
trend
increas
ventilatorfre
day
day
post
implement
day
vs
day
adjust
effect
estim
ci
p
mean
icu
length
stay
similar
group
day
vs
day
adjust
effect
estim
ci
p
icu
mortal
demonstr
signific
differ
group
vs
p
vs
p
respect
rate
protocol
adher
low
patient
n
protocol
group
deviat
sedat
protocol
conclus
mechan
ventil
patient
use
standard
sedat
protocol
may
reduc
durat
mechan
ventil
barrier
protocol
use
identifi
improv
protocol
adher
refer
barr
j
et
al
clinic
practic
guidelin
manag
pain
agit
delirium
adult
patient
intens
care
unit
crit
care
med
p
grant
acknowledg
studi
receiv
grant
introduct
mechan
ventil
intens
care
patient
tradit
sedat
assur
analgesia
anxiolysi
comfort
might
neg
effect
prolong
mechan
ventil
mv
longer
length
stay
lo
dexmedetomidin
shown
shorten
time
extub
role
wean
process
fulli
elucid
object
determin
whether
sedat
regim
affect
wean
process
method
nonintervent
multicent
retrospect
studi
lightli
moder
sedat
intub
adult
patient
mechan
ventil
h
includ
sap
iii
score
measur
admiss
admiss
intens
care
unit
icu
fit
wean
patient
sedat
standard
care
accord
respect
clinic
protocol
wean
period
patient
sedat
dexmedetomidin
dex
compar
sedat
midazolam
andor
propofol
standard
care
soc
soc
dexmedetomidin
socdex
concern
wean
time
wean
time
defin
time
fit
wean
extub
total
time
mv
lo
icu
measur
amount
sed
analges
use
well
anxieti
icu
delirium
record
use
nudesccamicu
measur
ptss
obtain
evalu
qualiti
life
incid
posttraumat
stress
disord
ptsd
month
icu
discharg
result
total
patient
record
review
includ
studi
dex
soc
socdex
dex
group
could
rapidli
wean
compar
soc
p
group
socdex
p
group
despit
longer
time
mv
prior
wean
hour
dexsocsocdex
respect
icu
lo
shortest
patient
soc
group
day
compar
socdex
dex
sap
iii
score
similar
three
group
dexsocsocdex
patient
respect
anxieti
wean
extub
present
dexsocsocdex
patient
respect
delirium
present
assess
assess
dexsocsocdex
patient
wean
icu
discharg
respect
qualiti
life
followup
measur
show
better
score
dex
group
compar
socdex
p
better
soc
p
point
socdex
patient
show
tendenc
symptom
relat
sever
pain
breath
troubl
nightmar
sever
anxieti
compar
dex
soc
patient
fulfil
ptsd
criteria
differ
among
group
conclus
dexmedetomidin
use
singl
sedat
contribut
shorter
wean
period
patient
tend
describ
better
qualiti
life
month
icu
discharg
grant
acknowledg
orion
pharma
sponsor
studi
introduct
sleep
disturb
common
critic
ill
patient
treat
intens
care
unit
icu
potenti
seriou
consequ
longterm
effect
health
outcom
patient
morbid
object
aim
describ
sleep
manag
sedat
practic
adult
icu
ten
countri
evalu
role
respons
icu
staff
relat
key
sleep
sedat
decis
method
multicent
selfadminist
survey
sent
nurs
manag
adult
icu
across
countri
questionnair
compris
four
domain
sleep
characterist
critic
ill
sleep
sedat
practic
nonpharmacolog
pharmacolog
intervent
use
improv
sleep
autonomi
influenc
nurs
sleep
practic
icu
result
overal
respons
rate
rang
uk
cypru
provid
data
icu
countri
frequent
patient
characterist
perceiv
identifi
sleep
lie
quietli
close
eye
n
rang
denmark
itali
commonli
use
sedat
scale
richmond
agitationsed
score
rass
n
rang
uk
denmark
cypru
icu
use
ramsay
score
icu
select
sleep
medic
n
assess
effect
n
perform
physician
nurs
base
collabor
discuss
minor
icu
n
decis
assess
made
physician
alon
commonli
use
countri
nonpharmacolog
intervent
promot
sleep
reduc
icu
staff
nois
n
rang
denmark
norway
canada
icu
use
earplug
frequent
basi
rang
greec
cypru
denmark
sweden
propofol
drug
use
commonli
sedat
n
rang
sweden
canada
chloral
hydrat
use
icu
rang
greec
cypru
denmark
itali
germani
sedat
scale
use
routin
basi
icu
particip
score
nurs
autonomi
sleep
sedat
manag
moder
median
score
scale
rang
canada
greec
sweden
norway
poland
nurs
influenc
sleep
sedat
decis
perceiv
consider
median
score
rang
denmark
poland
conclus
found
consider
across
countri
variat
sleep
promot
sedat
manag
practic
though
adopt
sedat
scale
recommend
profession
societi
guidelin
icu
countri
use
rang
pharmacolog
nonpharmacolog
intervent
promot
sleep
unit
report
interprofession
decisionmak
nurs
perceiv
substanti
influenc
sleepsed
decis
introduct
opioid
drug
depend
uncommon
worldwid
withdraw
syndrom
major
clinic
concern
patient
admit
intens
care
unit
icu
low
level
conscious
object
hypothes
softwar
could
design
estim
daili
need
patient
opioid
protocol
could
design
implement
concomitantli
control
pain
agit
delirium
pad
prevent
withdraw
sign
popul
icu
admiss
method
multidisciplinari
team
design
softwar
protocol
methadon
use
prevent
withdraw
syndrom
pain
assess
hourli
behavior
pain
scale
control
morphin
fentanyl
level
sedat
also
assess
hourli
richmond
agitationsed
scale
control
midazolam
propofol
accord
protocol
delirium
check
confus
assess
method
icu
everi
work
shift
result
thirti
patient
histori
opium
depend
recruit
period
mix
medicalsurg
icu
protocol
effect
complet
prevent
withdraw
syndrom
patient
averag
need
methadon
mg
patientsth
pain
sedat
delirium
evalu
document
staff
situat
respect
pain
sedat
score
within
accept
limit
occas
respect
delirium
occur
patient
icu
stay
conclus
implement
pad
protocol
use
softwar
especi
design
opium
depend
patient
feasibl
manag
pad
could
effect
done
multidisciplinari
approach
along
prevent
withdraw
syndrom
introduct
numer
rate
scale
nr
skin
conduct
respons
per
second
nscr
use
method
assess
pain
periop
set
experiment
studi
conduct
investig
relationship
nr
nscr
measur
relat
anxieti
degre
pain
stimul
method
eighteen
volunt
expos
condit
simul
icu
circumst
use
pictori
emot
stimuli
neutral
posit
neg
authent
icu
sound
nois
nois
electrocutan
stimul
pain
pain
electr
stimul
individu
titrat
prior
experi
induc
moder
pain
mm
va
mm
nscr
measur
throughout
experi
possibl
combin
condit
result
twelv
second
session
follow
nr
pain
rate
arous
valenc
indic
experienc
anxieti
result
nr
nscr
increas
pain
condit
nr
sd
nscr
compar
pain
nscr
p
p
respect
chang
time
nr
nscr
signific
posit
correl
found
nscr
magnitud
electr
stimul
r
p
also
nr
anxieti
index
mean
arous
valenc
rate
r
p
pain
condit
emot
x
nois
anova
nscr
nr
anxieti
show
nr
anxieti
sensit
experiment
manipul
shown
main
effect
emot
f
p
f
p
nr
anxieti
respect
main
effect
nois
f
p
f
p
nr
anxieti
respect
elev
rate
pain
anxieti
neg
condit
compar
rate
posit
neutral
condit
nscr
influenc
emot
nois
pain
condit
howev
helmert
contrast
emot
state
show
significantli
larger
nscr
emot
condit
compar
neutral
f
p
conclus
nr
nscr
reliabl
indic
pain
correspond
nscr
actual
pain
stimul
moreov
valid
use
nscr
measur
pain
patient
howev
nr
also
sensit
contextu
set
anxieti
nscr
discuss
whether
administ
analges
ataract
drug
periop
stage
nr
moder
higher
warrant
refer
schandl
bernhardsson
j
sundin
alvarsson
j
bottai
martl
cr
sackey
p
pain
rather
induc
emot
icu
sound
increas
skin
conduct
variabl
healthi
volunt
submit
grant
acknowledg
none
introduct
accord
recent
guidelin
nonbenzodiazepin
drug
like
propofol
prefer
benzodiazepin
sedat
icu
patient
undergo
mechan
ventil
due
decreas
durat
mechan
ventil
shorten
icu
stay
lower
risk
patient
death
decreas
cost
treatment
propofol
rel
well
known
drug
nevertheless
influenc
variou
factor
connect
patient
like
demograph
health
statu
coadminist
drug
propofol
pharmacokinet
fulli
understood
object
aim
studi
examin
pharmacokinet
propofol
heterogen
group
patient
sedat
icu
specif
object
investig
influenc
differ
variabl
monitor
patient
health
statu
descriptor
like
sofa
presenc
sepsi
pk
propofol
method
propofol
concentrationtim
profil
obtain
patient
subject
evalu
accord
apach
ii
score
sofa
score
wherea
level
sedat
appli
accord
modifi
ramsay
sedat
score
achiev
sedat
score
nonlinear
mixedeffect
model
nonmem
version
icon
develop
solut
ellicott
citi
md
usa
use
analys
observ
data
blood
sampl
propofol
assay
collect
patient
arteri
everi
day
infus
select
time
point
termin
propofol
concentr
plasma
measur
within
eight
week
hplc
method
fluoresc
detector
nonparametr
bootstrap
visual
predict
check
conduct
evalu
adequaci
induc
model
describ
observ
result
propofol
pharmacokinet
best
describ
threecompart
disposit
model
typic
valu
propofol
clearanc
lmin
approxim
liver
blood
flow
volum
distribut
steadi
state
high
l
consist
studi
icu
patient
unabl
identifi
statist
signific
covari
relationship
pk
paramet
opioid
type
sofa
score
admiss
apach
ii
predict
death
rate
reason
admiss
icu
sepsi
trauma
surgeri
gender
bodi
weight
age
infus
durat
creactiv
protein
conclus
popul
pk
model
success
develop
describ
time
cours
propofol
concentr
icu
patient
undergo
prolong
sedat
despit
heterogen
group
patient
consist
pk
profil
observ
refer
eleveld
dj
proost
jh
li
absalom
ar
struy
mm
gener
purpos
pharmacokinet
model
propofol
anesth
analg
gradwohlmati
mehta
mw
new
sedationstrategi
intens
care
med
grant
acknowledg
project
support
grant
found
polish
nation
scienc
centr
introduct
fluid
challeng
fc
commonli
use
increas
cardiac
index
oxygen
deliveri
tidal
volum
vt
mlkg
requir
guarante
efficaci
dynam
index
fluid
respons
predict
fluid
respons
nowaday
recommend
oper
room
identif
earli
variat
hemodynam
variabl
may
act
clinic
target
safeti
limit
stop
infus
approach
success
use
assess
fluid
respons
critic
ill
patient
ventil
low
tidal
volum
evalu
earli
variat
fc
oper
room
cardiac
cycl
efficaci
cce
dicrot
pressur
pdic
improv
baselin
puls
pressur
variat
ppv
reliabl
predict
fluid
respons
method
consecut
adult
patient
schedul
elect
abdomin
surgeri
ventil
vt
mlkg
fc
perform
accord
anesthetist
indic
consist
ml
crystalloid
infus
minut
respond
increas
cardiac
index
bivari
analysi
perform
use
student
test
wilcoxon
rank
sum
test
pearson
test
appropri
continu
categor
variabl
signific
set
p
withingroup
chang
baselin
analyz
anova
bonferroni
post
hoc
test
adjust
multipl
comparison
result
overal
patient
fluid
respond
baselin
auc
ppv
cce
pdic
respect
bivari
analysi
identifi
model
abl
predict
fluid
respons
patient
auc
ppv
pdic
ccenor
respond
reduct
ppv
fluid
challeng
statist
signific
baselin
minut
p
baselin
minut
p
increas
cce
fluid
challeng
statist
signific
baselin
minut
p
increas
dicrot
pressur
fluid
challeng
statist
signific
baselin
minut
p
baselin
minut
p
non
respond
ppv
dicrot
pressur
chang
significantli
fc
cce
significantli
reduc
baselin
minut
p
fig
discuss
pilot
studi
baselin
valu
cce
pdic
significantli
increas
reliabl
ppv
fc
ppv
neither
pdic
significantli
chang
non
respond
cce
reduc
end
fc
respond
reduct
ppv
increas
cce
pdic
signific
first
time
point
signific
minut
ppv
pdic
minut
cce
potenti
act
earli
safetylimit
fc
refer
guldner
et
al
anesthesiolog
j
mallat
et
al
br
j
anaesth
introduct
posit
fluid
balanc
associ
wors
outcom
critic
ill
suggest
conserv
fluid
administr
deresuscit
activ
remov
fluid
use
diuret
renal
replac
therapi
rrt
may
benefici
follow
haemodynam
stabilis
object
perform
systemat
review
metaanalysi
evalu
efficaci
safeti
conserv
deresuscit
fluid
strategi
adult
children
acut
respiratori
distress
syndrom
ard
sepsi
system
inflammatori
respons
syndrom
sir
follow
initi
resuscit
method
search
medlin
embas
cochran
central
regist
control
trial
without
restrict
manual
search
confer
proceed
last
year
two
review
independ
assess
public
includ
randomis
control
trial
compar
two
fluid
regimen
fluid
balanc
differ
observ
studi
investig
relationship
fluid
volum
administ
fluid
balanc
achiev
patient
outcom
exclud
studi
publish
studi
neonat
postcardiac
surgic
heart
failur
patient
observ
studi
fewer
particip
result
metaanalysi
includ
randomis
trial
n
found
nonsignific
reduct
mortal
conserv
deresuscit
fluid
strategi
pool
odd
ratio
confid
interv
ci
compar
liber
strategi
usual
care
fig
found
nonsignific
reduct
rrt
use
conserv
deresuscit
fluid
strategi
studi
pool
odd
ratio
ci
four
trial
report
shorter
length
icu
stay
increas
number
icufre
day
studi
report
shorter
durat
mechan
ventil
increas
ventilatorfre
day
conserv
deresuscit
fluid
strategi
compar
liber
strategi
usual
care
mark
clinic
heterogen
present
conclus
conserv
deresuscit
approach
fluid
manag
may
improv
patient
outcom
appear
increas
incid
acut
kidney
injuri
rrt
use
larg
randomis
trial
compar
altern
fluid
regimen
need
determin
optim
approach
fluid
manag
critic
ill
patient
refer
murphi
cv
et
al
chest
vincent
jl
et
al
crit
care
med
wiedemann
hp
et
al
n
engl
j
med
silversid
ja
et
al
syst
rev
grant
acknowledg
work
support
doctor
fellowship
award
js
northern
ireland
hsc
research
develop
divis
introduct
volum
expans
firstlin
treatment
major
case
acut
circulatori
failur
patient
shock
respond
fluid
challeng
fc
convent
manner
use
dynam
measur
increas
predict
patient
object
goal
studi
determin
correl
distens
index
inferior
vena
cava
divc
puls
pressur
variat
ppv
patient
shock
receiv
fc
method
prospect
observ
correl
studi
conduct
intens
care
unit
centro
nacion
del
uma
guanajuato
decemb
decemb
patient
admit
year
shock
mechan
ventil
hypoperfus
lactat
mean
arteri
pressur
urin
output
ppv
divc
measur
admiss
fc
analyz
hemodynam
variabl
exclud
patient
arrhythmia
tidal
volum
mlkg
unconvent
mode
mechan
ventil
statist
analysi
perform
use
spss
program
version
result
includ
patient
mean
age
year
femal
gender
male
mean
apach
ii
sofa
point
respect
frequent
admiss
diagnosi
sepsi
frequent
hypoperfus
criteria
lactat
mmoll
found
posit
correl
divc
ppv
r
p
fc
increas
cardiac
index
decreas
lactat
mmoll
increas
urin
output
mlkghour
decreas
mmhg
p
u
p
u
p
u
p
respect
conclus
posit
correl
divc
ppv
patient
shock
receiv
fc
convent
manner
refer
marik
pe
monnet
x
teboul
jl
hemodynam
paramet
guid
fluid
therapi
marik
et
al
annal
intens
care
monnet
x
teboul
jl
assess
volum
respons
mechan
ventil
recent
advanc
critic
care
cecconi
de
backer
antonelli
beal
r
bakker
j
hofer
c
consensu
circulatori
shock
hemodynam
monitor
task
forc
european
societi
intens
care
medicin
intens
care
med
grant
acknowledg
studi
receiv
grant
fund
agenc
introduct
contrast
static
paramet
eg
central
venou
pressur
cvp
dynam
variabl
repres
cardiorespiratori
interact
eg
stroke
volum
variat
allow
excel
predict
fluid
respons
fr
recent
publish
studi
suggest
posit
endexpiratori
pressur
peep
induc
chang
cvp
mean
arteri
pressur
map
might
repres
promis
tool
evalu
fr
ventil
patient
sepsi
object
evalu
abil
hemodynam
chang
produc
increas
peep
predict
fr
ventil
adult
patient
cardiac
surgeri
method
consecut
hemodynam
stabl
patient
undergo
cardiac
surgeri
use
cardiopulmonari
bypass
enrol
studi
hemodynam
monitor
includ
pulmonari
arteri
cathet
pac
transesophag
echocardiographi
tee
hemodynam
variabl
assess
differ
time
point
baselin
peep
cm
peep
challeng
peep
cm
minut
baselin
reduct
peep
initi
valu
crystalloid
fluid
challeng
mlkgbw
fluid
respons
defin
increas
stroke
volum
sv
fluid
challeng
measur
pac
result
patient
n
fluid
respond
peep
induc
chang
cvp
map
puls
pressur
pp
pulmonari
capillari
wedg
pressur
pwp
compar
nonrespond
cvp
mmhg
mmhg
mmhg
pcwp
mmhg
respond
cvp
mmhg
map
mmhg
mmhg
p
ns
accordingli
correl
peepinduc
chang
cvp
map
pp
pcwp
chang
sv
fluid
challeng
area
curv
auc
predict
fluid
respons
low
pp
contrast
increas
sv
peep
challeng
significantli
higher
fluidrespond
nonrespond
vs
ml
p
predict
fr
auc
p
conclus
data
suggest
peepinduc
chang
cvp
map
pp
pcwp
mechan
ventil
patient
cardiac
surgeri
predict
fluid
respons
wherea
increas
sv
peep
elev
appear
good
paramet
predict
fluid
respons
introduct
fluid
administr
one
princip
therapi
adopt
order
achiev
earli
haemodynam
stabil
septic
patient
despit
intern
guidelin
promot
rapid
volum
expans
earli
stage
shock
sever
studi
recent
shown
excess
fluid
balanc
septic
patient
correl
increas
mortal
object
studi
aim
investig
impact
fluid
balanc
mortal
septic
patient
along
associ
electrolyt
strong
ion
differencesid
ph
imbal
method
pilot
retrospect
studi
enrol
approxim
adult
patient
admit
intens
care
unit
icu
gemelli
univers
hospit
diagnosi
sever
sepsissept
shock
exclud
pregnant
women
surviv
less
hour
collect
data
concern
daili
fluid
balanc
arteri
blood
gase
abg
hemodynam
daili
sofa
day
icu
stay
discharg
fluid
balanc
hour
divid
quartil
subsequ
analysi
mortal
assess
day
result
patient
includ
pilot
analysi
januari
june
age
year
sap
ii
iqr
patient
die
higher
blood
lactat
vs
mmoll
p
develop
frequent
acut
kidney
injuri
aki
vs
p
present
posit
fluid
balanc
hour
vs
ml
p
vs
ml
p
vs
ml
p
respect
non
signific
trend
toward
increas
mortal
dead
vs
aliv
quartil
dead
vs
aliv
fluid
balanc
hour
also
found
signific
differ
term
ph
electrolyt
alter
emerg
though
trend
toward
higher
sid
quartil
evid
vs
vs
vs
vs
respect
p
multivari
analysi
includ
sap
ii
charlson
comorbid
score
aki
blood
lactat
admiss
confirm
associ
posit
fluid
balanc
surviv
even
adjust
sever
confound
factor
ci
p
conclus
popul
posit
fluid
balanc
independ
associ
increas
mortal
day
without
signific
differ
term
sid
ph
refer
delling
rp
et
al
surviv
sepsi
campaign
guidelin
committe
includ
pediatr
surviv
sepsi
campaign
intern
guidelin
manag
sever
sepsi
septic
shock
critic
care
medicin
boyd
jh
et
al
fluid
resuscit
septic
shock
posit
fluid
balanc
elev
central
venou
pressur
associ
increas
mortal
critic
care
medicin
introduct
gold
standard
evalu
fluid
respons
guid
fluid
administr
critic
ill
surgic
patient
fluid
challeng
techniqu
fc
recent
evid
highlight
import
variabl
current
practic
techniqu
differ
techniqu
may
lead
differ
result
differ
clinic
decis
object
aim
studi
describ
fluid
challeng
techniqu
report
fluid
respons
studi
clinic
trial
assess
whether
differ
proport
respond
depend
type
fluid
volum
durat
infus
method
conduct
systemat
review
use
medlin
embas
inclus
criteria
studi
use
fc
test
cardiac
preload
inclus
descript
fc
report
volum
type
fluid
durat
infus
report
definit
fluid
respons
report
proport
respond
nonrespond
clinic
set
icu
oper
theatr
includ
studi
examin
full
subject
quantifi
analysisth
predictor
categor
follow
volum
ml
ml
ml
fluid
type
colloid
crystalloid
infus
rate
min
min
min
proport
respond
compar
result
studi
includ
analysi
studi
use
less
ml
studi
use
ml
studi
use
ml
proport
respond
group
ml
median
iqr
group
ml
median
iqr
group
ml
median
iqr
evid
suggest
proport
respond
chang
volum
use
h
p
studi
report
use
crystalloid
whilst
studi
use
colloid
studi
type
fluid
clearli
report
evid
suggest
proport
respond
chang
colloid
crystalloid
sd
vs
sd
f
p
durat
infus
min
studi
min
studi
min
studi
proport
respond
chang
across
differ
infus
time
f
p
plan
contrast
reveal
proport
respond
group
min
group
min
similar
significantli
differ
proport
respond
group
infus
time
min
f
p
conclus
studi
assess
fluid
respons
use
ml
colloid
infus
minut
long
infus
rate
decreas
proport
fluid
respond
refer
cecconi
maurizio
et
al
fluid
challeng
intens
care
fenic
studi
intens
care
medicin
grant
acknowledg
sgul
introduct
patient
mechan
ventil
endexpiratori
endinspiratori
occlus
induc
chang
cardiac
preload
may
use
test
preload
depend
object
test
whether
volum
respons
predict
effect
respiratori
occlus
stroke
volum
sv
estim
transthorac
echocardiographi
measur
oesophag
doppler
method
mechan
ventil
patient
measur
puls
contour
analysisderiv
cardiac
index
sv
estim
measur
velocitytim
integr
left
ventricular
outflow
tract
transthorac
echocardiographi
n
measur
oesophag
doppler
n
last
second
endinspiratori
endexpiratori
occlus
separ
minut
subsequ
infus
salin
patient
volum
expans
induc
increas
cardiac
index
defin
volumerespond
result
volum
expans
increas
cardiac
index
p
patient
endexpiratori
occlus
sv
increas
respond
nonrespond
increas
vs
respect
p
similarli
endinspiratori
occlus
sv
decreas
respond
nonrespond
decreas
vs
respect
p
volum
respons
predict
endexpiratoryinduc
increas
sv
sensit
confid
interv
ci
specif
ci
absolut
valu
sv
chang
record
endexpiratori
plu
endinspiratori
occlus
ad
volum
respons
predict
increas
sv
sensit
ci
specif
ci
predict
accuraci
volum
respons
better
sv
chang
record
endexpiratori
occlus
area
roc
curv
ci
vs
ci
respect
p
conclus
sum
absolut
valu
chang
sv
record
consecut
endexpiratori
endinspiratori
occlus
reliabl
predict
volum
respons
predict
better
chang
sv
endexpiratori
occlus
nevertheless
combin
endexpiratori
endinspiratori
occlus
induc
larger
sv
chang
increas
valu
threshold
compat
precis
echocardiographi
oesophag
doppler
introduct
acut
bleed
life
threaten
condit
requir
immedi
adequ
intervent
adequ
fluid
resuscit
cornerston
maintain
correct
oxygen
deliveri
accord
starl
model
crystalloid
volum
effect
colloid
howev
volumereplac
ratio
remain
controversi
issu
may
affect
degrad
endotheli
glycocalyx
layer
often
found
critic
ill
object
aim
compar
colloid
crystalloid
base
fluid
resuscit
experiment
stroke
volum
index
svi
guid
hemorrhag
resuscit
model
vietnames
minipig
method
experi
anesthet
mechan
ventil
pig
random
receiv
colloid
he
n
crystalloid
rf
n
infus
anim
bled
till
baselin
svi
tbsl
drop
follow
resuscit
initi
svi
reach
four
step
statist
perform
use
statist
analysi
test
gener
linear
model
independ
sampl
ttest
mannwhitney
u
test
appropri
result
hemodynam
chang
experi
show
clinic
relev
differ
group
tbsl
svi
valu
similar
he
rf
bleed
svi
decreas
plan
he
rf
return
initi
valu
he
rf
cardiac
index
ci
also
decreas
tbsl
he
rf
he
rf
reach
higher
valu
he
rf
p
signific
increas
heart
rate
time
tbsl
he
rf
beatsmin
he
rf
beatsmin
similar
amount
blood
shed
group
he
ml
rf
ml
anim
receiv
significantli
less
resuscit
fluid
ml
p
respect
total
fluid
hesgroup
ml
p
respect
volum
replac
ratio
significantli
differ
he
median
rfgroup
median
iqr
p
respect
conclus
result
show
healthi
pig
volumereplac
ratio
follow
starl
principl
indic
acut
bleed
event
like
trauma
surgeri
glycocalix
like
still
intact
colloid
may
benefici
hemodynam
stabil
achiev
faster
crystalloid
refer
k
et
al
goaldirect
resuscit
aim
cardiac
index
mask
residu
hypovolemia
anim
experi
biom
re
int
grant
acknowledg
support
nkfih
introduct
passiv
leg
rais
plr
test
popular
method
use
detect
fluid
respons
fr
patient
acut
circulatori
failur
import
limit
plr
test
need
realtim
cardiac
output
co
monitor
trace
patient
hemodynam
respons
plr
increas
endtid
plr
report
surrog
increas
co
predict
fr
howev
use
endtid
limit
mechan
ventil
patient
increas
mix
venou
oxygen
satur
anoth
surrog
increas
co
predict
fr
plr
howev
paramet
need
insert
pulmonari
arteri
cathet
although
central
venou
oxygen
satur
surrog
mix
venou
oxygen
satur
howev
investig
predict
fr
venousarteri
gap
gap
defin
differ
central
venou
arteri
partial
pressur
gap
increas
case
tissu
hypoperfus
decreas
co
improv
object
investig
role
chang
gap
chang
plr
predict
fr
method
includ
patient
acut
circulatori
failur
elev
serum
lactat
plr
test
perform
detect
fr
fluid
respond
defin
patient
increas
stroke
volum
measur
icon
cardiometri
devic
plr
test
addit
demograph
hemodynam
data
arteri
central
venou
blood
gase
obtain
plr
predict
abil
chang
gap
chang
plr
predict
fr
obtain
use
area
receiv
oper
characterist
auroc
curv
result
fluid
respond
patient
auroc
chang
gap
predict
fr
ci
sensit
specif
cutoff
valu
mmhg
increas
gap
auroc
chang
predict
fr
ci
sensit
specif
cutoff
valu
decreas
conclus
chang
gap
plr
superior
chang
predict
fr
patient
acut
circulatori
failur
gap
consid
set
co
monitor
feasibl
refer
monnet
x
batail
magalha
e
barroi
j
le
corr
gosset
c
et
al
endtid
carbon
dioxid
better
arteri
pressur
predict
volum
respons
passiv
leg
rais
test
intens
care
med
kuiper
et
al
mix
venou
satur
fluid
respons
cardiac
major
vascular
surgeri
j
cardiothorac
surg
robin
e
futier
e
pire
fleyfel
taverni
b
lebuff
g
et
al
central
venoustoarteri
carbon
dioxid
differ
prognost
tool
highrisk
surgic
patient
crit
care
introduct
fluid
manag
one
difficult
task
critic
care
medicin
recent
studi
show
current
practic
fluid
administr
evid
base
despit
lot
tool
avail
physician
howev
mani
invas
alway
applic
depend
clinic
context
carotid
doppler
non
invas
easytous
method
shown
excel
predict
valu
monitor
fluid
respons
passiv
leg
rais
otherwis
mini
fluid
challeng
describ
reliabl
altern
classic
fluid
challeng
prevent
fluid
overload
object
assess
variat
carotid
doppler
flow
predict
fluid
respons
mini
fluid
challeng
method
prospect
observ
studi
perform
septemb
decemb
patient
requir
volum
expans
elig
enrol
patient
less
year
old
carotid
stenosi
poor
inson
exclud
record
variat
carotid
doppler
flow
cc
cristalloid
min
variat
veloc
time
integr
vti
addit
infus
cc
min
assess
transthorac
echocardiographi
cardiac
output
co
calcul
co
vti
x
heart
rate
x
aortic
surfac
patient
whose
co
increas
follow
cc
consid
fluid
respond
mechan
ventil
requir
lung
protect
strategi
appli
statist
spearman
correl
test
use
receiv
oper
curv
roc
grey
zone
defin
result
total
patient
includ
diagnosi
admiss
sever
sepsissept
shock
brain
injuri
post
oper
sixti
five
percent
patient
ventil
requir
vasopressor
support
differ
respond
non
respond
fourteen
patient
volum
respond
increas
respond
compar
non
respond
p
strongli
correl
r
p
best
threshold
sensit
specif
respect
area
roc
curv
bootstrap
resampl
grey
zone
rang
observ
patient
conclus
studi
show
variat
carotid
doppler
mini
fluid
challeng
predict
fluid
respons
heterogen
critic
care
popul
refer
cecconi
hofer
c
teboul
jl
et
al
fluid
challeng
intens
care
fenic
studi
global
incept
cohort
studi
intens
care
med
marik
pe
levitov
young
et
al
use
bioreact
carotid
doppler
determin
volum
respons
blood
flow
redistribut
follow
passiv
leg
rais
hemodynam
unstabl
patient
chest
background
sepsisrel
acut
circulatori
dysfunct
life
threaten
condit
peripher
perfus
marker
hypoperfus
could
use
trigger
initi
fluid
resuscit
fr
respons
peripher
perfus
fr
patient
abnorm
perfus
could
potenti
identifi
highrisk
patient
object
aim
studi
effect
first
protocol
fr
capillari
refil
time
crt
perfus
paramet
relationship
respons
outcom
method
prospect
observ
studi
includ
patient
sepsi
acut
circulatori
dysfunct
admit
emerg
depart
ed
initi
fr
indic
accord
standard
care
peripher
perfus
laboratori
assess
perform
protocol
fr
followup
patient
hospit
discharg
crt
respond
defin
patient
abl
maintain
normal
crt
normal
abnorm
crt
valu
fr
result
one
hundr
consecut
patient
includ
patient
abnorm
crt
admiss
normal
crt
initi
fr
crt
respond
show
signific
decreas
heart
rate
lactat
present
less
organ
dysfunct
requir
mechan
ventil
hospit
mortal
significantli
lower
crt
respond
compar
nonrespond
vs
p
logist
regress
analysi
crt
significantli
relat
hospit
mortal
associ
maintain
adjust
baselin
sever
conclus
patient
sepsisrel
acut
circulatori
dysfunct
exhibit
normal
crt
earli
fr
low
mortal
rate
contrast
failur
improv
peripher
perfus
respons
initi
fr
strong
predictor
mortal
find
could
import
ed
limitedresourc
set
sinc
could
help
decid
addit
diagnost
treatment
option
introduct
appropri
fluid
support
crucial
critic
care
guid
fluid
resuscit
fill
pressur
central
venou
pressur
cvp
volumetr
paramet
eg
global
enddiastol
volum
index
gedvi
dynam
paramet
fluid
respons
fr
like
stroke
volum
variat
svv
use
predict
fr
particular
difficult
patient
spontan
breath
sinc
use
svv
usual
restrict
patient
control
ventil
circumst
passiv
leg
rais
plr
mini
volum
challeng
use
intermitt
assess
fr
recent
fluid
respons
index
fri
introduc
experiment
marker
fr
fri
deriv
proprietari
algorithm
base
continu
analysi
arteri
centralven
pressur
special
softwar
provid
scientif
use
devic
pulsion
medic
system
se
feldkirchen
germani
object
aim
studi
compar
predict
fr
defin
increas
stroke
volum
index
fri
gedvi
cvp
svv
volum
challeng
vc
mlkg
crystalloid
within
minut
patient
assist
mechan
ventil
equip
tptdmonitor
irrespect
studi
method
haemodynam
paramet
measur
immedi
vc
modifi
provid
continu
fri
studi
approv
local
ethic
committe
statist
spss
result
male
femal
patient
apacheii
fri
rocauc
p
gedvi
auc
p
significantli
predict
increas
stroke
volum
index
wherea
neither
cvp
auc
p
svv
predict
auc
p
fri
significantli
higher
fluidrespond
nonrespond
vs
p
gedvi
significantli
lower
respond
vs
p
cvp
svv
differ
respond
nonrespond
cutoff
friprovid
sensit
specif
regard
increas
stroke
volum
index
gedvi
valu
predict
fr
sensit
specif
binari
regress
analysi
fri
p
independ
associ
primari
endpoint
similarli
fri
auc
p
gedvi
auc
p
predict
increas
ci
vc
wherea
cvp
svv
predict
final
fri
predict
increas
cardiac
power
index
cpi
auc
p
conclus
fri
significantli
independ
predict
fr
patient
spontan
assist
ventil
furthermor
gedvi
significantli
associ
fr
patient
cvp
svv
predict
regard
limit
number
patient
includ
confirmatori
valid
studi
requir
introduct
fluid
expans
fe
major
issu
manag
critic
ill
patient
accur
practic
tool
predict
fluid
respons
still
lack
venou
return
gradient
dvr
major
compon
venou
return
therefor
right
heart
preload
cardiac
output
dvr
differ
mean
system
fill
pressur
pmsf
central
venou
pressur
cvp
right
atrial
pressur
rap
pmsf
estim
measur
static
fill
pressur
arm
parm
later
shown
use
predictor
fluid
respons
cardiac
surgeri
patient
object
aim
studi
evalu
dvr
reliabl
variabl
predict
fluid
respons
method
twentynin
critic
ill
patient
requir
fe
includ
prospect
observ
studi
patient
parm
measur
three
time
fe
arteri
pressur
curv
obtain
radial
arteri
cathet
sec
occlud
arteri
flow
cuff
inflat
mmhg
systol
blood
pressur
averag
valu
triplic
measur
calcul
stroke
volum
estim
either
swanganz
cathet
transthorac
echocardiographi
posit
respons
fluid
expans
defin
sv
increas
least
optim
cut
off
chosen
use
receiv
oper
characterist
curv
roc
analysi
identifi
maxim
youden
index
sensit
specif
approxim
confid
interv
comput
result
group
patient
respond
fluid
expans
n
mean
cvprap
mmhg
mean
parm
mmhg
mean
dvr
mmhg
nonrespond
patient
n
mean
cvprap
mmhg
mean
parm
mmhg
mean
dvr
mmhg
best
paramet
order
predict
fluid
respons
dvr
area
curv
confid
interv
dvr
cutoff
mmhg
predict
success
fe
sensit
specif
comparison
parm
area
curv
confid
interv
parm
cutoff
mmhg
predict
success
fe
sensit
specif
conclus
venou
return
gradient
estim
arm
occlus
pressur
least
good
parm
predict
fluid
respons
critic
ill
patient
refer
geert
bf
et
al
arm
occlus
pressur
use
predictor
increas
cardiac
output
fluid
load
follow
cardiac
surgeri
eur
j
anaesthesiol
grant
acknowledg
none
introduct
abil
echocardiographi
analysi
mitral
profil
predict
fluid
respons
septic
shock
left
systol
heart
failur
difficult
manag
object
object
studi
evalu
abil
mitral
profil
evolut
test
passiv
leg
rais
discrimin
fluid
respons
septic
shock
left
systol
heart
failur
method
patient
septic
shock
left
systol
failur
monitor
transthorac
echocardiographi
tte
continu
measur
cardiac
output
co
cathet
pulmonari
arteri
cathet
pac
transpulmonari
thermodilut
tptd
includ
mitral
profil
e
ea
later
septal
averag
co
pulmonari
arteri
occlus
pressur
paop
extravascular
lung
water
evlw
collect
volum
expans
passiv
leg
rais
plr
ml
crystalloid
solut
variat
hemodynam
valu
plr
plr
perform
left
systol
heart
failur
defin
left
ventricl
eject
fraction
lvef
patient
classifi
two
group
accord
respons
measur
thermodilut
respond
r
defin
increas
co
nonrespond
nr
result
patient
monitor
tte
also
tptd
pac
r
nr
norepinephrin
gammakgmin
signific
differ
r
nr
e
ea
vs
averag
vs
averag
vs
found
correl
ee
paop
p
evlw
p
nr
lat
r
lat
p
averag
p
higher
r
lat
p
averag
p
higher
nr
correl
independ
lvef
r
p
found
posit
correl
ev
plr
r
p
plr
auc
optim
threshold
predict
fluid
respons
p
sensit
specif
plr
correl
averag
r
p
conclus
decompens
patient
septic
shock
left
systol
heart
failur
analysi
mitral
profil
alon
reliabl
predict
left
fill
pressur
predict
fluid
respons
plr
variat
mitral
profil
averag
lat
would
secur
popul
introduct
fluid
balanc
one
frequent
manipul
clinic
care
variabl
icu
risk
associ
invas
monitor
relationship
heighten
mortal
make
evalu
util
modal
track
volum
statu
critic
ill
patient
vital
object
correl
three
day
cumul
fluid
balanc
cfb
extravascular
lung
water
assess
lu
electr
cardiometri
end
day
assess
diagnost
accuraci
electr
cardiometri
assess
thorac
fluid
content
tfc
comparison
lung
ultrasound
method
three
day
cfb
measur
three
day
icu
stay
lung
ultrasound
score
obtain
scan
interspac
sum
bline
yield
score
electr
cardiometri
use
assess
tfc
consid
abnorm
exceed
predetermin
valu
ratio
done
assess
fluid
load
correl
cfb
lung
score
thorac
fluid
content
tfc
measur
done
day
day
variabl
collect
age
gender
cardiac
output
apach
ii
score
medic
surgic
patient
mechan
ventil
length
icu
stay
icu
mortal
result
patient
enrol
median
iqr
cumul
fluid
balanc
ten
patient
posit
fluid
balanc
patient
neg
fluid
balanc
median
iqr
tfc
day
day
signific
correl
cumul
fluid
balanc
either
lu
ratio
tfc
tabl
signific
correl
tfc
lu
day
day
r
p
r
p
respect
relationship
ratio
tfc
lu
day
becam
signific
day
tabl
tfc
correl
significantli
lu
patient
neg
fluid
balanc
posit
fluid
balanc
token
lu
correl
significantli
patient
neg
balanc
howev
correl
found
tfc
patient
either
neg
posit
fluid
balanc
tabl
conclus
good
relationship
tfc
lu
assess
extravascular
lung
water
howev
relationship
cfb
extravascular
lung
water
poor
futur
larger
studi
warrant
develop
predict
equat
assess
amount
extravascular
lung
water
tfc
refer
martin
gs
eli
ew
carrol
fe
bernard
gr
find
portabl
chest
radiograph
correl
fluid
balanc
critic
ill
patient
volpicelli
g
mussa
garofalo
g
cardinal
l
casoli
g
perotto
f
et
al
bedsid
lung
ultrasound
assess
alveolarinterstiti
syndrom
j
emerg
med
oct
introduct
obtain
maximum
oxygen
consumpt
direct
way
requir
equip
train
personnel
avail
intens
care
unit
modifi
formula
uth
niel
et
al
x
maximum
heart
rate
exercis
heart
rate
rest
replac
maximum
rate
exercis
maximum
heart
rate
age
frequenc
rest
heart
rate
hour
admiss
intens
care
unit
modifi
x
maximum
heart
rate
age
heart
rate
hour
object
evalu
use
maximum
oxygen
uptak
determin
patient
sepsi
septic
shock
prognost
marker
method
cohort
prospect
longitudin
analyt
studi
patient
year
old
admit
icu
abc
medic
center
diagnosi
sepsi
maximum
oxygen
consumpt
admiss
patient
sepsi
calcul
compar
accord
group
base
modifi
bivari
analysi
perform
use
roc
curv
rel
risk
result
patient
analyz
men
age
year
old
primari
site
infect
lung
follow
urinari
mod
point
sepsi
septic
shock
respect
patient
die
roc
curv
obtain
hour
modifi
auc
ci
p
cutoff
mlkgmin
sensit
specif
respect
patient
higher
mlkgmin
rr
ci
mortal
day
conclus
modifi
could
use
tool
identifi
septic
patient
adequ
reanim
trial
suggest
valu
calcul
hour
icu
admiss
greater
mlkgmin
reflect
good
reanim
howev
futur
research
need
corrobor
prognost
util
set
goal
reanim
bibliographi
uth
n
sorensen
h
et
al
estim
ratio
hrmax
hrrest
heart
rate
ratio
method
eur
j
appl
physiol
harm
f
bodmer
et
al
cutan
mitochondri
respirometri
noninvas
monitor
mitochondri
function
j
clin
monit
comput
koutliano
n
dimitro
e
et
al
indirect
estim
athlet
equat
valid
hippokratia
background
patient
critic
care
set
often
risk
develop
hypotens
lead
poor
outcom
address
need
earli
detect
hypotens
event
develop
hypotens
probabl
indic
hypotens
event
defin
time
period
map
mmhg
train
model
icu
surgic
patient
test
independ
data
set
demonstr
sensit
specif
detect
event
respect
minut
prior
start
give
clinic
valu
decis
support
index
need
understand
underli
reason
patient
trend
toward
hypotens
studi
evalu
use
stroke
volum
sv
cardiac
output
co
stroke
volum
variat
svv
dynam
elast
ea
dyn
system
vascular
resist
svr
dpdt
classifi
patient
prescript
hypotens
group
decreas
preload
decreas
afterload
decreas
contractil
uncertain
method
data
use
studi
came
mimic
ii
mit
databas
n
arteri
pressur
waveform
patient
process
flotrac
edward
lifesci
calcul
mean
arteri
pressur
map
co
sv
svv
ea
dyn
dpdt
svr
data
annot
event
defin
previous
event
classifi
group
base
chang
minut
prior
event
decreas
preload
decreas
sv
co
increas
svv
decreas
afterload
decreas
ea
svr
decreas
contractil
decreas
dpdt
uncertain
meet
criteria
event
met
group
criteria
use
analysi
avoid
overlap
classif
event
chang
sv
co
svv
ea
dyn
svr
dpdt
minut
prior
event
evalu
assess
event
underli
caus
could
identifi
earli
ttest
use
assess
signific
differ
p
mean
chang
group
result
conclus
total
hypotens
event
group
contain
event
event
use
analysi
due
data
outlier
meet
group
criteria
overal
group
minut
chang
profil
differ
minut
fig
chang
co
svv
sv
significantli
differ
compar
group
minut
chang
ea
dyn
svr
significantli
differ
compar
group
minut
prior
event
chang
dpdt
significantli
differ
compar
group
minut
prior
event
conclus
underli
caus
hypotens
event
potenti
classifi
prescript
group
minut
prior
start
event
introduct
dynam
arteri
elast
eadyn
use
predict
rise
mean
arteri
pressur
map
fluid
challeng
fluid
respond
howev
accord
ventriculararteri
coupl
arteri
resist
rart
arteri
elast
predictor
map
respons
object
studi
aim
understand
relationship
arteri
resist
variabl
arteri
elast
variabl
analyz
perform
predict
map
respond
septic
shock
patient
receiv
fluid
challeng
fc
method
rart
map
divid
cardiac
output
eastat
puls
pressur
pp
divid
stroke
volum
sv
eadyn
puls
pressur
variat
ppv
divid
stroke
volum
variat
svv
obtain
paramet
baselin
end
fluid
challeng
fc
perform
fc
ml
normal
salin
solut
infus
minut
relationship
among
variabl
determin
correl
coeffici
perform
determin
area
roc
curv
result
total
septic
shock
subject
includ
consecut
mean
apach
ii
sofa
lactat
respect
subject
receiv
fluid
therapi
prior
enrol
mean
map
baselin
mmhg
mean
rart
baselin
mmhgminl
mean
dbp
eastat
eadyn
baselin
mmhg
mmhgl
respect
mean
rart
baselin
similar
mean
rart
end
fc
mmhgminl
vs
mmhgminl
p
baselin
diastol
blood
pressur
dbp
eastat
correl
rart
r
p
vs
r
p
end
fc
dbp
eastat
correl
rart
r
p
vs
r
p
correl
observ
eadyn
rart
dbp
baselin
show
signific
differ
map
respond
nonrespond
mmhg
vs
mmhg
p
area
roc
curv
dbp
baselin
predict
map
respons
ci
valu
dbp
baselin
mmhg
predict
map
respond
sensit
specif
fluid
respond
mean
dbp
baselin
significantli
lower
nonrespond
mmhg
vs
mmhg
p
wherea
rart
eastat
eadyn
similar
group
conclus
rart
remain
stabl
throughout
period
fc
even
though
found
correl
dbp
eastat
rart
mean
dbp
arteri
elast
arteri
resist
ident
group
septic
shock
low
dbp
dbp
arteri
resist
elast
variabl
correl
increas
map
co
fc
thu
may
use
predictor
map
respond
instead
eadyn
introduct
highrisk
surgic
patient
arteri
catheter
need
monitor
blood
pressur
perform
blood
ga
analysi
oper
room
icu
selding
techniqu
consid
gold
standard
mani
cathet
recent
propos
effect
safe
object
evalu
effect
safeti
bbraun
introcan
safeti
arteri
catheter
adult
highrisk
surgic
patient
schedul
postop
icu
stay
compar
selding
devic
method
bbraun
introcan
safeti
vygon
leadercath
arrow
arteri
catheter
set
analys
arteri
cannul
adult
highrisk
surgic
patient
schedul
postop
icu
stay
follow
paramet
adequ
size
easi
recognit
vascular
space
easi
introduct
traumat
cannula
fixat
efficaci
blood
pressur
monitor
take
blood
sampl
first
hour
safeti
cathet
place
oper
room
induct
gener
anesthesia
maintain
icu
stay
questionnair
administr
physician
arteri
cannul
paramet
score
poor
point
middl
point
suffici
point
good
point
excel
point
maximum
score
point
failur
complic
record
appropri
statist
analysi
perform
compar
effect
safeti
three
devic
p
consid
signific
noninferior
margin
defin
result
arteri
cannul
devic
perform
medic
doctor
mean
experi
arteri
catheter
year
selding
kit
obtain
best
score
point
introcan
safeti
result
noninferior
point
failur
rate
statist
differ
found
adequ
size
easi
recognit
vascular
space
easi
introduct
traumat
cannula
fixat
efficaci
blood
pressur
monitor
take
blood
sampl
first
hour
introcan
safeti
emerg
safer
devic
due
antireflux
antipunctur
system
p
sever
complic
report
procedur
conclus
bbraun
introcan
safeti
result
safe
effect
devic
perform
arteri
catheter
adult
highrisk
surgic
patient
schedul
postop
icu
stay
refer
gershengorn
hb
et
al
variat
arteri
central
venou
cathet
use
unit
state
intens
care
unit
anesthesiolog
introduct
transpulmonari
thermodilut
tptd
techniqu
cardiac
output
monitor
appli
stewart
hamilton
principl
well
establish
term
cardiac
output
accuraci
howev
invas
procedur
involv
variou
risk
research
continu
explor
potenti
less
invas
altern
transthorac
echocardiograph
left
ventricular
outflow
tract
lvot
measur
recogn
tool
assess
cardiac
output
noninvas
howev
pauciti
definit
data
concern
accuraci
object
aim
valid
noninvas
transthorac
echocardiograph
estim
stroke
volum
stroke
volum
measur
obtain
invas
tptd
techniqu
method
twenti
success
critic
ill
patient
cardiac
output
monitor
femal
male
mean
sd
age
year
subject
studi
compar
pair
stroke
volum
sv
read
obtain
simultan
tptd
compon
cardiac
output
monitor
transthorac
echocardiographi
lvot
diamet
veloc
time
integr
result
averag
valu
sv
measur
echocardiographi
compar
tptd
vs
ml
sv
measur
echocardiographi
tptd
show
signific
correl
p
mean
bia
ml
limit
agreement
mean
differ
sd
ml
conclus
monitor
cardiac
output
noninvas
use
transthorac
echocardiographi
reproduc
feasibl
option
refer
reuter
da
huang
c
edrich
shernan
sk
eltzschig
hk
cardiac
output
monitor
use
indicatordilut
techniqu
basic
limit
perspect
anesthesia
analgesia
kornbau
c
lee
kc
hugh
gd
firstenberg
ms
central
line
complic
intern
journal
critic
ill
injuri
scienc
background
traumat
hemorrhag
shock
th
lead
caus
prevent
death
follow
sever
traumat
injuri
microcircul
ultim
structur
concern
tissu
perfus
therefor
primari
import
th
microcircul
examin
larg
anim
model
th
order
investig
effect
microcirculatori
dysfunct
resuscit
method
baselin
standard
microcirculatori
paramet
obtain
larg
white
pig
use
sublingu
incid
dark
field
idf
videomicroscopi
anim
subject
standard
hindlimb
injuri
follow
control
haemorrhag
approxim
blood
volum
shock
phase
follow
min
fluid
resuscit
either
salin
compon
blood
product
target
sbp
mmhg
earli
resuscit
phase
anim
given
blood
product
target
sbp
mmhg
min
mid
resuscit
phase
min
late
resuscit
phase
idf
read
obtain
mid
point
phase
cardiac
output
measur
use
pulmonari
arteri
cathet
anim
divid
averag
averag
b
perfus
vessel
densiti
pvd
group
base
lowest
record
pvd
measur
taken
shock
earli
resuscit
phase
result
shock
earli
resuscit
group
n
mean
pvd
sd
group
b
n
sd
later
resuscit
phase
group
maintain
significantli
higher
pvd
group
b
group
initi
higher
cardiac
output
differ
group
narrow
resuscit
progress
end
resuscit
group
significantli
lower
plasma
lactat
higher
lactat
clearanc
lower
standard
base
deficit
smaller
mix
venou
arteri
gradient
signific
differ
blood
pressur
two
group
stage
wide
spread
pvd
given
blood
pressur
especi
shock
earli
hypotens
resuscit
phase
fig
choic
initi
resuscit
fluid
appear
produc
differ
effect
term
microcirculatori
perfus
fig
note
abstract
previous
publish
avail
includ
complet
record
abstract
confer
refer
hutch
sd
naumaan
dn
watt
wilson
c
burton
c
wendon
j
kirkman
e
microcirculatori
perfus
show
wide
interindividu
variat
import
determin
shock
revers
resuscit
porcin
experiment
model
complex
traumat
hemorrhag
shock
intens
care
medicin
experiment
conclus
earli
chang
microvascular
perfus
key
determin
subsequ
tissu
perfus
follow
fluid
resuscit
appear
unrel
pressur
base
paramet
choic
initi
resuscit
fluid
appear
littl
impact
microcirculatori
perfus
resuscit
traumat
haemorrhag
shock
microcirculatori
paramet
may
reliabl
marker
physiolog
insult
global
haemodynam
paramet
potenti
target
goaldirect
resuscit
introduct
patient
critic
care
set
often
risk
develop
hypotens
increas
risk
complic
earli
hypotens
typic
manifest
subtl
chang
physiolog
signal
go
unnot
first
use
machin
learn
ml
techniqu
develop
predict
algorithm
hypotens
episod
exploit
arteri
pressur
waveform
characterist
object
test
accuraci
hypotens
probabl
algorithm
icu
patient
method
ml
techniqu
base
multivari
logist
regress
analysi
use
construct
mathemat
model
predict
hypotens
express
hypotens
probabl
indic
hypotens
episod
defin
map
mmhg
least
minut
multipl
hemodynam
featur
extract
arteri
pressur
waveform
use
predictor
variabl
model
model
train
crossvalid
data
patient
clinic
databas
icu
patient
multipl
clinic
site
use
calibr
set
use
test
set
final
valid
patient
includ
septic
shock
post
cardiac
surgeri
cardiogen
shock
post
liver
transplant
other
respiratori
failur
post
non
cardiac
surgeri
etc
patient
demograph
list
tabl
radial
arteri
pressur
waveform
record
sensor
edward
lifesci
irvin
ca
waveform
pass
algorithm
calcul
hypotens
probabl
receiv
oper
characterist
roc
analysi
use
assess
algorithm
perform
result
hypotens
event
regist
averag
event
per
patient
durat
minut
per
event
algorithm
abl
predict
hypotens
sensit
specif
minut
prior
event
respect
area
curv
auc
minut
prior
event
respect
fig
conclus
data
suggest
capabl
predict
hypotens
event
high
sensit
specif
icu
patient
minut
prior
event
introduct
machin
learn
emerg
techniqu
enabl
comput
learn
data
without
explicitli
program
medic
field
use
classif
predict
analysi
supervis
supervis
fashion
cardiomechan
determin
endsystol
arteri
elast
ventricular
arteri
coupl
vac
critic
care
patient
treat
hemodynam
derang
recent
investig
object
studi
aim
identifi
possibl
machin
learn
approach
classifi
hemodynam
data
intens
care
unit
method
use
three
non
linear
supervis
machin
learn
approach
multilay
perceptron
neural
network
decis
tree
gaussian
support
vector
machin
classifi
respond
vs
non
respond
dataset
patient
use
matlab
softwar
classif
model
run
three
time
respect
independ
variabl
mean
arteri
pressur
map
arteri
elast
ea
vac
result
best
perform
classif
model
carri
decis
tree
run
accuraci
respect
map
increas
respect
vac
decreas
respect
ea
increas
conclus
analysi
demonstr
feasibl
machin
learn
approach
hemodynam
data
analysi
intens
care
patient
decis
tree
found
effect
techniqu
analys
hemodynam
data
model
built
allow
predict
respond
vs
non
respond
respect
independ
variabl
vac
decrement
accuraci
refer
simon
p
big
ignor
busi
case
big
data
wiley
chen
l
dubrawski
wang
fiterau
guillamebert
bose
e
kaynar
wallac
dj
guttendorf
j
clermont
g
et
al
use
supervis
machin
learn
classifi
real
alert
artifact
onlin
multisign
vital
sign
monitor
data
critic
care
medicin
guarracino
f
ferro
b
morelli
bertini
p
baldassarri
r
pinski
mr
ventriculoarteri
decoupl
human
septic
shock
critic
care
introduct
evalu
monitor
contractil
cardiac
function
key
element
hemodynam
manag
critic
ill
patient
howev
evalu
intrins
contractil
cardiac
function
difficult
clinic
set
object
aim
studi
evalu
novel
approach
assess
loadindepend
leftventricular
contractil
base
puls
contour
analysi
rate
aortic
maximum
pressur
rise
dpdtao
estim
enddiastol
volum
ved
transcardiopulmonari
thermodilut
tcptd
experiment
anim
model
pig
method
domest
pig
studi
dpdtao
evalu
puls
contour
analysi
relat
ved
tcptd
direct
measur
rate
maximum
pressur
rise
left
ventricl
dpdtlv
relat
ved
cdpdtlv
serv
experiment
refer
preload
independ
contractil
measur
carri
normal
cardiac
function
experiment
impair
cardiac
function
continu
infus
verapamil
wide
modif
cardiac
preload
withdraw
blood
ml
kg
bodyweight
result
impair
contractil
cardiac
function
continu
infus
verapamil
result
signific
chang
cdpdtao
cdpdtlv
p
neither
normal
well
impair
cardiac
function
cdpdtao
cdpdtlv
present
signific
chang
preload
modif
p
conclus
estim
cdpdtao
mean
puls
contour
analysi
thermodilut
provid
reliabl
assess
preloadindepend
left
ventricular
contractil
chang
experiment
anim
model
refer
kass
da
maughan
wl
guo
zm
kono
sunagawa
k
sagawa
k
compar
influenc
load
versu
inotrop
state
index
ventricular
contractil
experiment
theoret
analysi
base
pressurevolum
relationship
circul
grant
acknowledg
studi
support
department
fund
background
aortic
correct
flow
time
ftc
easili
measur
doppler
techniqu
recent
data
use
transoesophag
doppler
suggest
may
predict
fluid
respons
critic
care
use
ftc
previous
evalu
septic
shock
one
preliminari
studi
incorpor
transcutan
measur
ftc
denot
import
predict
fluid
respons
septic
patient
furthermor
comparison
made
transesopahg
ftc
central
venou
pressur
cvp
object
aim
studi
compar
impact
use
ftc
versu
cvp
guid
fluid
resuscit
septic
shock
stroke
volum
denot
cardiac
respons
fluid
administr
method
prospect
studi
consecut
adult
septic
shock
patient
sinu
rhythm
patient
mechan
ventil
treat
intraven
fluid
challeng
ml
minut
guid
cvp
control
group
guid
ftc
doppler
group
assess
incorpor
transesophag
aortic
doppler
measur
surgic
tertiari
intens
care
unit
stroke
volum
sv
mechan
ventil
day
length
stay
mortal
group
record
result
percent
chang
stroke
volum
strongli
correl
baselin
ftc
r
p
central
venou
pressur
r
p
baselin
ftc
ms
discrimin
respond
nonrespond
auc
confid
interv
p
regard
surviv
statist
signific
differ
cvp
ftc
group
conclus
transesophag
aortic
doppler
simpl
noninvas
tool
guid
fluid
therapi
patient
sever
sepsi
septic
shock
ftc
chang
better
predictor
fluid
respons
cvp
septic
shock
refer
girb
arj
groeneveld
abj
circulatori
optim
patient
risk
shock
clin
intens
care
moor
fa
mckinley
ba
moor
ee
next
gener
shock
resuscit
lancet
tuchschmidt
j
sharma
impact
hemodynam
monitor
medic
intens
care
unit
grit
care
med
dalen
je
bone
rc
time
pull
pulmonari
arteri
cathet
jama
polanczyk
ca
rohd
le
goldman
l
et
al
right
heart
catheter
cardiac
complic
patient
undergo
noncardiac
surgeri
observ
studi
jama
groeneveld
ab
vascular
pharmacolog
acut
lung
injuri
acut
respiratori
distress
syndrom
vascul
pharmacol
groeneveld
ab
polderman
kh
acut
lung
injuri
hydrat
crit
care
sakr
vincent
jl
reinhart
k
et
al
behalf
sepsi
occurr
acut
ill
patient
investig
high
tidal
volum
posit
fluid
balanc
associ
wors
outcom
acut
lung
injuri
chest
lindezwirbl
wt
angu
dc
sever
sepsi
epidemiolog
sampl
select
societi
crit
care
delling
rp
levi
mm
carlet
jm
et
al
surviv
sepsi
campaign
intern
guidelin
manag
sever
sepsi
septic
shock
crit
care
med
sturgess
dj
pasco
rl
scalia
g
venkatesh
b
comparison
transcutan
doppler
correct
flow
time
btype
natriuret
peptid
central
venou
pressur
predictor
fluid
respons
septic
shock
preliminari
evalu
anaesth
intens
care
introduct
vascular
occlus
test
vot
util
alongsid
near
infrar
spectroscopi
mean
dynam
investig
microcirculatori
function
correl
demonstr
derang
muscl
tissu
oxygen
mortal
human
skin
exquisit
microcirculatori
blood
suppli
visual
mean
infrar
thermographi
thermographi
may
therefor
potenti
use
noncontact
realtim
monitor
microcirculatori
function
object
investig
thermal
infrar
profil
palm
vot
healthi
volunt
method
particip
recruit
faculti
student
univers
leicest
room
temperatur
confirm
throughout
data
acquisit
particip
allow
period
acclimat
prior
measur
baselin
blood
pressur
measur
left
forearm
right
forearm
place
bench
blood
pressur
cuff
place
around
flir
thermal
imag
camera
place
distanc
meter
particip
thermal
video
record
commenc
blood
pressur
cuff
inflat
mmhg
previous
measur
systol
pressur
total
minut
record
continu
minut
follow
deflat
cuff
averag
palm
temperatur
measur
use
x
pixel
sampl
data
extract
use
flir
tool
softwar
analyz
use
microsoft
excel
rstudio
result
data
collect
healthi
volunt
male
mean
age
year
rang
nonconsecut
day
two
distinct
stage
cool
reheat
seen
rapid
postocclusionreh
slope
demonstr
end
vot
volunt
fig
mean
rate
reheat
palm
sd
compar
mean
gradient
found
determin
linear
model
stage
return
result
sd
conclus
result
conclud
rate
reheat
per
second
measur
use
infrar
thermographi
follow
vascular
occlus
test
healthi
volunt
hypothesi
gradient
prolong
patient
sepsi
demonstr
true
techniqu
could
use
noninvas
diagnost
techniqu
sepsi
refer
mesquida
j
gruartmon
g
espin
c
skelet
muscl
oxygen
satur
measur
nearinfrar
spectroscopi
critic
ill
patient
biom
re
int
creteur
j
carollo
soldati
g
buchel
g
de
backer
vincent
jl
prognost
valu
muscl
septic
patient
intens
care
med
sep
introduct
focus
intens
care
echo
fice
becom
increasingli
import
tool
intensivist
arsen
haemodynam
assess
abil
diagnos
structur
dynam
problem
noninvas
interus
variabl
limit
rigor
train
cpd
essenti
order
prevent
mismanag
base
incorrect
find
uk
intens
care
societi
administ
fice
accredit
becom
compulsori
critic
care
traine
futur
method
everi
patient
undergo
diagnost
fice
result
document
note
audit
folder
follow
standardis
sticker
result
document
folder
rang
decemb
januari
collat
analys
spreadsheet
aim
assess
fice
impact
care
district
gener
critic
care
unit
result
patient
underw
document
fice
scan
occur
weekend
indic
scan
haemodynam
instabl
haemodynam
instabl
post
oper
pe
post
cardiac
arrest
pulmonari
oedema
respiratori
failur
sepsissir
documentedunclear
document
view
obtain
parastern
long
axi
parastern
short
axi
apic
chamber
view
subcost
view
fice
question
lv
significantli
moder
impair
lv
dilat
rv
impaireddil
hypovolaemia
pericardi
effus
trace
evid
pleural
effus
addit
find
valv
problem
patient
region
wall
abnorm
fluid
statu
improv
find
includ
dilat
bowel
loop
signific
conclus
patient
problem
cardiac
origin
patient
fluid
overloadedrequir
restrict
found
pericardi
effus
drainabl
respiratori
problem
patient
signific
abnormalitynot
document
chang
manag
patient
ventil
fluid
administr
inotrop
additionchang
vasopressor
additionchang
fluid
restrict
fluid
remov
diureticrrt
investig
contribut
decis
escalationlimit
critic
care
formal
echo
document
request
follow
fice
consult
registrar
fice
traine
document
review
fice
approv
consult
conclus
clear
fice
echo
signific
impact
manag
strategi
signific
number
patient
howev
impact
morbiditymort
imposs
assess
also
interest
see
disproportion
number
scan
perform
weekend
formal
cardiac
investig
nt
alway
avail
week
document
gener
good
gap
document
found
requir
improv
suggest
data
although
limit
number
support
fund
expand
fice
train
avail
district
gener
critic
care
unit
introduct
right
atrial
pressur
consid
surrog
right
ventricular
fill
pressur
cardiac
preload
evalu
inferior
vena
cava
common
techniqu
estim
rap
anoth
altern
approach
propos
use
tissu
doppler
imag
tricuspid
valv
object
investig
reliabl
use
tricuspid
eea
ratio
ivc
collaps
index
bedsid
echocardiographi
stroke
volum
variat
svv
electr
cardiometri
assess
right
atrial
pressur
critic
ill
septic
patient
altern
invas
cvp
method
thirti
patient
sever
sepsi
hypotens
mean
arteri
pressur
ie
map
mmhg
enrol
studi
fluid
resuscit
mlkg
administ
fluid
respons
defin
map
mmhg
preload
assess
done
cvp
ivc
collaps
tricuspid
eea
tissu
doppler
imag
tdi
stroke
volum
variat
svv
measur
use
assess
fluid
respons
result
studi
includ
male
age
pair
comparison
show
signific
chang
map
read
p
valu
right
ventricular
fill
pressur
cvp
correl
tricuspid
eea
r
p
valu
ivc
collaps
index
r
p
valu
roc
curv
show
cutoff
svv
predict
fluid
respons
area
curv
auc
sensit
specif
conclus
tricuspid
excurs
use
tdi
offer
noninvas
evalu
right
side
heart
pressur
svv
could
use
predict
fluid
respons
critic
ill
septic
patient
keyword
right
atrial
pressur
tricuspid
excurs
stroke
volum
variat
fluid
respons
refer
kircher
bj
himelman
rb
schiller
nb
noninvas
estim
right
atrial
pressur
inspiratori
collaps
inferior
vena
cava
j
cardiol
epub
arbo
je
maslov
dm
beraud
bedsid
assess
right
atrial
pressur
critic
ill
septic
patient
use
tissu
doppler
ultrasonographi
j
crit
care
epub
introduct
sepsi
clinic
syndrom
character
system
inflammatori
respons
infecti
process
patient
acut
myocardi
infarct
ami
may
predispos
develop
sepsi
admiss
object
aim
studi
evalu
rate
sepsi
admiss
patient
acut
myocardi
infarct
ami
associ
factor
longterm
mortal
patient
ami
associ
without
sepsi
method
data
nation
healthcar
insur
research
databas
nhird
taiwan
januari
decemb
use
studi
patient
first
admit
ami
enrol
among
identifi
case
hospit
ami
case
altern
diagnosi
sepsi
icd
identifi
remain
case
patient
diagnosi
infecti
diseas
exclud
leav
ami
case
comparison
analysi
surviv
defin
end
date
nation
healthcar
insur
coverag
result
overal
rate
sepsi
admiss
patient
ami
rate
sepsi
patient
ami
femal
male
p
rate
sepsi
patient
ami
percutan
coronari
intervent
pci
group
nonpci
group
p
rate
sepsi
patient
ami
group
group
p
comorbid
patient
ami
sepsi
signific
higher
rate
hypertens
dyslipidemia
diabet
peripher
vascular
diseas
congest
heart
failur
endstag
renal
diseas
cerebr
vascular
accid
chronic
obstruct
pulmonari
diseas
p
year
follow
surviv
rate
ami
signific
higher
patient
without
sepsi
admiss
vs
adjust
hr
ci
subgroup
analysi
reveal
male
femal
patient
ami
signific
higher
surviv
rate
nonsepsi
group
vs
male
p
vs
femal
p
patient
age
equal
year
ami
signific
higher
surviv
rate
nonsepsi
group
vs
year
p
vs
equal
year
p
pci
nonpci
patient
ami
signific
higher
surviv
rate
nonsepsi
group
vs
pci
group
p
vs
nonpci
group
p
conclus
studi
demonstr
femal
gender
pci
older
age
group
associ
higher
rate
sepsi
admiss
patient
ami
longterm
surviv
rate
ami
signific
higher
patient
without
sepsi
admiss
includ
subgroup
analysi
gender
age
pci
introduct
cardiogen
shock
cs
sever
complic
acut
myocardi
infarct
ami
esicm
congress
present
studi
mortal
cs
gender
spain
base
ariam
registri
object
evalu
gender
differ
regard
diagnosi
manag
prognosi
patient
cs
secondari
object
compar
differ
ten
year
later
method
observ
descript
retrospect
studi
patient
includ
studi
ariam
semicyuc
registri
ariam
registri
patient
studi
diagnos
cs
variabl
gender
age
pulmonari
cathet
support
measur
inotrop
mechan
ventil
thrombolysi
percutan
coronari
intervent
pci
statist
analysi
chi
squar
result
ami
patient
cs
men
women
pci
patient
die
icu
men
women
ami
patient
cs
pci
patient
die
icu
men
women
conclus
differ
gender
manag
outcom
patient
cs
support
measur
pci
use
less
frequent
women
men
mortal
higher
women
latest
result
similar
ten
year
ago
even
increas
use
pci
grant
acknowledg
ariamsemicyuc
registri
investig
introduct
acut
heart
failur
ahf
strong
neg
prognost
impact
patient
nonstelev
acut
coronari
syndrom
ac
st
elev
ac
object
establish
effect
coronari
revascular
prognosi
ac
complic
ahf
admiss
method
retrospect
studi
non
select
patient
admit
third
level
hospit
follow
mean
year
effect
coronari
revascular
outcom
patient
without
ahf
assess
use
multivari
regress
model
result
acut
heart
failur
present
patient
hospit
admiss
index
hospit
patient
receiv
coronari
revascular
percutan
coronari
intervent
pci
case
coronari
arteri
bypass
graft
cabg
patient
followup
mortal
patient
pci
group
cabg
group
non
revascular
group
ahf
independ
predictor
mortal
adjust
hr
ci
p
revascular
pci
protect
ahf
popul
non
ahf
popul
revascular
significantli
influenc
prognosi
patient
present
ahf
cabg
adjust
hr
ci
without
ahf
adjust
hr
ci
p
data
shown
figur
conclus
patient
ac
clinic
manifest
ahf
admiss
constitut
strong
predictor
advers
outcom
follow
may
significantli
modifi
coronari
revascular
strategi
introduct
earli
coronari
reperfus
improv
clinic
cours
prognosi
reduc
mortal
patient
stsegment
elev
acut
coronari
syndrom
object
analyz
period
year
evolut
reperfus
strategi
mortal
patient
stsegment
elev
myocardi
infarct
stemi
admit
bed
medicalsurg
intens
care
unit
icu
compar
hospit
region
andalusia
method
prospect
cohort
studi
patient
diagnosi
stemi
admit
second
level
universitari
hospit
virgen
de
la
victoria
uhvv
icu
n
icu
andalusia
n
data
extract
spanish
record
acut
myocardi
infarct
delay
ariam
degre
coronari
reperfus
system
fibrinolysi
primari
rescu
percutan
coronari
intervent
pci
mortal
compar
three
period
descript
compar
statist
analysi
perform
use
statist
softwar
packag
spss
version
spss
inc
chicago
il
usa
result
studi
patient
uhvv
group
mean
age
year
old
vs
vs
p
femal
vs
vs
p
andalusia
group
n
mean
age
year
old
vs
vs
p
femal
vs
vs
p
signific
differ
three
period
group
result
see
tabl
conclus
studi
period
found
higher
percentag
degre
coronari
reperfus
uhvv
vs
andalusia
vs
mainli
primari
rescu
pci
vs
greater
declin
mortal
first
group
region
benchmark
vs
refer
el
khouri
c
et
al
fiveyear
evolut
reperfus
strategi
earli
mortal
patient
stsegment
elev
myocardi
infarct
franc
eur
heart
j
acut
cardiovasc
care
dec
grant
acknowledg
ariam
spanish
record
introduct
levosimendan
improv
haemodynam
perform
may
cardioprotect
effect
small
trial
demonstr
efficaci
welldefin
popul
consist
evid
mortal
reduct
howev
recent
metaanalysi
demonstr
levosimendan
reduc
mortal
overal
popul
subpopul
cardiac
surgeri
cardiolog
object
given
uncertain
benefit
analysi
utilis
levosimendan
low
cardiac
output
state
undertaken
method
retrospect
analysi
perform
singl
center
data
admiss
due
low
cardiac
output
state
treat
levosimendan
retrospect
abstract
demograph
ill
sever
comorbid
haemodynam
metabol
biochem
resourc
utilis
organ
support
hospit
outcom
analys
result
popul
group
mean
age
year
rang
mean
apach
ii
score
rang
caus
low
co
state
includ
myocardi
infarct
n
cardiac
arrest
n
cardiac
surgeri
n
septic
cardiac
dysfunct
n
acut
cardiomyopathi
n
amongst
caus
n
levosimendan
receiv
variabl
point
icu
treatment
mean
day
rang
day
usual
inotrop
rang
commenc
treatment
levosimendan
result
signific
improv
ci
p
acidosi
p
trend
toward
improv
lactat
clearanc
oxygen
overal
length
stay
lo
icu
day
rang
mortal
surviv
discharg
commenc
levosimendan
within
hour
admiss
result
decreas
durat
ventil
p
icu
lo
p
trend
toward
reduct
length
renal
replac
therapi
p
tabl
similar
benefit
demonstr
levosimendan
introduc
first
second
vasoact
agent
compar
third
fourth
agent
howev
surviv
discharg
improv
vs
respect
conclus
levosimendan
use
earli
diseas
process
icu
lo
durat
ventil
reduc
use
first
second
inotrop
rather
third
fourth
surviv
discharg
higher
research
requir
determin
optimum
time
therapi
refer
mathieu
g
craig
levosimendan
treatment
acut
heart
failur
cardiogen
septic
shock
critic
review
jic
g
landoni
et
al
effect
levosimendan
mortal
hospitilis
metaanalysi
rct
ccm
introduct
cardiogen
shock
cs
syndrom
character
tissu
congest
hypoperfus
consequ
cardiac
pump
failur
mani
studi
evalu
outcom
postischem
cs
pauciti
data
nonischem
cs
etiolog
object
aim
studi
identifi
independ
predictor
death
cs
caus
differ
etiolog
method
perform
retrospect
observ
studi
patient
cs
admit
icu
jan
dec
patient
postcardiotomi
andor
posttranspl
cs
exclud
demograph
clinic
biochem
variabl
collect
continu
variabl
present
median
iqr
data
analyz
use
compar
statist
multivari
analysi
perform
cox
regress
result
recruit
patient
etiolog
cs
acut
decompens
chronic
cardiomyopathi
acut
myocard
acut
myocardi
infarct
caus
baselin
variabl
report
tabl
p
first
six
hour
present
patient
receiv
inotrop
need
invas
mechan
ventil
intra
aortic
ballon
pump
va
ecmo
refractori
cs
patient
die
icu
stay
surviv
patient
bridg
recoveri
patient
heart
transplant
patient
left
ventricl
assist
devic
lvad
differ
etiolog
nineti
day
mortal
observ
kaplanmey
logrank
p
nonsurvivor
character
higher
need
inotrop
dose
va
ecmo
assist
rate
first
hour
inotrop
score
vs
p
va
ecmo
vs
p
multivari
analysi
reveal
lactat
icu
admiss
independ
risk
factor
hospit
mortal
nineti
day
hr
per
mmoll
p
conclus
hyperlactatemia
present
independ
predictor
death
cs
caus
differ
etiolog
like
due
sever
state
global
hypoperfus
prolong
state
shock
introduct
earli
reperfus
may
prevent
damag
myocardium
improv
left
ventricular
function
prognosi
patient
suffer
st
elev
acut
myocardi
infarct
stemi
object
analyz
mortal
group
patient
stemi
fibrinolyt
therapi
relat
thrombolysi
place
hour
symptom
onset
method
prospect
cohort
studi
patient
diagnos
stemi
admit
coronari
intens
care
unit
icu
second
level
hospit
univers
hospit
virgen
de
la
victoria
uhvv
three
period
n
n
n
data
belong
ariam
delay
analysi
acut
myocardi
infarct
record
variabl
studi
icu
mortal
thrombolysi
place
prehospit
emerg
icu
time
minut
symptom
onset
patient
receiv
rescu
facilit
percutan
coronari
intervent
pci
descript
compar
statist
analysi
perform
use
statist
softwar
packag
spss
version
spss
inc
chicago
il
usa
result
studi
patient
mean
age
year
vs
vs
p
femal
vs
vs
p
signific
differ
three
period
result
see
tabl
conclus
three
period
studi
signific
differ
mortal
thrombolysi
place
stemi
earli
thrombolysi
prehospit
emerg
hospit
area
show
decreas
mortal
icu
refer
mccaul
louren
kredo
prehospit
versu
inhospit
thrombolysi
stelev
myocardi
infarct
cochran
databas
syst
rev
sep
grant
acknowledg
ariam
spanish
record
introduct
killip
class
classif
heart
failur
use
predict
shortterm
mortal
patient
acut
coronari
syndrom
ac
object
determin
contemporari
longterm
prognosi
ac
acut
heart
failur
grade
accord
killip
classif
method
cohort
studi
consecut
hospit
patient
ac
diagnosi
followup
done
clinic
review
telephon
contact
death
cardiovascular
event
record
well
caus
death
result
patient
includ
complet
follow
mean
year
clinic
characterist
analyz
relat
killip
class
admiss
shown
tabl
stepwis
gradient
adjust
hazard
ratio
hr
mortal
observ
increas
killip
class
class
hr
ci
unexpectedli
landmark
analysi
exclud
death
day
admiss
patient
killip
class
iv
lower
adjust
longterm
mortal
class
iii
shown
figur
conclus
heterogen
earli
versu
late
risk
patient
killip
class
iv
heart
failur
present
contemporari
cohort
highlight
import
appropri
earli
treatment
cardiogen
shock
patient
introduct
myocardi
infarct
mi
known
sever
subclassif
time
consensu
statement
classifi
mi
clinic
scenario
variou
subtyp
type
mi
defin
myocardi
injuri
necrosi
condit
cad
contribut
imbal
myocardi
oxygen
suppli
andor
demand
sever
mechan
identifi
lead
type
mi
condit
underrecogn
criticallyil
object
appreci
incid
type
mi
medic
icu
patient
identifi
risk
factor
associ
type
mi
method
retrospect
chart
review
consecut
patient
discharg
medic
icu
final
diagnosi
type
mi
two
chart
review
senior
intensivist
studi
medic
record
use
explicit
protocol
analyz
demograph
underli
condit
clinic
characterist
therapeut
intervent
outcom
result
januari
decemb
total
patient
hospit
medic
icu
patient
met
definit
criteria
type
mi
median
iqr
age
year
male
obes
diabet
mellitu
arteri
hypertens
chf
chronic
respiratori
failur
icu
admiss
acut
respiratori
failur
shock
near
drown
carbon
monoxid
poison
median
iqr
sap
ii
ratio
lactat
level
mmoll
ph
bicarbon
mmoll
patient
underw
tte
kinesi
abnorm
median
iqr
ctn
level
ngml
coronari
angiographi
lumin
irregular
invas
mechan
ventil
receiv
vasopressor
patient
receiv
antiischem
antithrombot
andor
anticoagul
therapi
receiv
fibrinolyt
therapi
demonstr
complet
regress
abnorm
correct
respiratori
andor
hemodynam
distress
die
conclus
type
mi
reveal
rather
common
frequent
misdiagnos
icu
patient
lead
manag
delay
error
patient
rather
young
without
underli
cardiovascular
risk
factor
exhibit
myriad
clinic
condit
common
factor
oxygen
supplydemand
mismatch
less
ctn
level
rel
high
mortal
relat
associ
ill
sever
refer
kristian
thygesen
joseph
alpert
allan
jaff
maarten
l
simoon
bernard
r
chaitman
harvey
white
write
group
behalf
joint
escaccfahawhf
task
forc
univers
definit
myocardi
infarct
third
univers
definit
myocardi
journal
american
colleg
cardiolog
background
bled
score
assess
bleed
risk
among
patient
atrial
fibril
proven
effect
risk
stratif
help
anticoagul
manag
well
assess
morbid
mortal
patient
atrial
fibril
anti
coagul
object
studi
aim
show
hasbl
score
also
use
bleed
risk
assess
among
patient
without
atrial
fibril
admit
medic
intens
care
unit
studi
design
singl
center
retrospect
cross
section
studi
method
descript
statist
report
mean
sd
median
iqr
proport
applic
present
tabl
graph
cox
regress
analysi
use
determin
associ
clinic
risk
factor
bleed
cardiovascular
event
mortal
hazardratio
predict
valu
also
estim
particip
includ
studi
filipino
patient
age
admit
medic
icu
emerg
room
outcom
seen
admiss
patient
satisfi
criteria
bled
score
exclud
patient
known
case
atrial
fibril
admit
episod
activ
bleed
patient
admit
major
surgeri
result
total
patient
chart
includ
studi
studi
abl
risk
stratifi
patient
high
risk
bleed
patient
without
atrial
fibril
twenti
percent
patient
atrial
fibril
major
patient
classifi
high
risk
bleed
hasbl
venou
thromboembol
risk
caprini
common
outcom
patient
acut
coronari
syndrom
hasbl
score
acut
coronari
event
cours
admiss
among
respond
episod
bleed
minor
major
af
nonaf
hasbl
score
signific
pvalu
howev
odd
ratio
present
mean
af
respond
compar
nonaf
time
like
like
hasbl
score
greater
equal
hasbl
also
show
high
hasbl
score
high
risk
bleed
even
among
patitn
without
atrial
fibril
howev
statist
analysi
show
clinic
signific
hasbl
caprini
score
found
directli
moder
correl
spearman
rho
pvalu
conclus
patient
admit
critic
care
unit
regardless
without
histori
atrial
fibril
hasbl
caprini
score
done
risk
stratifi
patient
bleed
longer
period
observ
warrant
introduct
myocardi
infarct
result
perman
ischaem
damag
earli
revascular
vital
spare
myocardium
howev
downsid
treatment
reperfus
injuri
contribut
longterm
ventricular
dysfunct
strategi
attenu
reperfus
injuri
date
prove
unsuccess
reactiv
oxygen
speci
ro
deriv
mitochondri
electron
transport
chain
etc
main
caus
reperfus
injuri
modul
oxid
phosphoryl
perirevascular
may
confer
benefit
sulphid
donor
revers
inhibit
complex
iv
etc
approach
offer
put
benefit
object
test
slowreleas
sulphid
donor
cell
cardiomyocyt
model
ischaemiareperfus
injuri
method
cell
subject
h
hypoxia
follow
h
reoxygen
room
air
cell
receiv
mm
vehicl
cell
medium
begin
reoxygen
period
separ
experi
normox
cell
treat
ro
hydrogen
peroxid
microm
h
ad
half
well
h
cell
viabil
assess
flow
cytometri
use
annexin
vpi
assay
oneway
anova
tukey
posthoc
test
spss
use
test
statist
signific
result
ischaemiareperfus
reduc
cell
viabil
fig
adminst
onset
reperfus
increas
cell
surviv
dosedepend
manner
highest
concentr
surviv
similar
cell
undergo
ir
protect
effect
also
seen
addit
normox
cell
data
shown
conclus
revers
cell
death
relat
reperfus
injuri
studi
ongo
confirm
mechan
action
via
mitochondri
etc
inhibit
introduct
rapid
revascularis
treatment
choic
minim
ischaem
injuri
acut
myocardi
infarct
howev
procedur
induc
reperfus
injuri
may
damag
myocardium
experiment
model
myocardi
infarct
reperfus
involv
temporari
ligat
left
anterior
descend
coronari
arteri
lad
model
though
repres
clinic
scenario
associ
infarct
variabl
size
consequ
insult
sever
howev
periprocedur
haemodynam
well
describ
object
assess
impact
insult
sever
cardiac
haemodynam
perfus
marker
method
eight
instrument
mechan
ventil
thoracotom
male
wistar
rat
g
subject
minut
myocardi
ischaemia
temporari
occlus
lad
anim
monitor
min
postreperfus
baselin
endischaemia
hourli
interv
postreperfus
mean
arteri
pressur
map
echocardiograph
arteri
blood
ga
measur
perform
aortic
peak
systol
blood
flow
veloc
vmax
use
marker
myocardi
contractil
experi
end
infarct
arealeft
ventricl
ratio
ialv
assess
histolog
determin
insult
sever
comparison
drawn
mild
ialv
n
sever
ialv
n
insult
analysi
twoway
anova
p
valu
consid
significantli
differ
normal
test
shapirowilk
test
result
insult
sever
ialv
ratio
normal
distribut
mean
sem
sever
group
ialv
significantli
lower
map
higher
lactat
valu
mild
sever
group
fig
top
panel
tempor
chang
cardiac
contractil
output
howev
relat
insult
sever
fig
bottom
panel
introduct
reduc
time
percutan
intervent
patient
diagnos
st
elev
myocardi
infarct
stemi
critic
issu
care
process
mani
intervent
prehospit
ecg
cardiac
catheter
laboratori
ccl
activ
emerg
physician
ep
prove
improv
result
howev
discord
diagnosi
ep
intervent
cardiologist
may
result
unnecessari
activ
ccl
commun
ep
intervent
cardiologist
often
verbal
report
via
telephon
develop
smartphon
ep
use
applic
transmit
ecg
imag
intervent
cardiologist
stemi
diagnos
object
studi
aim
evalu
use
smartphon
applic
facilit
commun
ep
intervent
cardiologist
order
minim
time
activ
ccl
time
percutan
intervent
method
retrospect
collect
timepoint
everi
step
manag
outcom
patient
diagnos
stemi
ed
total
patient
enrol
group
patient
ecg
describ
tradit
verbal
commun
via
telephon
group
use
smartphon
applic
transmit
ecg
intervent
cardiologist
timepoint
intervent
record
analysi
result
time
ecg
done
significantli
differ
group
minutesth
time
minut
group
compar
minut
group
p
reduct
time
driven
reduct
time
ecg
interpret
activ
ccl
group
minut
group
p
shown
tabl
mortal
rate
group
compar
group
p
shown
tabl
conclus
usag
smartphon
transmit
ecg
ed
intervent
cardiologist
facilit
commun
reduc
time
ccl
activ
balloon
inflat
refer
peterson
mc
syndergaard
bowler
j
doxey
r
systemat
review
factor
predict
door
balloon
time
stsegment
elev
myocardi
infarct
treat
percutan
intervent
intern
journal
cardiolog
introduct
prehospit
electrocardiogram
ecg
identifi
critic
part
treatment
patient
stemi
howev
remain
challeng
issu
set
prehospit
ecg
asia
object
studi
investig
applic
innov
design
electrocardiogram
exam
accessori
devic
improv
ambul
prehospit
ambul
electrocardiogram
implant
rate
via
citi
base
multicent
trail
method
studi
start
sinc
sep
via
multidisciplinari
team
among
kaohsiung
veteran
gener
hospit
fire
bureau
depart
health
kaohsiung
citi
govern
uniqu
accessori
devic
lead
electrocardiographi
apparatu
hole
arrang
accord
standard
electrod
placement
lead
ecg
measur
design
internippl
line
midsternum
line
devic
assist
staff
perform
ecg
shortli
breakthrough
innov
design
address
core
issu
effici
ambul
prehospit
ecg
system
therefor
invent
success
promot
kaohsiung
citi
council
set
asian
first
ambul
prehospit
telemetri
electrocardiogram
system
innov
design
ecg
exam
accessori
devic
patent
taiwan
golden
award
geneva
korean
intern
invent
consecut
chest
pain
patient
receiv
ambul
ecg
exam
enrol
jan
septemb
differ
fire
brigad
kaohsiung
citi
ecg
implement
rate
defin
chest
pain
patient
receiv
ambul
ecg
exam
divid
patient
chest
pain
result
ecg
implement
rate
increas
preintervent
postintervent
group
p
total
patient
stemi
detect
chest
pain
patient
receiv
ambul
ecg
exam
stemi
patient
averag
door
balloon
time
minut
averag
ischemia
balloon
time
minut
inhospit
mortal
conclus
studi
demonstr
applic
innov
design
electrocardiogram
exam
accessori
devic
solv
main
problem
system
assist
set
first
ambul
prehospit
telemetri
electrocardiogram
system
asia
improv
ambul
prehospit
electrocardiogram
implant
rate
kaohsiung
citi
introduct
demand
critic
care
servic
increas
steadili
nation
intern
import
increas
demand
qualiti
care
deliv
maintain
wellrecognis
qualiti
marker
intens
care
unit
icu
readmiss
within
hour
discharg
icu
readmiss
associ
significantli
increas
morbid
mortal
prolong
hospit
admiss
increas
cost
report
averag
unplan
readmiss
uk
global
vari
specif
causal
factor
found
object
identifi
hour
readmiss
rate
two
consecut
year
impact
patient
care
method
retrospect
studi
bed
adult
gener
medicosurg
icu
larg
acut
hospit
england
sampl
collat
icu
discharg
identifi
patient
readmit
within
hour
discharg
specif
time
discharg
readmiss
underli
caus
length
readmiss
stay
final
outcom
data
collect
result
compar
result
patient
discharg
icu
readmiss
within
hour
time
readmiss
rang
hour
follow
readmiss
length
stay
rang
day
day
discharg
readmiss
within
hour
time
readmiss
vari
hour
median
hour
cardiorespiratori
failur
common
caus
readmiss
length
readmiss
stay
icu
rang
day
day
median
day
two
year
period
icu
mortal
rate
remain
unchang
howev
patient
readmit
within
hour
show
consider
higher
hospit
mortal
rate
conclus
two
year
period
increas
admiss
discharg
icu
associ
increas
midnight
bed
occup
rate
howev
link
fold
rise
readmiss
within
hour
associ
hospit
mortal
rate
higher
previou
year
nation
averag
increas
demand
icu
servic
advers
effect
qualiti
care
deliv
research
need
inform
clinician
commission
qualiti
maintain
increas
demand
refer
faculti
intens
care
medicin
core
standard
intens
care
elliott
et
al
intens
care
readmiss
contemporari
review
literatur
intens
crit
care
nurs
http
roseberg
al
et
al
patient
readmit
icu
systemat
review
risk
factor
outcom
chest
icnarc
case
mix
programm
introduct
grow
evid
protect
lung
ventil
strategi
offer
benefit
patient
undergo
mechan
ventil
addit
deleteri
effect
excess
oxygen
critic
ill
patient
becom
increasingli
well
recognis
present
result
qualiti
improv
project
improv
adher
lung
protect
ventil
strategi
unit
project
also
yield
cultur
shift
way
oxygen
prescrib
titrat
patient
object
record
height
critic
care
patient
calcul
ideal
bodi
weight
ibw
adopt
lung
protect
mlkg
ibw
ventil
strategi
patient
receiv
control
ventilationtitr
oxygen
deliveri
accord
prescrib
satur
target
method
project
consist
seri
tool
rais
awar
educ
intervent
daili
prompt
practic
measur
promot
adher
addit
adopt
pressurecontrol
volumeguarante
mode
ventil
initi
standard
patient
ventil
unit
critic
care
technologist
offer
ongo
practic
educ
member
clinic
team
whilst
runchart
weekbyweek
perform
offer
immedi
feedback
statu
project
result
review
patientday
data
roll
audit
effect
project
fig
demonstr
percentag
patient
ibw
record
target
oxygen
satur
prescrib
month
latest
result
april
show
patient
unit
ibw
record
receiv
control
ventil
appropri
tidal
volum
prescrib
ventil
match
prescript
case
routin
know
ibw
everi
patient
unit
also
use
safe
prescrib
haemofiltr
critic
care
drug
patient
target
oxygen
satur
prescrib
although
target
time
data
collect
importantli
prescrib
oxygen
satur
target
empow
nurs
staff
wean
inspir
oxygen
concentr
without
wait
arteri
blood
ga
conclus
project
demonstr
seri
simpl
intervent
help
optimis
mechan
ventil
oxygen
titrat
within
critic
care
associ
benefit
term
safe
prescrib
reduct
relianc
arteri
blood
ga
analysi
refer
serpa
neto
associ
use
lungprotect
ventil
lower
tidal
volum
clinic
outcom
among
patient
without
acut
respiratori
distress
syndrom
jama
ridler
n
et
al
oxygen
therapi
critic
ill
friend
foe
jic
introduct
vap
icuspecif
nosocomi
infect
caus
import
addit
cost
healthcar
extend
icu
hospit
length
stay
attribut
mortal
sudden
rise
vaprat
urg
icu
az
sintblasiu
improv
qualiti
care
object
reduc
vaprat
systemat
introduct
evid
base
measur
support
pdcacycl
methodolog
method
process
improv
includ
tracheal
suction
protocol
prevent
colon
ventil
tube
hme
chang
oral
care
hexetidin
cuff
pressur
control
head
elev
ett
fixat
gastric
residu
control
ett
polyurethan
cuff
close
airway
suction
stop
close
airway
suction
ett
pvc
taper
shape
cuff
subglott
suction
digit
continu
cuff
pressur
control
autom
subglott
suction
pump
oral
care
chlorhexidin
oral
care
system
permit
social
control
belgian
vapbundl
continu
complianc
measur
rass
adjust
depth
sedat
result
measur
ineffect
nurs
identifi
ineffect
tracheal
suction
close
airway
suction
major
problem
stop
close
airway
suction
introduct
new
technolog
reduc
vaprat
half
oral
care
chlorhexidin
oral
care
system
permit
social
control
improv
result
although
almost
vapbundl
element
alreadi
use
icu
formal
implement
belgian
vapbundl
caus
import
addit
declin
vaprat
emphas
import
sedat
control
complianc
measur
adjust
depth
sedat
rass
result
lowest
vaprat
year
conclus
continu
qualiti
improv
program
show
systemat
use
evid
base
pdcacycl
driven
process
improv
may
contribut
reduc
vaprat
refer
blot
poelaert
j
kollef
avoid
microaspir
key
element
prevent
ventilatorassoci
pneumonia
intub
icu
patient
bmc
infecti
diseas
improv
institut
healthcar
improv
http
wwwihiorgresourcespageshowtoimprovedefaultaspx
access
introduct
morbid
mortal
confer
mmc
tradit
tool
improv
local
care
manag
clinic
manag
educ
especi
high
risk
specialti
lack
precis
format
practic
intens
care
unit
icu
object
explor
impact
goal
direct
mmc
mortal
rate
advers
event
method
year
prospect
studi
icu
bed
evalu
systemat
mmc
clear
goal
improv
local
care
avoid
case
discuss
analysi
brainstorm
clear
recommend
multidisciplinari
meet
involv
relat
caregiv
blame
free
environ
present
studi
includ
phase
preintervent
intervent
mayjuli
postintervent
washout
period
period
preval
icu
acquir
advers
event
audit
march
decemb
result
patient
includ
studi
die
intervent
postintervent
phase
mmc
held
discuss
die
case
review
caus
death
unit
perform
indic
made
recommend
accomplish
versu
mortal
rate
decreas
postintervent
phase
p
p
increas
washout
period
p
p
convers
mortal
rate
washout
period
relat
preintervent
phase
decreas
p
increas
p
subanalysi
mortal
reveal
signific
decreas
earli
postintervent
p
signific
increas
late
postintervent
p
advers
event
decreas
insignificantli
decemb
compar
april
unplan
extub
ventil
day
unexpect
cardiac
arrest
patient
day
stress
ulcer
bleed
patient
day
patient
day
deep
vein
thrombosi
patient
day
patient
day
iatrogen
pneumothorax
patient
day
patient
day
howev
unexpect
cardiac
arrest
patient
day
p
vap
rate
ventil
day
p
unplan
extub
ventil
day
p
decreas
significantli
conclus
although
confound
factor
control
goal
orient
mmc
reduc
advers
event
probabl
mortal
rate
especi
continu
monitor
improv
introduct
intens
care
one
resourceintens
form
medic
care
due
sever
ill
patient
recent
year
qualiti
intens
care
focu
howev
still
lack
result
nurs
point
view
object
describ
nursepati
ratio
relat
care
burden
measur
vt
optim
medic
nursingrel
result
usual
use
indic
mortal
complic
intens
care
method
retrospect
registri
studi
includ
survey
critic
care
registri
data
patient
year
receiv
care
two
gener
level
critic
care
unit
similar
rate
admiss
data
nursepati
ratio
collect
unit
data
analyz
descript
compar
statist
method
result
result
show
differ
special
nursepati
ratio
ratio
care
burden
measur
vt
despit
similar
admiss
rate
differ
caus
admiss
surgicalv
medic
amount
unexpect
surgeri
patient
found
differ
also
found
mean
time
noninvas
ventil
mean
time
ventil
complic
critic
care
measur
readmiss
unplan
reintub
show
unplan
reintub
vari
percent
icu
mortal
show
differ
lowest
icu
mortal
hospit
lower
nursepati
ratio
howev
day
mortal
lower
hospit
higher
nursepati
ratio
analysi
need
conclus
preliminari
result
show
differ
nursepati
ratio
care
burden
measur
vt
differ
qualiti
measur
gener
critic
care
unit
refer
soini
k
h
redlarsson
rubertsson
liber
torino
italien
institut
medicin
cross
qualiti
chasm
new
health
system
st
centuri
washington
dc
nation
academi
press
aiken
l
et
al
nurs
staf
educ
hospit
mortal
nine
european
countri
retrospect
observ
studi
lancet
http
mcgahan
kucharski
g
coyer
f
nurs
staf
level
incid
mortal
morbid
adult
intens
care
unit
literatur
review
australian
critic
care
introduct
use
qualiti
indic
qi
improv
care
intens
care
unit
icu
increas
incid
advers
event
like
ventil
associ
pneumonia
vap
pressur
ulcer
routin
measur
norwegian
icu
object
aim
pilot
studi
evalu
frequenc
two
advers
event
measur
specif
qi
two
icu
oslo
univers
hospit
ouhu
method
icupati
two
differ
icu
ouhu
includ
studi
predefin
time
period
autumn
data
determin
vap
pressur
ulcer
retriev
daili
electron
patient
record
journal
bedsid
specif
studi
sheet
pneumonia
pn
identifi
use
european
centr
diseas
prevent
control
ecdc
protocol
combin
imag
clinic
laboratori
criteria
vap
defin
pn
patient
mechan
ventil
hour
ventil
place
day
event
day
pressur
ulcer
identifi
use
european
pressur
ulcer
advisori
panel
epuap
classif
system
determin
sever
pressur
ulcer
four
categori
use
descript
statist
present
use
spss
version
result
present
mean
standard
deviat
sd
result
includ
adult
icu
patient
mechan
ventil
minimum
hour
surgic
patient
among
trauma
patient
acut
surgeri
patient
mean
sapsii
score
mean
time
mechan
ventil
day
pn
present
patient
per
definit
vap
per
ecdc
classif
pn
classifi
microbiolog
confirm
bronchoalveolar
lavag
bal
five
microbiolog
confirm
endotrach
aspir
four
without
microbiolog
confirm
clinic
pneumonia
incid
vap
ventil
day
pressur
ulcer
present
patient
major
patient
one
ulcer
ulcer
classifi
epuap
categori
one
two
three
four
incid
pressur
ulcer
icu
day
conclus
ouhu
potenti
reduc
incid
vap
pressur
ulcer
reach
current
standard
care
identif
specif
qi
import
futur
improv
qualiti
care
grant
acknowledg
oslo
univers
hospit
introduct
care
take
need
famili
account
import
order
offer
familycent
care
necessari
understand
famili
experi
object
develop
valid
reliabl
tool
measur
perceiv
qualiti
care
qualiti
process
death
satisfact
gener
perspect
rel
deceas
patient
icu
method
elabor
ad
hoc
questionnair
literatur
review
valid
multidisciplinari
panel
expert
construct
qualiti
servic
qs
measur
use
three
differ
construct
qualiti
commun
two
dimens
kind
respect
sincer
empathi
qualiti
inform
four
dimens
welcom
inform
diseas
share
deciss
make
empathi
famili
need
technic
infraestructur
qualiti
six
dimens
human
aproach
profession
wait
room
facil
visit
hour
meal
construct
process
death
measur
use
three
dimens
technic
qualiti
human
qualiti
qualiti
inform
given
final
construct
overal
satisfact
servic
measur
three
dimens
satisfact
form
content
inform
technic
structur
qualiti
process
death
rel
deceas
patient
particip
post
mail
questionnair
respons
rate
month
sinc
death
recruit
telephon
carri
analysi
psychometr
properti
converg
valid
correl
coeffici
pearson
predict
valid
multipl
regress
model
order
predict
dimens
satisfact
scale
qualiti
reliabl
cronbach
test
two
halv
result
nearli
correl
coeffici
item
construct
meant
therefor
construct
converg
valid
three
regress
model
perform
evalu
predict
valid
show
high
determin
coeffici
evalu
item
dimens
high
mean
valu
around
except
dimens
empathi
famili
need
wait
room
score
conclus
ad
hoc
tool
develop
easi
use
show
adequ
psychometr
properti
valid
reliabl
could
improv
remov
item
show
low
correl
refer
van
den
broek
jm
brunsveldreind
ah
zedlitz
et
al
questionnair
famili
satisfact
adult
icu
systemat
review
includ
psychometr
properti
crit
care
med
wall
rj
curti
jr
cook
cr
et
al
famili
satisfact
famili
survivor
nonsurvivor
chest
object
purpos
studi
evalu
profil
antibiot
resist
effect
introduct
antibiot
protocol
icu
length
stay
mortal
cost
consumpt
antibiot
method
conduct
retrospect
studi
total
patient
admit
icu
januari
decemb
purpos
studi
obtain
profil
microorgan
icu
resist
microorgan
rm
defin
nonsuscept
one
one
class
antibiot
also
compar
result
whit
previou
studi
conduct
icu
result
preval
microorgan
staphylococcu
aureu
escherichia
coli
pseudomona
aeruginosa
klebsiella
pneumonia
microorgan
identifi
resist
one
class
antibiot
patient
statist
significantli
p
associ
previou
stay
ward
particular
patient
come
surgic
ward
emerg
number
day
admiss
hospit
icu
admiss
patient
mean
hospit
stay
icu
admiss
day
number
previou
surgeri
hospit
event
identifi
patient
averag
two
previou
surgeri
admiss
type
mainli
patient
come
urgent
surgeri
medic
caus
number
day
icu
patient
stay
averag
least
day
icu
patient
microorgan
resist
antibiot
treatment
previou
icu
admiss
least
day
icu
admiss
patient
submit
antibiot
treatment
icu
admissionaft
implement
antibiot
protocol
verifi
icu
length
stay
reduc
almost
day
number
agent
isol
increas
microbiolog
analys
increas
allow
us
practic
deescal
consumpt
antibiot
categori
decreas
carbapenem
antifung
antipseudomon
betalactamsther
signific
decreas
mortal
reduct
antibiot
consumpt
total
save
one
year
conclus
resist
associ
previou
stay
ward
previou
surgeri
antibiot
treatment
previou
surgeri
implement
antibiot
protocol
posit
impact
significantli
associ
reduct
length
icu
stay
icu
mortal
well
consumpt
cost
associ
antibiot
therapi
refer
spellberg
b
futur
antibiot
critic
care
european
centr
diseas
prevent
control
antimicrobi
resist
surveil
europ
annual
report
european
antimicrobi
resist
surveil
network
earsnet
stockholm
ecdc
introduct
advanc
cardiac
surgeri
techniqu
postop
care
led
decreas
major
postop
morbid
mortal
sinc
oper
risk
declin
improv
qualiti
life
becam
import
patient
centr
outcom
depend
physic
also
mental
statu
individu
percept
health
rehabilit
object
primari
aim
studi
defin
impact
preoper
patient
characterist
qualiti
preoper
life
health
relat
qualiti
life
hrqol
dynam
one
year
cardiac
surgeri
secondari
aim
identifi
factor
influenc
longterm
hrqol
postop
method
prospect
cohort
studi
tertiari
referr
univers
hospit
studi
protocol
approv
institut
bioethic
committe
short
form
health
survey
use
assess
hrqol
amongst
studi
particip
inpati
questionnair
complet
day
elect
surgeri
repeat
one
year
surgeri
via
telephon
interview
compos
domain
cover
physic
mental
aspect
health
answer
convert
scale
higher
valu
repres
better
health
statu
effect
size
method
use
establish
clinic
signific
chang
therefor
improv
defin
posit
chang
exceed
standard
deviat
baselin
follow
score
particular
domain
summari
score
physic
compon
pc
mental
compon
mc
use
identifi
patient
overal
improv
hrqol
base
result
studi
group
divid
improv
nonimprov
clinic
data
collect
medic
record
independ
sampl
pair
sampl
ttest
use
compar
baselin
followup
data
differ
two
group
result
patient
enrol
studi
underw
surgeri
one
year
abl
contact
patient
henc
final
analysi
includ
patient
overal
posit
signific
chang
identifi
half
domain
signific
improv
pc
mc
mean
pc
baselin
followup
mc
baselin
followup
p
patient
nonimprov
group
patient
improv
group
signific
differ
identifi
group
demograph
periop
variabl
nonimprov
significantli
higher
preoper
score
domain
includ
mc
vs
p
pc
vs
p
conclus
find
suggest
patient
wors
hrqol
baselin
like
experi
longterm
improv
follow
cardiac
surgeri
identifi
factor
influenc
longterm
hrqol
outcom
introduct
patient
treat
icu
often
affect
mental
physic
health
complic
depress
anxieti
posttraumat
stress
disord
ptsd
sleep
disturb
decreas
healthrel
qualiti
life
hrqol
icu
stay
shown
mix
icupopul
lack
knowledg
hrqol
surgic
intens
care
object
aim
studi
describ
hrqol
month
discharg
gener
surgic
icu
analyz
factor
associ
impair
hrqol
method
prospect
cohort
studi
gener
surgic
icu
sweden
includ
patient
icu
length
stay
hr
year
old
hrqol
measur
month
discharg
icu
age
gender
apach
ii
lo
mechan
ventil
admiss
diagnosi
preexist
diseas
marit
statu
record
wilcoxon
sign
rank
test
use
compar
hrqol
chang
time
gener
linear
regress
analysi
perform
analyz
impact
background
icurel
factor
hrqol
standard
gener
popul
age
sweden
result
total
patient
yr
includ
hrqol
significantli
improv
month
icu
six
domain
pf
p
rp
p
gh
p
vt
p
sf
p
p
still
lower
eight
domain
compar
standard
popul
age
year
risk
factor
conclus
surgic
intens
care
patient
lower
hrqol
compar
standard
popul
one
year
stay
icu
age
yr
risk
factor
wors
hrqol
studi
also
contribut
knowledg
risk
factor
impair
hrqol
import
consid
select
patient
icu
followup
clinic
refer
jackson
jc
pandharipand
pp
girard
td
et
al
depress
posttraumat
stress
disord
function
disabl
survivor
critic
ill
brainicu
studi
longitudin
cohort
studi
lancet
respiratori
medicin
deja
denk
c
webercarsten
et
al
social
support
intens
care
unit
stay
might
improv
mental
impair
consequ
healthrel
qualiti
life
survivor
sever
acut
respiratori
distress
syndrom
critic
care
london
england
jone
c
backman
c
capuzzo
flaatten
h
ryland
c
griffith
rd
precipit
posttraumat
stress
disord
follow
intens
care
hypothesi
gener
studi
divers
care
intens
care
medicin
parson
ec
hough
cl
vitiello
mv
zatzick
davydow
ds
insomnia
associ
qualiti
life
impair
medicalsurg
intens
care
unit
survivor
heart
lung
journal
critic
care
introduct
critic
ill
survivor
physic
impair
reduc
function
capac
chang
qualiti
life
discharg
intens
care
unit
icu
object
evalu
pulmonari
function
qualiti
life
critic
ill
patient
three
month
discharg
icu
method
cohort
studi
conduct
posticu
followup
outpati
clinic
univers
hospit
southern
brazil
april
june
perform
spirometri
test
patient
answer
three
month
discharg
icu
patient
divid
group
normal
spirometri
restrict
obstruct
variabl
accord
assumpt
normal
homoscedast
evalu
analysi
varianc
anova
singlefactor
accord
assumpt
evalu
kruskalw
test
result
patient
admit
discharg
aliv
hospit
outpati
clinic
patient
evalu
male
age
year
smoker
copd
main
caus
admiss
postop
elect
surgeri
trauma
head
injuri
mean
apach
ii
icu
length
time
day
hospit
length
time
day
mv
hour
mean
mv
time
hour
group
show
signific
differ
spirometr
data
shown
tabl
area
vital
social
aspect
show
statist
differ
tabl
conclus
patient
normal
spirometri
main
pulmonari
impair
obstruct
featur
area
qualiti
life
icu
discharg
present
relationship
worsen
lung
function
introduct
evolut
care
critic
ill
patient
provid
consider
number
survivor
admiss
icu
sever
patient
impair
qualiti
life
owe
chang
physic
function
social
emot
disord
often
culmin
prolong
recoveri
lowincom
countri
pictur
poorli
describ
object
evalu
healthrel
qualiti
life
patient
surviv
icu
stay
three
month
icu
discharg
method
prospect
cohort
studi
conduct
period
posticu
multiprofession
followup
outpati
clinic
teach
hospit
southern
brazil
includ
patient
hour
icu
year
old
attend
outpati
evalu
evalu
qualiti
life
appli
questionnair
result
period
patient
evalu
male
mean
age
year
trauma
lead
caus
hospit
comorbid
hypertens
diabet
alcohol
tobacco
mean
icu
length
stay
day
remain
hour
mechan
ventil
sedat
tracheostomi
mean
apach
ii
signific
impair
relat
limit
physic
emot
aspect
main
factor
associ
chang
qol
physic
compon
mechan
ventil
sedat
presenc
posticu
sequela
mental
compon
admiss
neurotrauma
presenc
posticu
sequela
conclus
impair
qualiti
life
relat
limit
physic
social
emot
aspect
justifi
need
monitor
rehabilit
discharg
mainli
patient
victim
neurolog
trauma
underw
sedat
prolong
mv
introduct
patient
experi
key
marker
healthcar
qualiti
focu
depart
health
critic
ill
patient
die
surviv
often
littl
memori
intens
care
stay
famili
member
valuabl
proxi
patient
experi
icu
famili
satisfact
intens
care
unit
fs
icu
questionnair
develop
canada
wide
valid
domain
satisfact
care
satisfact
decis
make
uk
free
studi
adapt
questionnair
found
high
intern
consist
criterion
valid
free
text
respons
demonstr
scope
improv
object
assess
level
satisfact
famili
member
icu
patient
guid
improv
qualiti
care
method
patient
admit
fs
icu
questionnair
sent
next
kin
month
death
icu
discharg
question
analys
use
likert
scale
result
questionnair
return
respond
femal
mean
age
yr
rel
previou
icu
experi
live
patient
prior
ill
patient
partner
overal
satisfact
satisfact
care
score
highest
score
concern
care
lowest
wait
room
atmospher
satisfact
decis
make
score
highest
score
honesti
inform
lowest
score
frequenc
commun
doctor
rel
felt
could
use
time
make
decis
felt
support
decisionmak
process
felt
overwhelm
felt
control
care
patient
although
alway
neg
leav
expert
free
text
respons
insight
valuabl
contribut
data
conclus
low
respons
rate
potenti
respons
bia
due
dissatisfi
rel
declin
respond
limit
studi
strength
provid
individualis
feedback
use
enhanc
qualiti
care
local
futur
qualiti
improv
project
target
improv
commun
includ
dissemin
studi
summari
staff
member
highlight
import
commun
inform
wait
room
expect
intens
care
unit
use
famili
ward
round
refer
wall
rj
engelberg
ra
downey
l
et
al
refin
score
valid
famili
satisfact
intens
care
unit
fsicu
survey
crit
care
med
wright
se
walmsley
e
harvey
se
et
al
familyreport
experi
evalu
studi
mixedmethod
studi
evalu
famili
satisfact
adult
critic
care
servic
nh
health
servic
deliveri
research
issn
introduct
critic
ill
differ
etiolog
trigger
inflammatori
cascad
associ
organ
dysfunct
howev
known
inflammatori
pattern
diseas
specif
relat
sever
injuri
hypothes
critic
ill
patient
differ
etiolog
specif
pattern
cytokin
measur
earli
phase
icu
admiss
may
predict
mortal
object
aim
studi
investig
earli
inflammatori
profil
critic
ill
patient
associ
icu
mortal
method
local
ethic
committe
approv
studi
protocol
critic
ill
patient
admit
icu
sepsisassoci
acut
respiratori
distress
syndrom
ard
sever
traumat
brain
injuri
tbi
subarachnoid
hemorrhag
sah
studi
demograph
data
sever
index
admiss
physiolog
variabl
record
blood
sampl
cytokin
analysi
collect
day
admiss
cytokin
analysi
perform
bioplex
technolog
cytokin
analys
statist
analysi
multivari
project
techniqu
appli
analys
variat
collinear
within
cytokin
dataset
without
priori
select
potenti
relev
molecul
princip
compon
analysi
pca
use
identifi
princip
compon
pc
account
major
variat
within
dataset
result
eightysix
critic
ill
patient
admit
sepsisassoci
ard
n
sever
tbi
n
sah
n
studi
mean
age
apach
ii
sap
ii
mean
sofa
first
week
median
iculength
stay
day
rang
median
hospitallo
day
rang
icu
mortal
use
pca
first
five
pc
gener
model
explain
variat
within
dataset
first
compon
strongli
correl
follow
cytokin
fgf
basic
gcsf
moreov
second
compon
strongli
correl
vegf
correct
age
apacheii
sap
sofa
two
princip
compon
evalu
predictor
icu
mortal
ci
ci
respect
conclus
critic
ill
patient
differ
etiolog
multivari
project
method
repres
valuabl
techniqu
identifi
inflammatori
pattern
predictor
outcom
refer
mickiewicz
b
et
al
integr
metabol
inflammatori
mediat
profil
potenti
prognost
approach
septic
shock
intens
care
unit
critic
care
helmi
et
al
recombin
human
ili
receptor
antagonist
promot
mi
microglia
bias
cytokin
chemokin
follow
human
traumat
brain
injuryjcbfm
grant
acknowledg
univers
torino
introduct
high
qualiti
clinic
databas
facilit
repeat
evalu
clinic
practic
compar
audit
howev
inaccur
data
entri
lead
inaccur
conclus
object
sought
determin
whether
patient
intens
care
unit
icu
appropri
code
chronic
sever
respiratori
diseas
method
conduct
retrospect
case
note
review
patient
admit
gener
adult
icu
januari
decemb
label
chronic
sever
respiratori
diseas
sever
respiratori
diseas
defin
chronic
restrict
obstruct
vascular
diseas
result
sever
exercis
restrict
document
chronic
hypoxia
hypercapnia
secondari
polycythaemia
sever
pulmonari
hypertens
respir
depend
patient
identifi
databas
electron
record
interrog
statist
signific
assess
use
pair
ttest
chi
squar
test
result
icu
patient
men
label
chronic
sever
respiratori
diseas
six
year
period
patient
median
age
year
iqr
year
median
apach
ii
score
iqr
electron
record
insuffici
confirm
refut
label
chronic
sever
respiratori
diseas
case
patient
exclud
analys
fortytwo
remain
patient
chronic
sever
respiratori
diseas
standardis
definit
signific
differ
apacheii
icu
mortal
icu
length
stay
hospit
mortal
hospit
stay
standardis
mortal
ratio
ci
appropri
code
patient
ci
inappropri
code
patient
conclus
almost
half
patient
wrongli
code
chronic
sever
respiratori
diseas
moreov
clearli
impact
smr
group
patient
error
data
entri
compromis
conclus
drawn
cohort
comparison
made
prior
cohort
icu
order
improv
resourc
stringent
document
clinician
educ
input
data
requir
refer
harris
bradi
rowan
k
case
mix
outcom
length
stay
admiss
adult
gener
critic
care
unit
england
wale
northern
ireland
critic
care
introduct
primari
graft
dysfunct
signific
caus
lung
transplant
morbid
mortal
underli
mechan
complet
understood
object
aim
studi
confirm
right
ventricular
function
risk
factor
sever
primari
graft
dysfunct
propos
clinic
model
predict
develop
sever
primari
graft
dysfunct
method
prospect
cohort
studi
perform
month
primari
outcom
develop
primari
graft
dysfunct
grade
echocardiogram
perform
immedi
transplant
measur
convent
speckletrack
paramet
pulmonari
arteri
cathet
data
also
measur
classif
regress
tree
made
identifi
prognost
model
develop
sever
graft
dysfunct
result
seventi
lung
transplant
recipi
includ
patient
develop
sever
primari
graft
dysfunct
better
right
ventricular
function
estim
cardiac
index
vs
lmin
p
basal
longitudin
strain
vs
p
regress
tree
analysi
provid
algorithm
base
combin
use
three
variabl
basal
longitudin
strain
pulmonari
fibrosi
diseas
ischemia
time
allow
accur
preoper
discrimin
three
distinct
subgroup
low
intermedi
high
risk
sever
primari
graft
dysfunct
auroc
conclus
better
right
ventricular
function
risk
factor
develop
sever
primari
graft
dysfunct
preoper
estim
right
ventricular
function
could
allow
earli
identif
recipi
increas
risk
would
benefit
care
periop
manag
order
limit
pulmonari
overflow
refer
p
et
al
influenc
right
ventricular
function
develop
primari
graft
dysfunct
lung
transplant
j
hear
lung
transplant
liu
et
al
recipientrel
clinic
risk
factor
primari
graft
dysfunct
lung
transplant
systemat
review
metaanalysi
plo
one
champion
hc
et
al
comprehens
invas
noninvas
approach
right
ventriclepulmonari
circul
unit
state
art
clinic
research
implic
circul
wrobel
jp
et
al
preoper
echocardiographicdefin
moderatesever
pulmonari
hypertens
predict
prolong
durat
mechan
ventil
follow
lung
transplant
patient
copd
lung
grant
acknowledg
dr
recipi
rio
hortega
grant
ref
instituto
de
salud
carlo
iii
ministerio
de
ciencia
e
introduct
pulmonari
alveolar
proteinosi
pap
rare
disord
character
perturb
surfact
homeostasi
result
accumul
within
alveolar
space
consequ
develop
sever
hypoxemia
whole
lung
lavag
wll
complex
procedur
dedic
patient
affect
sever
condit
respons
medic
treatment
object
analyz
evolut
ga
exchang
wll
evalu
variat
differ
phase
procedur
patient
method
enrol
patient
pap
male
age
year
underw
wll
icu
wll
conduct
gener
anesthesia
use
select
endotrach
tube
consist
differ
phase
lung
bipulmonari
mechan
ventil
supin
posit
zeep
bipulmonari
ventil
supin
posit
peep
monopulmonari
ventil
supin
posit
order
achiev
complet
atelectasi
contralater
lung
monopulmonari
ventil
later
posit
ventil
lung
downward
lavag
whole
atelectat
lung
liquid
tidal
ventil
differ
level
hydrostat
lavag
pressur
collect
data
regard
patient
ga
exchang
perform
sever
blood
ga
analysi
differ
step
wll
express
data
mean
standard
deviat
sd
result
figur
show
mean
valu
differ
phase
wll
bipulmonari
ventil
ga
exchang
improv
respons
peep
monopulmonari
ventil
instead
induc
clear
reduct
increas
later
posit
liquid
tidal
ventil
substanti
effect
elev
hydrostat
lavag
pressur
wide
sd
indic
uneven
respons
ga
exchang
studi
popul
conclus
pathophysiolog
pap
character
alter
alveolocapillari
diffus
intrapulmonari
shunt
thu
significantli
respons
peep
respect
monopulmonari
ventil
shunt
reduc
later
posit
provid
better
perfus
ventil
lung
elev
hydrostat
lavag
pressur
abl
limit
perfus
contralater
lung
wll
refer
pulmonari
alveolar
proteinosi
diagnost
therapeut
challeng
campo
et
al
multidisciplinari
respiratori
medicin
introduct
report
influenza
pandem
caus
death
global
new
delhi
report
case
confirm
death
till
march
mortal
sever
refractori
ard
relat
influenza
pneumonia
high
swine
flu
epidem
hospit
admit
adult
patient
either
suspect
confirm
case
object
studi
epidemiolog
clinic
profil
patient
admit
blk
superspeci
hospit
new
delhi
influenza
epidem
method
data
collect
retrospect
hospit
record
irb
approv
patient
admit
either
suspect
proven
case
outsid
influenza
pneumonia
demograph
detail
categori
present
hospit
icu
cours
ventil
strategi
appli
patient
exclud
signific
data
miss
record
result
analys
patient
n
urban
background
n
rural
background
n
patient
posit
rtpcr
techniqu
n
posit
histori
contact
establish
case
wherea
histori
travel
affect
area
present
n
patient
maximum
admiss
report
month
februari
n
march
n
patient
n
belong
age
group
year
year
age
n
posit
patient
categori
c
admit
icu
directli
n
manag
non
invas
ventilatori
support
n
intub
mechan
ventil
patient
requir
intub
mechan
ventil
belong
categori
c
n
intub
patient
refractori
hypoxemia
mean
ratio
patient
requir
earli
prone
ventil
n
patient
die
mechan
ventil
n
success
discharg
hospit
mean
icu
hospit
lo
day
day
respect
higher
mortal
rate
also
seen
patient
day
time
lag
initi
oseltamivir
symptom
onset
n
conclus
influenza
pneumonia
signific
burden
epidem
associ
high
morbid
mortal
among
sever
refractori
ard
patient
invas
ventil
high
refer
mohfw
press
inform
bureau
releas
march
cdc
guidelin
lapinski
se
macia
et
al
critic
ill
patient
influenza
mexico
jama
nov
introduct
sever
communityacquir
pneumonia
patient
bear
highest
morbid
inhospit
mortal
cost
patient
commun
acquir
pneumonia
appropri
manag
patient
receiv
close
attent
current
era
rise
health
care
cost
nevertheless
outcom
patient
remain
poor
unknown
patient
characterist
treatment
modal
associ
better
outcom
combin
nation
registri
specif
design
questionnair
abl
examin
factor
relat
organiz
characterist
treatment
polici
might
explain
variat
mortal
outcom
scap
patient
icu
method
studi
use
dataset
nation
registri
contain
data
patient
icu
level
combin
webbas
survey
treatment
polici
relationship
inhospit
mortal
determin
analyz
use
multivari
logist
regress
analysi
result
januari
januari
dutch
icu
provid
data
registri
return
questionnair
respond
icu
admit
patient
sever
communityacquir
pneumonia
patient
higher
sever
ill
gener
medic
icu
popul
mortal
also
higher
icu
mortal
hospit
mortal
versu
icu
mortal
hospit
mortal
respect
sever
communityacquir
pneumonia
patient
comorbid
stay
longer
icu
rare
use
tracheostomi
wean
process
associ
better
outcom
patient
need
mechan
ventil
associ
poor
outcom
case
mean
number
icu
admiss
per
year
conclus
cap
diseas
high
inhospit
mortal
shown
correct
confound
factor
treatment
organiz
factor
relat
outcom
patient
scap
need
mechan
ventil
remain
independ
risk
factor
mortal
liber
use
tracheostomi
wean
process
also
associ
higher
mortal
mean
number
icu
admiss
scap
per
year
invers
correl
hospit
mortal
mani
paramet
often
claim
associ
better
wors
outcom
like
differ
antibiot
therapi
correl
outcom
refer
mandel
l
et
al
infecti
diseas
societi
americaamerican
thorac
societi
consensu
guidelin
manag
communityacquir
pneumonia
adult
clininfectdi
suppl
brinkman
et
al
mortal
hospit
discharg
icu
patient
crit
care
med
grant
acknowledg
none
background
object
sever
asthmat
patient
requir
use
invas
mechan
ventil
intens
care
unit
despit
low
incid
potenti
seriou
case
requir
earli
specif
respiratori
care
care
larg
determin
averag
icu
stay
occurr
secondari
injuri
even
death
object
describ
characterist
sever
asthmat
patient
admit
icu
analyz
initi
treatment
method
descript
studi
patient
admit
icu
clinic
hospit
virgin
arrixaca
period
januari
septemb
analyz
differ
variabl
age
sex
apach
ii
sap
ii
paramet
mechan
ventil
icu
stay
laboratori
paramet
result
patient
women
admit
icu
diagnosi
sever
asthma
averag
age
averag
stay
icu
day
apach
ii
sap
ii
point
eight
patient
need
non
invas
mechan
ventil
failur
rate
patient
use
invas
mechan
ventil
requir
patient
need
tracheostomi
prolong
mechan
ventil
sevofluran
devic
use
data
respir
paramet
collect
first
hour
highlight
vt
ml
kg
initi
peep
ppeak
autopeep
cm
averag
ph
admiss
rang
mm
hg
lactat
concentr
mmoll
patient
administ
inhal
betaagonist
two
patient
salbutamol
endoven
corticosteroid
patient
requir
magnesium
sulfat
patient
requir
sedat
patient
requir
relax
atracurium
cisatracurium
one
patient
present
barotrauma
use
noninvas
mechan
ventil
prior
endotrach
intub
conclus
clinic
profil
patient
admit
icu
severestatu
asthmaticu
young
male
requir
invas
mechan
ventil
failur
use
medic
gase
helium
noninvas
mechan
ventil
strategi
ventil
protect
permiss
hypercapnia
introduct
viral
influenza
especi
influenza
pandem
influenza
associ
signific
increas
morbid
intens
care
unit
icu
admiss
object
aim
studi
characteris
burden
ill
secondari
infect
among
critic
unwel
patient
admit
icu
year
method
retrospect
observ
cohort
studi
critic
ill
adult
patient
influenza
admit
level
icu
dublin
decemeb
march
intellivu
clinic
inform
portfolio
icip
use
obtain
data
result
critic
ill
occur
twenti
patient
confirm
influenza
nonsubtyp
b
median
age
year
patient
male
thirteen
comorbid
includ
respiratori
diseas
morbid
obes
malign
immunosuppress
one
pregnant
smoke
histori
nine
retriev
outsid
ireland
east
hospit
group
mean
apach
acut
physiolog
chronic
health
evalu
ii
score
mean
sofa
sequenti
organ
failur
assess
score
day
one
respect
twenti
mechan
ventil
median
day
eighteen
satisfi
criteria
acut
respiratori
distress
syndrom
mean
ratio
day
one
fifteen
requir
rescu
therapi
sever
hypoxaemia
includ
extracorpor
life
support
ecl
five
prone
ventil
inhal
nitric
oxid
sixteen
receiv
vasopressor
requir
renal
replac
therapi
median
icu
length
stay
day
march
three
die
four
document
earli
secondari
infect
less
hour
streptococcu
pneumonia
sole
isol
seven
treat
presum
late
greater
hour
secondari
infect
aspergillu
fumigatu
pansensit
staphylococcu
aureu
preval
patient
receiv
neuraminidas
inhibitor
oseltamivir
prescrib
median
day
patient
receiv
higher
mg
twice
daili
dose
regim
conclus
season
influenza
major
public
health
concern
associ
sever
morbid
result
signific
econom
consequ
well
substanti
burden
tertiari
icu
keep
nation
trend
predomin
circul
viru
influenza
secondari
coinfect
common
although
tradit
teach
emphasis
saureu
common
coinfect
viral
ill
result
highlight
import
consid
broad
spectrum
bacteri
viral
fungal
microorgan
prescrib
empir
critic
ill
patient
introduct
patient
reintub
plan
endotrach
intub
hour
reintub
increas
risk
pneumonia
ventil
icu
day
result
mortal
mani
studi
explor
risk
factor
fail
extub
integr
index
success
plan
endotrach
extub
inadequ
object
establish
use
predictor
successfullyplan
extub
follow
medic
personnel
method
patient
admit
adult
icu
tertiari
hospit
southern
taiwan
met
criteria
intub
hour
prepar
extub
collect
retrospect
januari
decemb
patient
characterist
diseas
sever
rapid
shallow
breath
index
rsbi
maxim
inspiratori
pressur
mip
maxim
expiratori
pressur
mep
cuff
leak
test
clt
extub
icu
day
outcom
record
retrospect
clt
classifi
audibl
flow
without
stethoscop
audibl
flow
stethoscop
neg
n
audibl
flow
even
stethoscop
failur
extub
defin
reintub
within
hour
result
total
patient
enrol
patient
failur
extub
extub
failur
rate
femal
higher
male
vs
p
failur
group
patient
note
older
age
vs
p
higher
apach
ii
score
vs
p
lower
coma
scale
vs
p
higher
rsbi
vs
p
lower
mip
mep
vs
p
vs
p
respect
higher
mortal
rate
vs
p
compar
success
group
multivari
logist
regress
cuff
leak
test
p
p
rsbi
p
mip
p
found
predictor
success
extub
conclus
cuff
leak
test
rsbi
mip
identifi
effect
predictor
success
plan
endotrach
extub
refer
penuela
frutosvivar
f
fernandez
c
et
al
characterist
outcom
ventil
patient
accord
time
liber
mechan
ventil
american
journal
respiratori
critic
care
medicin
thill
aw
harroi
schortgen
f
brunbuisson
c
brochard
l
outcom
extub
failur
medic
intens
care
unit
patient
critic
care
medicin
thill
aw
boissier
f
ben
ghezala
h
razazi
k
mekontsodessap
brunbuisson
c
risk
factor
predict
caregiv
extub
failur
icu
patient
prospect
studi
critic
care
medicin
grant
acknowledg
financi
support
chi
mei
medic
center
background
respiratori
system
impair
may
caus
increas
intraabdomin
pressur
aim
work
assess
role
measur
intraabdomin
pressur
predict
success
wean
mechan
ventil
method
patient
arf
fulfil
criteria
wean
includ
underw
sbt
clinic
respiratori
paramet
mechan
record
iap
measur
use
kron
techniqu
begin
everi
minut
till
end
sbt
mean
iap
sbt
calcul
result
patient
includ
studi
patient
achiev
success
sbt
extub
patient
need
reintub
within
hour
mean
iap
lower
patient
achiev
success
sbt
compar
patient
vs
p
valu
moreov
patient
need
reintub
within
hour
higher
mean
iap
compar
patient
vs
p
valu
use
rank
correl
coeffici
found
mean
iap
posit
correl
auto
peep
measur
begin
end
sbt
admiss
apach
ii
score
correl
coeffici
measur
respect
conclus
high
iap
predict
failur
sbt
need
reintub
within
hour
refer
torquato
jamili
anbar
lucato
jeanett
janaina
jaber
antun
telma
barba
carmen
valent
interact
intraabdomin
pressur
positiveend
expiratori
pressur
clinic
feb
malbrain
ml
differ
techniqu
measur
intraabdomin
pressur
iap
time
critic
reapprais
int
care
med
introduct
use
life
support
intens
care
unit
icu
common
associ
high
risk
poor
outcom
howev
prognost
import
durat
life
support
less
studi
object
aim
assess
use
life
support
associ
durat
mortal
adult
icu
patient
method
perform
posthoc
analysi
supicu
incept
cohort
studi
conduct
dec
till
april
icu
countri
cohort
n
includ
adult
gener
icu
patient
icu
stay
day
assess
use
life
support
day
icu
crude
adjust
associ
durat
mortal
use
logist
regress
analysi
result
includ
patient
mortal
rate
first
day
icu
patient
receiv
respiratori
support
circulatori
support
renal
replac
therapi
rrt
patient
receiv
day
rrt
worst
outcom
ci
compar
patient
receiv
day
respiratori
circulatori
support
odd
ratio
respect
fig
conclus
outcom
adult
icu
patient
associ
type
durat
life
support
rrt
seem
associ
worst
outcom
potenti
kidney
failur
often
occur
concomitantli
respiratori
circulatori
failur
refer
krag
perner
wetterslev
j
et
al
preval
outcom
gastrointestin
bleed
use
acid
suppress
acut
ill
adult
intens
care
patient
intens
care
med
grant
acknowledg
receiv
support
novo
nordisk
foundat
fund
sourc
influenc
design
studi
introduct
effect
lung
volum
elv
calcul
continu
use
capnodynam
equat
correl
well
function
residu
capac
frc
healthi
lung
porcin
model
hypercapnia
common
icu
lung
protect
mechan
ventil
may
affect
capnodynam
method
object
aim
studi
evalu
elv
induc
hypercapnia
pig
confirm
stabil
hemodynam
challeng
method
cyclic
sequenc
alter
breath
expiratori
hold
normal
breath
induc
period
chang
alveolar
concentr
carbon
dioxid
integr
variat
capnodynam
equat
elv
calcul
hypercapnia
induc
increas
instrument
dead
space
eight
anaesthet
relax
mechan
ventil
pig
frc
measur
sulfurhexafluorid
wash
techniqu
cardiac
output
co
measur
use
ultrason
flow
probe
place
around
pulmonari
arteri
trunk
hemodynam
measur
blood
ga
analysi
obtain
normocapnia
hypercapnia
baselin
preload
reduct
cava
balloon
inflat
dobutamin
stimul
result
carbon
dioxid
level
rais
mean
sd
kpa
kpa
hypercapnia
bia
limit
agreement
loa
elv
normocapnia
ml
percentag
error
pe
hypercapnia
bia
loa
decreas
ml
pe
hemodynam
intervent
result
signific
chang
co
ie
decreas
caval
occlus
follow
increas
dobutamin
inf
elv
frc
remain
stabl
throughout
chang
fig
conclus
elv
show
good
perform
hypercapnia
method
show
good
stabil
sever
chang
cardiac
output
indic
would
interest
evalu
method
could
suitabl
monitor
lung
function
icu
instanc
protect
lung
ventil
permiss
hypercapnia
septic
patient
hyper
dynam
hemodynam
refer
capnodynam
assess
effect
lung
volum
cardiac
output
manipul
porcin
model
sander
c
pa
sipmann
fs
wallin
oldner
h
j
clin
monit
comput
sept
grant
acknowledg
reciv
grant
maquet
critic
care
introduct
ard
independ
sever
lung
protect
strategi
impli
highpeep
ventil
set
prevent
endexpiratori
collaps
prevent
cyclic
alveolar
open
close
object
measur
intratid
collaps
decollaps
similar
tidal
volum
posit
endexpiratori
pressur
peep
method
ard
patient
underw
expiratori
inspiratori
ct
scan
peep
inspiratori
expiratori
paus
keep
constant
tidal
volum
mlkg
ibw
ct
slice
lung
profil
manual
delin
exclud
hilar
structur
thereaft
quantit
analysi
ct
scan
imag
perform
dedic
softwar
packag
softefilm
wwwelektonit
lung
tissu
classifi
accord
gastissu
content
inflat
ct
number
lung
collapsedecollaps
estim
collapsedecollaps
peep
inflat
insp
g
inflat
esp
g
collapsedecollaps
peep
inflat
insp
g
inflat
esp
g
result
thirtythre
ard
patient
enrol
mild
moder
sever
shown
fig
within
given
class
sever
gram
tissu
undergo
intratid
collaps
chang
significantli
peep
vs
vs
vs
mild
moder
sever
ard
respect
observ
clear
tendenc
decreas
peep
though
statist
signific
p
respect
mild
moder
sever
ard
pair
ttest
conclus
consist
intratid
collaps
decollaps
still
present
peep
observ
clear
tendenc
decreas
peep
though
signific
refer
musceder
jg
j
respir
crit
care
med
caironi
p
j
respir
crit
care
med
ard
definit
task
forc
jama
j
med
assoc
gattinoni
l
rev
respir
di
introduct
chronic
obstruct
pulmonari
diseas
copd
common
prevent
treatabl
diseas
low
level
laser
lll
therapi
appear
promis
noninvas
modal
copd
manag
object
studi
shortterm
effect
lll
therapi
clinic
cardiac
statu
stabl
copd
patient
method
exclus
patient
impair
left
ventricular
systol
function
atrial
fibril
pulmonari
hypertens
due
caus
copd
contraind
exercis
test
thirti
stabl
copd
patient
divid
laser
control
group
pt
medic
treatment
optim
group
addit
lll
laser
group
addit
histori
physic
examin
mmrc
scale
mwt
echocardiographi
measur
rv
dimens
taps
later
tricuspid
annulu
tissu
doppler
veloc
assess
patient
lll
lll
done
use
follow
paramet
wave
length
nm
output
mw
frequenc
hz
laser
probe
place
intercost
space
correspond
site
lesion
anteriorli
posteriorli
chest
wall
arm
standard
laser
acupunctur
point
applic
frequenc
sessionsweek
success
week
result
signific
differ
group
regard
demograph
data
laser
group
higher
pasp
lower
higher
veloc
versu
control
p
respect
laser
group
show
improv
mmrc
scale
mwt
versu
control
laser
patient
show
improv
mmrc
scale
least
one
grade
versu
control
laser
group
mwt
studi
versu
meter
end
studi
p
control
mwt
versu
p
signific
chang
echocardiograph
criteria
studi
conclus
use
lll
associ
clinic
improv
echocardiograph
chang
notic
lll
introduct
time
extub
clinic
import
extend
period
intub
prematur
extub
result
reintub
associ
neg
patient
outcom
adult
intens
care
unit
aicu
extub
failur
rate
report
within
larg
uk
teach
hospit
identifi
extub
assess
multidisciplinari
decis
differ
clinician
appli
vari
criteria
assess
standardis
follow
review
extub
failur
rate
qualiti
improv
initi
instig
includ
develop
local
ventil
wean
guidelin
physiotherapi
pt
led
assess
extub
suitabl
object
aim
evalu
describ
pt
assess
extub
suitabl
aicu
report
extub
failur
rate
method
patient
consider
extub
aicu
physician
underw
pt
assess
extub
includ
assess
document
within
patient
electron
casenot
data
collect
retrospect
casenot
review
week
period
august
project
regist
servic
evalu
therefor
ethic
requir
waiv
demograph
detail
pt
assess
outcom
follow
extub
collect
tabl
extub
failur
defin
reintub
one
week
follow
extub
result
data
collect
pt
assess
assess
frequent
includ
neurolog
statu
rapid
shallow
breath
index
rsbi
occlus
pressur
initi
ms
inspir
neg
inspiratori
forc
nif
peak
cough
flow
pcf
secret
load
rang
valu
assess
paramet
shown
provid
opinion
regard
suitabl
extub
pt
gave
weight
neurolog
statu
pcf
secret
load
wean
paramet
see
imag
like
recommend
extub
presenc
low
pcf
inappropri
neurolog
larg
secret
load
conclus
physiotherapist
frequent
includ
neurolog
statu
work
breath
pcf
secret
load
nif
assess
extub
predominantli
use
neurolog
statu
cough
strength
secret
load
inform
recommend
regard
extub
extub
failur
rate
keep
current
literatur
although
studi
sampl
size
small
refer
menon
n
joff
deem
yanez
nd
grabinski
dagal
ah
daniel
treggiari
mm
occurr
complic
tracheal
reintub
critic
ill
adult
respir
care
oct
thill
aw
richard
jc
brochard
l
decis
extub
intens
care
unit
j
respir
crit
care
med
jun
introduct
reclassif
hour
use
peep
threshold
improv
prognost
patient
moderatesever
ard
uncertain
also
hold
true
patient
mild
ard
object
aim
investig
determin
reclassif
hour
use
peep
threshold
improv
prognost
mortal
cohort
prospect
identifi
patient
mild
ard
two
intens
care
unit
netherland
method
patient
mild
ard
accord
berlin
definit
categor
group
base
measur
obtain
present
ard
hour
mm
hg
peep
cm
group
mm
hg
peep
cm
group
ii
mm
hg
peep
cm
group
iii
mm
hg
peep
cm
group
iv
patient
longer
receiv
mechan
ventil
hour
classifi
extub
group
patient
die
within
hour
primari
outcom
allcaus
hospit
mortal
secondari
outcom
icu
mortal
number
ventilatorfre
day
aliv
day
result
patient
patient
ard
patient
mild
ard
invas
ventil
includ
analysi
tabl
show
outcom
per
group
moment
mild
ard
diagnos
hour
reclassif
hour
show
improv
prognost
regard
hospit
mortal
icu
mortal
number
ventilatorfre
day
aliv
day
conclus
reclassif
hour
use
two
simpl
cutoff
improv
prognost
mild
ard
patient
refer
villar
j
rl
et
al
crit
care
med
bo
ld
cremer
ol
ong
dsi
et
al
intens
care
med
ard
definit
task
forc
jama
grant
acknowledg
research
perform
within
framework
ctmm
center
translat
molecular
medicin
wwwctmmnl
project
mar
grant
introduct
ard
still
carri
high
mortal
therefor
extracorpor
lung
membran
oxygen
ecmo
consid
patient
howev
indic
time
ecmo
still
controversi
sever
recent
ecmo
registri
suggest
earli
initi
ecmo
might
benefici
use
rescu
therapi
howev
consensu
accord
criteria
ecmo
initi
recent
multicentr
studi
cesar
eolia
exodu
includ
patient
base
ard
definit
score
like
murrayscor
howev
predict
capabl
score
depend
time
intub
poorli
investig
object
compar
predict
capabl
oxygenationindex
oi
mean
airway
pressur
aecc
berlindefinit
ard
singl
compon
murrayscor
total
score
without
radiolog
point
murraywrp
regard
icu
hospit
mortal
patient
screen
exodusstudi
method
male
femal
patient
ard
accord
berlindefinit
piccomonitor
pulsion
germani
patient
statist
spss
result
primari
ard
case
secondari
ard
ali
ard
accord
aecc
case
mild
moder
sever
ard
accord
berlin
definit
patient
due
prolong
hospit
final
outcom
avail
patient
icu
hospitalmort
rate
day
intub
mortal
primari
endpoint
best
predict
oi
rocauc
p
rocauc
p
murraywrp
auc
p
contrast
aecc
auc
berlin
auc
apacheii
auc
predict
murraywrp
predict
predict
auc
p
auc
p
auc
p
pulmonari
vascular
permeabl
index
pvpi
auc
p
largest
auc
auc
p
auc
p
well
extravascular
lung
water
index
evlwi
auc
p
significantli
predict
mortal
pvpi
predict
specif
sensit
accuraci
conclus
oi
murraywrp
predict
mortal
patient
ard
day
intub
contrast
aecc
berlindefinit
predict
sinc
murraywrp
day
intub
less
predict
day
intub
earlier
consider
ecmo
might
prefer
high
valu
pvpi
evlwi
best
predictor
mortal
subgroup
picco
grant
acknowledg
exodu
support
xenio
germani
introduct
lung
injuri
prevent
studi
budesonid
formoterol
lipsb
studi
feasibl
nebul
budesonid
formoterol
prevent
allevi
lung
injuri
patient
risk
ard
avail
blood
sampl
obtain
prior
studi
drug
hospit
day
analyz
biomark
associ
progress
sever
ard
object
determin
earli
administr
inhal
budesonid
formoterol
modul
ardsassoci
plasma
biomark
method
serum
sampl
analyz
duplic
luminex
plate
dilut
per
direct
analyt
rage
spd
analyz
biomark
concentr
specimen
treatment
versu
placebo
arm
baselin
studi
drug
deliveri
day
least
one
dose
studi
drug
observ
concentr
calibr
expect
rang
replac
highest
lowest
observ
within
rang
concentr
valu
respect
subsequ
valu
logtransform
differ
treatment
arm
compar
type
fold
f
test
result
enrol
patient
sampl
avail
baselin
day
logtransform
valu
rage
decreas
day
observ
decreas
greater
treatment
arm
howev
differ
statist
signific
p
p
p
rage
p
p
interestingli
also
decreas
treatment
arm
slightli
increas
placebo
arm
although
differ
signific
p
concentr
spd
increas
day
arm
nonsignific
greater
increas
placebo
arm
p
conclus
earli
treatment
nebul
budesonid
formoterol
patient
risk
ard
lipsb
trial
significantli
alter
serum
level
biomark
associ
acut
lung
injuri
day
hospit
admiss
howev
show
trend
toward
greater
reduct
treat
patient
small
sampl
size
like
lack
power
detect
smaller
differ
two
arm
introduct
past
year
manag
acut
respiratori
distress
syndrom
ard
revolutionis
applic
lower
tidal
volum
lung
protect
ventil
strategi
whilst
understand
ard
manag
improv
worldwid
incid
outcom
unclear
sever
studi
report
highli
variabl
region
incid
rate
studi
characteris
ard
epidemiolog
asia
object
goal
observ
studi
determin
incid
mortal
manag
practic
ard
develop
south
east
asian
countri
method
conduct
prospect
popul
base
observ
studi
public
hospit
one
month
period
may
june
identifi
patient
admit
singapor
public
hospit
intens
care
unit
icu
met
ard
criteria
demograph
inform
clinic
manag
data
icu
outcom
data
collect
concurr
survey
conduct
determin
ard
manag
prefer
physician
studi
centr
involv
result
total
adult
patient
admit
icu
studi
period
patient
met
ard
criteria
use
berlin
definit
base
unadjust
incid
ard
singapor
case
per
popul
icu
patient
patient
belong
medic
icu
male
chines
pneumonia
manag
strategi
vari
across
icu
survey
result
show
major
physician
thought
use
studi
ard
preval
believ
overal
mortal
preval
decreas
day
hospit
mortal
median
length
stay
day
conclus
incid
ard
develop
se
asia
countri
compar
european
report
rate
proport
ventil
patient
develop
ard
lower
intern
studi
publish
differ
region
howev
manag
strategi
vari
consider
refer
rubenfeld
gd
caldwel
e
granton
j
hudson
ld
matthay
interobserv
variabl
appli
radiograph
definit
ard
chest
villar
j
perezmendez
l
lopez
j
et
al
earli
trial
identifi
differ
degre
lung
injuri
patient
acut
respiratori
distress
syndrom
j
respir
crit
care
med
ard
definit
task
forc
acut
respiratori
distress
syndrom
berlin
definit
jama
epub
may
bellingan
gj
pulmonari
physician
critic
care
pathogenesi
aliard
thorax
tomashefski
jf
jr
pulmonari
patholog
adult
respiratori
distress
syndrom
clin
chest
med
grant
acknowledg
acknowledg
receiv
nicer
grant
singapor
intens
care
medicin
societi
introduct
restrict
post
resuscit
fluid
balanc
strategi
patient
acut
respiratori
distress
syndrom
ard
suggest
fluid
cathet
treatment
trial
factt
studi
show
increas
ventil
free
day
trend
toward
reduc
mortal
chang
organ
dysfunct
restrict
fluid
balanc
compar
liber
fluid
balanc
object
quantifi
fluid
balanc
sever
ill
mortal
ard
patient
aim
reduc
post
resuscit
fluid
balanc
popul
method
retrospect
review
patient
code
ard
intens
care
nation
audit
research
centr
icnarc
review
electron
record
comparison
apach
ii
score
ventil
free
day
mortal
fluid
balanc
data
compar
factt
studi
result
patient
includ
analysi
mean
age
predomin
femal
ventil
mean
ventil
free
day
mean
post
resuscit
fluid
balanc
patient
underli
diagnosi
pneumonia
mean
apach
ii
score
unit
stay
day
overal
mortal
compar
factt
trial
group
mean
fluid
balanc
litr
less
survivor
compar
die
howev
apach
ii
score
survivor
group
die
p
valu
mortal
patient
receiv
cumul
post
resuscit
fluid
balanc
less
litr
patient
fluid
balanc
greater
litr
p
valu
conclus
trend
toward
improv
mortal
less
fluid
observ
statist
signific
higher
expect
mortal
could
explain
exclus
criteria
factt
popul
particular
chronic
lung
diseas
educ
junior
medic
nurs
staff
daili
review
fluid
balanc
emphasis
reaudit
month
keep
awar
high
recommend
refer
nation
heart
lung
blood
institut
acut
respiratori
distress
syndrom
ard
clinic
trial
network
comparison
two
fluidmanag
strategi
acut
lung
injuri
n
engl
j
med
introduct
old
patient
becom
increasingli
preval
proport
critic
ill
popul
outcom
patient
acut
respiratori
distress
syndrom
ard
improv
recent
year
howev
limit
inform
exist
studi
elderli
ard
patient
object
evalu
factor
associ
mortal
ard
patient
investig
relationship
age
mortal
ard
patient
method
perform
prospect
observ
studi
adult
icu
chang
gung
memori
hospit
octob
may
patient
includ
met
berlin
definit
ard
data
collect
includ
patient
demograph
sever
ill
manag
clinic
outcom
studi
patient
follow
discharg
hospit
result
studi
period
receiv
invas
mechan
ventil
patient
admit
adult
icu
mmhg
screen
total
ard
patient
includ
analysi
mean
age
hospit
mortal
year
ard
patient
patient
older
year
multivari
logist
regress
analysi
factor
associ
hospit
mortal
includ
bodi
mass
index
odd
ratio
confid
interv
p
sequenti
organ
failur
assess
score
odd
ratio
confid
interv
p
lung
injuri
score
odd
ratio
confid
interv
p
odd
ration
confid
interv
p
hospit
mortal
ard
patient
younger
year
significantli
lower
ard
patient
older
year
patient
vs
p
ard
patient
older
year
classifi
patient
youngold
year
n
middleold
year
n
oldold
year
n
hospit
mortal
significantli
differ
three
group
vs
p
conclus
ard
patient
younger
patient
lower
mortal
older
patient
ard
patient
older
year
age
influenc
hospit
mortal
keyword
elderli
outcom
berlin
definit
mechan
ventil
introduct
ard
lifethreaten
condit
character
increas
lung
weight
loss
lung
aerat
recent
prone
posit
adjunct
lung
protect
ventil
demonstr
signific
mortal
reduct
ard
patient
lung
ultrasound
lu
emerg
power
diagnost
tool
could
help
diagnosi
guid
manag
bedsid
perform
serial
ct
scan
gold
standard
lung
recruit
assess
challeng
feasibl
outsid
research
protocol
object
hypothes
ard
patient
lu
could
detect
chang
region
inflat
prone
posit
compar
supin
posit
time
also
hypothes
chang
correl
commonli
monitor
paramet
aerat
oxygen
ventil
measur
arteri
blood
ga
analysi
respiratori
mechan
final
hypothes
specif
lu
aerat
pattern
identifi
immedi
prone
posit
initi
predict
clinic
respons
adjunct
treatment
method
observ
prospect
studi
ard
patient
perform
lu
first
day
prone
posit
treatment
differ
time
point
supin
immedi
hour
initi
prone
posit
immedi
pfin
return
patient
supin
sfin
lu
protocol
use
mhz
curvilinear
transduc
divid
hemithorax
anterior
later
posterior
zone
worst
lu
pattern
detect
zone
consid
character
examin
region
offlin
imag
review
two
independ
physician
unawar
time
posit
patient
characterist
use
calcul
modifi
lu
aerat
score
previous
describ
spearman
rank
correl
coeffici
use
correl
chang
lu
score
vluss
chang
complianc
pf
result
enrol
ard
patient
admit
padova
univers
hospit
icu
median
age
year
iqr
median
sapsii
iqr
vluss
correl
chang
complianc
r
p
pf
r
p
sfin
vluss
also
correl
chang
pf
r
p
complianc
r
p
sfin
conclus
lu
feasibl
ard
patient
prone
posit
vluss
correl
chang
complianc
pf
moreov
vluss
hour
initi
prone
posit
may
predict
chang
complianc
pf
end
pronat
cycl
return
patient
supin
posit
refer
c
et
al
prone
posit
sever
acut
respiratori
distress
syndrom
n
engl
j
med
soummer
et
al
ultrasound
assess
lung
aerat
loss
success
wean
trial
predict
postextub
distress
crit
care
med
introduct
influenza
pneumonia
could
caus
sever
hypoxemia
need
mechan
ventil
support
incid
develop
ard
relat
mortal
rate
pneumonia
respiratori
failur
clear
object
purpos
analyz
outcom
patient
ard
caus
influenza
intens
care
unit
icu
requir
mechan
ventil
method
retrospect
studi
includ
adult
patient
ard
due
confirm
influenza
pneumonia
need
mechan
ventil
medic
center
juli
may
chang
gung
memori
hospit
taiwan
investig
patient
characterist
clinic
present
sever
ill
outcom
result
influenzainfect
patient
hospit
icu
studi
period
seventythre
patient
confirm
influenza
patient
develop
ard
includ
sever
ard
moder
ard
berlin
definit
compar
nonard
influenza
patient
age
younger
vs
year
p
bodi
mass
index
bmi
higher
vs
p
ard
patient
durat
oseltamivir
therapi
ard
patient
longer
vs
day
p
ard
patient
despit
significantli
prolong
mechan
ventil
support
vs
day
p
intens
care
unit
stay
vs
day
p
ard
patient
signific
differ
mortal
rate
icu
vs
p
hospit
vs
p
ard
nonard
patient
conclus
patient
influenza
pneumonia
complic
respiratori
failur
high
incid
develop
sever
ard
correspond
high
mortal
rate
refer
estenssoro
e
r
fg
apeztegu
c
reina
r
neira
j
ceraso
dh
orlandi
c
valentini
r
tiribelli
n
brizuela
balasini
c
mare
domeniconi
g
ilutovich
gomez
giuliani
j
barrio
c
valdez
p
pandem
influenza
argentina
studi
patient
mechan
ventil
j
respir
crit
care
med
rello
j
rodr
iban
ez
p
socia
l
cebrian
j
marqu
guerrero
j
ruizsantana
marquez
e
del
nogal
saezf
alvarezlermaf
mart
ferrer
avellana
granada
r
marav
albertp
sierrar
vidaur
l
ortiz
p
prieto
del
portillo
galva
n
b
leo
ngil
c
semicyuc
work
group
intens
care
adult
patient
sever
respiratori
failur
caus
influenza
v
spain
crit
care
introduct
last
year
enorm
research
effort
knowledg
physiopatholog
acut
respiratori
distress
syndrom
ard
togeth
advanc
critic
care
led
reduct
mortal
declin
fatal
rate
interest
research
shift
mortal
statist
outcom
paramet
healthrel
qualiti
life
hrql
ard
object
aim
studi
investig
hrql
longterm
survivor
longer
year
ard
ventil
lowtid
volum
protocol
method
total
patient
surviv
adr
episod
identifi
june
may
patient
exclud
pulmonari
cardiovascular
previou
diseas
patient
refus
particip
final
previous
healthi
patient
particip
studi
medic
record
search
demograph
data
smoke
statu
ventil
data
length
icu
hospit
stay
measur
sever
ill
apacheii
li
sofa
hrql
evalu
use
st
georg
respiratori
questionnair
sgrq
sgrq
selfadminist
questionnair
measur
perceiv
qualiti
life
impair
health
due
respiratori
diseas
contain
item
three
domain
symptom
activ
impact
daili
life
summari
total
score
score
rang
good
health
poor
health
questionnair
valid
spanish
popul
result
result
demograph
clinic
variabl
shown
tabl
regard
evalu
hrql
sgrq
mean
score
slightli
higher
domain
regard
refer
valu
spanish
popul
age
sex
indic
subject
respiratori
problem
impact
daili
life
patient
score
normal
domain
total
score
patient
higher
score
domain
patient
higher
score
domain
tabl
conclus
ard
neg
impact
qualiti
life
survivor
detect
even
beyond
two
year
acut
episod
domain
activ
symptom
affect
patient
surviv
adr
refer
herridg
ms
longterm
outcom
critic
ill
curr
opin
crit
care
aug
hopkin
ro
et
al
twoyear
cognit
emot
qualityoflif
outcom
acut
respiratori
distress
syndrom
j
respir
crit
care
med
feb
ferrer
et
al
interpret
qualiti
life
score
st
respiratori
questionnair
eur
respir
j
mar
ferrer
et
al
valid
reliabl
st
respiratori
questionnair
adapt
differ
languag
cultur
spanish
exampl
eur
respir
j
jun
introduct
appropri
level
posit
end
expiratori
pressur
peep
improv
oxygen
avoid
ventil
induc
lung
injuri
mani
method
set
peep
propos
longstand
difficult
perform
clinic
practic
base
oxygen
tabl
ignor
individu
mechan
characterist
propos
method
titrat
peep
bedsid
consid
region
respiratori
mechan
differ
fast
practic
way
object
compar
agreement
peep
titrat
method
perform
fast
minut
slow
minut
method
eleven
mechan
ventil
patient
elect
cardiac
surgeri
moder
ard
accord
berlin
criteria
use
pf
mmhg
receiv
descend
peep
titrat
step
perform
two
randomli
way
one
perform
step
second
total
time
less
minut
step
minut
total
time
minut
peep
trial
preced
standard
maxim
alveolar
recruit
manouv
peep
trial
perform
peep
titrat
tool
avail
electr
imped
tomographi
eit
devic
enlight
timpel
tool
provid
report
function
map
ventil
demonstr
amount
collaps
hyperdistens
tissu
step
peep
minor
peep
less
collaps
chosen
optim
peep
part
translat
research
experiment
set
pig
establish
lung
injuri
receiv
descend
peep
titrat
use
eit
monitor
dynam
comput
tomographi
ct
ct
perform
evalu
correl
collaps
tissu
amount
step
peep
ct
eit
result
differ
optim
peep
titrat
fast
slow
titrat
method
versu
p
mean
differ
two
method
limit
agreement
analys
amount
collaps
entir
titrat
signific
differ
fast
slow
titrat
p
howev
differ
peep
step
p
interact
fast
slow
titrat
group
peep
step
p
good
correl
collaps
tissu
provid
eit
ct
conclus
agreement
fast
slow
titrat
method
peep
titrat
perform
easili
less
minut
eit
monitor
bedsid
refer
costa
el
et
al
bedsid
estim
recruit
alveolar
collaps
hyperdistens
electr
imped
tomographi
intens
care
med
p
grant
acknowledg
financi
support
grant
de
amparo
pesquisa
estado
de
paulo
fapesp
introduct
ventil
induc
lung
injuri
vili
associ
increas
mortal
ard
mechan
stress
strain
lung
vili
trigger
inflammatori
respons
may
spatial
character
imag
techniqu
positron
emiss
tomographi
combin
comput
tomographi
petct
pet
radiotrac
short
halflif
potenti
repeatedli
quantifi
macrophag
inflamm
object
evalu
lung
uptak
associ
mechan
strain
assess
ct
well
relat
macrophag
lung
recruit
histolog
injuri
method
vili
perform
anesthet
pig
increas
tidal
volum
vt
obtain
transpulmonari
pressur
tpp
zero
endexpiratori
pressur
ct
pet
acquisit
perform
hour
high
volum
ventil
measur
perform
global
whole
lung
region
partit
lung
region
defin
cephalocaud
anteroposterior
plane
uptak
quantifi
use
standard
uptak
valu
suv
correct
fraction
tissu
lung
region
assess
ct
region
strain
dynam
static
estim
ct
analysi
euthanasia
semiquantit
lung
injuri
score
macrophag
recruit
quantifi
lung
sampl
result
vt
tpp
increas
mlkg
respect
global
suv
global
dynam
strain
increas
significantli
respect
wherea
static
strain
chang
significantli
region
suv
significantli
increas
without
signific
interregion
differ
region
dynam
strain
increas
vili
signific
interregion
differ
anterocaud
posterocaud
region
region
static
strain
differ
neither
region
multivari
analysi
region
dynam
strain
independ
associ
region
suv
p
histolog
analysi
show
greater
alveolar
damag
caudal
region
p
suv
posit
correl
macrophag
recruit
p
conclus
macrophagespecif
pet
radiotrac
whose
lung
uptak
independ
associ
dynam
strain
macrophag
lung
recruit
highvolum
vili
model
refer
ard
network
ventil
lower
tidal
volum
compar
tradit
tidal
volum
acut
lung
injuri
acut
respiratori
distress
syndrom
n
engl
j
med
grant
acknowledg
research
found
french
societi
intens
care
medicin
la
fondat
pour
la
recherch
introduct
experiment
evid
suggest
ventil
induc
lung
injuri
vili
depend
energi
load
appli
respiratori
system
healthi
lung
encompass
tidal
volum
respiratori
rate
flow
object
investig
put
mechan
vili
lung
strain
lung
inhomogen
collaps
decollaps
associ
increas
energi
load
per
breath
method
patient
underw
ct
scan
peep
endexpir
second
ct
scan
endinspir
airway
esophag
pressur
record
tidal
ventil
energi
load
per
breath
joul
defin
area
inspiratori
limb
deltatranspulmonari
pressur
xaxi
volum
curv
volum
axi
tidal
strain
defin
tidal
volum
ml
ga
volum
peep
ml
lung
inhomogen
comput
previoulsi
describ
intratid
collaps
decollaps
defin
differ
inflat
tissu
endinspir
endexpir
express
fraction
total
lung
weight
result
twentyseven
ard
patient
studi
peep
age
year
median
iq
rang
bmi
mmhg
tidal
volum
mlkg
ibw
energi
deliv
per
breath
j
significantli
relat
lung
strain
fig
upper
panel
inhomogen
fig
lower
panel
relationship
deliv
energi
intratid
collapsedecollaps
reach
statistist
signific
p
conclus
greater
lung
strain
lung
inhomogen
increas
energi
deliv
respiratori
system
tidal
volum
refer
cressoni
anesthesiolog
chiumello
j
respir
crit
care
med
cressoni
j
respir
crit
care
med
caironi
j
respir
crit
care
med
grant
acknowledg
esicm
clinic
scienc
award
mc
introduct
invas
mechan
ventil
imv
frequent
appli
critic
ill
elderli
patient
age
comprehens
geriatr
assess
cga
paramet
recent
frailti
report
gener
prognost
factor
patient
howev
nt
enough
studi
prognost
factor
specif
patient
imv
object
investig
clinic
characterist
elderli
patient
receiv
imv
show
impact
age
cga
paramet
particularli
frailti
wean
success
outcom
patient
method
patient
year
old
admit
medic
pulmonari
intens
care
unit
icu
gazi
univers
hospit
prospect
includ
patient
without
consent
stay
hour
icu
exclud
fri
clinic
edmonton
frailti
score
fs
calcul
cga
paramet
assess
geriatrician
length
result
wean
record
wean
classifi
simpl
difficult
prolong
wean
result
imv
appli
patient
age
impact
need
imv
p
frailti
defin
edmonton
fs
independ
factor
imv
increas
need
approxim
time
p
presenc
degre
frailti
accord
fss
cga
paramet
impact
wean
mortal
patient
imv
p
whole
studi
group
patient
without
frailiti
accord
edmonton
fs
compar
diseas
sever
score
apach
sofa
score
durat
wean
similar
group
p
comorbid
icu
develop
infect
septic
shock
frequenc
renal
replac
therapi
mortal
higher
frail
patient
p
p
p
p
respect
conclus
presenc
frailti
critic
ill
elderli
patient
increas
need
imv
initi
imv
frailti
impact
wean
mortal
patient
hand
need
imv
comorbid
icu
therefor
overal
mortal
found
incresead
frailiti
refer
avelinosilva
tj
farfel
jm
curiati
ja
amar
jr
campora
f
jacobfilho
f
comprehens
geriatr
assess
predict
mortal
advers
outcom
hospit
older
adult
bmc
geriatr
bagshaw
sm
stelfox
ht
mcdermid
rc
rolfson
db
tsuyuki
rt
baig
n
artiuchb
ibrahim
q
stolleri
de
rokosh
e
majumdar
sr
associ
frailti
short
long
term
outcom
among
critic
ill
patient
multicentr
prospect
cohort
studi
cmaj
grant
acknowledg
nt
receiv
grant
nt
acknowledg
introduct
refractori
hypoxemia
lead
caus
earli
mortal
follow
lung
transplant
lt
rescu
therapi
extracorpor
membran
oxygen
shown
use
support
lt
recipi
refractori
hypoxemia
prone
posit
pp
low
cost
measur
shown
improv
ga
interchang
patient
sever
acut
respiratori
distress
syndrom
major
thorac
surgeri
consid
contraind
implement
thu
date
publish
evid
benefici
effect
pp
bridg
recoveri
patient
refractori
hypoxemia
lt
object
primari
object
assess
ga
interchang
improv
pp
secondari
object
compar
outcom
patient
gener
popul
lt
recipi
method
prospect
collect
data
consecut
adult
patient
undergo
lt
januari
decemb
evalu
indic
associ
complic
time
initi
durat
maneuv
analyz
effect
pp
ga
interchang
evalu
final
outcom
cohort
compar
rest
lt
recipi
continu
data
report
median
interquartil
rang
iqr
categor
data
number
percentag
differ
categor
variabl
assess
chisquar
test
continu
variabl
mannwhitney
test
student
test
use
evalu
effect
pp
ga
interchang
result
twentytwo
patient
receiv
pp
maneuv
frequent
implement
within
first
hour
main
indic
primari
graft
dysfunct
maneuv
maintain
median
hour
pp
ratio
significantli
increas
mmhg
iqr
iqr
p
complic
relat
techniqu
report
patient
underw
maneuv
longer
hospit
stay
day
iqr
vs
iqr
p
rest
popul
differ
found
compar
either
oneyear
mortal
vs
p
oneyear
graft
function
iqr
vs
iqr
p
conclus
pp
found
safe
success
therapi
refractori
hypoxemia
lt
consid
option
treat
patient
refer
fuehner
greer
welt
gottlieb
j
lung
transplant
patient
icu
curr
opin
crit
care
bermudez
ca
adusumilli
ps
mccurri
kr
et
al
extracorpor
membran
oxygen
primari
graft
dysfunct
lung
transplant
longterm
surviv
ann
thorac
surg
c
reignier
j
richard
jc
et
al
proseva
studi
group
prone
posit
sever
acut
respiratori
distress
syndrom
n
engl
j
med
background
iron
essenti
element
proper
immun
function
growth
human
pathogen
alter
iron
statu
may
affect
immun
system
risk
infect
populationbas
studi
investig
associ
marker
iron
statu
risk
bloodstream
infect
bsi
object
assess
associ
serum
iron
concentr
si
total
iron
bind
capac
tibc
transferrin
satur
percent
ts
risk
bsi
fatal
bsi
death
within
day
detect
bsi
method
studi
particip
baselin
measur
si
tibc
ts
second
survey
populationbas
hunt
studi
counti
norway
si
tibc
ts
categor
low
high
percentil
quintil
valu
percentil
incid
bsi
identifi
though
linkag
prospect
record
inform
local
region
hospit
measur
iron
statu
assess
risk
firsttim
bsi
fatal
bsi
use
cox
proport
hazard
regress
middl
quintil
refer
primari
analys
adjust
age
sex
addit
adjust
selfreport
comorbid
condit
lung
diseas
cardiovascular
diseas
cancer
kidney
failur
diabet
bodi
mass
index
baselin
result
median
followup
year
person
least
one
episod
bsi
experienc
fatal
bsi
age
sexadjust
analys
bsi
risk
increas
among
particip
indic
iron
defici
either
low
si
hr
ci
low
ts
hr
ci
high
tibc
hr
ci
adjust
comorbid
associ
remain
similar
low
si
hr
ci
low
ts
hr
ci
attenu
high
tibc
hr
ci
correspond
hr
fatal
bsi
ci
low
si
ci
low
ts
ci
high
tibc
found
increas
bsi
risk
relat
indic
high
iron
statu
conclus
larg
populationbas
cohort
studi
indic
low
iron
statu
associ
increas
risk
bsi
iron
crucial
element
immun
respons
find
suggest
alter
fine
tune
system
could
influenc
risk
bsi
grant
acknowledg
studi
support
grant
liasion
committe
central
norway
region
health
author
norwegian
univers
scienc
technolog
introduct
bloodstream
infect
bsi
caus
consider
morbid
mortal
emerg
antibiot
resist
serious
threaten
global
public
health
primari
prevent
bacteri
infect
prioriti
lifestyl
factor
particular
interest
sinc
modifi
optim
could
reduc
populationlevel
burden
bsi
object
assess
associ
smoke
obes
alcohol
intak
physic
inact
risk
incid
fatal
bsi
method
prospect
populationbas
cohort
studi
particip
survey
norway
follow
linkag
prospect
record
inform
bsi
local
region
hospit
use
cox
regress
estim
age
sex
adjust
hazard
ratio
hr
firsttim
bsi
fatal
bsi
death
within
day
bsi
baselin
bodi
mass
index
bmi
measur
selfreport
smoke
habit
leisur
time
physic
activ
alcohol
intak
addit
analysi
also
adjust
educ
lifestyl
factor
result
year
followup
particip
experienc
least
one
episod
bsi
experienc
fatal
bsi
obes
dosedepend
associ
increas
risk
bsi
fatal
bsi
compar
normal
weight
particip
bmi
age
sexadjust
risk
firsttim
bsi
confid
interv
ci
higher
bmi
ci
higher
bmi
ci
higher
bmi
correspondingli
risk
fatal
bsi
ci
higher
bmi
ci
higher
bmi
ci
higher
bmi
compar
normal
weight
particip
current
smoker
ci
higher
risk
bsi
ci
higher
risk
fatal
bsi
compar
neversmok
inact
particip
ci
higher
risk
bsi
ci
higher
risk
fatal
bsi
compar
physic
activ
particip
find
essenti
unchang
adjust
educ
lifestyl
factor
conclus
studi
underscor
maintain
healthi
lifestyl
normal
weight
nonsmok
physic
activ
may
contribut
prevent
invas
bacteri
infect
grant
acknowledg
work
support
grant
liaison
committe
central
norway
region
health
author
rha
norwegian
univers
scienc
technolog
ntnu
object
recent
observ
studi
show
obes
criticallyil
patient
unexpectedli
reduc
risk
death
low
mortal
rate
cours
septic
shock
well
situat
describ
obes
paradox
leptin
hormon
made
white
adipos
cell
regul
energi
balanc
inhibit
hunger
rise
proport
bodi
weight
also
shown
role
immun
modul
therefor
leptin
could
play
pivot
role
case
obes
paradox
aim
studi
investig
relationship
mortal
bodi
mass
index
bmi
patient
septic
shock
addit
test
associ
leptin
level
bmi
mortal
method
septemb
januari
patient
septic
shock
includ
studi
control
group
healthi
peopl
bmi
similar
patient
bmi
valu
includ
patient
uncontrol
diabet
mellitu
malign
receiv
corticosteroid
chronic
prior
icu
admiss
exclud
patient
categor
five
group
accord
bmi
group
n
group
n
group
n
group
n
grup
n
measur
leptin
level
patient
diagnos
septic
shock
result
median
minmax
age
patient
patient
male
median
apach
ii
score
median
leptin
level
ngml
control
patient
median
age
bmi
leptin
level
respect
septic
shock
patient
die
within
day
apach
ii
score
similar
survivor
nonsurvivor
group
p
surviv
patient
lower
statist
insignific
bmi
valu
compar
nonsurvivor
p
day
mortal
rate
group
stratifi
accord
bmi
similar
p
leptin
level
similar
surviv
nonsurviv
patient
p
howev
differ
among
bmi
group
term
leptin
level
median
leptin
group
group
group
group
group
p
group
bmi
highest
leptin
level
compar
group
p
control
patient
higher
leptin
level
patient
septic
shock
p
statist
signific
correl
bmi
leptin
level
patient
n
r
p
conclus
studi
show
increas
bmi
relat
increas
surviv
leptin
level
lower
patient
septic
shock
compar
control
patient
although
leptin
level
correl
bmi
differ
leptin
level
surviv
nonsurviv
patient
introduct
icuacquir
weak
relat
loss
muscl
mass
function
especi
longstay
factor
assess
bedsid
use
independ
techniqu
correl
mass
function
unknown
object
evalu
correl
muscl
mass
forc
longstay
icu
patient
method
muscl
mass
forc
assess
admiss
end
icu
stay
patient
expect
length
stay
lo
least
day
mass
measur
anthropometr
variabl
skinfold
calf
arm
use
lee
formula
bioelectr
imped
phase
angl
pha
hz
forc
measur
use
medic
research
council
mrc
score
dynamometri
handgrip
test
effect
time
icu
stay
assess
use
student
test
correl
mass
forc
variabl
apach
ii
score
durat
icu
stay
mechan
ventil
investig
result
eighteen
patient
age
year
male
apach
ii
includ
icu
stay
day
muscl
mass
assess
skin
fold
pha
hz
decreas
kg
kg
p
ns
respect
likewis
forc
evalu
mrc
score
decreas
ns
correl
percentag
chang
mass
forc
r
p
percentag
chang
mass
length
icu
stay
r
p
durat
mechan
ventil
icu
stay
r
p
apach
ii
score
neg
correl
forc
measur
use
handgrip
test
r
p
mrc
score
r
p
muscl
mass
evalu
pha
r
p
conclus
muscl
mass
function
decreas
long
icu
stay
chang
correl
use
bedsid
method
guid
therapeut
manag
need
assess
refer
lee
r
wang
z
heo
ross
r
janssen
heymsfield
sb
totalbodi
skelet
muscl
mass
develop
crossvalid
anthropometr
predict
model
clin
nutr
de
jongh
b
bastujigarin
sharshar
tarek
outin
h
brochard
l
icuacquir
paresi
lengthen
wean
mechan
ventil
intens
care
medicin
introduct
mortal
sever
acut
respiratori
distress
syndrom
ard
caus
pulmonari
infect
renal
transplant
high
prone
posit
ventil
effect
improv
prognosi
patient
ard
post
pyloru
feed
significantli
improv
nutrit
intak
reduc
risk
aspir
object
evalu
valu
prone
posit
combin
post
pyloru
feed
sever
ard
caus
sever
pneumonia
renal
transplant
method
prospect
observ
studi
surgic
intens
care
unit
bed
univers
hospit
patient
met
berlin
criteria
sever
ard
renal
transplant
need
invas
mechan
ventil
consect
hour
prone
posit
ventil
postpyloru
feed
tube
placement
appli
includ
patient
result
total
patient
includ
averag
year
men
mortal
ratio
partial
pressur
arteri
oxygen
fraction
inspir
oxygen
h
h
prone
positon
improv
significantli
p
time
reach
target
feed
hour
postpylor
feed
rate
aspir
nutrit
statu
patien
gradual
improv
conclus
prone
posit
combin
post
pyloru
feed
improv
prognosi
sever
ard
cuas
pulmonari
infect
renal
transplant
refer
sun
q
liu
zh
chen
j
et
al
aggress
systemat
strategi
acut
respiratori
distress
syndrom
caus
sever
pneumonia
renal
transplant
transpl
int
tu
g
ju
zheng
et
al
earli
lateonset
sever
pneumonia
renal
transplant
int
j
clin
exp
c
reignier
j
richard
jc
et
alpron
posit
sever
acut
respiratori
distress
syndrom
n
engl
j
med
introduct
nutrit
support
essenti
part
intens
care
unit
manag
howev
appropri
calor
intak
critic
ill
patient
still
remain
unclear
permiss
underfeed
base
fact
provis
estim
nutrient
requir
may
metabol
function
detriment
patient
popul
also
shown
meet
patient
estim
need
may
result
inflamm
cytokin
releas
oxid
product
short
term
restrict
nutrient
intak
may
limit
patholog
process
occur
critic
ill
reduc
organ
dysfunct
object
evalu
effect
permiss
underfeed
compar
standard
protocol
enter
feed
mortal
among
septic
mechan
ventil
critic
ill
patient
method
singl
centr
studi
patient
admit
bed
univers
hospit
icu
period
one
year
demograph
sever
ill
score
apach
sofa
bmi
malnutrit
univers
screen
tool
must
measur
upon
admiss
daili
nutrit
requir
calcul
patient
patient
randomli
assign
permiss
underfeed
group
calor
goal
calcul
requir
standard
protocol
feed
group
calor
goal
calcul
requir
patient
monitor
day
protein
intak
gkgday
maintain
group
primari
outcom
mortal
result
express
mean
sd
p
consid
signific
result
total
patient
men
mechan
ventil
septic
patient
mean
age
year
studi
patient
met
consensu
criteria
sepsi
baselin
characterist
similar
two
group
apach
ii
sofa
studi
entri
mean
height
patient
cm
mean
bmi
obes
patient
exclud
studi
studi
period
permissiveunderfeed
group
receiv
fewer
calori
standardprotocol
feed
group
kcal
per
day
vs
kcal
per
day
achiev
calor
requir
vs
respect
p
protein
intak
similar
group
g
per
day
g
per
day
respect
mortal
lower
permissiveunderfeed
group
standardfeed
group
signific
differ
among
group
respect
feed
intoler
diarrhoea
seriou
advers
event
conclus
critic
ill
patient
permiss
underfeed
may
associ
lower
mortal
rate
standardprotocol
feed
evid
permiss
underfeed
strategi
consid
icu
septic
patient
employ
approach
may
offer
clinic
benefit
introduct
serum
total
cholesterol
tc
level
known
associ
surviv
critic
ill
especi
sepsi
surgic
patient
howev
studi
evalu
tc
prognost
factor
medic
patient
object
aim
studi
determin
relationship
tc
level
surviv
medic
patient
admit
intens
care
unit
icu
method
septemb
februari
data
acquir
nine
intens
care
unit
four
provinci
academ
medic
center
retrospect
statist
analysi
conduct
confirm
risk
factor
use
correl
analysi
logist
regress
result
studi
total
patient
enrol
hospit
mortal
base
day
admiss
tc
level
deriv
specif
point
time
show
neg
correl
apach
iv
score
initi
tc
r
p
second
week
tc
r
p
third
week
tc
r
p
tc
level
second
week
creactiv
protein
level
statu
ard
independ
risk
factor
mortal
multivari
analysi
hazard
ratio
hr
p
hr
p
hr
p
respect
conclus
lower
tc
level
prognost
indic
hospit
mortal
medic
patient
admit
icu
follow
tc
level
regularli
advantag
manag
critic
ill
patient
refer
chenaud
c
merlani
pg
rouxlombard
p
et
al
low
apolipoprotein
ai
level
intens
care
unit
admiss
system
inflammatori
respons
syndrom
exacerb
crit
care
med
giovannini
boldrini
g
chiarla
c
et
al
pathophysiolog
correl
hypocholesterolemia
critic
ill
surgic
patient
intens
care
medicin
gui
spada
pl
de
gaetano
pacelli
f
hypocholesterolemia
risk
death
critic
ill
surgic
patient
intens
care
medicin
gordon
br
parker
ts
levin
dm
et
al
relationship
hypolipidemia
cytokin
concentr
outcom
critic
ill
surgic
patient
critic
care
medicin
chien
jy
jerng
js
yu
cj
yang
pc
low
serum
level
highdens
lipoprotein
cholesterol
poor
prognost
factor
sever
sepsi
critic
care
medicin
doi
introduct
acut
pancreat
accompani
organ
dysfunct
term
sever
acut
pancreat
sap
local
complic
infect
pancreat
pseudocyst
develop
may
describ
complex
sap
patient
often
requir
care
specialist
hepatopancreaticobiliari
hpb
surgeon
intervent
radiologist
may
transfer
specialist
hpb
centr
icuacquir
weak
affect
patient
icu
greatest
multipl
organ
system
requir
support
associ
prolong
need
mechan
ventil
icu
stay
increas
risk
death
follow
hospit
discharg
longterm
complic
includ
impair
physic
function
one
method
quantifi
muscl
wast
measur
cross
section
area
csa
paraspin
muscl
level
third
lumbar
vertebra
ct
imag
icu
rsch
receiv
patient
transfer
icu
specialist
care
relat
complex
sap
clinic
reason
patient
often
repeat
ct
imag
abdomen
object
characteris
patient
requir
critic
care
transfer
specialist
care
complex
pancreat
measur
paraspin
muscl
csa
ct
scan
ascertain
rate
muscl
wast
method
patient
identifi
icu
patient
databas
wardwatch
addit
clinic
detail
acquir
electron
databas
ct
imag
export
dicom
file
pac
system
crosssect
area
paraspin
muscl
measur
use
imagej
softwar
duplic
two
independ
user
averag
valu
use
analysi
use
excel
ms
graphpad
prism
result
patient
met
inclus
criteria
patient
ct
scan
icu
enabl
serial
estim
paraspin
muscl
csa
averag
age
year
median
apach
ii
score
patient
underw
median
interventionalsurg
procedur
mean
icu
lo
day
icu
mortal
patient
decreas
icu
stay
see
tabl
median
chang
day
higher
pancreat
sever
score
glasgow
score
admiss
icu
associ
greater
loss
muscl
p
increas
system
inflamm
time
crp
mgl
associ
increas
rate
loss
muscl
r
p
demonstr
relat
durat
ventil
icu
mortal
conclus
cohort
icu
patient
complex
sap
show
profound
muscl
wast
greatest
persist
sever
inflamm
identif
prevent
strategi
research
prioriti
refer
nejm
jama
appl
physiol
nutr
metab
introduct
oxid
stress
known
advers
affect
varieti
cellular
function
promot
inflamm
take
part
develop
multiorgan
dysfunct
oxid
statu
evalu
thioldisulphid
homeostasi
previou
studi
indic
certain
lipid
formul
may
contribut
decreas
oxid
stress
potenti
activ
one
suggest
mechan
object
aim
evalu
basal
activ
salt
stimul
paraoxonas
arylesteras
plasma
nativ
thiol
total
thiol
disulphid
level
critic
ill
patient
parenter
nutrit
pn
contain
differ
lipid
formul
method
critic
ill
patient
pn
plan
contraind
pn
includ
studi
patient
alreadi
pn
give
consent
exclud
three
differ
pn
solut
use
soya
oil
contain
solut
long
chain
fatti
acid
lct
oliv
oil
contain
solut
solut
contain
middl
long
chain
fatti
acid
mctlct
nutrit
support
plan
provid
kcalkgday
age
sex
admiss
diagnosi
smoke
statu
apacheii
sofa
score
invas
procedur
perform
level
administ
drug
transfus
record
day
hour
lipid
profil
hdl
ldl
total
cholesterol
triglycerid
liver
enzym
level
ast
alt
ggt
alp
totaldirect
bilirubin
crp
prealbumin
valu
record
well
nosocomi
infect
develop
admiss
icu
hospit
length
stay
outcom
record
serum
sampl
collect
start
pn
hour
pn
total
thiol
level
store
biochem
studi
conduct
collect
sampl
measur
spectrophotometr
plasma
nativ
thiol
total
thiol
disulphid
level
measur
previous
defin
result
total
patient
group
includ
studi
age
sex
day
admiss
hospit
apacheii
score
smoke
statu
similar
across
group
lipid
profil
liver
enzym
level
crp
level
also
similar
although
initi
prenutrit
plasma
nativ
thiol
total
thiol
disulfit
level
differ
across
group
followup
differ
observ
group
basi
plasma
thiol
total
thiol
disulphid
level
conclus
base
result
studi
differ
pn
solut
differ
lipid
composit
seem
alter
oxid
statu
evalu
thioldisulphid
homeostasi
although
oliv
oil
expect
promot
activ
could
demonstr
studi
prospect
random
dose
depend
studi
may
plan
evalu
refer
loubonafont
jm
et
al
nutrient
introduct
autophagi
surviv
process
involv
remov
protein
aggreg
organel
process
proteasom
recent
impair
system
hypothes
develop
organ
failur
icu
patient
object
autophagi
highli
dynam
process
studi
human
vivo
aim
studi
develop
experiment
model
studi
autophagi
flux
icu
patient
investig
step
autophag
pathway
impair
develop
vitro
screen
method
measur
autophag
flux
human
primari
myotub
incub
serum
icu
patient
method
human
primari
myotub
incub
serum
consecut
icu
patient
taken
first
h
admiss
n
healthi
volunt
n
similar
age
rang
year
old
myotub
cultur
plate
day
differenti
incub
human
serum
hour
presenc
absenc
chloroquin
hr
inhibitor
autophagi
express
marker
autophag
vacuol
accumul
measur
incel
western
odyssey
scanner
autophag
flux
calcul
follow
autophag
flux
express
cq
express
cq
result
normal
cell
number
express
autophag
flux
control
condit
screen
serum
sampl
repeat
independ
experi
result
analyz
anova
fisher
posthoc
test
introduct
nasal
orogastr
nutrit
tube
placement
verifi
radiolog
daili
placement
verif
typic
air
insuffl
tube
auscult
shown
unreli
tube
may
move
patient
movement
patient
pull
cough
necessit
ongo
placement
verif
verif
method
test
gastric
aspir
ph
pepsin
tube
output
visual
gastric
aspir
record
tube
insert
length
intens
care
unit
icu
mount
sinai
hospit
initi
qualiti
improv
qi
project
chang
auscult
gastric
ph
record
tube
insert
length
visual
gastric
aspir
object
adopt
evidenc
base
practic
chang
complet
plan
see
act
pdsa
cycl
make
chang
base
result
method
gastric
aspir
sampl
sent
laboratori
test
ph
meter
nurs
educ
done
introduc
test
procedur
ph
consid
confirm
gastric
placement
data
collect
includ
aspir
ph
use
acid
inhibit
drug
calori
en
order
deliv
time
en
held
ph
test
tube
insert
mark
length
aspir
appear
ongo
educ
chang
nurs
nutrit
practic
made
result
evalu
part
pdsa
cycl
statist
analysi
includ
mean
ph
stratifi
acid
inhibitor
mean
calori
deficit
hold
en
test
percentil
laboratori
turnaround
time
result
nineti
ph
test
done
test
miss
patient
overal
mean
ph
median
ph
stratif
drug
therapi
result
found
tabl
cumul
percentil
chart
ph
acid
inhibitor
method
report
fig
patient
receiv
en
mean
calori
deficit
observ
calori
reason
gastric
ph
test
alon
en
held
h
test
lab
report
result
usual
minut
length
feed
tube
insert
point
record
patient
conclus
nurs
accept
process
evidenc
miss
test
test
nt
done
due
confus
tube
type
requir
test
inabl
aspir
fluid
tube
forget
creat
opportun
staff
educ
improv
process
data
suggest
gastric
aspir
ph
alon
reliabl
marker
gastric
feed
tube
placement
patient
receiv
acid
inhibit
drug
opportun
develop
confirm
bundl
includ
descript
aspir
record
length
tube
insert
use
acid
suppress
therapi
possibl
underfeed
opportun
implement
volum
base
en
protocol
allow
nurs
adjust
hourli
volum
en
compens
time
en
held
icu
qi
project
implement
best
practic
follow
pdsa
cycl
introduct
follow
insert
nasooro
gastric
enter
tube
period
afterward
unit
kingdom
essenti
ensur
distal
portion
tube
lower
protion
gi
tract
stomach
achiev
princip
measur
ph
gastric
aspir
line
test
xray
line
test
npsa
small
pilot
studi
illumin
accuraci
potenti
error
use
ph
indic
strip
confirm
gastric
placment
object
establish
accuraci
nurs
doctor
interpret
rang
known
ph
solut
use
ce
mark
ph
indic
strip
visual
interpret
ph
result
method
nurs
medic
staff
ask
identifi
ph
clearcolourless
solut
ph
valu
rang
blind
ph
valu
soultion
complet
test
ph
indic
strip
use
possibl
rang
result
staff
agre
particip
small
studi
assur
anonym
staff
observ
perform
test
correctli
theywait
second
prior
read
strip
wipe
strip
immers
test
solut
acheiv
accur
test
procedur
major
staff
approxim
correctli
interpret
ph
solut
demonstr
slightli
less
accuraci
ph
accur
er
lower
valu
ph
indic
strip
challeng
ph
solut
know
ten
staff
could
identifi
ph
valu
sinc
colour
chang
rang
ph
indic
strip
rema
staff
incorrectli
interpret
solut
ph
conclus
although
small
studi
clearli
danger
reli
visual
interpret
colour
chang
ce
mark
ph
indic
strip
confirm
correct
placement
nasoorogastr
feed
tube
futurefurth
studi
intend
compar
altern
method
ph
quantif
incud
electron
ph
test
devic
refer
nation
patient
safeti
agenc
reduc
harm
caus
misplac
nasogastr
feed
tube
adult
children
infant
npsa
london
introduct
measur
cardiac
output
co
frequentlydon
surgic
critic
ill
patient
part
optimizationstrategi
transthorac
echocardiographi
tte
method
co
measur
popular
critic
ill
patient
object
whether
tte
method
co
measur
accur
transpulmonari
thermodilut
tptd
method
compar
nearsimultan
perform
co
measur
sever
sepsi
patient
use
tptd
picco
puls
index
continu
cardiac
output
system
tte
outcom
compar
use
ttest
linear
regress
result
forti
sever
sepsi
patient
studi
analysi
data
pair
reveal
picco
yield
similar
co
measur
tte
p
picco
deriv
co
measur
highli
relat
tte
deriv
co
measur
r
p
conclus
tte
use
object
cardiovascular
monitor
guid
goaldirect
fluid
resuscit
sever
sepsi
patient
instead
picco
noninvas
conveni
refer
morgaz
j
granado
mdel
p
et
al
comparison
thermodilut
lithium
dilut
puls
contour
analysi
measur
cardiac
output
differ
hemodynam
state
dogsj
vet
emerg
crit
care
san
antonio
itami
endo
hanazono
k
ishizuka
et
alcomparison
cardiac
output
measur
use
transpulmonari
thermodilut
convent
thermodilut
techniqu
anaesthet
dog
fluid
overload
vet
anaesth
analg
doi
introduct
norepinephrin
ne
common
vasoconstrictor
drug
use
treatment
septic
shock
high
dose
ne
associ
bad
prognosi
limit
refractori
septic
shock
well
establish
object
analyz
prognost
valu
maximum
dose
norepinephrin
mortal
patient
admit
icu
septic
shock
method
twoyear
retrospect
studi
singl
icu
patient
admit
septic
shock
treat
ne
ne
maximum
dose
analyz
time
reach
dose
day
treatment
origin
focu
sepsi
use
amin
apach
ii
sofa
score
icu
hospit
mortal
prognost
valu
maximum
dose
ne
analyz
use
multivari
logist
regress
roc
curv
analysi
carri
assess
discrimin
abil
result
analyz
consecut
patient
averag
age
year
sd
mean
apach
ii
sd
mean
sofa
score
sd
averag
valu
maximum
dose
ne
sd
median
time
achiev
day
rang
icu
mortal
hospit
mortal
multivari
analysi
maximum
dose
ne
independ
associ
icu
mortal
ci
p
hospit
mortal
ci
p
roc
curv
maximum
dose
ne
show
high
discrimin
abil
icu
mortal
r
ci
p
hospit
mortal
r
ci
p
cutoff
point
maximum
sensit
specif
inhospit
mortal
patient
dose
maximum
ne
versu
patient
lower
dose
patient
septic
shock
dose
greater
case
introduct
trial
show
increas
mortal
hydroxyethyl
starch
he
vs
ringer
acet
patient
sever
sepsi
pathophysiolog
drive
fulli
elucid
object
compar
chang
cytokin
plasma
concentr
day
randomis
trial
method
subgroup
patient
trial
analys
differ
he
ringer
group
delta
plasma
concentr
baselin
day
randomis
use
multipl
linear
regress
analysi
addit
associ
chang
cytokin
mortal
investig
use
multipl
logist
regress
analysi
imput
valu
miss
due
discharg
error
use
multipl
imput
result
baselin
characterist
similar
he
ringer
group
day
patient
he
group
die
vs
ringer
group
p
plasma
concentr
decreas
baselin
day
he
ringer
group
mean
delta
cytokin
concentr
differ
group
tabl
also
associ
observ
chang
cytokin
plasma
concentr
mortal
odd
ratio
increas
confid
interv
p
p
p
conclus
resuscit
he
vs
ringer
acet
affect
plasma
concentr
chang
cytokin
associ
mortal
patient
sever
sepsi
consequ
result
suggest
increas
mortal
seen
he
trial
mediat
earli
chang
system
inflamm
refer
perner
haas
n
guttormsen
ab
et
al
hydroxyethyl
starch
versu
acet
sever
sepsi
n
engl
j
med
grant
acknowledg
trial
fund
rigshospitalet
danish
research
council
support
acta
foundat
b
braun
medic
introduct
fluid
overload
associ
poor
outcom
septic
patient
btype
natriuret
peptid
bnp
concentr
use
tool
guid
therapi
patient
heart
failur
howev
bnp
concentr
patient
septic
shock
resucit
poorli
studi
bnp
concentr
predict
day
peak
fluid
balanc
bnp
guid
therapi
enabl
us
restrict
fluid
volum
start
diuresi
appropri
object
investig
daili
bnp
concentr
fluid
balanc
septic
patient
hypothes
day
peak
bnp
concentr
predict
day
maximum
fluid
balanc
patient
age
sourc
infect
includ
analysi
confound
method
inclus
criteria
follow
septic
patient
sourc
infect
urinari
tract
infect
pneumonia
soft
tissu
infect
upper
lower
gi
tract
perfor
bacteremia
admit
icu
daili
bnp
concentr
measur
icu
stay
exclud
patient
alreadi
hemodialysi
first
describ
time
lag
day
peak
bnp
concentr
maximum
daili
fluid
balanc
conduct
multivari
regress
analysi
time
lag
patient
age
sourc
infect
maximum
daili
fluid
balanc
covari
result
includ
patient
age
averag
peak
bnp
concentr
follow
maximum
daili
fluid
balanc
day
sd
multivari
regress
analysi
delay
maximum
bnp
concentr
maximum
daili
fluid
balanc
associ
older
age
p
associ
net
daili
fluid
balanc
site
infect
conclus
studi
suggest
time
maximum
bnp
concentr
maximum
daili
fluid
balanc
might
parallel
septic
patient
howev
peak
bnp
concentr
tend
follow
maximum
daili
fluid
balanc
patient
get
older
thu
bnp
use
estim
refil
phase
grant
acknowledg
none
introduct
microcirculatori
alter
sepsi
play
vital
role
develop
multi
organ
system
failur
clear
observ
despit
correct
system
hemodynam
paramet
still
usual
cours
multi
organ
system
failur
continu
effect
fluid
resuscit
corner
stone
effect
manag
patient
septic
shock
goal
improv
tissu
perfus
micro
circulatori
level
object
aim
work
compar
evalu
influenc
gelatin
salin
sublingu
microcircul
patient
sever
sepsi
septic
shock
anoth
object
assess
effect
incid
renal
dysfunct
acid
base
disturb
method
prospect
random
control
studi
conduct
patient
sever
sepsi
septic
shock
patient
meet
inclus
criteria
randomli
assign
receiv
either
gelatin
pt
salin
pt
patient
receiv
ml
either
solut
everi
minut
till
reach
goal
initi
resuscit
use
sidestream
dark
field
devic
mean
flow
index
determin
hour
resuscit
arteri
blood
pressur
heart
rate
vasopressor
therapi
record
everi
min
first
h
arteri
blood
sampl
collect
three
specif
time
random
fluid
administr
hour
initi
resuscit
urea
creatinin
urin
output
sofa
score
measur
daili
first
day
resuscit
result
among
forti
two
patient
enrol
studi
demograph
data
characterist
compar
among
group
hour
resuscit
differ
aros
sublingu
microcircul
paramet
group
mean
flow
index
resuscit
gelatin
group
superior
salin
group
differ
notic
acut
kidney
injuri
acid
base
disturb
significantli
greater
net
cumul
fluid
balanc
salin
group
ml
compar
gelatin
group
ml
p
indic
fluid
need
first
hour
salin
group
conclus
main
find
prospect
random
studi
use
gelatin
resuscit
patient
septic
shock
confer
advantag
salin
recruit
sublingu
microcircul
refer
shapiro
ni
arnold
r
sherwin
r
et
al
associ
nearinfrar
spectroscopyderiv
tissu
oxygen
measur
sepsi
syndrom
organ
dysfunct
mortal
emerg
depart
patient
sepsi
crit
care
zanotticavazzoni
sl
guglielmi
parrillo
je
et
al
fluid
resuscit
influenc
cardiovascular
perform
mortal
murin
model
sepsi
intens
care
med
introduct
central
venou
oxygen
satur
indirect
indic
adequaci
oxygen
deliveri
cardiac
output
reduct
level
normal
level
indic
increas
oxygen
extract
tissu
respons
decreas
arteri
oxygen
content
cardiac
output
wide
util
hemodynam
optim
sever
sepsissept
shock
time
lag
usual
occur
admiss
septic
patient
emerg
depart
insert
central
venou
cathet
cvc
thu
need
surrog
easili
rapidli
obtain
date
peripher
venou
oxygen
satur
involv
antecubit
blood
sampl
valid
replac
purpos
hemodynam
optim
sever
sepsissept
shock
object
object
studi
assess
feasibl
replac
antecubit
manag
sever
sepsissept
shock
method
thirti
five
success
patient
sever
sepsissept
shock
cvc
insert
subject
studi
simultan
central
venou
antecubit
peripher
venou
sampl
withdrawn
test
oxygen
satur
compar
pair
simultan
sampl
result
mean
age
year
sexratio
mf
eleven
patient
sever
sepsi
patient
septic
shock
spearman
correl
coeffici
p
subgroup
analysi
patient
sever
sepsi
patient
septic
shock
show
spearman
rho
coeffici
p
p
respect
conclus
show
good
correl
patient
sever
sepsi
therefor
may
use
tool
earli
implic
hemodynam
optim
patient
sever
sepsi
refer
walley
kr
use
central
venou
oxygen
satur
guid
therapi
american
journal
respiratori
critic
care
medicin
delling
rp
levi
mm
rhode
annan
gerlach
h
opal
sm
et
al
surviv
sepsi
campaign
intern
guidelin
manag
sever
sepsi
septic
shock
crit
care
med
introduct
sever
decad
rdw
typic
use
combin
mcv
differenti
caus
underli
anaemia
clinic
practic
recent
high
rdw
associ
increas
mortal
patient
sever
sepsi
septic
shock
pathophysiolog
mechan
underli
associ
rdw
mortal
unclear
howev
possibl
relationship
inflamm
oxid
state
play
role
rdw
link
inflamm
critic
ill
patient
oxid
stress
anim
model
object
assess
prognost
valu
red
cell
distribut
patient
sepsi
relat
hemodynam
paramet
assess
noninvas
method
prospect
observ
studi
includ
thirti
patient
admit
micu
sepsi
rdw
shock
index
hemodynam
paramet
cardiac
bio
imped
measur
assess
hospit
stay
patient
result
rdw
higher
nonsurvivor
survivor
vs
p
valu
cutoff
valu
mortal
sensit
specif
auc
higher
shock
index
nonsurvivor
survivor
vs
p
valu
cutoff
valu
mortal
sensit
specif
auc
signific
correl
rdw
lactat
rdw
shock
index
p
respect
cardiac
output
cardiac
index
higher
nonsurvivor
survivor
vs
vs
p
valu
respect
without
signific
correl
rdw
conclus
high
rdw
associ
higher
mortal
sepsi
patient
higher
patient
develop
respiratori
failur
icu
stay
rdw
show
signific
correl
shock
index
lactat
level
refer
red
cell
distribut
width
famili
practic
notebook
retriev
octob
jo
hwan
et
al
red
cell
distribut
width
prognost
factor
sever
sepsi
septic
shock
american
journal
emerg
medicin
ghaffari
oxid
stress
regul
normal
neoplast
hematopoiesi
antioxid
redox
signal
buri
cschockindex
deutsch
medizinisch
wodenschrift
lorent
leonardo
et
al
red
blood
cell
distribut
width
first
week
associ
sever
mortal
septic
patient
instal
progress
microcirculatori
dysfunct
identifi
crucial
factor
develop
mod
sepsi
identif
prevent
recoveri
microcirculatori
damag
major
focu
research
clinic
practic
sublingu
region
site
choic
evalu
dysfunct
sepsi
mainli
eas
access
howev
doubt
valid
relat
microcircul
organ
commonli
commit
sepsi
studi
aim
compar
sublingu
microcircul
intestin
initi
phase
sepsi
order
assess
whether
site
embryolog
origin
similar
microcirculatori
dynam
method
wistar
rat
subject
sepsi
iv
e
coli
cfuml
hour
n
microcircul
sublingu
region
jejunum
captur
sidestream
darkfield
imag
sdf
total
vessel
densiti
tvd
analyz
softwar
consecut
hour
post
sepsi
sham
group
inject
salin
n
period
studi
anim
kept
gener
anesthesia
mechan
ventil
receiv
hydrat
ml
salinekghr
iv
result
sublingu
signific
reduct
vascular
densiti
anim
sepsi
hour
sepsi
compar
sham
group
fig
suggest
reduc
densiti
sepsi
notic
period
increas
sever
sepsi
comparison
period
sepsi
show
first
two
hour
higher
densiti
compar
period
sepsi
result
shown
sepsi
densiti
microcircul
decreas
sever
sepsi
howev
method
abl
show
differ
extrem
stage
almost
normal
stage
extrem
sever
indic
low
sensit
method
differenti
small
chang
densiti
gut
chang
detect
group
period
show
jejunum
densiti
variabl
sepsi
data
show
dynam
microcirculatori
organspecif
independ
embryolog
origin
short
evalu
microcirculatori
dysfunct
sitedepend
appear
requir
assess
method
also
organspecif
kinet
measur
microcirculatori
dysfunct
sepsi
grant
acknowledg
fapesp
introduct
derang
microvascular
blood
flow
distribut
impli
impair
oxygen
extract
peripher
tissu
object
evalu
effect
dobutamin
heterogen
microvascular
blood
flow
intestin
sublingu
territori
relationship
mesenter
system
oxygen
extract
sever
hypodynam
septic
shock
model
method
fifteen
landrac
pig
anesthet
mechan
ventil
cathet
insert
carotid
arteri
pulmonari
arteri
portal
vein
blood
sampl
invas
pressur
cardiac
output
monitor
gastonomet
place
jejunum
determin
jejunostomi
prepar
visual
gutmucos
microcircul
measur
timepoint
arteri
mesentericven
mixedven
blood
sampl
obtain
blood
gase
analysi
imag
intestin
microcircul
acquir
use
sidestream
dark
field
techniqu
videosequ
store
random
number
ulterior
blind
analysi
baselin
measur
bl
fecal
periton
induc
hypotens
respons
fluid
resuscit
norepinephrin
start
shock
declar
ts
pig
random
fixeddos
dobutamin
n
placebo
n
new
measur
perform
hour
three
sham
anim
subject
ident
monitor
serv
timematch
control
result
observ
signific
decreas
proport
intestinalvilli
perfus
villippv
ts
dobutamin
placebo
group
cardiac
output
system
evolv
similarli
experiment
group
start
resuscit
villippv
significantli
increas
dobutamin
group
friedman
repeatedmeasur
analysi
varianc
p
time
timegroup
interact
variat
villippv
baselin
measur
measur
timepoint
bltot
exhibit
good
agreement
variat
mesenter
oxygen
extract
ratio
respect
p
variat
smallvessel
perfus
ppv
sublingu
mucosa
slppv
track
villippv
throughout
experi
well
correl
mesenter
conclus
dobutamin
improv
heterogen
gut
microvascular
blood
flow
sever
hypodynam
septic
shock
decreas
heterogen
flow
associ
improv
region
oxygen
extract
suggest
crucial
role
microvascular
blood
flow
distribut
oxygen
consumpt
sepsi
grant
acknowledg
tecnoquimica
sa
colombia
centro
investigacion
clinica
fundacion
vall
del
lili
co
cic
universidad
icesi
co
introduct
septic
shock
character
alter
perfus
potenti
lead
tissu
hypoxia
centralperipher
differ
metabolit
lactat
oxygen
ratio
may
good
marker
peripher
hypoperfus
object
character
evolut
peripher
index
perfus
metabol
model
sepsi
due
periton
method
studi
anesthet
mechan
ventil
invas
monitor
sheep
autolog
fece
inject
abdomen
fluid
administr
titrat
maintain
initi
pulmonari
arteri
occlus
pressur
vasopressor
use
arteri
mix
venou
v
right
femor
venou
fv
blood
sampl
collect
baselin
everi
hour
perform
blood
ga
analysi
lactat
lact
measur
microdialysi
cathet
place
posterior
leg
muscl
measur
lactatepyruv
lp
ratio
everi
hour
calcul
fco
gap
flact
gap
fvlact
art
lact
fo
content
gap
hb
hb
fo
sat
gap
flacto
index
gap
fco
index
gap
modifi
fco
index
gap
variabl
investig
baselin
hypotens
map
mmhg
death
midpoint
time
result
present
median
valu
statist
analys
perform
use
spss
result
anim
die
observ
period
result
time
point
present
tabl
data
develop
hypotens
present
tabl
anim
p
vs
conclus
peripher
index
influenc
decreas
blood
flow
gap
flact
gap
alter
earlier
index
could
potenti
use
detect
tissu
hypoperfus
sepsi
introduct
shock
best
defin
lifethreaten
gener
form
acut
circulatori
failur
associ
inadequ
oxygen
util
cell
importantli
peripher
vasodil
rel
hypovolemia
low
system
vascular
resist
coexist
cardiac
dysfunct
left
ventricular
lv
diastol
systol
dysfunct
secondari
primari
myocardi
injuri
right
ventricular
dysfunct
due
pulmonari
hypertens
result
ventriculoarteri
decoupl
ventriculoarteri
coupl
defin
ratio
arteri
elast
ea
left
ventricular
endsystol
elast
ee
object
studi
analyz
variabl
ventriculoarteri
coupl
icu
patient
septic
shock
effect
therapeut
intervent
vasopressor
inotrop
agent
improv
perfus
method
prospect
studi
measur
routin
hemodynam
use
indwel
arteri
cathet
transthorac
echocardiogram
septic
patient
upon
icu
admiss
hemodynam
variabl
includ
cardiac
index
ci
heart
rate
hr
mean
arteri
pressur
map
ee
measur
echocardiographi
use
singlebeat
eessb
method
ea
calcul
systol
arteri
pressurestrok
volum
eaeessb
ratio
calcul
normal
valu
measur
repeat
everi
day
maximum
seven
day
result
analyz
seri
measur
paramet
six
patient
time
diagnosi
septic
shock
patient
present
hyperdynam
state
median
ci
hr
beatsmin
hypotens
map
higher
eaeessb
ratio
start
treatment
norepinephrin
levosimendan
improv
state
septic
patient
parallel
normal
haemodynam
paramet
especi
ventriculoarteri
coupl
eaeessb
ratio
respect
day
conclus
septic
shock
patient
higher
percentag
ventriculoarteri
decoupl
ventriculoarteri
decoupl
index
cardiovascular
ineffici
determin
cardiac
energet
specul
uncoupl
patient
may
benefit
therapi
aim
normal
eaee
ratio
refer
guarracino
f
ferro
b
morelli
et
al
ventriculoarteri
decoupl
human
septic
shock
critic
care
object
evalu
characterist
fluid
therapi
first
week
septic
shock
possibl
impact
mortal
method
prospect
observ
studi
conduct
polyval
icu
intens
care
unit
patient
diagnosi
septic
shock
includ
period
month
demograph
data
comorbid
apach
ii
sofa
clinic
hemodynam
paramet
well
fluid
therapi
characterist
analys
first
week
hospit
impact
mortal
evalu
defin
hidden
volum
volum
deliv
beyond
resuscit
fluid
therapi
result
first
hour
treatment
icu
patient
receiv
averag
total
volum
litter
amount
resuscit
fluid
decreas
progress
mean
ml
mean
ml
within
first
hour
opposit
found
regard
mainten
drugassoci
volum
increas
mean
ml
mean
ml
mean
ml
mean
ml
respect
within
first
hour
tendenc
toward
hemodynam
stabil
observ
within
first
hour
mean
arteri
pressur
mmhg
mmhg
diuresi
ml
ml
lactat
mmoll
mmoll
found
mortal
significantli
lower
patient
receiv
resuscit
fluid
first
hour
hospitalis
ml
vs
ml
p
contrast
patient
higher
cumul
hydric
balanc
ml
vs
ml
p
show
higher
mortal
clinic
hemodynam
characterist
admiss
icu
compar
survivor
nonsurvivor
without
signific
differ
except
left
ventricular
systol
dysfunct
within
nonsurvivor
vs
p
conclus
first
week
icu
admiss
excess
fluid
seem
caus
hidden
fluid
mainten
drugrel
fluid
furthermor
appear
relat
higher
mortal
insuffici
resuscit
within
first
hour
icu
admiss
refer
surviv
sepsi
campaign
intern
guidelin
manag
sever
sepsi
septic
shock
intens
care
med
cordeman
c
et
al
fluid
manag
critic
ill
patient
role
extravascular
lung
water
abdomin
hypertens
capillari
leak
fluid
balanc
ann
intens
care
mikkelsen
et
al
serum
lactat
associ
mortal
sever
sepsi
independ
organ
failur
shock
crit
care
med
introduct
heart
rate
variabl
hrv
shown
promis
predict
pediatr
patient
high
risk
sepsi
death
howev
use
clinic
practic
preclud
absenc
realtim
data
object
studi
conduct
evalu
util
electr
cardiometri
realtim
determin
hrv
use
data
predict
outcom
pediatr
patient
present
septic
shock
method
prospect
enrol
pediatr
patient
met
criteria
septic
shock
electr
cardiometri
icon
use
measur
timedomain
hrv
continu
real
time
hour
admiss
intens
care
unit
electr
imped
cardiographi
use
determin
cardiac
output
hemodynam
paramet
discrimin
survivor
nonsurvivor
evalu
result
enrol
pediatr
patient
septic
shock
patient
discharg
die
heart
rate
similar
survivor
nonsurvivor
median
interquartil
rang
iqr
hrv
enrol
patient
significantli
lower
among
non
survivor
survivor
p
cutoff
hrv
valu
predict
mortal
cutoff
valu
sensit
specif
area
curv
confid
interv
p
conclus
conclud
decreas
hrv
good
predictor
mortal
pediatr
patient
septic
shock
realtim
hrv
may
use
adjunct
standard
vital
sign
monitor
popul
refer
griffin
mp
lake
de
bissonett
ea
et
al
heart
rate
characterist
novel
physiomark
predict
neonat
infect
death
pediatr
introduct
appropri
resuscit
intravascular
volum
optim
treatment
cornerston
septic
shock
optim
requir
invas
monitor
static
measur
due
necessari
non
invas
fast
dynam
method
thorac
fluid
content
tfc
thorac
bioimped
surg
monitor
system
fulfil
requir
non
invas
easi
placement
dynam
object
evalu
effect
fluid
thorac
content
measur
bioimped
guid
intravascular
volum
optim
patient
septic
shock
method
sixti
patient
enrol
divid
two
group
subject
admit
icu
septic
shock
diagnosi
f
group
form
patient
tfc
measur
thorac
bioimped
order
guid
intravascular
volum
optim
c
group
patient
optim
follow
surviv
sepsi
campaign
guidelin
record
mortal
icu
discharg
day
mechan
ventil
length
icu
length
stay
result
base
tfc
f
group
obtain
faster
higher
mean
arteri
pressur
map
increas
hour
compar
c
group
map
aris
hour
p
due
lactat
clearanc
f
group
obtain
total
clearanc
hour
c
group
clearanc
came
hour
p
higher
mortal
icu
discharg
reach
c
group
vs
p
f
group
day
mortal
c
f
group
respect
note
abstract
previous
publish
avail
includ
complet
record
abstract
confer
refer
aguilar
arzapalo
barrada
l
lopez
v
cetina
effect
fluid
thorac
content
measur
bioimped
guid
intravascular
volum
optim
patient
septic
shock
critic
care
suppl
measur
thorac
fluid
content
thorac
bioimped
effect
optim
intravascular
volum
septic
shock
refer
facchini
c
malfatto
g
et
al
lung
ultrasound
transthorac
imped
noninvas
evalu
pulmonari
congest
heart
failur
jcm
ene
grant
acknowledg
hospit
introduct
posttraumat
stress
symptom
ptss
follow
intens
care
treatment
frequent
accid
victim
strong
sens
coher
soc
previous
associ
less
ptss
knowledg
studi
investig
associ
ptss
soc
mix
intens
care
unit
icu
popul
object
examin
preval
ptss
icu
stay
relationship
ptss
soc
demograph
clinic
characterist
icu
patient
method
cross
section
studi
patient
year
treat
two
icu
oslo
univers
hospit
hour
consecut
includ
one
year
demograph
clinic
data
collect
pt
symptom
soc
measur
post
traumat
stress
scale
intens
care
screen
sens
coher
scale
ward
icu
discharg
score
use
cut
valu
indic
clinic
signific
ptss
descript
multivari
logist
regress
analysi
perform
ibm
spss
statist
result
includ
patient
mean
age
sd
male
trauma
patient
receiv
ventil
treatment
preval
rate
defin
ptss
demograph
clinic
variabl
investig
associ
ptss
variabl
p
valu
includ
multivari
logist
regress
analysi
adjust
gender
age
soc
ci
ventil
treatment
ci
significantli
associ
ptss
symptom
conclus
studi
popul
low
soc
ventil
treatment
associ
clinic
signific
ptss
patient
discharg
icu
introduct
intens
care
unit
icu
character
care
sickest
patient
also
due
high
level
anxieti
stress
health
worker
take
maximum
express
burnout
syndrom
caus
burden
frequent
relat
specif
icu
work
factor
physic
emot
workload
sever
theoret
approach
problem
exampl
imbal
effort
reward
eri
model
poorli
test
icu
chilean
icu
multidisciplinari
team
mostli
compos
regist
nurs
nurs
aid
must
work
hand
hand
ensur
qualiti
safeti
care
aim
studi
investig
preval
effortreward
imbal
burnout
among
icu
regist
nurs
nurs
aid
teach
hospit
methodolog
compar
crosssect
studi
conveni
sampl
icu
regist
nurs
rn
nurs
aid
na
teach
hospit
santiago
chile
obtain
three
questionnair
use
data
collect
sociodemograph
questionnair
ii
spanish
short
version
effortreward
imbal
questionnair
siegrist
eri
indic
imbal
effort
reward
andiii
maslach
burnout
inventori
includ
subscal
emot
exhaust
ee
person
accomplish
pa
deperson
dp
pvalu
consid
result
respons
rate
n
sampl
na
rn
na
report
eri
regist
nurs
reach
p
compar
rn
na
higher
eri
vs
p
lower
reward
vs
p
one
case
burnout
observ
among
na
case
observ
among
rn
higher
proport
rn
observ
medium
level
dp
vs
p
pa
vs
p
compar
na
howev
na
higher
proport
low
level
pa
compar
rn
vs
p
conclus
icu
nurs
team
effortreward
imbal
higher
nurs
aid
due
lower
percept
reward
burnout
seem
problem
low
degre
person
accomplish
suggest
necessari
perform
earli
intervent
base
recognit
opportun
person
develop
specif
nurs
aid
intervent
could
help
maintain
low
level
burnout
improv
effort
reward
imbal
grant
acknowledg
none
author
work
receiv
grant
financi
aid
introduct
climat
safeti
design
factor
guid
judgment
behavior
health
care
profession
highlight
issu
patient
safeti
top
prioriti
safeti
climat
employe
direct
act
accord
companywid
commit
safeti
state
maintain
person
safeti
norm
colleagu
form
consensu
rel
import
safe
behavior
situat
present
conflict
requir
safeti
competitor
meet
deadlin
object
check
safeti
climat
concept
among
intens
care
nurs
make
comparison
icu
nurs
ccu
nurs
check
whether
theoret
model
fail
predict
safe
cultur
among
intens
care
nurs
method
studi
popul
consist
nurs
work
intens
care
unit
hospit
tel
aviv
district
subject
ask
complet
structur
questionnair
contain
item
examin
percept
patient
safeti
climat
workplac
commun
employe
frequenc
report
incid
organiz
department
polici
procedur
practic
data
collect
aprilmay
result
studi
increas
moder
posit
correl
exist
percept
worker
icu
patient
safeti
total
score
atmospher
safeti
r
p
posit
medium
correl
percept
icu
worker
corpor
polici
department
process
methodolog
r
p
icu
gener
r
p
compar
intens
care
cardiolog
r
p
conclus
find
support
theori
zohar
safeti
climat
meaning
intens
care
nurs
refer
common
percept
among
member
aspect
organiz
environ
dictat
behavior
work
extent
certain
aspect
reward
support
organ
differ
gener
intens
care
cardiac
intens
care
evalu
patient
safeti
atmospher
safeti
particularli
assess
evalu
work
area
corpor
polici
refer
colla
jb
bracken
ac
kinney
lm
week
wb
measur
patient
safeti
climat
review
survey
qualiti
safe
health
care
dov
z
gil
l
multilevel
model
safeti
climat
cross
level
relationship
organ
group
level
climat
journal
appli
psycholog
grant
acknowledg
current
research
publish
yet
introduct
ventilatorassoci
respiratori
infect
vari
import
sourc
morbid
icu
patient
continu
endotrach
pcuffcontrol
way
minim
microaspir
subglott
secret
consid
major
pathogen
mechan
vari
object
perform
systemat
review
metaanalysi
assess
efficaci
continu
pcuffcontrol
prevent
vari
method
medlin
embas
centralcctr
clinicaltrialsgov
ictrp
systemat
search
elig
trial
random
control
clinic
trial
rct
quasirct
compar
continu
pcuffcontrol
manual
intermitt
pcuffcontrol
intub
patient
studi
report
vari
incid
includ
vari
includ
ventilatorassoci
pneumonia
ventilatorassoci
tracheobronch
inclus
trial
irrespect
public
statu
date
public
languag
result
two
rct
one
quasirct
meet
inclus
criteria
identifi
one
use
pneumat
devic
two
use
electron
devic
continu
pcuffcontrol
studi
singlecent
none
trial
blind
intervent
patient
alloc
intervent
arm
control
arm
vari
episod
occur
intervent
group
control
group
pool
odd
ratio
incid
vari
random
effect
model
confid
interv
z
p
conclus
metaanalysi
show
continu
pcuffcontrol
appear
reduc
incid
vari
howev
number
includ
studi
small
inher
risk
bia
due
unblind
design
refer
valencia
et
al
crit
care
med
nseir
et
al
j
respir
crit
care
med
lorent
l
et
al
j
infect
control
grant
acknowledg
receiv
grant
studi
introduct
acut
kidney
injuri
aki
commom
complic
heart
transplant
associ
high
morbid
mortal
object
evalu
incid
acut
kidney
injuri
aki
outcom
adult
patient
undergo
heart
transplant
accord
kdigo
criteria
method
perform
retrospect
cohort
studi
tertiari
hospit
special
cardiac
surgeri
refer
latin
america
patient
older
year
old
undergon
heart
transplant
januari
januari
includ
patient
congenit
heart
diseas
exclud
result
patient
divid
two
group
develop
aki
develop
aki
incid
acut
kidney
injuri
observ
difer
group
relat
male
vs
p
age
year
vs
year
p
euroscor
vs
p
respect
aki
aki
group
compar
clinic
characterist
transplant
found
signific
differ
relat
inotrop
dosi
mcgkgmin
vs
mcgkgmin
p
use
intraaort
balloon
pump
vs
p
respect
aki
aki
group
outcom
length
stay
mortal
greater
postop
period
group
patient
develop
aki
compar
group
develop
aki
conclus
incid
acut
kidney
injuri
patient
undergo
heart
transplant
mortal
higher
presenc
aki
refer
hobson
ce
yava
segal
ms
schold
jd
tribbl
cg
layon
aj
bihorac
acut
kidney
injuri
associ
increas
longterm
mortal
cardiothorac
surgeri
circul
sampaio
mc
ca
montenegro
cm
mota
dm
fernand
tr
bianco
ac
amodeo
c
cordeiro
ac
comparison
diagnost
criteria
acut
kidney
injuri
cardiac
surgeri
arq
bra
cardiol
thakar
cv
liango
yare
jp
nelson
piedmont
mr
hariachar
paganini
ep
arf
openheart
surgeri
influenc
gender
race
j
kidney
di
introduct
team
leadership
staff
engag
key
influenc
perform
clinic
outcom
patient
satisfact
increas
recognit
stress
experienc
critic
care
nurs
factor
alongsid
shortag
critic
care
nurs
indic
recruit
retent
profession
support
nurs
key
issu
deliveri
safe
effect
healthcar
object
studi
aim
posit
engag
nurs
key
stakehold
critic
care
identifi
gold
standard
framework
high
perform
team
nurs
perspect
studi
use
qualit
methodolog
recognis
underutilis
research
tool
critic
care
method
critic
care
nurs
n
particip
focu
group
discuss
address
four
key
theme
identif
gold
standard
high
perform
team
critic
care
identif
current
team
perform
identif
current
team
strength
identif
key
prioriti
qualiti
improv
result
result
analys
use
induct
content
analysi
reveal
outlin
gold
standard
high
perform
critic
care
team
nurs
perspect
key
factor
includ
high
moral
posit
team
climat
effectiveopen
commun
role
clariti
good
clinic
outcom
patient
satisfact
profession
develop
opportun
job
satisfact
strong
leadership
support
manag
result
also
indic
nurs
team
percept
current
team
strength
key
prioriti
chang
conclus
first
studi
outlin
gold
standard
high
perform
team
critic
care
nurs
perspect
use
qualit
research
methodolog
work
form
part
wider
qualiti
improv
strategi
engag
multidisciplinari
staff
critic
care
team
perform
work
aim
improv
qualiti
safeti
patient
healthcar
refer
factor
support
high
perform
health
care
organis
review
literatur
la
trobe
univers
health
manag
group
reader
w
flin
r
mearn
k
cuthbertson
b
h
develop
team
perform
framework
intens
care
unit
crit
care
med
doi
epp
k
burnout
critic
care
nurs
literatur
review
dynam
bakker
b
le
blanc
p
schauf
w
b
burnout
contagion
among
intens
care
nurs
j
adv
nur
doi
spenc
lasching
hk
leiter
mp
impact
nurs
work
environ
patient
safeti
outcom
mediat
role
burnoutengag
journal
nurs
administr
leggatt
dwyer
j
charlesworth
b
qualit
research
critic
care
time
final
come
journal
intens
care
societi
introduct
nurs
staf
guidelin
critic
care
gener
suggest
nursepati
ratio
high
depend
unit
hdu
patient
intens
care
unit
icu
ficm
current
recommend
depend
mainli
organ
failur
evid
avail
judg
adequ
level
staf
rel
limit
base
opinion
expert
group
object
unit
kingdom
critic
care
nurs
allianc
ukccna
allianc
lead
critic
care
nurs
organis
unit
kingdom
develop
propos
commiss
direct
literatur
review
critic
care
nurs
activ
tool
current
exist
utilis
around
world
method
rapid
review
methodolog
employ
team
critic
care
expert
inform
specialist
two
nurs
academ
scope
search
includ
research
studi
guidelin
survey
within
outsid
unit
kingdom
last
year
search
encompass
subject
specif
electron
databas
spice
standardis
framework
use
booth
result
abstract
consid
abstract
exclud
total
consid
studi
drawn
around
globe
consider
work
undertaken
uk
studi
brazil
studi
empir
studi
rang
retrospect
analys
staff
diari
survey
observ
studi
prospect
studi
use
specif
tool
staf
model
instrument
develop
tool
examin
fell
two
main
group
relat
condit
need
patient
relat
nurs
activ
intervent
conclus
understand
nurs
workload
activ
complex
numer
tool
avail
measur
nurs
activ
score
na
extens
examin
tool
gener
reliabl
result
focus
whole
icu
nurs
workload
suitabl
evalu
overal
staf
level
risk
base
model
provid
mean
determin
nurs
alloc
around
risk
oppos
workload
patient
depend
howev
conclud
scope
develop
new
tool
use
element
tool
examin
review
need
test
clinic
practic
refer
ficm
guidelin
provis
intens
care
servic
faculti
intens
care
medicin
intens
care
societi
booth
formul
answer
question
booth
brice
ed
evid
base
practic
inform
profession
handbook
pp
london
facet
publish
introduct
direct
link
intens
care
unit
icu
staff
number
clinic
outcom
increas
icu
staff
capac
translat
improv
clinic
outcom
result
decreas
icu
mortal
rate
effect
pronounc
staff
dedic
specif
train
care
critic
ill
patient
furthermor
increas
icu
staff
number
cost
save
benefit
patient
healthcar
institut
increas
staff
number
result
declin
patient
length
stay
henc
drop
risk
hospit
relat
complic
includ
hospitalacquir
infect
also
cost
laboratori
test
hospit
procedur
special
medic
background
paediatr
critic
care
nurs
program
pccn
launch
nairobi
kenya
object
program
aim
train
nurs
per
year
two
intak
per
year
nurs
per
nurs
council
kenya
guidelin
build
capac
critic
care
nurs
east
africa
method
pccn
train
program
tailor
state
regist
nurs
bachelor
scienc
nurs
graduat
wish
special
critic
care
environ
critic
care
neonat
infant
children
adolesc
along
critic
care
continuum
across
varieti
health
servic
resuscit
critic
stabil
transfer
vigil
respons
care
often
turbul
dynam
period
critic
ill
paediatr
intens
care
unit
picu
neonat
intens
care
unit
nicu
high
depend
unit
hdu
train
period
includ
theori
week
critic
nurs
experi
week
addit
cours
includ
epl
european
advanc
pediatr
life
support
etat
emerg
treatment
triag
pew
chart
pediatr
earli
warn
score
result
total
nurs
healthcar
institut
across
east
africa
benefit
train
sinc
launch
program
todat
four
nurs
rwanda
one
uganda
forti
kenya
nurs
train
nine
male
thirti
six
femal
mean
age
thirti
seven
year
graduat
taken
leadership
posit
use
skill
acquir
improv
paediatr
critic
care
evid
base
clinic
practic
besid
manag
critic
care
unit
translat
strateg
health
care
polici
tactic
oper
plan
effect
implement
posit
outcom
nation
healthcar
system
conclus
effort
line
unit
nation
convent
right
child
place
ensur
qualiti
healthcar
children
global
introduct
well
acknowledg
intens
care
unit
icu
environ
creat
stress
work
atmospher
clinician
promot
healthi
work
environ
icu
set
identifi
way
reduc
workrel
stress
icu
part
overal
initi
enhanc
work
environ
icu
bed
univers
affili
medic
center
employe
appreci
day
design
minut
massag
provid
clinic
staff
object
object
studi
assess
impact
massag
intervent
selfreport
stress
rate
method
numer
stress
scale
establish
likert
scale
rang
stress
unbear
stress
use
collect
selfassess
percept
stress
rate
minut
massag
provid
certifi
massag
therapist
use
portabl
massag
chair
set
confer
room
result
total
nurs
clinician
complet
prepost
assess
self
report
level
stress
massag
clinician
rate
level
stress
averag
ten
moder
minut
massag
stress
rate
found
decreas
one
third
respond
report
low
level
stress
respond
report
stress
number
clinician
report
high
level
stress
decreas
massag
intervent
independ
sampl
ttest
use
compar
pre
mean
standard
deviat
post
mean
standard
deviat
stress
rate
chang
selfreport
level
stress
found
statist
signific
decreas
tstatist
df
p
conclus
minut
massag
intervent
found
result
decreas
level
selfreport
stress
level
icu
clinician
singl
center
studi
explor
impact
stress
reduc
intervent
icu
clinician
requir
investig
part
overal
focu
promot
healthi
work
environ
icu
introduct
diabet
ketoacidosi
dka
major
complic
diabet
mellitu
frequent
tunisia
incid
rang
per
diabet
patient
mani
insulin
administr
protocol
mani
unresolv
question
place
alkalin
signif
hyperchlorem
acidosi
object
aim
work
evalu
manag
dka
tunisian
medic
intens
care
unit
determin
prognosi
factor
diabet
patient
method
conduct
retrospect
analysi
two
year
januari
decemb
record
patient
admit
intens
care
unit
icu
diabet
ketoacidosi
diagnos
biochem
triad
ketonaemia
hyperglycemia
acidaemia
pick
clinic
laboratori
data
fluid
replac
complic
diseas
progress
result
patient
enrol
preval
ketoacidosi
nearli
patient
attend
emerg
depart
mean
age
year
sex
ratio
patient
type
juvenil
diabet
type
diabet
inaugur
ketoacidosi
mean
sap
ii
score
asthenia
frequent
clinic
sign
patient
express
digest
symptom
nine
patient
alter
vital
sign
mainli
shock
nine
patient
alter
mental
statu
patient
hyper
leukocytosi
patient
venou
capillari
glycaemia
mean
capillari
glycaemia
gl
twenti
two
patient
pseud
hyponatremia
seven
patient
present
hyperkaliemia
admiss
mean
creactiv
protein
level
mgl
mean
level
bicarbon
valu
meql
admiss
mean
overal
osmolar
meql
patient
infect
patient
close
bedsid
monitor
blood
glucos
blood
ga
blood
electrolyt
measur
accord
local
protocol
manag
detail
work
fluid
replac
therapi
base
crystalloid
three
patient
receiv
alkalin
four
patient
present
coronari
syndrom
five
patient
develop
hyperchlorem
acidosi
overal
mortal
rate
patient
mean
hospit
stay
icu
hour
factor
associ
mortal
type
diabet
p
sap
p
shock
p
acut
renal
failur
arf
p
univari
analysi
sap
arf
independ
associ
poor
outcom
multivari
analysi
conclus
clinic
assess
aim
treatment
manag
dka
similar
literatur
mani
controversi
point
optimum
treatment
regimen
fluid
use
alkalin
manag
hyperchlorem
acidosi
discuss
work
introduct
nt
probnp
doppler
echocardiographi
approv
diagnosi
heart
failur
studi
compar
contribut
ntprobnp
level
doppler
echocardiographi
find
diagnosi
decompens
congest
leftheart
failur
chf
patient
acut
dyspnea
object
compar
ntprobnp
level
echocardiographi
find
determin
etiolog
difficulttodiagnos
sever
dyspnea
emerg
depart
method
prospect
observ
studi
teach
depart
emerg
intens
care
region
hospit
zaghouan
includ
patient
sever
dyspnea
six
month
patient
underw
physic
examin
ecg
rx
thorax
ntprobnp
essay
echocardiographi
attend
cardiologist
admiss
accuraci
two
method
etiolog
diagnosi
compar
basi
final
diagnos
establish
medic
staff
result
patient
enrol
includ
chf
diagnosi
chf
due
coronari
arteri
diseas
hypertens
valv
diseas
arrhythmia
dilat
cardiomyopathi
nonchf
due
decompens
chronic
obstruct
pulmonari
diseas
pneumonia
sever
asthma
fifteen
patient
misdiagnos
admiss
mean
ntprobnp
concentr
pgml
chf
subgroup
pgml
patient
p
systol
lv
dysfunct
lvef
found
patient
chf
patient
caus
dyspnea
p
ea
ratio
deceler
time
ewav
dt
respect
group
chf
group
nonchf
p
impair
relax
restrict
mitral
pattern
observ
respect
patient
chf
two
patient
th
ree
patient
group
conclus
ntprobnp
assay
echocardiographi
use
diagnosi
chf
inacut
dyspneic
patient
howev
echocardiographi
accur
patient
intermedi
bnp
level
note
abstract
previous
publish
avail
includ
complet
record
abstract
confer
refer
snouda
ben
ghezala
h
abb
mf
daoudi
r
kaddour
benchiekh
ntprobnp
level
echocardiographi
find
etiolog
diagnosi
acut
dyspnea
annal
intens
care
suppl
introduct
despit
decad
research
predictor
wean
extub
failur
remain
unclear
although
ineffect
cough
secret
retent
like
play
role
cough
augment
techniqu
lung
volum
recruit
lvr
manual
assist
cough
mac
mechan
insufflationexsuffl
mie
use
prevent
manag
respiratori
complic
chronic
diseas
may
improv
short
longterm
outcom
patient
experienc
acut
respiratori
failur
role
cough
augment
enabl
extub
prevent
postextub
respiratori
failur
critic
ill
patient
acut
respiratori
failur
unclear
object
determin
extub
success
durat
ventil
icu
stay
mortal
harm
use
cough
augment
techniqu
compar
cough
augment
critic
ill
adult
paediatr
patient
acut
respiratori
failur
method
systemat
review
trial
evalu
lvr
mac
mie
compar
control
group
without
intervent
consid
nonrandom
studi
nr
harm
evalu
two
author
independ
screen
electron
databas
april
abstract
data
standard
form
accuraci
verifi
author
result
screen
refer
identifi
full
text
review
exclud
includ
studi
compris
rct
particip
evalu
mie
mac
lvr
mac
nr
includ
casecontrol
studi
larg
case
seri
one
trial
report
greater
extub
success
need
reintub
hour
mie
mac
group
vs
rel
risk
rr
ci
one
trial
report
statist
signific
reduct
mechan
ventil
favour
mie
mac
mean
differ
day
ci
two
trial
report
icu
stay
mortal
demonstr
differ
harm
report
rct
compris
intervent
patient
experienc
hemodynam
compromis
compar
control
arm
patient
rr
ci
trial
mie
mac
control
group
patient
compar
mie
mac
patient
experienc
secret
retent
sever
hypoxemia
warrant
reintub
rr
ci
patient
either
trial
experienc
new
onset
arrhythmia
pneumothorax
case
seri
studi
patient
evalu
mac
invas
ventil
report
complic
hemodynam
compromis
pneumothorax
hypoxemia
mucu
plug
case
seri
evalu
mie
mac
patient
consid
nonwean
complic
report
howev
requir
reintub
due
plug
relat
desatur
extub
harm
report
case
control
studi
conclus
data
efficaci
lvr
mac
mie
promot
extub
success
limit
though
complic
appear
uncommon
grant
acknowledg
cihr
introduct
major
oesophagogastr
surgeri
associ
signific
postop
morbid
reduc
function
capac
qualiti
life
evid
colorect
surgeri
popul
demonstr
signific
benefit
prehabilit
evid
support
approach
patient
undergo
oesophagectomi
tg
object
assess
impact
implement
prehabilit
enhanc
postop
physiotherapi
patient
undergo
oesophagectomi
tg
method
consecut
patient
novemb
march
enter
standardis
era
programm
incorpor
twice
daili
physiotherapi
five
day
postop
prespecifi
mobil
mileston
elig
offer
prehabilit
incorpor
twiceweekli
cardiovascular
strengthen
class
week
attend
outcom
measur
function
capac
increment
shuttl
walk
test
iswt
anxieti
depress
had
score
perceiv
health
statu
also
compar
data
attend
prehabilit
receiv
era
post
oper
postop
outcom
time
mobilis
mobil
level
critic
care
discharg
mm
total
hospit
length
stay
lo
result
thirteen
patient
attend
prehabilit
improv
seen
outcom
complet
see
tabl
post
oper
patient
attend
prehabilit
mobil
icu
discharg
mm
vs
quicker
mobilis
vs
day
reduct
lo
also
seen
prehabilit
patient
comparison
receiv
era
alon
day
vs
day
conclus
implement
programm
prehabilit
feasibl
patient
undergo
major
oesophagogastr
surgeri
associ
improv
outcom
preoper
improv
associ
higher
level
mobil
point
critic
care
discharg
shorter
hospit
length
stay
futur
appropri
power
research
need
confirm
find
refer
mcculloch
p
ward
j
tekki
pp
et
al
mortal
morbid
gastrooesophag
cancer
surgeri
initi
result
ascot
multicentr
prospect
cohort
studi
bmj
mayo
ne
et
al
impact
preoper
chang
physic
function
postop
recoveri
argument
support
prehabilit
colorect
surgeri
surgeri
sep
introduct
infus
pump
often
associ
poor
usabl
increas
likelihood
medic
error
critic
ill
patient
intens
care
unit
icu
usual
receiv
multipl
infus
simultan
increas
likelihood
pumprel
error
furthermor
icu
frequent
hectic
environ
compound
likelihood
human
error
improv
usabl
infus
pump
could
help
prevent
injuri
death
vulner
popul
previou
usabl
studi
focus
individu
pump
studi
focus
pump
system
whole
situat
repres
icu
object
aim
studi
develop
test
pump
display
facilit
central
monitor
control
multipl
infus
pump
improv
safeti
effici
interact
infus
technolog
method
central
pump
display
develop
accord
latest
guidelin
usercent
design
usabl
display
compar
convent
pump
setup
simul
studi
icu
nurs
perform
common
pumprel
task
either
central
convent
interfac
particip
mean
year
icu
work
experi
task
execut
time
key
press
record
log
scan
error
experi
usabl
questionnair
likert
scale
administ
end
experiment
run
assess
endus
satisfact
result
overal
differ
total
task
execut
time
central
second
convent
system
p
fewer
click
need
execut
task
central
system
compar
convent
system
click
respect
p
fewer
error
made
central
system
compar
convent
system
error
respect
p
questionnair
result
indic
overal
prefer
toward
central
system
vs
p
conclus
expert
user
signific
experi
use
convent
pump
interfac
demonstr
effici
safer
perform
use
central
control
display
central
control
display
better
overal
usabl
convent
pump
control
interfac
despit
particip
never
use
result
studi
underlin
import
usabl
test
improv
highrisk
medic
system
refer
husch
sullivan
c
rooney
et
al
insight
sharp
end
intraven
medic
error
implic
infus
pump
technolog
qual
saf
health
care
zhang
j
johnson
tr
patel
vl
et
al
use
usabl
heurist
evalu
patient
safeti
medic
devic
j
biom
inform
grant
acknowledg
studi
support
umcg
healthi
age
grant
introduct
renal
failur
patient
whether
develop
hospit
admiss
independ
predictor
mortal
effort
detect
earlier
icu
set
perform
patient
order
set
prevent
therapeut
maneuv
despit
well
establish
diagnost
criteria
acut
kidney
injuri
aki
detect
often
delay
clinic
practic
make
analog
cardiac
angina
even
though
sever
biomark
develop
earli
detect
aki
none
sensit
specif
troponin
level
cardiac
set
therefor
concept
renal
angina
develop
consid
risk
factor
clinic
sign
renal
failur
score
patient
group
accord
need
continu
renal
replac
therapi
crrt
high
high
moder
low
risk
pediatr
icu
popul
concept
widespread
well
adult
icu
patient
object
present
pilot
studi
describ
patient
requir
crrt
last
month
determin
risk
presenc
renal
angina
admiss
method
descript
pilot
studi
retrospect
analyz
adult
patient
requir
crrt
march
data
need
evalu
risk
renal
angina
complet
obtain
interpret
demograph
laboratori
result
well
premed
histori
result
patient
male
mean
age
patient
die
common
diagnosi
commun
acquir
pneumonia
second
acut
chronic
cardiac
failur
admiss
classifi
high
risk
group
also
patient
one
mayor
chronic
criteria
frequent
risk
factor
hypertens
histori
hypotens
admiss
respect
age
sepsi
respect
patient
earli
elev
serum
creatinin
scr
least
mgdl
averag
day
admiss
icu
begin
crrt
conclus
determin
renal
angina
score
patient
admit
icu
might
cornerston
treatment
prevent
renal
failur
especi
patient
within
high
high
risk
group
allow
clinician
suspici
slightest
scr
elev
low
mgdl
predict
need
crrt
thu
establish
prevent
maneuv
initi
replac
therapi
earli
refer
chawla
et
al
renal
angina
concept
develop
pretest
probabl
assess
acut
kidney
injuri
critic
care
cruz
dn
ferrernad
piccinni
p
goldstein
sl
chawla
ls
alessandri
e
et
al
util
small
chang
serum
creatinin
clinic
risk
factor
assess
risk
aki
critic
ill
adult
clin
j
soc
nephrol
introduct
acut
kidney
cardiac
surgeri
well
describ
aki
associ
increas
morbid
mortal
short
long
term
sever
aki
directli
proport
outcom
independ
associ
mortal
specif
sustain
injuri
occur
implement
protocol
post
cardiac
surgeri
ensur
adequ
fluid
resuscit
strategi
reduc
complic
name
aki
incid
aki
reduc
object
ensur
effort
reduc
incid
aki
still
effect
method
preoper
baselin
peak
creatinin
data
prospect
record
audit
team
monitor
incid
aki
baselin
characterist
collect
along
discharg
creatinin
incid
cvvh
length
icu
hospit
stay
icu
readmiss
mortal
result
month
period
cardiac
surgic
admiss
occur
cticu
n
sustain
aki
use
kdigo
classif
n
sustain
stage
n
sustain
stage
ii
n
sustain
stage
iii
n
die
n
readmit
icu
n
surviv
aki
resolv
prior
hospit
discharg
conclus
incid
aki
remain
baselin
though
resolut
aki
occur
follow
requir
gp
ensur
injuri
nt
occur
highlight
caution
evid
aki
within
surgic
discharg
summari
recommend
write
icu
discharg
letter
includ
event
although
incid
aki
remain
lower
aki
still
occur
identifi
patient
risk
aki
preop
assess
recommend
modifi
risk
factor
optim
high
risk
patient
identifi
prior
cardiac
surgeri
recommend
literatur
reduc
complic
refer
rosner
mh
okusa
md
acut
kidney
injuri
associ
cardiac
surgeri
clin
j
soc
nephrol
doi
corredor
c
thomson
r
alsubai
n
longterm
consequ
acut
kidney
injuri
cardiac
surgeri
systemat
review
metaanalysi
j
cardiothorac
vasc
anaesth
vanderbergh
w
gevaert
kellum
ja
bagshaw
sm
peperstraet
h
herck
decruyenaer
j
host
ea
acut
kidney
injuri
cardioren
syndrom
type
patient
systemat
review
metaanalysi
ncbi
cardioren
med
feb
host
ea
de
cort
w
epidemiolog
aki
icu
ncbi
acta
clinica
belgica
suppl
kidney
diseas
improv
global
outcom
kdigo
acut
kidney
injuri
work
group
kdigo
clinic
practic
guidelin
acut
kidney
injuri
kidney
inter
suppl
background
pressur
ulcer
pu
frequent
advers
event
intens
care
unit
icu
main
risk
factor
develop
patient
immobl
analysi
part
studi
name
capcri
object
determin
factor
relat
headofb
elev
hobe
patient
mechan
ventil
object
investig
risk
factor
develop
pu
relat
patient
posit
critic
ill
patient
mechan
ventil
effect
presenc
pressur
ulcer
hobe
method
descript
longitudin
multicentr
studi
spanish
icu
march
decemb
inclus
criteria
patient
year
old
mechan
ventil
h
abl
measur
hobe
first
hour
mechan
ventil
patient
contraind
hobe
exclud
sampl
size
calcul
result
patientscent
pu
diagnos
accord
npuapepuap
guidelin
descript
bivari
multivari
analys
perform
signific
level
set
p
result
patient
includ
develop
pu
repres
pu
frequent
diagnos
surgic
patient
admit
icu
median
day
day
mechan
ventil
patient
develop
pu
mean
admiss
time
pu
diagnosi
day
major
pu
stage
stage
ii
respect
diagnos
sacrum
heel
multivari
logist
regress
analysi
independ
risk
factor
pu
sedat
time
vasoact
drug
durat
time
mean
arteri
pressur
mmhg
contrari
factor
prevent
pu
higher
apach
ii
score
higher
valu
albumin
prealbumin
respect
degre
hobe
statist
signific
analyz
impact
presenc
pu
affect
hobe
remain
similar
previou
diagnosi
mean
vs
diagnosi
mean
p
conclus
patient
analys
develop
pu
relat
bodi
posit
degre
hobe
evidenc
risk
factor
pu
hypotens
durat
sedat
vasoact
drug
import
risk
factor
develop
pu
besid
prevent
measur
maintain
adequ
valu
albumin
prealbumin
import
prevent
pu
presenc
pu
affect
attitud
nurs
toward
degre
hobe
grant
acknowledg
project
fund
nation
award
nurs
research
marqu
de
valdecilla
hospit
spain
object
assess
ngal
predictor
acut
kidney
injuri
patient
undergo
cardiac
surgeri
method
prospect
longitudin
studi
involv
icu
patient
undergo
cardiac
surgeri
without
renal
diseas
creatinin
plasma
urinari
ngal
level
determin
perform
hour
post
icu
admiss
ngal
cutoff
consid
predict
acut
renal
failur
ngml
ngml
plasma
urin
respect
statist
analysi
patient
classifi
accord
presenc
absenc
renal
failur
categor
variabl
summar
frequenc
percentag
numer
mean
standard
deviat
sd
median
interquartil
rang
iqr
percentag
compar
appropri
test
exact
test
mean
ttest
median
wilcoxon
test
independ
group
order
evalu
diagnost
potenti
ngal
urin
plasma
renal
failur
roc
receiv
oper
characterist
analysi
marker
perform
predict
abil
marker
assess
area
correspond
roc
curv
estim
confid
interv
optim
cutoff
marker
consid
one
correspond
sensit
specif
valu
minim
follow
express
cutoff
sensit
specif
posit
predict
valu
neg
predict
valu
posit
likelihood
ratio
neg
likelihood
ratio
obtain
paramet
estim
confid
hypothesi
test
consid
statist
signific
correspond
pvalu
less
obtain
area
two
roc
curv
also
compar
result
figur
show
variabl
studi
group
defin
presenc
absenc
renal
failur
behavior
variabl
analyz
similar
studi
group
conclus
ngal
good
marker
earli
acut
renal
injuri
patient
cardiac
surgeri
show
statist
signific
differ
compar
urin
vs
plasma
level
introduct
immedi
diagnosi
sepsi
critic
condit
cancer
patient
complic
due
similar
manifest
drug
toxic
system
infecti
complic
gener
categori
patient
overdiagnosi
sepsi
case
sir
criteria
use
new
clinic
criteria
sepsi
diagnosi
develop
rational
use
patient
receiv
anticanc
therapi
yet
determin
object
determin
sensit
specif
new
sepsi
clinic
criteria
patient
receiv
anticanc
therapi
method
total
record
patient
sir
criteria
admit
therapeut
icu
subject
retrospect
analysi
patient
anticanc
drugrel
advers
event
variou
grade
diagnosi
sepsi
criteria
sir
defin
infecti
lesion
defin
infecti
agent
determin
case
retrospect
patient
met
criteria
sensit
specif
accuraci
criteria
calcul
calcul
confid
interv
ci
carri
mean
wilson
method
result
time
icu
admiss
patient
met
criteria
sepsi
confirm
patient
sensit
ci
specif
ci
accuraci
ci
sensit
ci
conclus
new
clinic
criteria
sepsi
suffici
specif
high
sensit
patient
receiv
anticanc
therapi
refer
levi
mm
fink
mp
marshal
jc
et
al
intes
care
med
singer
deutschman
cs
seymour
chw
et
al
jama
grant
acknowledg
none
introduct
traumat
brain
injuri
tbi
nt
seem
singl
insult
monophas
resolut
recent
degen
mechan
suggest
occur
chronic
phase
could
constitut
tertiari
lesion
degen
phenomena
potenti
worsen
impact
longterm
function
prognosi
object
object
prospect
studi
longitudin
evalu
white
grey
matter
structur
volum
measur
threedimension
white
matter
integr
assess
diffus
tensor
imag
dti
sever
tbi
method
sever
tbi
yr
healthi
volunt
hv
yr
underw
multimod
magnet
reson
imag
subacut
phase
within
day
injuri
longitudin
followup
obtain
chronic
phase
injuri
median
month
injuri
togeth
neuropsycholog
assess
longitudin
imag
chang
assess
use
cortic
volumetr
reconstruct
segment
white
deep
grey
matter
structur
freesurf
cortic
sulci
automat
reconstruct
identifi
brainvisa
softwar
voxelbas
dti
analysi
perform
comasoft
extend
go
gose
use
classifi
year
tbi
subject
good
gose
n
intermedi
gose
n
recoveri
cortic
morphometri
fraction
anisotropi
fa
deriv
dti
use
linear
mix
effect
model
link
chang
behaviour
statu
result
baselin
volumetr
differ
group
gose
gose
hv
year
patient
tbi
demonstr
signific
volumetr
reduct
whole
white
matter
p
deep
grey
matter
structur
p
contrast
hv
present
signific
chang
period
specif
direct
comparison
patient
group
reveal
time
gose
show
greater
atrophi
gose
pariet
lobe
vs
respect
p
brain
stem
vs
p
corpu
callosum
vs
p
cingul
vs
p
associ
higher
depth
mean
sulci
data
furthermor
fa
lower
first
mri
gose
group
regionsfin
neuropsycholog
score
zscore
correl
significantli
volum
loss
anatom
region
conclus
observ
strong
correl
neuropsycholog
score
morphometr
chang
time
suggest
occurr
tertiari
lesion
lesion
locat
influenc
function
outcom
data
provid
insight
earli
late
pathophysiolog
cognit
dysfunct
tbi
refer
newcomb
et
al
nnr
reuter
et
al
neuroimag
grant
acknowledg
fondat
gueul
introduct
differ
degre
matur
variou
system
organ
children
neonat
might
disturb
desir
therapeut
effect
therefor
identif
interindividu
differ
affect
pharmacokinet
pk
drug
import
dose
individu
especi
children
sever
condit
especi
appli
new
drug
dexmedetomidin
dex
rel
small
number
studi
perform
pediatr
intens
care
unit
picu
object
goal
studi
assess
pharmacokinet
dexmedetomidin
picu
set
prolong
infus
assess
influenc
routin
collect
covari
underli
pk
paramet
method
thirti
eight
patient
enrol
studi
continu
intraven
infus
dex
initi
rate
follow
gradual
increas
decreas
keep
level
sedat
point
cook
scale
blood
sampl
pk
assess
ml
collect
arteri
cathet
analysi
made
concentr
obtain
two
occas
first
hr
infus
initi
second
hr
infus
end
data
analysi
conduct
use
winbug
softwar
inform
literatur
prior
result
incorpor
timedepend
differ
two
occas
pk
paramet
improv
model
typic
valu
volum
central
compart
v
scale
kg
l
wherea
volum
peripher
compart
slightli
higher
v
l
typic
system
clearanc
cl
dex
distribut
clearanc
q
lh
lh
patient
weight
kg
iiv
estim
cl
q
v
v
strong
correl
q
v
valu
consist
literatur
paramet
children
adult
close
prior
use
observ
volum
distribut
clearanc
respect
higher
second
occas
conclus
popul
pk
model
success
develop
describ
time
cours
variabl
dexmedetomidin
picu
patient
use
allometr
principl
clearanc
matur
model
data
need
fulli
confirm
clinic
signific
phenomenon
increas
volum
distribut
clearanc
infus
cessat
diseas
statu
describ
prism
score
durat
infus
gender
bodi
weight
age
found
independ
signific
covari
studi
refer
harnisch
l
shepard
pon
g
della
pasqua
model
simul
tool
bridg
efficaci
safeti
data
special
popul
cpt
pharmacometr
syst
pharmacol
grant
acknowledg
project
support
grant
found
polish
nation
scienc
centr
introduct
crrt
use
increasingli
intens
care
unit
renal
indic
also
organsupport
strategi
although
earli
initi
rrt
clearli
associ
benefit
avoid
delay
rrt
associ
higher
mortal
increas
hospitalicu
length
stay
object
describ
use
crrt
treatment
nonren
metabol
acidosi
cardiothorac
intens
care
unit
method
perform
retrospect
observ
studi
includ
patient
admit
level
area
requir
crrt
refractori
metabol
acidosi
harefield
hospit
ie
ph
less
base
deficit
less
equal
mmoll
popul
includ
patient
admit
cardiac
thorac
surgeri
heart
lung
transplant
mechan
circulatori
devic
hospit
cardiac
arrest
oohca
medic
admiss
cardiolog
cardiothorac
surgic
ward
demograph
variabl
collect
along
time
durat
crrt
result
patient
admit
level
area
harefield
hospit
requir
crrt
admiss
patient
initi
crrt
due
refractori
metabol
acidosi
median
age
group
year
male
hypertens
diabet
patient
patient
haemodynam
unstabl
defin
need
one
inotrop
drug
high
dose
combin
two
vasoact
drug
reason
admiss
also
differ
gener
crrt
group
higher
frequenc
heart
transplant
oohca
shown
tabl
fig
time
admiss
itu
initi
crrt
shorter
day
refractori
metabol
acidosi
crrt
group
vs
day
gener
crrt
group
itu
mortal
studi
group
vs
gener
crrt
group
conclus
crrt
refractori
metabol
acidosi
context
cardiac
instabl
use
critic
ill
patient
adjunct
strategi
appli
earlier
crrt
initi
indic
refer
karvella
cj
farhat
mr
sajjad
mogensen
ss
leung
aa
wald
r
bagshaw
sm
comparison
earli
versu
late
initi
renal
replac
therapi
critic
ill
patient
acut
kidney
injuri
systemat
review
metaanalysi
crit
care
clec
h
c
darmon
lautrett
chemouni
f
azoulay
e
schwebel
c
dumenil
garrousteorg
goldgrantoledano
cohen
timsit
jf
efficaci
renal
replac
therapi
critic
ill
patient
propens
analysi
crit
care
introduct
respect
proport
final
etiolog
dispar
cohort
cardiac
arrest
patient
depend
examin
popul
diagnost
algorithm
particular
incid
characterist
sudden
unexplain
death
sud
debat
aim
describ
etiolog
larg
cohort
outofhospit
cardiac
arrest
ohca
patient
order
character
victim
without
identifi
diagnosi
patient
method
analyz
data
prospect
registri
ohca
patient
admit
januari
decemb
initi
diagnost
strategi
includ
coronari
angiographi
brain
chest
ct
scan
complet
extens
diagnost
strategi
encompass
biolog
toxicolog
test
repeat
electrocardiogram
echocardiographi
mri
holter
monitor
endocavitari
explor
two
independ
investig
review
final
diagnosi
baselin
characterist
compar
subgroup
patient
chisquar
test
mannwhitney
test
appropri
oneyear
mortal
compar
subgroup
use
univari
kaplanmei
curv
result
studi
period
patient
admit
unit
resuscit
ohca
event
relat
noncardiac
cardiac
caus
patient
respect
main
caus
cardiac
relat
ohca
ischem
heart
diseas
nonstructur
cardiomyopathi
account
diagnosi
evidenc
patient
sud
patient
baselin
characterist
oneyear
surviv
patient
similar
identifi
nonstructur
cardiomyopathi
conclus
observ
ischem
heart
diseas
far
common
caus
cardiac
arrest
nonstructur
cardiomyopathi
account
low
part
diagnosi
young
patient
victim
sudden
unexplain
death
share
similar
baselin
characterist
outcom
patient
nonstructur
cardiomyopathi
focus
subgroup
patient
investig
followup
may
help
manag
rel
note
abstract
previous
publish
avail
includ
complet
record
abstract
confer
refer
passouant
geri
g
duma
f
bougouin
w
champigneul
b
arnaout
chelli
jd
varenn
mira
jp
cariou
incid
characterist
sudden
unexplain
cardiac
death
insight
parisian
registri
annal
intens
care
suppl
introduct
patient
cardiac
surgeri
prone
develop
postop
pulmonari
complic
ppc
current
diagnos
chest
xray
cxr
lu
may
provid
accur
diagnost
inform
patient
acut
respiratori
distress
role
lu
detect
ppc
patient
cardiac
surgeri
yet
determin
object
compar
rate
ppc
detect
lu
cxr
patient
cardiac
surgeri
admit
icu
addit
assess
interobserv
agreement
lu
compar
time
take
perform
lu
cxr
method
prospect
observ
singl
centr
studi
studi
approv
institut
review
board
admiss
icu
rate
ppc
detect
lu
accord
blueprotocol
cxr
compar
addit
accuraci
lu
cxr
detect
clinic
relev
crppc
ppc
attend
physician
blind
lu
data
initi
therapi
evalu
crppc
consid
composit
refer
standard
blue
point
assess
determin
interobserv
agreement
patient
time
perform
techniqu
compar
result
enrol
patient
male
mean
age
lu
identifi
ppc
compar
cxr
p
ppc
identifi
posit
posterolater
alveolar
andor
pleural
syndrom
plap
vs
pulmonari
edema
vs
pneumothorax
vs
incid
crppc
tabl
summar
diagnost
accuraci
lu
cxr
crppc
identifi
lu
perform
within
minut
compar
minut
cxr
p
overal
interobserv
agreement
lu
show
near
perfect
agreement
k
p
conclus
lu
detect
ppc
cxr
patient
cardiac
surgeri
good
interobserv
agreement
addit
time
perform
lu
significantli
shorter
howev
ppc
detect
lu
come
littl
clinic
consequ
therefor
suggest
studi
quantifi
extent
ppc
detect
lu
improv
valu
clinic
decis
make
refer
touw
hr
tuinman
pr
gelissen
hp
lust
e
elber
pw
lung
ultrasound
routin
practic
next
gener
internist
neth
j
med
lichtenstein
van
hs
elber
p
malbrain
ml
ten
good
reason
practic
ultrasound
critic
care
anaesthesiol
intens
ther
grant
acknowledg
studi
support
grant
introduct
respiratori
infect
common
complic
icu
patient
admit
cardiac
arrest
amoxicillinclavulan
use
empir
antibiot
therapi
patient
prevent
aspir
pneumonia
howev
recent
studi
shown
resist
rate
object
describ
resist
pattern
microorgan
isol
bronchial
sampl
patient
admit
icu
resuscit
cardiac
arrest
assess
appropri
empir
antibiot
therapi
method
prospect
observ
studi
includ
patient
admit
icu
recov
outofhospit
cardiac
arrest
patient
inofhospit
cardiac
arrest
admit
hospit
less
hour
without
previou
administr
antibiot
took
sampl
tracheobronchi
secret
endotrach
tube
patient
within
first
three
day
admiss
demograph
inform
comorbid
perform
therapeut
hypothermia
empir
antibiot
therapi
administ
result
bronchial
aspir
cultur
collect
empir
antibiot
therapi
consid
adequ
least
one
effect
antibiot
administ
within
first
hour
icu
admiss
result
patient
includ
averag
age
male
outofhospit
cardiac
arrest
receiv
therapeut
hypothermia
use
antibiot
amoxicillinclavulan
follow
piperacillintazobactam
levofloxacin
case
antibiot
prescrib
posit
microbiolog
result
obtain
bronchial
aspir
common
microorgan
isol
aureu
e
coli
e
cloaca
k
pneumonia
marcescen
h
influenza
isol
microorgan
resist
amoxicillinclavulan
piperacillintazobactam
thirdgener
cephalosporin
organ
resist
quinolon
carbapenem
accord
pattern
sensit
patient
microbiolog
isol
bronchial
sampl
receiv
inappropri
empir
antibiot
therapi
conclus
result
suggest
high
resist
rate
amoxicillinclavulan
germ
isol
respiratori
sampl
patient
resuscit
cardiac
arrest
common
microorgan
isol
sampl
aureu
e
coli
e
cloaca
result
high
rate
inappropri
empir
antibiot
therapi
refer
perbet
et
al
earlyonset
pneumonia
cardiac
arrest
characterist
risk
factor
influenc
prognosi
j
respir
crit
care
med
mongardon
n
et
al
infecti
complic
outof
hospit
cardiac
arrest
patient
therapeut
hypothermia
era
crit
care
med
introduct
refractori
septic
shock
mortal
earli
phase
septic
shock
hemofiltr
attenu
inflammatori
cascad
thu
allevi
cell
tissu
damag
reduc
mortal
due
multipleorgan
failur
syndrom
object
patient
refractori
septic
shock
hemofiltr
venoven
continu
high
volum
hfvvchv
ml
kgr
h
hemofiltr
venoven
continu
high
volum
hfvvcvhv
ml
kgr
h
decreas
vasoact
support
mortal
method
refractori
septic
shock
patient
without
renal
dysfunct
consecut
admit
icu
treat
earli
resuscit
support
bundl
accord
surviv
sepsi
campaign
ssc
hour
septic
shock
onset
randomli
assign
group
ml
kg
h
group
ml
kg
h
variabl
studi
hemodynam
paramet
arteri
pressur
heart
rate
cardiac
output
system
vascular
resist
central
venou
pressur
vasoact
drug
paramet
dose
time
norepinephrin
hourli
fluid
intak
pulmonari
renal
function
result
group
percentag
initi
dose
norepinephrin
reduc
hour
septic
shock
onset
higher
group
group
icu
mortal
seri
patient
global
higher
percentag
group
group
hospit
mortal
show
increas
point
group
point
group
global
hospit
mortal
conclus
refractori
septic
shock
patient
ssc
measur
correctli
appli
time
earli
horizont
treatment
hfvvchv
hfvvcvhv
could
improv
prognosi
refer
joannesboyau
pm
perez
p
bagshaw
sm
grand
h
canivet
jl
highvolum
versu
standardvolum
haemofiltr
septic
shock
patient
acut
kidney
injuri
ivoir
studi
multicentr
random
control
trial
intens
care
med
introduct
neutrophil
gelatinaseassoci
lipocalin
ngal
use
biomark
acut
kidney
injuri
aki
measur
serum
urin
recent
serum
ngal
report
biomark
mortal
organ
dysfunct
sepsi
post
cardiac
arrest
patient
relat
system
inflamm
therefor
measur
serum
ngal
emerg
depart
patient
tri
assess
type
pathophysiolog
relat
increas
serum
ngal
object
assess
serum
ngal
could
biomark
system
inflamm
emerg
depart
method
fortyfour
case
admit
emerg
depart
retrospect
analyz
serum
ngal
creactiv
protein
crp
white
blood
cell
count
wbc
compar
group
estim
glomerular
filtrat
rate
egfr
correl
analysi
also
perform
serum
ngal
other
result
median
age
yo
patient
male
median
valu
serum
ngal
ngml
valu
serum
ngal
signific
differ
group
egfr
ngml
egfr
ngml
ngml
vs
ngml
p
serum
ngal
crp
significantli
correl
group
egfr
ngml
r
p
conclus
serum
ngal
might
reflect
system
inflamm
patient
emerg
depart
refer
wang
b
chen
g
zhang
j
et
al
increas
neutrophil
gelatinaseassoci
lipocalin
associ
mortal
multipl
organ
dysfunct
syndrom
sever
sepsi
septic
shock
shock
grant
acknowledg
none
introduct
comatos
cardiac
arrest
survivor
extent
myocardi
damag
cardiovascular
instabl
import
role
cours
develop
post
cardiac
arrest
syndrom
predict
longterm
outcom
recent
clinic
studi
reveal
inhal
xenon
provid
benefici
cardiovascular
effect
mitig
ischem
brain
injuri
outofhospit
cardiac
arrest
ohca
patient
object
purpos
studi
assess
effect
xenon
inhal
myocardi
ischem
damag
left
ventricular
function
ohca
method
total
comatos
patient
experienc
ohca
random
receiv
either
inhal
xenon
combin
hypothermia
hour
n
xenon
group
hypothermia
treatment
alon
n
control
group
whenev
indic
coronari
angiographi
percutan
intervent
perform
intens
care
unit
admiss
later
hospit
stay
xenon
administ
least
endtid
concentr
complet
start
rewarm
troponint
tnt
measur
hospit
admiss
h
h
h
post
cardiac
arrest
left
ventricular
function
assess
echocardiographi
cardiologist
intens
care
arriv
hour
complet
rewarm
result
among
patient
comprehens
tnt
measur
avail
xenon
patient
median
age
control
patient
median
age
complet
echocardiograph
data
avail
xenon
control
patient
number
stelev
myocardi
infarct
primari
coronari
intervent
time
return
spontan
circul
cardiovascular
medic
among
baselin
characterist
differ
significantli
group
median
interquartil
rang
iqr
postarriv
increment
chang
tnt
hour
xenon
group
control
group
p
differ
group
mean
confid
interv
absolut
postarriv
increment
chang
left
ventricular
eject
fraction
hour
rewarm
xenon
group
control
group
p
differ
group
conclus
inhal
xenon
combin
mild
therapeut
hypothermia
may
protect
ischem
myocardi
injuri
demonstr
significantli
attenu
shortterm
tnt
releas
better
left
ventricular
function
compar
hypothermia
treatment
alon
observ
suggest
inhal
xenon
may
provid
cardioprotect
effect
ohca
patient
refer
arola
et
al
crit
care
med
laitio
r
et
al
jama
grant
acknowledg
studi
fund
academi
finland
clinic
research
fund
evo
hospit
district
southwest
finland
introduct
nt
probnp
doppler
echocardiographi
approv
diagnosi
heart
failur
studi
compar
contribut
ntprobnp
level
doppler
echocardiographi
find
diagnosi
decompens
congest
leftheart
failur
chf
patient
acut
dyspnea
patient
method
prospect
observ
al
studi
teach
depart
emerg
intens
care
region
hospit
zaghouan
includ
patient
sever
dyspnea
six
month
patient
underw
physic
examin
ecg
rx
thorax
ntprobnp
essay
echocardiographi
attend
cardiologist
admiss
accuraci
two
method
etiolog
diagnosi
compar
basi
final
diagnos
establish
medic
staff
result
patient
enrol
includ
chf
diagnosi
chf
due
coronari
arteri
diseas
hypertens
valv
diseas
arrhythmia
dilat
cardiomyopathi
nonchf
due
decompens
chronic
obstruct
pulmonari
diseas
pneumonia
sever
asthma
fifteen
patient
misdiagnos
admiss
mean
ntprobnp
concentr
pgml
chf
subgroup
pgml
patient
p
systol
lv
dysfunct
lvef
found
patient
chf
patient
caus
dyspnea
p
ea
ratio
deceler
time
ewav
dt
respect
group
chf
group
nonchf
p
impair
relax
restrict
mitral
pattern
observ
respect
patient
chf
two
patient
tree
patient
group
conclus
ntprobnp
assay
echocardiographi
use
diagnosi
chf
acut
dyspneic
patient
howev
echocardiographi
accur
patient
intermedi
bnp
level
note
abstract
previous
publish
avail
includ
complet
record
abstract
confer
refer
snouda
ben
ghezala
h
abb
mf
daoudi
r
kaddour
benchiekh
ntprobnp
level
echocardiographi
find
etiolog
diagnosi
acut
dyspnea
annal
intens
care
suppl
introduct
predict
mortal
major
trauma
patient
south
korea
high
mortal
late
major
trauma
south
korea
due
underdevelop
prehospit
manag
transport
system
hospit
care
system
insuffici
support
system
govern
polici
establish
oper
level
trauma
center
manag
major
trauma
patient
south
korea
earli
stage
hous
trauma
role
initi
resuscit
patient
major
trauma
import
object
studi
evalu
effect
hous
trauma
surgeon
iht
time
decis
make
major
procedur
td
time
hospit
th
time
oper
patient
major
trauma
method
retrospect
cohort
studi
use
trauma
databas
uijeonbu
st
hospit
accord
hospit
system
iht
take
trauma
patient
emerg
room
three
day
week
four
day
trauma
patient
manag
oncal
surgeon
januari
decemb
major
trauma
patient
consecut
enrol
studi
td
th
trauma
team
activ
tta
data
analyz
presenc
iht
result
patient
admit
depart
trauma
surgeri
gener
surgeri
td
th
iht
took
significantli
less
without
iht
td
minut
vs
minut
p
minut
vs
minut
p
also
iht
took
shorter
without
iht
minut
vs
minut
although
show
statist
signific
p
patient
admit
depart
orthoped
surgeri
neurosurgeri
thorac
surgeri
plastic
surgeri
td
th
iht
took
minut
lower
without
iht
minut
show
statist
signific
p
likewis
iht
took
shorter
without
iht
minut
vs
minut
show
statist
differ
p
patient
tta
td
th
took
statist
less
time
without
tta
td
minut
vs
minut
p
th
minut
vs
minut
p
howev
show
statist
differ
patient
without
tta
minut
vs
minut
p
conclus
iht
prove
import
role
deduc
td
th
initi
trauma
resuscit
refer
luchett
f
kelli
b
davi
k
johanningman
j
et
al
impact
inhous
trauma
surgeon
initi
patient
care
outcom
cost
j
trauma
mar
hell
ts
nelson
pw
shook
jw
lainhart
k
kintigh
presenc
inhous
attend
trauma
surgeon
improv
manag
outcom
critic
injur
patientsj
trauma
jul
introduct
fluid
resuscit
crucial
compon
initi
resuscit
major
burn
patient
avoid
earli
mortal
larg
amount
intraven
fluid
given
period
time
matter
parkland
formula
formula
use
fluid
resuscit
guidelin
furthermor
trend
administr
even
larger
amount
intraven
fluid
year
known
fluid
creep
phenomenon
howev
excess
intraven
fluid
would
produc
gener
lung
edema
may
preclud
wound
heal
prolong
intub
besid
guidelin
tell
us
adjust
intraven
fluid
first
hour
object
investig
impact
total
intraven
fluid
given
first
week
prognosi
method
retrospect
cohort
studi
patient
injur
taiwan
formosa
fun
coast
explos
event
admit
intens
care
unit
icu
hospit
day
includ
group
patient
admit
icu
restrict
fluid
manag
method
conduct
group
b
patient
admit
icu
liber
fluid
manag
approach
appli
compar
outcom
sepsi
insult
organ
dysfunct
intub
day
icu
day
hospit
day
group
patient
differ
fluid
manag
strategi
major
burn
patient
result
patient
includ
mean
age
total
bodi
surfac
area
burn
tbsa
burn
year
old
respect
tabl
total
intraven
fluid
first
week
group
patient
ml
much
less
group
b
patient
ml
daili
fluid
group
patient
significantli
less
day
day
tabl
compar
group
b
patient
group
patient
also
less
bodi
weight
gain
group
b
patient
fig
result
group
patient
significantli
less
day
mechan
ventil
group
b
patient
length
icu
stay
length
hospit
sepsi
insult
organ
dysfunct
similar
group
tabl
conclus
conclud
restrict
fluid
resuscit
strategi
might
shorten
period
mechan
ventil
major
burn
patient
aggress
resuscit
fluid
taper
quickli
hour
refer
saffl
ji
phenomenon
fluid
creep
acut
burn
resuscit
j
burn
care
re
grant
acknowledg
emerg
burn
team
taiwan
fun
coast
explos
event
icu
nation
taiwan
univers
hospit
introduct
time
critic
trauma
patient
care
critic
diseas
sepsi
im
decreas
time
definit
treatment
improv
patient
outcom
comput
tomographi
ct
help
us
detect
lifethreaten
lesion
time
definit
treatment
highli
relat
ct
acquisit
time
due
variat
current
literatur
consist
arriv
ct
time
establish
object
describ
time
relat
comput
tomographi
trauma
patient
well
determin
associ
factor
method
design
prospect
unicentr
previou
protocol
inclus
criteria
trauma
patient
accept
icu
februari
decemb
exclus
criteria
previou
admiss
hospit
collect
inform
demograph
characterist
sever
trauma
score
treatment
trauma
room
tr
form
use
collect
timepoint
minut
five
timeperiod
defin
admiss
tr
start
transfer
ct
start
transfer
first
imag
first
last
ct
imag
admiss
tr
first
oral
report
radiologist
admiss
tr
definit
destin
icu
oper
room
intervent
radiolog
continu
data
present
median
interquartil
rang
iqr
categor
data
percent
analys
perform
wilcoxon
test
depend
data
perform
multivari
logist
analysi
ass
factor
implic
time
use
stata
calcul
tail
pvalu
set
signific
result
patient
admit
studi
period
median
age
year
men
injuri
sever
score
iss
patient
urgent
surgeri
requir
frequent
mechan
injuri
precipit
describ
time
period
minut
median
total
bodi
strategi
achiev
subgroup
time
longer
vs
vs
p
multivari
analysi
factor
includ
sex
age
gc
relat
resuscit
factor
associ
increas
time
definit
treatment
shock
thorac
drainag
tr
p
factor
shock
thorac
drainag
whole
bodi
strategi
p
conclus
ct
acquisit
time
center
similar
center
prolong
time
associ
shock
patient
need
aggress
therapi
awar
timewast
activ
trauma
patient
could
help
us
detect
correct
delay
refer
huberwagn
et
al
effect
localis
ct
scanner
trauma
resuscit
surviv
injuri
oct
introduct
tracheal
intub
associ
signific
complic
includ
death
neurolog
injuri
patient
requir
rapid
sequenc
induct
rsi
emerg
tracheal
intub
often
critic
ill
injur
littl
physiolog
reserv
desatur
common
problem
studi
demonstr
sever
hypoxaemia
arteri
oxygen
satur
patient
emerg
rsi
perform
intens
care
unit
icu
episod
hypoxaemia
rsi
associ
wors
morbid
increas
mortal
preoxygen
intend
reduc
desatur
hypoxaemia
druginduc
apnoeic
phase
rsi
applic
oxygen
via
nasal
prong
promot
movement
oxygenenrich
air
alveoli
apnoea
help
sustain
major
studi
though
variabl
methodolog
suggest
benefit
apnoeic
oxygen
improv
apnoeic
phase
difficult
laryngoscopi
one
rct
compar
apnoeic
oxygen
standard
facemask
oxygen
prior
laryngoscopi
fail
show
benefit
apnoeic
oxygen
object
clinic
effect
studi
apnoeic
oxygen
preoxygen
strategi
reduc
episod
hypoxaemia
patient
undergo
emerg
rsi
primari
endpoint
number
patient
desatur
less
perirsi
period
method
patient
undergo
emerg
rsi
emerg
depart
ed
icu
southmead
hospit
bristol
includ
studi
southmead
hospit
region
major
trauma
neurosci
vascular
centr
addit
larg
unselect
medic
surgic
take
data
collect
includ
patient
demograph
observ
rsi
indic
rsi
data
current
standard
practic
preoxygen
via
facemask
collect
period
establish
current
rate
hypoxaemia
data
collect
subsequ
month
use
apneic
oxygen
result
total
patient
underw
emerg
rsi
studi
period
common
reason
intub
clinic
cours
failur
oxygen
failur
ventil
twentyon
complic
experienc
rsi
patient
hypoxia
common
complic
occur
patient
studi
period
patient
receiv
apnoeic
oxygen
nine
patient
receiv
apnoeic
oxygen
experienc
hypoxia
compar
patient
p
summari
incid
hypoxia
associ
emerg
rsi
unselect
patient
high
use
apnoeic
oxygen
reduc
hypoxia
druginduc
apnoeic
phase
rsi
remain
much
debat
intervent
establish
feasibl
intend
investig
util
apnoeic
oxygen
larger
patient
number
introduct
given
increas
intra
interhospit
transport
critic
ill
patient
vital
import
transport
ventil
perform
level
icu
ventil
despit
compact
design
challeng
condit
transport
object
determin
accuraci
tidal
volum
vt
plateau
pressur
pplat
posit
expiratori
pressur
peep
deliveri
gasdriven
turbin
equip
transport
ventil
differ
simul
pulmonari
condit
ventil
set
oxygen
suppli
mode
method
six
transport
ventil
gasdriven
hamilton
raphael
oxylog
medumat
transport
turbineequip
hamilton
two
icu
ventil
servoi
hamilton
test
pulmonari
condit
simul
healthi
lung
acut
respiratori
distress
syndrom
ard
chronic
obstruct
pulmonari
diseas
copd
accuraci
vt
pplat
peep
measur
calibr
pneumotachograph
percentag
differ
actual
display
valu
defin
inaccur
result
inaccuraci
vt
deliveri
demonstr
gasdriven
transport
ventil
medumat
transport
experi
oxylog
experi
hamilton
raphael
experi
well
turbineequip
ventil
experi
inaccuraci
peep
present
mainli
medumat
transport
experi
turbineequip
hamilton
experi
pplat
inaccuraci
detect
ventil
pulmonari
condit
ard
copd
ventil
set
high
peep
respiratori
rate
consist
influenc
inaccuraci
vt
influenc
deliveri
oxygen
cylind
vt
inaccuraci
present
gasdriven
ventil
oxylog
medumat
transport
ardscondit
conclus
transport
ventil
differ
accuraci
deliv
tidal
volum
demonstr
better
perform
turbin
equip
model
oxygen
suppli
cylind
limit
influenc
two
gasdriven
ventil
two
three
turbin
equip
transport
ventil
hamilton
test
show
accuraci
compar
icu
ventil
therefor
suitabl
critic
care
transport
use
mani
gasdriven
ventil
critic
care
transport
question
consid
inaccur
perform
refer
boussen
gainnier
michelet
p
evalu
ventil
use
transport
critic
ill
patient
bench
studi
respiratori
care
introduct
earli
detect
clinic
respons
determin
clinic
outcom
peopl
acut
ill
ihca
intrahospit
cardiac
arrest
often
preced
clinic
deterior
could
identifi
treat
train
personnel
news
nation
earli
warn
score
nh
nation
health
system
base
simpl
score
system
score
alloc
six
simpl
vital
sign
paramet
respiratori
rate
oxygen
satur
temperatur
systol
blood
pressur
puls
rate
level
conscious
figur
object
describ
patient
clinic
state
prior
ihca
relationship
prognosi
univers
hospit
method
retrospect
singlecent
descript
studi
conduct
analyz
patient
admit
hospit
ward
assist
ihca
team
patient
admit
less
hour
ward
patient
elig
resuscit
exclud
demograph
data
age
gender
collect
describ
type
patient
medic
surgic
featur
ihca
attent
news
level
score
low
medium
high
relat
clinic
risk
perform
evalu
data
vital
sign
regist
ward
hour
prior
ihca
statisticsqualit
variabl
express
percentag
compar
use
quantit
one
express
mean
standard
deviat
sd
analyz
use
ttest
level
signific
place
p
statist
analysi
perform
use
specif
softwar
ibm
spss
statist
window
version
armonk
ny
ibm
corp
result
patient
includ
tabl
describ
characterist
studi
popul
begin
cardiopulmonari
resuscit
cpr
maneuv
immedi
ward
accord
ihca
protocol
arriv
ihca
team
less
minut
case
figur
show
distribut
news
ihca
analyz
case
enough
inform
make
news
remain
patient
abl
perform
news
although
could
obtain
data
patient
remain
ihca
calcul
news
data
vital
sing
miss
respiratori
rate
oxygen
satur
frequent
miss
data
could
probabl
underestim
news
perform
figur
show
relationship
greater
hospit
mortal
higher
news
conclus
abnorm
vital
sign
common
within
hour
ihca
event
hospit
ward
suitabl
record
vital
sign
could
use
alert
patient
risk
anticip
detect
ihca
refer
royal
colleg
physician
nation
earli
warn
score
news
standardis
assess
acuteil
sever
nh
report
work
parti
london
rcp
introduct
conduct
retrospect
review
icu
admiss
post
cardiac
arrest
identifi
oohvf
survivor
compar
care
post
ttm
era
ilcor
standard
care
unit
guidelin
object
analys
electron
record
oohvf
patient
admit
unit
octob
juli
identifi
perform
achiev
key
compon
current
standard
postresuscit
care
adopt
target
post
rosc
unit
lo
outcom
also
collect
method
identifi
admiss
unit
post
cardiac
arrest
use
icnarc
databas
electron
record
analys
identifi
patient
admit
post
oohvf
electron
record
use
identifi
age
sex
unit
lo
estim
rosc
durat
cool
method
time
achiev
ttm
target
max
temp
record
post
rosc
presenc
rebound
hyperthermia
within
post
ttm
incid
seizur
use
anticonvuls
nmb
drug
ssep
eeg
gc
unit
discharg
unit
outcom
result
oohvf
survivor
admit
icu
audit
period
median
age
f
median
unit
lo
day
admiss
discharg
aliv
icu
patient
seizur
eeg
ssep
use
prognost
patient
requir
atracurium
prevent
shiver
ttm
period
ttm
target
achiev
within
h
post
rosc
patient
receiv
cool
via
icycath
remaind
via
surfac
method
patient
rebound
hyperthermia
within
h
post
ttm
one
patient
discharg
survivor
gc
unit
discharg
conclus
unit
adopt
control
temperatur
manag
h
post
rosc
public
ttm
trial
admiss
number
demograph
remain
unchang
adher
guidelin
good
though
receiv
iv
cool
cathet
stipul
unit
surviv
ident
audit
previous
perform
line
publish
outcom
despit
use
cool
cathet
control
temperatur
ttm
period
patient
suffer
rebound
hyperthermia
window
seem
advers
affect
mortal
use
eeg
ssep
assist
prognost
common
unit
prolong
coma
incid
seizur
common
post
ttm
phase
refer
nolan
j
et
al
ilcor
consensu
statement
resuscit
nielsen
et
alttm
vs
cardiac
arrest
nejm
grant
acknowledg
help
mr
lympani
support
dept
introduct
sudden
cardiac
death
repres
major
health
problem
adult
preval
hospit
cardiac
arrest
ohca
attend
emerg
medic
servic
per
mortal
remain
high
exce
well
document
patient
shockabl
rhythm
consist
higher
surviv
whose
initi
cardiac
rhythm
nonshock
object
aim
studi
look
outcom
cardiac
arrest
admit
tertiari
referr
servic
assess
whether
present
shockabl
rhythm
associ
better
prognosi
method
retrospect
case
note
review
one
year
period
patient
admit
golden
jubile
nation
hospit
ohca
initi
rhythm
ventricular
tachycardia
vt
ventricular
fibril
vf
includ
look
caus
cardiac
arrest
icu
surviv
depend
upon
surviv
age
length
stay
result
sixti
three
patient
identifi
full
data
set
obtain
median
age
admiss
year
age
rang
year
year
present
rhythm
either
vf
vt
cohort
patient
surviv
post
cardiac
arrest
median
length
stay
day
iq
rang
surviv
patient
went
live
independ
life
die
patient
die
admiss
intens
care
die
post
icu
discharg
interestingli
patient
whose
caus
cardiac
arrest
pure
arrhythmogen
surviv
hospit
discharg
although
number
small
n
conclus
mortal
cardiac
arrest
high
place
huge
burden
icu
servic
median
length
stay
ohca
patient
day
patient
number
studi
attribut
one
icu
bed
per
day
length
stay
thought
quantifi
difficulti
prognost
surviv
cohort
patient
particularli
come
secondari
brain
injuri
although
sampl
size
small
demonstr
surviv
ohca
shockabl
rhythm
present
rhythm
higher
quot
literatur
interestingli
patient
surviv
ohca
like
lead
independ
life
post
discharg
cardiac
arrest
caus
arrhythmogen
although
number
small
surviv
cohort
refer
templ
et
al
predict
neurolog
outcom
surviv
cardiac
arrest
anaesthesia
occurr
septic
shock
sepsi
critic
ill
patient
hospit
icu
continu
among
seriou
complic
despit
new
method
diagnosi
treatment
aim
studi
investig
effect
fever
onset
endotoxin
marker
materi
method
eighteen
polytrauma
patient
admit
icu
healthi
volunt
enrol
studi
ml
blood
collect
patient
within
h
admiss
onset
fever
f
ii
healthi
individu
h
clinic
demograph
data
record
admiss
serumplasma
sampl
isol
centrifug
store
c
lipopolysacharid
bind
protein
lbp
measur
elisa
circul
endotoxin
lal
chromatometr
assay
result
admiss
level
lbp
endotoxin
signific
differ
patient
healthi
h
p
onset
fever
f
accompani
abund
signific
lbp
releas
pfa
pfh
parallel
reduct
circul
endotoxin
pfa
pfh
conclus
increas
lbp
releas
onset
fever
could
account
marker
circul
endotoxin
follow
inflammatori
implic
trauma
patient
hospit
icu
introduct
intens
care
unit
icu
per
cutan
tracheotomi
play
vital
role
airway
manag
patient
cervic
spinal
cord
injuri
csci
retrospect
studi
evalu
favor
effect
earli
tracheotomi
patient
csci
objeticv
evalu
time
tracheotomi
patient
cervic
injuri
effect
icu
stay
method
retrospect
data
analysi
patient
csci
underw
tracheotomi
primari
object
evalu
impact
earli
tracheotomi
perform
within
week
csci
better
outcom
term
day
mechan
ventil
icu
stay
patient
high
low
csci
outcom
measur
also
compar
high
low
csci
patient
earli
tracheotomi
perform
addit
impact
earli
tracheotomi
term
surviv
benefit
ventil
depend
requir
inotrop
medic
whether
surgic
intervent
result
better
outcom
term
day
mechan
ventil
icu
stay
also
analys
result
patient
high
csci
patient
earli
tracheotomi
significantli
less
day
mechan
ventil
inotrop
support
compar
late
tracheostomi
p
p
respect
low
csci
patient
earli
tracheotomi
also
significantli
less
day
mechan
ventil
compar
late
tracheotomi
p
earli
tracheotomi
result
significantli
less
day
inotrop
support
high
csci
patient
compar
low
csci
p
trend
observ
toward
lesser
icu
stay
day
mechan
ventil
patient
high
csci
earli
tracheotomi
differ
term
surviv
benefit
ventil
depend
impact
surgeri
outcom
measur
conclus
retrospect
analysi
support
hypothesi
earli
tracheotomi
benefici
reduc
period
mechan
ventil
inotrop
support
patient
csci
irrespect
anatom
level
injuri
refer
herkowitz
hn
grafin
sr
eismont
fj
bell
gr
balderston
ra
spine
expert
consult
edit
thesleff
niskakanga
luoto
tm
ohman
j
ronkainen
fatal
cervic
spine
inuri
finnish
nationwid
regist
base
epidemiolog
studi
data
spine
j
epub
dec
tanaka
j
yugu
shiba
k
maeyama
naito
studi
risk
factor
tracheostomi
patient
cervic
spinal
cord
injuri
spine
phila
pa
nov
epub
ahead
print
grant
acknowledg
staff
khoula
icu
share
articl
introduct
sever
abdomin
sepsi
one
import
risk
factor
icu
hospit
mortal
abdomin
postop
period
object
object
analyz
icu
hospit
mortal
day
mechan
ventil
kidney
failur
pneumonia
adult
respiratori
distress
syndrom
vasoact
drug
use
also
studi
differ
temporari
abdomin
closur
neg
pressur
therapi
abthera
kci
method
analyz
patient
admit
icu
emerg
abdomin
trauma
surgeri
area
januari
januari
retrospect
studi
comper
differ
variabl
age
sex
manheim
periton
index
charlson
index
apach
ii
sofa
first
day
admiss
icu
hospit
mortal
pneumonia
day
mechan
ventil
two
group
patient
patient
primari
temporari
abdomin
closur
patient
previou
neg
pressur
assist
signific
static
result
p
level
result
patient
admit
icu
mean
apach
ii
mean
sofa
group
patient
primari
abdomin
closur
hospit
mortal
lower
patient
prymari
abdomin
closur
vs
ns
p
patient
previou
neg
abdomin
pressur
assist
longer
stay
day
vs
day
patient
without
primari
abdomin
closur
p
ns
less
day
mechan
ventil
day
vs
day
patient
without
abdomin
closur
p
pneumonia
vs
ns
nosocomi
infect
vs
p
ns
kidney
failur
rifl
score
vs
ns
conclus
studi
primari
abdomin
closur
show
less
icu
hospit
mortal
also
less
icu
complic
pneumonia
kidney
failur
although
differ
signific
static
probabl
need
bigger
sampl
observ
signific
differ
introduct
quantiti
blood
loss
liver
resect
known
predictor
poor
clinic
outcom
one
gener
use
approach
minim
blood
loss
decreas
central
venou
pressur
cvp
rational
concept
low
cvp
suppos
reduc
hepat
blood
congest
object
order
assess
blood
congest
liver
aim
evalu
influenc
positiveendexpiratorypressur
peep
posit
patient
cvp
venou
hepat
blood
flow
patient
undergo
liver
resect
analyz
correl
cvp
venou
hepat
blood
flow
paramet
method
analyz
patient
schedul
elect
liver
resect
studi
measur
cvp
quantifi
venou
hepat
hemodynam
ultrasound
assess
flow
veloc
diamet
right
hepat
vein
portal
vein
follow
maneuv
supin
posit
peep
supin
posit
peep
reversetrendelenburg
posit
peep
reversetrendelenburg
posit
peep
result
chang
supin
reversetrendelenburg
posit
accompani
signific
decreas
cvp
mmhg
vs
mmhg
p
mmhg
p
respect
reduct
peep
reversetrendelenburg
posit
decreas
cvp
mmhg
vs
mmhg
p
mmhg
p
mmhg
p
respect
peep
posit
induc
signific
chang
diamet
right
hepat
portal
vein
combin
peep
reversetrendelenburg
posit
led
signific
reduct
systol
vshv
diastol
vdhv
flow
veloc
right
hepat
vein
vshv
cm
vs
cm
p
vdhv
cm
vs
cm
p
cm
p
respect
wherea
signific
chang
flow
veloc
portal
vein
occur
maneuv
correl
cvp
diamet
flow
veloc
right
hepat
portal
vein
found
conclus
chang
central
venou
pressur
due
chang
peep
posit
correl
chang
venou
liver
blood
flow
therefor
strategi
aim
low
central
venou
pressur
maneuv
liver
resect
support
result
refer
katz
sc
shia
j
liau
kh
gonen
ruo
l
jarnagin
wr
fong
mi
blumgart
lh
dematteo
rp
oper
blood
loss
independ
predict
recurr
surviv
resect
hepatocellular
carcinoma
annal
surgeri
j
wang
wd
liang
lj
huang
xq
yin
xy
low
central
venou
pressur
reduc
blood
loss
hepatectomi
world
journal
gastroenterolog
wjg
introduct
data
report
hemodynam
variabl
associ
despit
widespread
echocardiographi
indic
assess
cardiac
function
icu
use
cardiolog
ward
although
valid
systol
longitudin
function
maps
total
isovolum
time
tivt
although
recogn
sensit
earli
marker
myocardi
perfus
mismatch
latter
cardiac
output
co
chang
patient
coronari
arteri
diseas
chronic
heart
object
sought
determin
correl
echocardiograph
systodiastol
indic
includ
tivt
maps
hemodynam
paramet
outcom
valu
mortal
cardiothorac
icu
method
local
ethic
committe
approv
studi
retrospect
analyz
data
patient
n
age
male
admit
icu
requir
echocardiographi
januari
august
patient
divid
group
patient
sever
respiratori
failur
patient
cardiac
surgeri
primari
cardiocirculatori
failur
addit
demograph
hemodynam
paramet
echocardiograph
indic
includ
maps
mmode
four
portion
mitral
annulu
eject
fraction
ef
fraction
shorten
fs
ea
ee
doppler
assess
eject
time
etaort
forward
flow
fill
time
ftmitral
inflow
tivt
calcul
total
et
total
ft
sv
co
deriv
aortic
vti
continu
variabl
compar
use
wilcoxon
ranksum
test
categor
variabl
compar
use
pearson
test
signific
differ
mortal
group
assess
use
logrank
test
result
univari
analysi
strong
invers
correl
found
tivt
maps
sv
co
univari
logist
analysi
sv
co
maps
tivt
good
predictor
day
outcom
multivari
model
along
sap
ii
hr
ic
tivt
hr
ic
maps
hr
show
independ
predictor
mortal
ef
fs
correl
echocardiograph
hemodynam
paramet
relat
outcom
found
conclus
first
studi
investig
role
echocardiograph
indic
icu
cohort
ef
valid
index
stratifi
patient
accord
systol
function
fail
correl
hemodynam
paramet
outcom
tivt
index
systodiastol
interact
correl
consequ
term
cardiac
output
variat
maps
result
sensit
paramet
reflect
cardiac
effici
outcom
refer
torgersen
ccrit
care
duncan
jacc
introduct
improv
access
central
vein
catheter
upper
bodi
region
classic
done
trendelenburg
posit
may
impos
potenti
disadvantag
respiratori
system
disturb
physiolog
statu
mani
organ
passiv
leg
rais
plr
simpl
maneuv
wide
use
improv
cardiac
preload
predict
patient
volum
respons
could
altern
object
studi
evalu
effect
plr
maneuv
right
intern
jugular
vein
rijv
diamet
intens
care
unit
patient
mechan
ventil
method
prospect
studi
twenti
patient
synchron
intermitt
mandatori
ventil
simv
without
valvular
heart
problem
heart
failur
acut
respiratori
distress
syndrom
studi
rijv
diamet
measur
bedsid
color
doppler
sonographi
neck
first
supin
posit
second
third
measur
plr
minut
measur
end
inspiratori
cycl
posit
end
expiratori
pressur
chose
plr
keep
bedridden
patient
away
possibl
damag
may
induc
higher
upward
slope
result
rijv
diamet
increas
plr
maneuv
promin
minut
comparison
minut
time
point
mean
rijv
diamet
mm
supin
mm
p
mm
p
minut
plr
maneuv
respect
increment
diamet
slightli
lower
associ
trendelenburg
posit
report
studi
complic
note
conclus
plr
maneuv
safe
consid
altern
trendelenberg
posit
increas
intern
jugular
vein
diamet
mechan
ventil
patient
refer
monnet
x
teboul
jl
passiv
leg
rais
intens
care
med
april
lee
jg
park
hb
shin
hy
et
al
effect
trendelenburg
posit
right
left
intern
jugular
vein
crosssect
area
korean
j
anesthesiol
nov
schummer
w
schummer
c
nieen
wd
gerstenberg
h
dopplerguid
cannul
intern
jugular
vein
subclavian
vein
innomin
brachiocephal
vein
case
control
comparison
patient
reduc
normal
intracrani
complianc
intens
care
med
sep
grant
acknowledg
studi
receiv
confim
ethic
committe
universitywritten
consent
obtain
patient
first
rel
author
would
like
thank
deputi
research
shiraz
univers
medic
scienc
kindli
cooper
also
thank
nurs
staff
gener
central
icu
nemaze
hospit
kind
help
introduct
assess
central
venou
pressur
cvp
fundament
critic
patient
particularli
shock
inferior
vena
cava
ivc
ultrasound
exam
suggest
predict
cvp
diverg
conclus
effect
spontan
breath
patient
object
check
level
reliabl
valid
correl
cvp
ivc
ultrasound
measur
qualiti
report
literatur
topic
method
review
base
prisma
guidelin
systemat
search
literatur
publish
june
explor
pubm
cochran
librari
web
knowledg
scopu
databas
inclus
criteria
studi
investig
reliabl
valid
predict
cvp
correl
cvp
ivc
ultrasound
measur
adult
yr
spontan
breath
patient
two
research
select
studi
use
inclus
criteria
assess
qualiti
use
stard
quada
guidelin
key
word
literatur
search
inferior
vena
cava
ultrasonographi
volum
statu
central
venou
pressur
result
collect
studi
exclud
reason
duplic
studi
includ
final
analysi
report
includ
spontan
breath
patient
mix
popul
spontan
ventil
reliabl
correl
cvp
valid
ivc
ultrasound
measur
ivc
ratio
ivc
max
diamet
ivc
min
diamet
caval
index
ivcci
show
interrat
agreement
rang
moder
good
ivc
max
diamet
signific
high
correl
cvp
diverg
conclus
ivcci
poorli
correl
ivc
ratio
ivcmax
ivcci
show
good
valid
predict
low
cvp
ivc
max
ivcci
show
good
valid
predict
high
cvp
one
studi
eight
studi
respect
stard
item
five
quada
item
conclus
report
publish
reliabl
valid
ivc
ultrasound
measur
conclus
review
confirm
anyway
qualiti
report
methodolog
studi
collect
good
ivc
max
min
diamet
seem
correl
cvp
ivc
measur
show
good
accuraci
predict
low
high
cvp
introduct
transesophag
echocardiographi
tee
standard
procedur
intens
care
patient
respiratori
insuffici
tee
often
necessari
sedat
may
lead
deterior
perform
tee
pt
alreadi
niv
via
full
face
mask
method
consecut
pt
alreadi
niv
respiratori
failur
pt
age
year
sap
ii
score
clinic
given
indic
immedi
tee
equip
full
face
mask
endoscopi
mask
vbm
medizintechnik
gmbh
sulz
germani
ventil
uniform
set
bipap
f
min
e
sedat
disoprivan
given
need
heart
rate
arteri
blood
pressur
transcutan
monitor
continu
blood
gase
taken
min
start
everi
five
min
troughout
tee
min
thereaft
indic
tee
includ
endocard
sepsi
focu
n
intracavitari
thrombu
tachyarrhythmia
n
quantif
vituim
cordi
n
result
tee
complet
pt
mean
durat
procedur
min
mean
ejectionfract
percutan
never
fell
pt
intub
within
h
mean
hr
min
map
mmhg
ph
ratio
und
mmhg
chang
significantli
p
anova
pt
tee
lead
definit
diagnosi
pt
immedi
therapi
ie
electr
cardiovers
perform
conclus
perform
experienc
physician
tee
bedsid
niv
sedat
pt
feasibl
save
introduct
electr
imped
tomographi
eit
noninvas
radiat
free
bedsid
monitor
technolog
primarili
use
detect
ventil
disord
first
experiment
data
anim
suggest
measur
central
hemodynam
within
descend
aorta
might
becom
possibl
achiev
goal
first
necessari
determin
within
eit
imag
exact
locat
aorta
object
aim
studi
improv
valid
algorithm
automat
detect
aorta
eit
use
hyperton
salin
method
ten
domest
pig
anesthet
mechan
ventil
bolu
hyperton
salin
ml
higher
conduct
blood
administ
ascend
aorta
eit
data
record
result
eit
imag
analyz
pixel
pixel
identifi
aortic
pixel
pa
bolu
caus
highest
transient
imped
peak
time
fig
complet
eit
measur
thorac
comput
tomographi
scan
ct
perform
pig
ctimag
segment
individu
relev
anatom
structur
eit
imag
reconstruct
use
greit
model
base
thorac
contour
deriv
segment
result
spatial
resolut
eit
imag
mm
pixel
result
locat
aorta
could
detect
eit
anim
show
mean
offset
mm
compar
center
true
anatom
locat
identifi
ct
fig
conclus
possibl
detect
aorta
eit
use
intraaort
bolu
hyperton
salin
misalign
locat
aorta
identifi
eit
ct
signific
offset
accur
measur
fluid
respons
need
determin
studi
refer
maisch
bohm
sh
j
et
al
heartlung
interact
measur
electr
imped
tomographycrit
care
med
f
waldmann
et
al
hyperton
salin
inject
detect
aorta
porcin
eit
accept
confer
eit
adler
arnold
jh
bayford
r
et
al
greit
unifi
approach
linear
eit
reconstruct
lung
imagesphysiol
mea
grant
acknowledg
studi
support
department
fund
depart
anesthesiolog
univers
medic
center
hamburgeppendorf
germani
introduct
capnodynam
equat
use
continu
calcul
non
shunt
pulmonari
blood
flow
coepbf
sever
hemodynam
chang
addin
encit
addin
encitedata
hypercapnia
common
clinic
state
periop
period
icu
theoret
elev
carbon
dioxid
level
could
affect
perform
capnodynam
method
object
aim
current
studi
evalu
perform
coepbf
elev
porcin
model
method
requir
alter
alveolar
concentr
carbon
dioxid
creat
ventilatori
pattern
contain
cyclic
reoccur
expiratori
hold
control
ventil
mathemat
model
use
calcul
coepbf
assum
steadi
state
level
hypercapnia
induc
three
mean
decreas
minut
ventil
either
lower
respiratori
rate
tidal
volum
final
increas
dead
space
preserv
minut
ventil
coepbf
compar
refer
method
co
ultrason
flow
probe
around
pulmonari
trunk
hemodynam
measur
blood
ga
analysi
obtain
baselin
hypercapnia
three
differ
type
hypercapnia
preload
reduct
inflat
cava
balloon
dobutamin
stimul
perform
low
respiratori
rate
increas
dead
space
result
hypercapnia
level
rais
averag
within
normal
limit
respect
bia
loa
att
baselin
induct
hypercapnia
lmin
percentag
error
pe
hypercapnia
bia
loa
lmin
pe
follow
lower
respiratori
rate
lmin
pe
tidal
volum
decreas
lmin
pe
dead
space
increas
hemodynam
chang
pe
slightli
increas
see
tabl
valu
concord
rate
see
fig
conclus
coepbf
perform
well
hypercapnia
differ
type
low
minut
ventil
increas
dead
space
perform
maintain
major
chang
cardiac
output
trend
excel
result
indic
capnodynam
method
test
lung
protect
ventil
permiss
hypercapnia
even
laparoscop
surgeri
refer
hallsjo
sander
c
hallback
wallin
emtel
p
oldner
bjorn
h
novel
continu
capnodynam
method
cardiac
output
assess
mechan
ventil
british
journal
anaesthesia
grant
acknowledg
receiv
research
grant
maquet
critic
care
introduct
echocardiographi
set
critic
ill
patient
might
hinder
due
poor
transthorac
acoust
window
modifi
subcost
window
obtain
extrathorac
region
give
us
shortaxi
parasternallik
view
level
great
vessel
object
address
consist
cardiac
output
valu
measur
modifi
subcost
view
compar
obtain
transthorac
approach
method
consecut
criticallyil
patient
undergo
transthorac
ecocardiographi
philip
sparq
initi
diagnosi
shock
subsequ
hemodynam
monitor
veloc
time
integr
puls
wave
doppler
left
ventricular
outflow
tract
vtilvot
pulmonari
flow
vtipup
vtipum
measur
apic
fourchamb
view
shortaxi
paraestern
modifi
subcost
view
respect
result
analyz
predict
perform
test
consist
analysi
interobserv
reproduc
analysi
assess
patient
repeat
measur
two
experienc
physician
use
intraclass
correl
coeffici
icc
result
baselin
characterist
includ
mean
heart
rate
beat
per
minut
age
year
male
previu
cardiac
diseas
medic
diagnosi
admiss
patient
primari
cardiac
diagnosi
mechan
ventil
patient
mean
peep
vasoact
drug
patient
mean
norepinephrin
dose
mcgkgmin
median
vtilvot
cm
interquartil
rang
iqr
vtipup
cm
iqr
vtipum
cm
iqr
comparison
vtilvot
vtipum
reveal
consist
ci
p
see
fig
vtilvot
vtipup
ci
p
see
fig
icc
observ
conclus
consist
vtilvot
vtipum
vtilvot
vtipup
moder
vtilvot
vtipum
consist
improv
exclud
patient
vtilvot
cm
vtipum
underestim
vtilvot
mean
cm
research
requir
order
assess
introduct
assess
left
ventricl
function
paramount
import
manag
patient
acut
circulatori
failur
regard
measur
left
ventricl
eject
fraction
lvef
echocardiographi
consid
gold
standard
studi
investig
correl
lvef
cardiac
function
index
cfi
calcul
transpulmonari
thermodilut
object
assess
use
cardiac
function
index
cfi
surrog
left
ventricl
eject
fraction
lvef
patient
acut
circulatori
failur
method
conduct
prospect
studi
medic
surgic
intens
care
unit
patient
admit
acut
circulatori
failur
monitor
transpulmonari
thermodilut
devic
includ
studi
exclud
patient
acut
core
pulmonal
poor
echogen
bedsid
transthorac
echocardiographi
perform
simultan
transpulmonari
thermodilut
cardiac
function
index
left
ventricl
eject
fraction
record
simultan
result
twentyon
patient
includ
studi
median
quartil
age
year
sexratio
mf
fourteen
patient
admit
septic
shock
wherea
patient
cardiogen
shock
mechan
ventil
requir
patient
median
quartil
cfi
median
quartil
lvef
spearman
coeffici
p
moreov
cfi
predict
lvef
sensit
specif
conclus
cfi
use
reliabl
tool
predict
lvef
patient
acut
circulatori
failur
refer
jabot
j
monnet
x
bouchra
l
chemla
richard
c
teboul
jl
cardiac
function
index
provid
transpulmonari
thermodilut
behav
indic
left
ventricular
systol
function
crit
care
med
comb
berneau
jb
luyt
ce
trouillet
jl
estim
left
ventricular
systol
function
singl
transpulmonari
thermodilut
intens
care
med
grant
acknowledg
none
object
hypotens
common
problem
critic
ill
patient
arteri
blood
pressur
abp
influenc
chang
intravascular
volum
cardiac
output
vascular
tone
particular
system
vascular
resist
svr
main
determin
arteri
elast
ea
svr
also
influenc
peripher
endotheli
function
eg
microcirculatori
flow
howev
data
avail
correl
paramet
set
method
prospect
studi
conduct
medicosurg
icu
sinc
januari
patient
invas
abp
monitor
requir
cardiac
output
co
monitor
fluid
challeng
fc
simultan
assess
puls
wave
analysi
pwa
system
mostcar
vygon
franc
estim
ea
incid
dark
field
idf
handheld
devic
braediu
medic
bv
netherland
evalu
sublingu
microcircul
microvascular
perfus
assess
use
proport
smallperfus
vessel
ppv
svr
calcul
accord
standard
formula
rel
chang
variabl
calcul
fc
fluid
respond
co
increas
least
baselin
result
includ
patient
age
year
male
requir
fluid
challeng
n
hypotens
n
oliguria
n
hypovolemia
baselin
mean
arteri
pressur
mmhg
heart
rate
hr
bpm
co
lmin
fluid
challeng
map
mmhg
hr
bpm
co
lmin
seven
patient
fluid
respond
correl
ppv
svr
p
ea
p
likewis
chang
svr
ea
fluid
challeng
correl
chang
ppv
p
conclus
correl
found
either
svr
elast
index
microvascular
perfus
sublingu
region
impact
microcirculatori
perfus
arteri
load
defin
introduct
monitor
system
hemodynam
victim
sever
combin
injuri
allow
outlin
volum
structur
infus
therapi
moment
invas
method
typic
use
monitor
system
hemodynam
howev
invas
monitor
imposs
extrem
limit
patient
mode
failur
exampl
pelvic
fractur
consum
cost
case
noninvas
monitor
system
hemodynam
use
option
method
object
compar
cardiac
output
measur
transthorac
doppler
sonographi
echocardiographi
echokg
materi
method
twenti
four
patient
age
enrol
studi
womenmen
traumat
brain
injuri
spinal
trauma
concomit
injuri
determin
stroke
volum
sv
cardiac
output
co
use
transthorac
doppler
sonographi
uscom
australia
transthorac
echokg
ge
vivid
q
usa
transthorac
doppler
sonographi
provid
doctor
intens
care
unit
echokg
perform
doctor
function
diagnost
result
nt
find
differ
averag
valu
sv
co
evalu
ds
echokg
ml
vs
ml
lmin
vs
lmin
conclus
usag
transthorac
doppler
sonographi
determin
system
hemodynam
valu
victim
sever
injuri
allow
receiv
measur
data
systol
discharg
cardiac
output
compar
data
transthorac
echokg
td
provid
compar
result
sv
co
measur
echokg
could
use
trauma
care
practic
introduct
transcrani
cerebr
oximetri
noninvas
method
monitor
chang
cerebr
oxygen
metabol
nearinfrar
spectroscopi
method
use
multiwavelength
radiat
nm
spectrum
photon
pass
skin
bone
brain
cerebrospin
fluid
object
aim
studi
analyz
associ
monitor
transcrani
cerebr
oximertri
morbid
mortal
patient
postresuscit
syndrom
method
studi
retrospect
analyz
data
patient
postresuscit
syndrom
data
includ
age
sex
arrest
time
locat
arrest
light
reflex
glascow
coma
scale
cerebr
oximetri
valu
compar
mean
arteri
pressur
valu
surviv
result
glascow
coma
scale
surviv
well
correl
higher
valu
cerebr
oximetri
p
conclus
studi
suggest
high
cerebr
oxygen
satur
valu
patient
postresuscit
syndrom
associ
lower
morbid
mortal
refer
associ
hemoglobin
cerebr
oxygen
neurolog
outcom
postcardiac
arrest
patient
meex
k
ameloot
c
genbrugg
dupont
b
ferdinand
j
den
c
dedeyn
crit
care
suppl
publish
onlin
march
doi
introduct
classic
central
venou
pressur
cvp
pulmonari
arteri
occlus
pressur
paop
use
surrog
volum
measurementshowev
dynam
preload
variabl
like
puls
pressur
variat
ppv
stroke
volumen
variat
svv
could
use
hepat
postresect
phase
optim
volumen
need
patient
object
aim
studi
assess
better
reduc
postop
complic
optim
hemodynam
situat
hepat
resect
guid
dynam
variabl
preload
ppv
svv
versu
use
liber
fluid
manag
method
experiment
clinic
trial
control
random
singl
blind
patient
undergo
hepat
resect
group
periop
fluid
restrict
done
mlkghour
ringer
lactat
remov
surgic
specimen
perform
affer
two
random
group
establish
control
group
fluid
colloid
administ
stabil
achivev
standard
pressur
got
map
mmhg
cvp
urin
output
ml
kg
h
group
volum
administ
svv
ppv
map
mmhg
achiev
group
volum
administ
achiev
quantifi
object
postop
complic
nausea
vomit
respiratori
infecti
complic
registr
result
patient
enrol
gdt
group
patient
control
group
statist
signific
differ
preoper
variabl
statist
signific
differ
volum
administ
resect
group
vs
p
found
surgic
time
found
correl
vpp
cvp
r
p
vss
cvp
r
p
found
good
abil
predict
respons
volum
vpp
roc
curv
vss
roc
curv
defin
improv
cardiac
output
found
decreas
complic
statist
signific
differ
respiratori
complic
vs
p
infecti
complic
vs
p
nausea
vomit
vs
p
conclus
guid
therapi
goal
gtd
abl
decreas
volum
liquid
provid
hepat
resect
fact
optim
hemodynam
valu
patient
cardiac
output
mean
arteri
pressur
therefor
reduc
postop
complic
due
excess
intak
volumen
refer
de
wolf
aggarw
monitor
preload
liver
transplant
liver
traspl
grant
acknowledg
express
gratitud
mutua
fundat
madrid
spain
grant
collabor
without
work
could
complet
introduct
critic
ill
children
expos
multipl
nephrotox
medic
due
natur
underli
diseas
process
well
comorbid
condit
acut
kidney
injuri
aki
preval
pediatr
critic
ill
nephrotoxin
exposur
potenti
modifi
risk
factor
aki
noncrit
ill
children
exposur
three
discret
nephrotox
agent
significantli
increas
odd
aki
despit
higher
inher
risk
data
aki
nephrotoxin
use
pediatr
intens
care
unit
picu
set
scarc
fluid
overload
kidney
injuri
score
foki
decis
support
tool
pilot
picu
daili
score
incorpor
subscor
aki
prifl
creatinin
urin
output
fluid
overload
total
fluid
icu
admiss
weight
exposur
nephrotox
medic
priori
determin
list
medic
object
aim
investig
aki
preval
frequenc
nephrotoxin
exposur
use
foki
subscor
method
retrospect
analysi
daili
foki
subscor
picu
patient
pt
month
aki
defin
stage
use
prifl
creatinin
criteria
nephrotoxin
exposur
exp
defin
exposur
three
nephrotox
agent
hour
addit
medic
exposur
also
record
result
pt
median
age
year
iqr
year
male
includ
month
pt
exp
picu
stay
differ
nephrotoxin
fifti
eight
percent
pt
exp
aki
r
f
compar
without
r
f
p
conclus
major
picu
pt
aki
exposur
nephrotoxin
patient
exposur
three
nephrotoxin
increas
aki
compar
patient
associ
need
studi
prospect
determin
causal
specif
explor
time
aki
onset
relat
nephrotoxin
exposur
critic
ill
pediatr
patient
cumul
nephrotoxin
exposur
possibl
modifi
aki
risk
factor
critic
ill
children
introduct
two
third
critic
ill
patient
develop
acut
kidney
injuri
aki
associ
increas
risk
death
renal
angina
index
score
evalu
risk
present
aki
object
studi
use
determin
effect
renal
angina
index
develop
predictor
aki
day
method
studi
base
prospect
cohort
critic
ill
patient
renal
angina
index
score
complet
hour
follow
serum
creatinin
level
water
balanc
urinari
output
establish
patient
develop
aki
afterward
relationship
establish
renal
angina
index
score
predict
capac
develop
aki
determin
sensibl
specif
posit
predict
valu
neg
predict
valu
score
result
final
sampl
patient
obtain
end
studi
incid
aki
studi
popul
n
averag
score
renal
angina
index
develop
aki
nt
develop
aki
score
offer
sensibl
specif
area
de
curv
posit
predict
valu
obtain
neg
predict
valu
conclus
renal
angina
index
score
effect
predict
aki
critic
ill
adult
patient
note
abstract
previous
publish
avail
includ
complet
record
abstract
confer
refer
chawla
l
goldstein
kellum
j
ronco
c
renal
agina
concept
develop
pretest
probabl
assess
acut
kidney
injuri
critic
care
basu
r
zappitelli
brunner
l
wang
wong
h
et
al
kidney
intern
basu
r
wang
wong
h
chawla
l
wheeler
goldstein
incorpor
biomark
renal
angina
index
predict
sever
aki
critic
ill
children
clin
j
soc
nephrol
aguilar
arzapalo
barrada
l
lopez
v
escalant
jimmi
g
cetina
effect
renal
angina
index
score
predict
acut
kidney
injuri
critic
ill
patient
critic
care
suppl
grant
acknowledg
hospit
introduct
incid
acut
kidney
injuri
critic
ill
patient
increas
chronic
diseas
nephrotox
drug
use
contrast
diagnostictherapeut
techniqu
contrastassoci
acut
kidney
injuri
caaki
strongli
predict
advers
outcom
object
build
statist
predict
model
evalu
probabl
develop
contrastassoci
acut
kidney
injuri
critic
patient
method
studi
endors
spanish
societi
intens
critic
emerg
care
medicin
semicyuc
data
obtain
prospect
multicent
studi
spanish
intens
care
unit
total
patient
criteria
use
defin
caaki
akin
criteria
rise
serum
creatinin
mgdl
rel
rise
creatinin
hour
contrast
exposur
predict
model
develop
employ
binari
logist
regress
use
softwar
r
roc
curv
obtain
fig
model
calibr
use
graph
model
gener
graphic
nomogram
fig
facilit
use
clinic
environ
nomogram
includ
variabl
shown
prognost
valu
result
patient
develop
caaki
predict
factor
elev
apach
ii
test
score
hemoglobin
baselin
serum
creatinin
shock
acut
myocardium
infarct
admiss
vasoact
drug
diuret
moment
contrast
administr
follow
comorbid
chronic
heart
failur
chronic
kidney
failur
signific
risk
factor
univari
analysi
select
predict
model
tabl
bootstrap
method
use
select
best
subset
risk
factor
avoid
overfit
data
correspond
roc
curv
model
fig
area
curv
auc
rang
conclus
predict
model
caaki
develop
predict
variabl
prognost
valu
hemoglobin
content
apach
ii
test
score
admiss
use
vasoact
drug
diuret
correspond
nomogram
allow
easi
evalu
probabl
develop
caaki
critic
patient
refer
host
ea
doom
de
wael
j
et
al
epidemiolog
contrastassoci
acut
kidney
injuri
patient
retrospect
cohort
analisi
intens
care
med
mcdonald
j
macdonald
r
comin
j
et
al
frequenc
acut
kidney
injuri
follow
intraven
contrast
medium
administr
systemat
review
metaanalysi
radiolog
introduct
postul
effect
continu
renal
replac
therapi
crrt
deliv
hemofiltr
might
benefit
critic
ill
patient
sepsisassoci
acut
kidney
injuri
aki
better
clear
larg
toxic
inflammatori
cytokin
object
compar
crrt
deliv
hemodialysi
associ
adsorpt
membran
crrt
deliv
septic
patient
aki
method
random
nonblind
control
trial
patient
recruit
icu
barcelona
spain
assign
one
two
arm
intervent
primari
outcom
mortal
secondari
outcom
inflammatori
cytokin
clearanc
consumpt
extracorpor
circuit
icu
hospit
lengthofstay
lo
presenc
crrt
associ
complic
dialytrauma
result
median
durat
follow
day
mean
age
year
distribut
baselin
characterist
similar
group
overal
mortal
group
cvvhdst
group
p
number
extracorpor
circuit
employ
hour
crrt
initi
group
group
p
median
extracorpor
circuit
lifespan
hour
group
group
p
respect
heparin
employ
group
group
p
mean
icu
stay
day
day
group
group
p
respect
hospit
lengthof
stay
lo
group
compar
group
p
serum
level
inflammatori
cytokin
similar
group
conclus
differ
surviv
dialytrauma
inflammatori
cytokin
clearanc
group
howev
use
associ
lower
hospit
lo
less
consumpt
extracorpor
circuit
first
hour
crrt
grant
acknowledg
feder
isciii
introduct
critic
ill
patient
acut
kidney
injuri
aki
receiv
renal
replac
therapi
rrt
high
mortal
rate
rrt
markedli
chang
metabol
macro
micronutri
may
caus
malnutrit
result
impair
renal
recoveri
patient
surviv
object
aim
examin
predict
role
macro
micronutri
surviv
renal
outcom
critic
ill
patient
undergo
continu
rrt
crrt
method
prospect
observ
studi
enrol
critic
ill
patient
requir
crrt
intens
care
unit
king
chulalongkorn
memori
hospit
novemb
novemb
serum
urin
effluent
fluid
serial
collect
first
three
day
calcul
protein
metabol
includ
dietari
protein
intak
dpi
nitrogen
balanc
normal
protein
catabol
rate
npcr
serum
zinc
selenium
copper
measur
micronutri
analysi
first
three
day
crrt
survivor
defin
aliv
day
initi
crrt
dialysi
statu
day
also
determin
result
critic
ill
patient
requir
crrt
patient
surviv
day
dpi
serum
albumin
survivor
significantli
higher
nonsurvivor
vs
gkgday
p
vs
gdl
p
respect
marker
compar
dpi
alon
predict
patient
surviv
area
curv
auc
combin
clinic
model
predict
surviv
auc
adjust
differ
albumin
level
clinic
sever
score
apacheii
sofa
score
serum
creatinin
initi
crrt
dpi
still
independ
predict
surviv
odd
ratio
p
serum
level
micronutri
group
compar
unalt
follow
crrt
regard
renal
outcom
patient
dialysisindepend
group
higher
serum
albumin
level
dialysisdepend
group
p
conclus
critic
ill
patient
requir
crrt
dpi
good
predictor
patient
surviv
serum
albumin
good
prognost
renal
outcom
grant
acknowledg
fund
ratchadapisek
sompoch
research
grant
chulalongkorn
univers
note
abstract
previous
publish
avail
includ
complet
record
abstract
confer
refer
kriemetapak
k
peerepornratana
srisaway
n
et
al
impact
macroand
micronutri
predict
outcom
critic
ill
patient
requir
continu
renal
replac
therapi
plo
one
http
introduct
hydroxyethylstarch
he
part
tripl
htherapi
prophylaxi
therapi
vasospasm
patient
suffer
subarachnoid
haemorrhag
sah
ema
restrict
use
he
base
studi
show
signific
increas
renal
failur
septic
critic
ill
patient
receiv
he
compar
crystalloid
fluid
therapi
still
lack
data
examin
occurr
renal
insuffici
nonsept
patient
group
object
purpos
studi
evalu
effect
he
renal
function
sah
patient
receiv
larg
amount
he
context
tripl
h
therapi
method
medic
record
patient
present
januari
decemb
nontraumat
sah
analys
patient
divid
two
group
base
administr
he
andor
n
vs
control
receiv
crystalloid
fluid
therapi
n
primari
outcom
acut
kidney
injuri
aki
assess
use
rifl
criteria
refer
increas
serum
creatinin
andor
oliguria
result
studi
group
similar
baselin
characterist
except
sap
score
incid
vasospasm
icu
lo
patient
receiv
he
fulfil
significantli
often
sepsi
criteria
patient
he
group
aki
time
icu
stay
compar
control
p
patient
need
renal
replac
therapi
signific
differ
group
control
group
vs
he
group
p
conclus
nontraumat
sah
associ
aki
he
therapi
use
he
fluid
replac
therapi
might
less
risk
nonsept
critic
ill
patient
refer
muench
e
horn
p
bauhuf
c
roth
h
philipp
hermann
p
quintel
schmiedek
p
vajkoczi
p
effect
hypervolemia
hypertens
region
cerebr
blood
flow
intracrani
pressur
brain
tissu
oxygen
subarachnoid
hemorrhag
crit
care
med
sen
j
belli
albon
h
morgan
l
petzold
kitchen
n
tripleh
therapi
manag
aneurysm
subarachnoid
haemorrhag
lancet
neurolog
mayor
ema
confirm
hydroxyethyl
starch
solut
use
critic
ill
sepsi
burn
patient
bmj
clinic
research
ed
bellomo
r
ronco
c
kellum
ja
mehta
rl
palevski
p
acut
dialysi
qualiti
initi
acut
renal
failur
definit
outcom
measur
anim
model
fluid
therapi
inform
technolog
need
second
intern
consensu
confer
acut
dialysi
qualiti
initi
adqi
group
crit
care
object
studi
preval
factor
relat
develop
earli
aki
day
late
aki
day
method
critic
burn
patient
studi
period
year
resuscit
resuscit
protocol
guid
transpulmonari
thermodilut
monitor
lactic
acid
level
resuscit
phase
artifici
colloid
use
low
dosesth
incid
aki
accord
akin
criteria
earli
aki
defin
day
recoveri
progress
late
aki
relat
factor
develop
comorbid
sever
score
need
mechan
ventil
develop
shock
mortal
studi
descript
analysi
kruskallw
test
perform
result
averag
total
bodi
surfac
area
tbsa
burn
mean
age
year
mean
absi
score
median
total
volum
need
first
hour
mlkg
patient
develop
aki
stage
ii
iii
patient
develop
earli
aki
stage
ii
iii
differ
comorbid
en
aki
earli
aki
late
aki
patient
differ
late
aki
aki
patient
late
aki
patient
older
vs
p
tbsa
burn
vs
p
present
wors
sever
score
absi
vs
p
sofa
day
vs
p
sofa
day
vs
p
present
greater
need
mechan
ventil
vs
p
preval
shock
vs
p
mortal
vs
p
aki
patient
differ
studi
factor
differ
earli
late
aki
patient
aki
earli
aki
patient
except
mortal
vs
p
patient
earli
aki
return
basal
valu
day
continu
akin
day
increas
akin
ii
level
akin
iii
two
patient
one
aliv
anoth
dead
recov
basal
valu
conclus
patient
without
aki
similar
characterist
patient
develop
earli
aki
patient
develop
late
aki
older
tbsa
burn
wors
sever
score
greater
need
mechan
ventil
present
preval
shock
higher
mortal
one
third
earli
aki
patient
recov
normal
valu
day
recov
normal
valu
discharg
introduct
acut
normovolem
hemodilut
anh
use
artifici
colloid
starch
solut
common
techniqu
reduc
requir
allogen
blood
transfus
controversi
especi
concern
renal
function
much
data
exist
influenc
starch
set
hemodilut
renal
function
microvascular
perfus
object
present
studi
design
investig
impact
anh
renal
cortex
microcirculatori
flow
distribut
shortterm
function
consequ
system
renal
hemodynam
oxygen
method
fulli
instrument
femal
yorkshir
pig
kg
divid
two
group
hemodilut
n
anh
control
ctr
group
n
hemodilut
perform
replac
blood
he
solut
hydroxyethyl
starch
voluven
freseniu
kabi
till
hematocrit
level
reach
cardiac
output
co
mean
arteri
pressur
map
central
venou
blood
pressur
cvp
pulmonari
arteri
pressur
pap
system
vascular
resist
svr
heart
rate
hr
monitoredth
right
kidney
expos
flow
probe
transon
system
inc
place
around
renal
arteri
measur
renal
blood
flow
rbf
renal
cortex
microcirculatori
flow
distribut
measur
laser
speckl
imag
moor
instrument
uk
result
despit
map
cvp
stabl
entir
studi
found
hr
anh
group
vs
ctr
group
p
co
anh
group
vs
ctr
group
p
increas
pap
anh
group
vs
ctr
p
decreas
significantli
hct
compar
ctr
oxygen
deliveri
chang
svr
anh
group
vs
ctr
group
p
oxygen
consumpt
anh
group
vs
ctr
group
p
anh
group
vs
ctr
group
p
found
lower
control
rbf
increas
mlmin
anh
group
mlmin
ctrl
group
p
accompani
slightli
right
shift
histogram
signific
chang
mean
flux
valu
kidney
found
fig
differ
found
creatinin
clearanc
tubular
sodium
reabsorpt
fraction
sodium
excret
kidney
hct
anh
ctr
group
conclus
studi
show
anh
use
he
caus
reduct
system
oxygen
consumpt
sustain
oxygen
deliveri
maintain
increas
co
anh
he
also
caus
increas
rbf
chang
microvascular
perfus
flow
heterogen
kidney
present
studi
demonstr
deleteri
effect
he
renal
function
microvascular
perfus
set
sever
anh
grant
acknowledg
studi
support
dutch
kidney
foundat
innov
grant
introduct
requir
magnesium
mg
supplement
increas
region
citrat
anticoagul
rca
citrat
act
chelat
bival
cation
within
blood
circuit
level
magnesium
commerci
avail
fluid
continu
renal
replac
therapi
crrt
may
suffici
prevent
hypomagnesemia
object
test
dialysishaemofiltr
fluid
mg
concentr
mmoll
variou
common
set
crrt
rca
method
patient
n
cvvh
n
cvvhdf
rrt
dosag
mlh
blood
flow
qb
mlmin
rca
modal
trisodium
citrat
use
calcium
free
fluid
mmoll
mg
magnesium
substitut
observ
switch
calciumfre
fluid
magnesium
level
mmoll
n
extra
magnesium
replenish
patient
renal
indic
crrt
treat
devic
filter
postfilt
ioniz
calcium
endpoint
mmoll
prefilt
citrat
dosag
high
level
mg
fluid
qb
dosag
citrat
crrt
consequ
escal
h
step
test
variou
set
result
median
balanc
mg
mmolh
mg
mmoll
mmolh
fluid
mg
mmoll
use
close
zero
mmolh
higher
blood
flow
dosag
citrat
increas
mmolh
mlh
high
magnesium
contain
fluid
p
arteri
level
mg
mildli
increas
chang
high
level
magnesium
contain
fluid
p
conclus
compar
ordinari
dialysi
fluid
mildli
hypermagnesem
fluid
provid
even
balanc
adequ
level
within
ordinari
configur
crrt
rca
without
need
extra
magnesium
replenish
note
abstract
previous
publish
avail
includ
complet
record
abstract
confer
refer
zakharchenko
leden
p
rulisek
j
lo
f
brodska
h
balik
ioniz
magnesium
region
citrat
anticoagul
continu
renal
replac
therapi
blood
purif
zakharchenko
lo
f
brodska
h
balik
effect
high
level
magnesium
dialysissubstitut
fluid
magnesium
homeostasi
region
citrat
anticoagul
critic
ill
plo
one
http
grant
acknowledg
support
part
esicm
stoutenbeek
award
introduct
undetect
decreas
blood
flow
known
factor
decreas
circuit
lifespan
continu
venoven
cvvh
connect
cvvh
line
circuit
extracorpor
membran
oxygen
ecmo
may
allow
stabl
blood
flow
possibl
increas
circuit
lifespan
compar
convent
cvvh
realiz
use
central
venou
cathet
cvc
object
assess
lifespan
cvvh
connect
ecmo
circuit
compar
convent
cvvh
use
central
venou
cathet
method
singlecent
prospect
studi
patient
requir
cvvh
acut
kidney
injuri
elig
inclus
group
patient
without
ecmo
receiv
cvvh
cvc
c
group
compar
patient
receiv
ecmo
e
group
cvvh
line
connect
ecmo
circuit
circuit
lifespan
measur
connect
session
discontinu
reason
end
cvvh
classifi
follow
effect
session
primari
clot
circuit
unsuit
inflow
outflow
line
pressur
cvvhrelat
end
session
nrce
session
patient
record
includ
data
relat
cvvh
record
time
initi
cvvh
hour
primari
endpoint
lifespan
circuit
result
present
median
interquartil
rang
iqr
absolut
number
proport
statist
analysi
use
mannwhitney
u
test
two
way
independ
anova
comparison
multipl
measur
differ
time
timetoev
group
estim
use
kaplan
meier
analysi
logrank
test
result
januari
may
patient
includ
group
session
cvvh
record
e
group
c
group
session
interrupt
prematur
nrce
leav
episod
respect
e
c
group
analyz
circuit
lifespan
circuit
lifespan
statist
increas
e
group
compar
c
group
median
lifespan
cvvh
circuit
respect
h
vs
h
e
c
group
rel
risk
session
end
ci
log
rank
p
fig
cvvh
blood
flow
higher
stabl
throughout
session
e
group
p
fig
median
heparin
dose
use
anticoagul
higher
c
group
p
fig
without
effect
activ
partial
thromboplastin
time
aptt
session
conclus
experi
connect
cvvh
line
ecmo
associ
increas
lifespan
cvvh
circuit
direct
connect
cvvh
circuit
ecmo
allow
higher
blood
flow
refer
icm
cc
resuscit
introduct
continu
venoven
hemofiltr
cvvh
use
renal
replac
critic
ill
patient
acut
kidney
injuri
aki
unfortun
substrat
remov
aselect
previou
studi
shown
substanti
loss
amino
acid
aa
ultrafiltr
howev
none
studi
investig
loss
amino
acid
due
adsorpt
filter
membran
object
quantifi
total
loss
amino
acid
predilut
cvvh
critic
ill
patient
includ
loss
ultrafiltr
uf
adsorpt
ad
secondli
determin
siev
coeffici
differ
amino
acid
method
prospect
observ
studi
critic
ill
patient
aki
receiv
predilut
cvvh
blood
mlmin
predilut
flow
mlh
freseniu
polysulfon
membran
ultraflux
av
amino
acid
measur
arteri
plasma
postfilt
plasma
ultrafiltr
baselin
start
new
cvvh
session
measur
high
perform
liquid
chromatographi
hplc
calcul
total
aa
loss
aa
filter
aa
filter
ghour
loss
ultrafiltr
uf
aa
uf
gl
quf
lh
loss
adsorpt
ad
total
loss
loss
ufsiev
coeffici
aa
uf
aa
prefilt
aa
postfilt
result
mean
age
year
apach
ii
score
nutrit
enter
patient
parenter
patient
receiv
nutrit
shock
total
aa
loss
mgh
aa
loss
ultrafiltr
mgh
aa
loss
adsorpt
mgh
start
cvvh
shown
fig
patient
nr
acut
ischem
liver
failur
greatest
loss
amino
acid
total
amino
acid
loss
p
loss
ultrafiltr
p
loss
adsorpt
p
chang
cours
cvvh
estim
median
amino
acid
loss
gday
shown
tabl
siev
coeffici
amino
acid
near
siev
coeffici
glutam
acid
taurin
tryptophan
ornithin
lower
conclus
cvvh
modern
polysulfon
membran
estim
amino
acid
loss
gday
total
loss
consist
loss
ultrafiltr
loss
adsorpt
loss
uf
adsorpt
stabl
first
amino
acid
loss
higher
report
previous
loss
adsorpt
measur
introduct
volum
resuscit
mainstay
treatment
type
shock
especi
hypovolem
hemorrhag
septic
shock
although
increas
amount
research
within
last
decad
order
evalu
optim
amount
composit
fluid
volum
resuscit
eg
colloid
crystalloid
red
blood
cell
transfus
albumin
fresh
frozen
plasma
result
remain
inconclus
extent
contradict
object
evalu
impact
amount
type
fluid
administ
use
renal
replac
therapi
rrt
outcom
method
singlecentr
retrospect
observ
studi
analys
patient
chart
medic
surgic
icu
univers
hospit
basel
result
retrospect
analys
type
amount
fluid
administ
within
first
hour
icu
admiss
patient
receiv
continu
venoven
hemodiafiltr
rrt
hemodialysi
surgic
medic
icu
basel
univers
hospit
period
total
icu
patient
underw
rrt
januari
decemb
median
durat
day
interquartil
rang
iqr
day
found
signific
differ
compar
patient
surviv
patient
death
among
age
p
sap
ii
score
total
volum
within
first
hour
icu
fluid
balanc
second
third
h
p
p
also
balanc
discharg
p
patient
die
annual
mortal
vari
averag
p
number
rrt
icu
chang
studi
period
he
administ
patient
number
hesreceiv
patient
decreas
final
patient
patient
given
he
receiv
intraven
fluid
within
first
hour
p
noradrenalin
p
signific
higher
fluid
balanc
measur
timepoint
mortal
patient
without
he
administr
lower
receiv
he
vs
p
phicram
v
conclus
contrari
expect
rate
renal
replac
therapi
decreas
last
year
despit
abandon
administr
he
solut
nevertheless
administr
he
associ
higher
mortal
addit
high
fluid
load
posit
balanc
highli
associ
mortal
research
need
evalu
relationship
high
mortal
higher
amount
administ
fluid
base
correl
causat
refer
rochwerg
b
et
al
intens
care
med
haas
n
et
al
bmj
introduct
current
continu
renal
replac
therapi
crrt
guidelin
recommend
deliveri
dose
mlkghr
previou
studi
shown
tendenc
higher
intens
dose
requir
new
queen
elizabeth
univers
hospit
glasgow
qeuhg
merg
three
intens
care
unit
icu
practic
new
unit
yet
evalu
object
determin
deliv
dose
crrt
patient
icu
number
length
break
deliveri
choic
filtrat
fluid
method
patient
receiv
crrt
icu
qeuhg
may
decemb
sampl
patient
examin
effluent
dose
collect
electron
patient
record
epr
normalis
patient
weight
time
crrt
prescript
interrupt
deliveri
crrt
includ
note
reason
break
choic
filtrat
fluid
also
retriev
result
patient
receiv
hour
crrt
period
daili
prescript
complet
case
prescript
complet
case
crrt
requir
prior
review
ward
round
median
prescrib
dose
mlkghr
day
saw
recommend
dose
deliv
patient
day
studi
patient
receiv
dose
lower
mlkghr
anoth
day
patient
receiv
greater
mlkghr
median
deliv
dose
mlkghr
greater
variat
prescript
deliveri
note
first
day
crrt
break
crrt
constitut
total
hour
examin
frequent
reason
clot
filter
averag
filter
lifespan
hour
last
maximum
hour
prismasol
filtrat
fluid
use
hour
spent
crrt
conclus
rate
daili
prescript
poor
complet
prescript
show
reason
adher
recommend
dosag
suggest
may
role
prompt
completereassess
prescript
within
epr
day
saw
correct
dose
crrt
deliv
may
break
crrt
adjust
prescrib
dose
lead
underdos
higher
prescript
context
anticip
disrupt
may
reduc
underdos
howev
would
worsen
case
higherintens
deliveri
work
requir
understand
reason
highintens
prescript
deliveri
improv
anticoagul
may
reduc
break
crrt
deliveri
improv
filter
lifespan
could
reduc
workload
cut
cost
potenti
improv
patient
outcom
refer
ostermann
forni
l
acut
renal
replac
therapi
guidelin
provis
intens
care
servic
ficmic
p
black
e
chalmer
j
walli
c
cole
behalf
sic
traine
audit
share
group
renal
replac
therapi
scottish
critic
care
unit
nation
audit
practic
j
intens
care
soc
feb
introduct
high
flow
nasal
cannula
hfnc
noninvas
respiratori
support
posit
modifi
clinic
outcom
hypoxem
acut
respiratori
failur
arf
patient
avail
data
suggest
hfnc
support
induc
number
physiolog
benefit
convent
oxygen
therapi
howev
littl
known
correl
physiolog
effect
hfnc
flow
rate
object
aim
studi
disclos
whether
physiolog
effect
hfnc
linearli
nonlinearli
follow
increas
flow
rate
method
perform
prospect
random
crossov
studi
hypoxem
arf
patient
mmhg
noninvas
oxygen
support
set
obtain
facial
mask
left
unchang
throughout
studi
patient
underw
four
random
step
last
minut
facial
mask
ga
flow
lmin
vs
hfnc
lmin
phase
assess
ga
exchang
lung
volum
electr
imped
tomographi
inspiratori
effort
esophag
pressur
data
measur
step
compar
use
oneway
anova
best
fit
linear
vs
nonlinear
correl
assess
lower
inform
criterion
aic
valu
result
patient
yearold
five
femal
enrol
mmhg
higher
flow
rate
tabl
improv
p
ph
nt
vari
endexpiratori
lung
volum
increas
p
peak
expiratori
flow
pef
decreas
suggest
posit
expiratori
pressur
effect
increas
expiratori
resist
andor
improv
respiratori
system
complianc
respiratori
rate
rr
decreas
p
tidal
volum
vt
nt
chang
p
anyway
yield
decreas
minut
ventil
mv
p
correct
minut
ventil
mvcorr
mv
mmhg
p
indic
enhanc
remov
final
esophag
pressur
swing
pressuretim
product
ptpe
decreas
p
aic
linear
correl
flow
rate
lower
rr
pef
improv
aerat
effect
oxygen
constantli
increas
flow
nonlinear
aic
lower
mv
mvcorr
ptpe
possibl
suggest
improv
washout
upper
airway
dead
space
consequ
patient
effort
alreadi
obtain
lmin
conclus
hfnc
induc
multipl
benefici
physiolog
effect
might
delay
respiratori
decompens
improv
clinic
outcom
howev
effect
linearli
increas
hfnc
flow
select
might
person
target
clinic
relev
physiolog
derang
refer
papazian
et
al
intens
care
med
grant
acknowledg
department
introduct
cip
appear
frequent
icu
occur
patient
extub
cip
caus
poor
airway
clearanc
due
respiratori
muscl
weak
lead
respiratori
failur
reintub
reintub
increas
sever
ill
independ
risk
nosocomi
pneumonia
increas
hospit
stay
mortal
current
standard
treatment
includ
respiratori
physiotherapi
manual
assist
cough
howev
respiratori
failur
still
occur
patient
within
hour
plan
extub
though
conduct
studi
evalu
patient
cip
effici
mie
devic
prevent
respiratori
failur
hour
extub
mie
noninvas
technic
assist
respiratori
physiotherapi
aim
suction
tracheal
mucu
mie
evalu
neuromuscular
diseas
patient
shown
increas
peak
expiratori
flow
improv
airway
clearanc
object
primari
outcom
incid
respiratori
failur
extub
secondari
outcom
reintub
ratemean
length
stay
icumort
day
method
medic
icu
univers
hospit
conduct
prospect
random
open
studi
two
parallel
group
intub
patient
screen
medic
research
council
mrc
muscular
test
patient
diagnos
cip
mrc
score
equal
patient
cip
without
exclus
criteria
random
studi
treatment
period
patient
receiv
two
daili
session
mie
plu
manual
assist
cough
standard
treatment
manual
assist
cough
result
patient
includ
three
year
standard
group
mie
group
differ
two
group
baselin
result
show
differ
primari
outcom
p
respiratori
failur
standard
group
mie
group
secondari
outcom
found
statist
differ
concern
reintub
vs
mean
length
stay
icu
vs
day
mortal
day
vs
conclus
studi
demonstr
superior
mie
devic
prevent
postextub
respiratori
failur
icu
patient
cip
refer
bach
jr
smith
wh
michael
j
et
al
airwaiy
secret
clearanc
mechan
exsuffl
post
poliomyelisti
ventil
assist
individualsarch
phi
med
rehabil
de
jongh
b
sharshar
lefaucheur
jp
et
al
paresi
acquir
intens
care
unit
prospect
multicent
studi
introduct
nois
associ
morbid
mortal
critic
ill
patient
relat
sleep
fragment
delirium
primarili
ventil
devic
gener
nois
impact
effect
techniqu
exampl
noninvas
cpap
devic
high
nasal
flow
wide
use
icu
object
evalu
intens
nois
level
perceiv
patient
compar
differ
nois
intens
sever
differ
devic
noninvas
respiratori
support
differ
level
assist
method
made
patient
acut
respiratori
failur
pulmonari
dummysimul
spontan
breath
connect
differ
devic
cpap
high
flow
system
lmin
studi
model
noninvas
cpap
wisperflowvit
sign
hf
starm
intersurg
vigon
devic
high
flow
whisperflow
high
flow
gener
fisher
paykel
flow
measur
ohmeda
volum
monitor
intens
sound
measur
ear
level
use
speedlink
microphon
audio
signal
record
second
wav
format
khz
three
measur
perform
level
assist
devic
nois
intens
obtain
spectral
power
psd
sound
pressur
wave
han
window
fast
fourier
transform
use
psd
report
decibel
sound
pressur
level
db
spl
khz
db
spl
log
p
intens
stimulu
refer
intens
threshold
human
hear
frequenc
khz
analysi
perfom
softwar
matlab
maximum
mean
sd
spectral
powerfrequ
signal
comparison
perform
analysi
varianc
multipl
sampl
result
tabl
show
measur
nois
intens
level
devic
support
leve
studi
figur
show
power
spectral
dbkhz
signal
level
repres
devic
cpap
high
nasal
flow
boussignac
cpap
hf
ventumask
produc
highest
level
nois
dbkhz
high
cpap
level
lowest
nois
level
produc
high
flow
nasal
lmin
dbkhz
max
nois
intens
increas
proport
flow
conclus
result
suggest
devic
studi
noisiest
valveboussignac
ventumask
nois
intens
increas
proport
flow
regardless
level
appli
pressur
less
noisi
devic
lmin
nois
rel
flow
gener
use
refer
figueroaramo
mi
icm
milbrandt
eb
ccm
e
wesley
eli
jama
k
neonatolog
introduct
high
flow
nasal
cannula
hfnc
emerg
support
therapi
patient
acut
respiratori
failur
howev
accord
berlin
definit
unclear
whether
patient
acut
hypoxemia
bilater
opac
fulli
explain
cardiac
failur
treat
hfnc
consid
acut
respiratori
distress
syndrom
ard
patient
object
examin
whether
hfnc
patient
acut
hypoxemia
bilater
opac
treat
hfnc
ard
patient
directli
mechan
ventil
similar
term
lung
epitheli
endotheli
inflammatori
biomark
method
prospect
multicent
studi
three
univers
tertiari
hospit
enrol
intub
nonintub
patient
admit
icu
acut
hypoxemia
bilater
opac
hfnc
mechan
ventil
initi
discret
attend
physician
measur
plasma
biomark
lung
epitheli
receptor
advanc
glycat
endproduct
rage
surfact
protein
spd
endotheli
injuri
inflamm
interleukin
il
solubl
suppress
within
first
hour
ard
onset
propens
score
match
perform
use
differ
variabl
apach
ii
sofa
origin
ard
need
vasopressor
nonhypoxem
mechan
ventil
critic
ill
patient
healthi
volunt
serv
control
result
enrol
patient
intub
treat
hfnc
ard
onset
patient
initi
treat
hfnc
lower
apach
ii
vs
p
sofa
score
vs
p
less
like
develop
shock
icu
stay
vs
p
propens
score
match
hnfc
patient
vs
mv
patient
signific
differ
observ
rage
spd
match
patient
treat
hfnc
ard
onset
intub
match
differ
mortal
length
stay
observ
biomark
except
higher
group
match
ard
patient
control
group
conclus
acut
hypoxem
patient
bilater
infiltr
treat
hfnc
present
similar
pattern
biomark
inflamm
injuri
compar
ard
patient
directli
mechan
ventil
result
suggest
hfnc
patient
may
consid
ard
patient
grant
acknowledg
studi
support
grant
instituto
de
salud
carlo
iiifed
spanish
foundat
critic
patient
feec
fisher
paykel
support
postdoctor
fellow
medic
research
hospit
del
mar
institut
jrm
receiv
travel
expens
fisher
paykel
introduct
critic
ill
patient
acut
respiratori
failur
arf
undergo
bronchoscopi
increas
risk
hypoxemiarel
complic
previou
studi
shown
awak
hypoxem
patient
noninvas
ventil
help
prevent
hypoxemia
bronchoscop
procedur
recent
highflow
nasal
cannula
hfnc
therapi
use
improv
oxygen
patient
arf
howev
minim
data
evalu
use
high
flow
nasal
cannula
undergo
bronchoscopi
bronchoalveolar
lavag
bal
object
studi
investig
feasibl
safeti
highflow
nasal
cannula
hfnc
oxygen
therapi
arf
adult
patient
undergo
bronchoscopi
bal
method
identifi
patient
suspect
pneumonia
hypoxem
arf
admit
medic
intens
care
unit
receiv
hfnc
therapi
undergo
bronchoscopi
bal
may
march
dankook
univers
hospit
medic
record
review
retrospect
result
subject
includ
men
women
mean
age
year
rang
patient
success
complet
bal
hfnc
patient
requir
endotrach
intub
bal
two
patient
requir
endotrach
intub
mechan
ventil
hour
bal
respect
etiolog
acut
respiratori
failur
bacteri
pneumonia
influenza
pneumonia
pneumonia
due
undefin
pathogen
diffus
alveolar
hemorrhag
acut
exacerb
idiopath
pulmonari
fibrosi
hfnc
initi
mean
rang
flow
lmin
rang
lmin
mean
baselin
rang
mm
hg
end
procedur
rang
chang
mean
blood
pressur
heart
rate
respiratori
rate
valu
induc
procedur
reach
signific
p
conclus
applic
hfnc
safe
effect
altern
intub
accomplish
bronchoscopi
bal
patient
hypoxem
arf
refer
antonelli
et
al
noninvas
positivepressureventil
via
face
mask
bronchoscopi
bal
highrisk
hypoxem
patient
chest
ricard
jd
high
flow
nasal
oxygen
acut
respiratori
failur
minerva
anestesiol
introduct
although
sever
approach
provid
supplement
oxygen
suggest
best
option
patient
acut
respiratori
failur
remain
unclear
object
studi
effect
hfnc
ard
method
chose
patient
ard
studi
averag
year
patient
treat
hfnc
pla
icu
accord
berlin
standard
patient
divid
mild
moder
ard
group
case
sever
ard
group
case
order
detect
effect
hfnc
record
respiratori
frequenc
h
treatment
hfnc
well
failur
rate
group
result
failur
rate
mild
moder
ard
group
percent
hfnc
nt
caus
signific
chang
group
p
respiratori
frequenc
patient
group
amelior
h
due
hfnc
treatment
p
result
better
long
treatment
hfnc
significantli
higher
h
p
sever
ard
group
failur
rate
percent
statist
signific
treatment
hfncthe
respiratori
frequenc
could
amelior
proceed
hfnc
treatment
p
h
p
achiev
normal
level
p
conclus
hfnc
amelior
symptom
mild
moder
ard
effect
sever
ard
nt
certain
symptom
patient
must
monitor
frequent
order
avoid
miss
chanc
intub
refer
nishimura
highflow
nasal
cannula
oxygen
therapi
adult
physiolog
benefit
indic
clinic
benefit
advers
effect
respir
care
masaji
nishimura
highflow
nasal
cannula
oxygen
therapi
adult
j
nishimura
journal
intens
care
chiumello
gotti
c
chiurazzi
highflow
nasal
cannula
oxygen
therapi
physiolog
effect
clinic
data
jl
vincent
ed
annual
updat
intens
care
emerg
medicin
doi
laurent
papazian
amanda
corley
dean
hess
et
alus
highflow
nasal
cannula
oxygen
icu
adult
narr
review
j
intens
care
med
doi
lemial
v
mokart
rescherigon
et
al
effect
noninvas
ventil
vs
oxygen
therapi
mortal
among
immunocompromis
patient
acut
respiratori
failur
random
clinic
trial
j
jama
introduct
oxygen
therapi
one
popular
treatment
icu
typic
use
oxygen
mask
give
oxygen
patient
breath
spontan
howev
ordinari
oxygen
mask
risk
lower
flow
rate
less
lmin
bench
studi
investig
use
open
face
mask
atom
medic
japan
allevi
risk
rebreath
still
deliv
rel
high
result
show
open
face
mask
mitig
safeti
concern
provid
higher
inspir
oxygen
lower
inspir
carbon
dioxid
reduct
ordinari
mask
imj
japan
result
present
congress
wfsiccm
object
hypothes
use
open
face
mask
better
spontan
breath
patient
need
oxygen
ordinari
mask
give
patient
better
oxygen
clearanc
method
studi
perform
among
icu
patient
suffer
mild
respiratori
failur
appli
mask
ordinari
open
face
mask
variou
flow
rate
lmin
three
minut
respect
first
tri
ordinari
mask
lmin
minut
decreas
flow
lmin
everi
three
minut
patient
whose
achiev
lmin
oxygen
exclud
respiratori
paramet
respiratori
rate
rr
endtid
record
end
flow
rate
measur
via
capnostreamtm
medtron
us
next
investig
open
face
mask
manner
appli
lmin
oxygen
minut
final
check
patient
satisfact
mask
use
visual
analogu
scale
va
end
trial
use
wilcoxon
matchedpair
signedrank
test
detect
signific
differ
two
group
result
data
patient
analys
median
age
rang
patent
underw
oper
cardiovascular
surgeri
orthopaed
surgeri
abdomin
surgeri
patient
receiv
oper
congest
heart
failur
group
use
open
face
mask
show
higher
mean
vs
p
lower
vs
p
vs
p
respiratori
rate
reveal
signific
differ
vs
p
patient
satisfact
open
face
mask
superior
ordinari
oxygen
mask
va
vs
p
conclus
open
face
mask
provid
better
oxygen
reduc
rebreath
icu
patient
comparison
ordinari
mask
refer
lamb
k
et
al
j
respir
ther
introduct
peak
expiratori
flow
pef
strong
predictor
success
failur
extub
risk
extub
failur
pef
lmin
time
higher
pef
lmin
object
evalu
impact
extub
outcom
prophylact
noninvas
assist
extub
patient
weak
cough
identifi
optim
devic
assist
method
prospect
collect
databas
conduct
decemb
april
weak
cough
defin
pef
lmin
pef
measur
cosm
poni
spiromet
scz
extub
patient
mechan
ventil
h
without
tracheostomi
pass
success
sponyaneu
breath
trial
sbt
least
min
pressur
support
cpap
tt
patient
extub
regardless
pef
patient
pef
lmin
convent
oxygen
therapi
appli
group
risk
extub
failur
pef
lmin
appli
randomli
prophylact
cpap
noninvas
ventil
vni
bilevel
humidifi
high
flow
nasal
cannula
hfnc
extub
failur
defin
need
reintub
within
h
follow
extub
compar
group
patient
accord
pef
prophylact
assist
group
patient
weak
cough
outcom
extub
continu
variabl
express
mean
sd
median
irq
categor
variabl
absolut
valu
percentag
comparison
continu
variabl
perform
student
test
mannwhitney
test
comparison
categor
variabl
perform
fisher
exact
test
chisquar
test
result
patient
studi
male
two
group
patient
accord
pef
similar
regard
age
apach
ii
underli
chronic
diseas
durat
mechan
ventil
extub
prophylat
assist
effect
appli
patient
pef
lmin
pef
lmin
vni
appli
cpap
bilevel
signific
differ
found
prophylact
devic
assist
risk
group
extub
failur
patient
pef
lmin
extub
failur
rate
differ
diagnosi
extub
failur
differ
total
stay
icu
group
conclus
prophylact
non
invas
assist
extub
could
reduc
risk
extub
failur
patient
weak
cough
strength
without
increas
length
stay
could
appli
mode
devic
hfnc
cpap
vni
refer
smina
cough
peak
flow
extub
outcom
chest
jul
beuret
p
interest
object
evalu
cough
wean
mechan
ventil
intens
care
med
introduct
numer
studi
shown
weak
cough
strength
evalu
object
extub
measur
peak
cough
expiratori
flow
pcef
strong
predictor
extub
failur
howev
report
cutoff
valu
depend
devic
use
measur
measur
pcef
screen
ventil
flow
sensor
seem
easi
perform
without
disconnect
patient
ventil
could
provid
method
avail
everywher
bedsid
object
prospect
studi
aim
compar
measur
pcef
screen
ventil
servo
maquet
solna
sweden
measur
obtain
electron
flowmet
ferrari
respiratori
hertford
uk
whose
accuraci
predict
extub
outcom
previous
report
optim
cutoff
valu
lmin
method
pcef
measur
respiratori
therapist
extub
patient
mechan
ventil
hour
pass
success
spontan
breath
trial
minut
pressur
support
cm
order
measur
two
devic
chang
inclus
half
patient
best
valu
obtain
two
measur
kept
analysi
result
one
year
patient
elig
studi
measur
pcef
imposs
achiev
lack
understand
patient
among
patient
includ
analysi
signific
correl
measur
obtain
servo
rs
p
fig
linear
regress
line
obtain
predict
cutoff
valu
pcef
servo
lmin
correspond
valu
lmin
previous
determin
conclus
measur
pcef
extub
screen
ventil
servo
easi
perform
well
correl
measur
perform
electron
flowmet
allow
propos
cutoff
valu
lmin
ventil
cough
strength
may
judg
weak
refer
beuret
p
interest
object
evalu
cough
wean
mechan
ventil
intens
care
med
introduct
noninvas
ventil
niv
first
option
treatment
cystic
fibrosi
cf
patient
acut
exacerb
high
flow
nasal
oxygen
cannula
hfnc
heat
humidifi
high
flow
oxygen
deliveri
system
demonstr
benefit
term
surviv
patient
acut
hypoxem
respiratori
failur
prevent
postextub
failur
devic
may
also
benefit
patient
hypercapn
respiratori
failur
includ
cf
patient
hypothes
hfnc
would
inferior
niv
term
reduc
work
breath
improv
breath
pattern
cf
patient
requir
ventil
support
object
compar
hfnc
vs
niv
induc
chang
inspiratori
work
breath
assess
thicken
fraction
diaphragm
tfdi
breath
pattern
hemodynam
dyspnea
comfort
method
cf
patient
acut
exacerb
requir
ventil
support
ventil
hfnc
niv
minut
random
order
tfdi
measur
use
ultrasound
baselin
minut
devic
puls
oximetri
transcutan
continu
record
respiratori
rate
tidal
volum
vt
minut
ventil
mv
measur
bioimped
techniqu
hemodynam
dyspnea
comfort
assess
visual
analog
scale
also
record
result
compar
use
mann
whitney
tail
test
express
mean
sd
intervent
compar
baselin
condit
result
patient
enrol
mean
age
year
mean
mean
predict
tfdi
similar
two
techniqu
hfnc
compar
niv
result
signific
decreas
respiratori
rate
vs
p
lower
mean
arteri
pressur
vs
p
signific
differ
found
heart
rate
vt
mv
comfort
dyspnea
tabl
conclus
hfnc
inferior
niv
respect
diaphragmat
work
cf
patient
indic
ventil
support
preliminari
data
suggest
hfnc
may
confer
physiolog
benefit
decreas
respiratori
rate
constitut
interest
altern
niv
refer
madden
bp
kariyawasam
h
siddiqi
aj
machin
pryor
ja
hodson
noninvas
ventil
cystic
fibrosi
patient
acut
chronic
respiratori
failur
eur
respir
j
vivier
e
mekontso
dessap
dimassi
varga
f
lyazidi
thill
aw
et
al
diaphragm
ultrasonographi
estim
work
breath
noninvas
ventil
intens
care
med
grant
acknowledg
studi
support
cystic
fibrosi
canada
grant
siriraj
hospit
bangkok
lb
laboratori
receiv
grant
equip
fisher
paykel
studi
lb
hold
keenan
chair
critic
care
acut
respiratori
failur
introduct
washout
effect
hfnc
well
evalu
prior
studi
present
esicm
congress
evalu
reduct
hfnc
use
tracheal
intub
trainer
test
lung
although
conclud
washout
effect
effect
rel
low
flow
model
larg
upper
airway
dead
space
ml
thought
influenc
also
abl
measur
peep
also
thought
interact
hfnc
flow
therefor
develop
sophist
artifici
respiratori
model
use
printer
use
lung
model
equip
pressur
sensor
quantit
evalu
washout
effect
hfnc
interact
peep
object
quantit
evalu
washout
effect
interact
peep
use
differ
level
hfnc
flow
method
airway
model
made
printer
use
craniocerv
ct
data
healthi
male
total
anatom
dead
space
adjust
ml
mlkg
model
lung
lungoo
air
water
safeti
servic
inc
kobe
japan
follow
set
normal
complianc
c
resist
r
tidal
volum
vt
ml
respiratori
rate
rr
min
obstruct
c
r
vt
rr
restrict
c
r
vt
rr
inspiratori
time
second
residu
volum
ml
infus
respiratori
lung
model
reach
mmhg
without
hfnc
set
lung
model
hfnc
flow
lmin
appli
chang
subglott
area
inlet
lung
model
measur
peep
insid
model
also
record
result
normal
lung
openmouth
model
lmin
hfnc
flow
decreas
subglott
area
inlet
lung
model
mmhg
increas
hfnc
flow
decreas
either
area
normal
lung
closedmouth
model
site
requir
hfnc
flow
lmin
decreas
reach
mmhg
hfnc
flow
lmin
obstruct
lung
open
mouth
model
site
trend
normal
lung
openmouth
model
restrict
lung
open
mouth
model
lmin
hfnc
flow
decreas
subglott
area
inlet
mmhg
decreas
thereaft
hfnc
flow
increas
peep
gradual
gener
around
cm
open
mouth
model
normal
lung
close
mouth
model
conclus
washout
effect
hfnc
thought
reduc
enough
clinic
effect
contrari
relat
hfnc
flow
gener
peep
hfnc
reduc
rel
low
flow
open
mouth
model
hfnc
requir
flow
reduc
close
mouth
model
thought
due
less
effici
wash
dead
space
open
model
grant
acknowledg
noth
declar
introduct
clinic
frailti
increasingli
use
recognis
predict
mortal
function
depend
follow
critic
although
less
known
regard
impact
specif
patient
group
bilevel
noninvas
ventil
niv
frequent
use
treat
acut
respiratori
failur
arf
variou
aetiolog
whilst
niv
known
benefici
exacerb
acut
cardiogen
pulmonari
present
arf
scarc
data
avail
impact
frailti
may
success
niv
patient
group
object
examin
impact
frailti
score
outcom
patient
receiv
niv
mix
aetiolog
arf
within
critic
care
cc
unit
method
case
note
electron
patient
data
record
metavis
imdsoft
usa
retrospect
review
adult
patient
arf
receiv
niv
decemb
april
patient
receiv
continu
posit
airway
pressur
primari
surgic
problem
exclud
patient
frailti
score
record
admiss
use
rockwood
frailti
index
consecut
patient
demograph
data
bodi
mass
index
bmi
primari
caus
arf
hospit
mortal
recordedpati
divid
two
group
accord
frailti
score
fit
vulner
frail
sever
frail
result
patient
identifi
male
mean
age
year
present
diagnosi
pneumonia
patient
acut
exacerb
copd
patient
overal
cc
surviv
rate
surviv
hospit
discharg
patient
frailti
score
male
mean
age
year
patient
frailti
score
less
male
mean
age
year
patient
lower
frailti
score
higher
overal
surviv
rate
cc
hospit
discharg
compar
higher
frailti
score
cc
hospit
discharg
mean
bmi
group
ident
differ
mean
length
stay
cc
hospit
durat
niv
use
two
group
conclus
data
suggest
rockwood
frailti
score
associ
reduc
cc
hospit
surviv
patient
arf
requir
niv
use
frailti
index
may
use
predict
marker
patient
admit
critic
care
work
warrant
defin
prognost
valu
frailti
score
refer
le
maguet
pet
al
preval
impact
frailti
mortal
elderli
icu
patient
prospect
multicent
observ
studi
intens
care
med
robert
cmet
al
acidosi
noninvas
ventil
mortal
hospitalis
copd
exacerb
thorax
masip
jet
al
noninvas
ventil
acut
cardiogen
pulmonari
edema
systemat
review
metaanalysi
jama
introduct
use
high
flow
therapi
critic
care
unit
adult
becom
common
year
therapi
approach
patient
acut
respiratori
failur
new
way
treatment
object
goal
analyz
impact
result
applic
high
flow
therapi
intens
care
unit
tertiari
hospit
evalu
use
therapi
avoid
use
mechan
ventil
patient
materi
method
studi
summar
patient
treat
oxygen
therapi
treatment
may
review
data
sofa
apach
ii
sap
ii
tabul
diagnosi
etiolog
respiratori
failur
length
stay
use
high
flow
intub
evalu
intub
avoid
mortal
mortal
day
result
studi
includ
patient
medium
averag
age
men
women
sever
index
studi
sofa
apach
ii
averag
stay
patient
day
origin
diseas
respiratori
caus
hematolog
septic
cardiolog
miscellan
rest
caus
ventil
decompens
respiratori
septic
miscellan
case
caus
respiratori
failur
hypoxem
case
hipercapn
mix
caus
rest
time
high
flow
therapi
provid
mechan
ventil
time
mechan
ventil
consid
avoid
mechan
ventil
case
appli
non
parametr
test
group
patient
need
mechan
ventil
higher
mortal
p
conclus
use
high
flow
therapi
chang
attitud
toward
patient
insuffici
respiratori
diseas
avoid
mani
case
use
mechan
ventil
control
studi
need
show
patient
benef
high
flow
therapi
prevent
delay
start
mechan
ventil
refer
william
r
rankin
n
smith
galler
seakin
p
relationeship
humid
temperatur
inspir
ga
function
airway
mucosa
crit
care
william
ab
ritchi
je
gerard
c
evalu
highflownas
oxygen
deliveri
system
ga
analysi
pharyng
presur
intens
care
med
grove
n
tobin
high
flow
nasal
oxygen
gener
posit
airway
pressur
adult
volunt
au
crit
sztrymf
b
messika
j
mayot
lenglet
h
dreyfuss
ricard
jd
impact
high
flow
nasal
cannula
oxygen
therapi
intens
care
unit
pacient
acut
respiratori
failur
prospect
observacion
studi
j
crit
introduct
full
face
mask
propos
improv
patient
comfort
niv
thu
increas
niv
success
object
compar
three
full
face
mask
ff
dimax
dimar
itali
performax
respiron
us
bitrac
pulmodyn
us
method
adult
mannequin
connect
activ
lung
simul
complianc
respiratori
resist
breath
breathsminut
ventil
three
ff
pressur
support
ps
peep
fast
pressur
ramp
expiratori
trigger
data
analysi
evalu
patientventil
interact
delay
trinsp
delay
trexp
time
sync
mask
perform
swing
trigger
ptp
ptp
ptp
index
result
rr
timesync
longer
ffpulmo
ffdimar
rr
signific
differ
found
mask
ffdimar
ffrespir
significantli
increas
swingtrigg
ptpt
rr
ff
show
better
perform
term
signific
differ
found
term
index
conclus
independ
set
ff
guarante
timesync
neural
inspiratori
time
differ
shape
materi
ff
significantli
influenc
result
softer
flang
need
less
headstrip
tight
requir
ffdimar
caus
initi
pressur
dissip
longer
delaytrinsp
swingtrigg
ptpt
convers
need
strongli
pull
headstrip
ffpulmo
reduc
leak
explain
superior
perform
interact
grant
acknowledg
none
introduct
venou
thromboembol
encompass
deep
venou
thrombosi
dvt
pulmonari
embol
pe
signific
impact
morbid
mortal
respons
death
everi
year
european
countri
nowaday
clinic
score
diagnost
noninvas
techniqu
improv
diagnosi
earli
treatment
anticoagul
thrombolyt
therapi
object
character
patient
admit
intermedi
care
unit
icu
due
pe
submit
thrombolyt
therapi
method
retrospect
observ
studi
patient
admit
due
pe
icu
januari
decemb
data
collect
analys
spss
descript
analyt
statist
perform
valu
p
consid
statist
signific
result
year
patient
femal
median
age
rang
year
admit
due
pe
frequent
emerg
servic
common
symptom
dyspnea
chest
pain
syncop
patient
classifi
low
probabl
pe
use
well
criteria
comput
tomographi
posit
patient
use
pulmonari
embol
sever
index
pesi
score
patient
low
risk
score
mean
age
year
low
risk
mean
age
year
moder
risk
mean
age
year
high
risk
mean
age
year
high
risk
score
mean
age
year
age
differ
pesi
score
class
p
common
dvt
risk
factor
age
peripher
venou
insuffici
obes
previou
immobil
icu
patient
admit
due
massiv
pe
submass
pe
due
hypoxemia
reason
frequent
due
need
constant
monitor
dvt
confirm
patient
thrombolyt
therapi
administ
patient
submass
pe
massiv
pe
regist
complic
haemoptysi
haematuria
multipl
hematoma
skin
haemorrhag
ventil
vasopressor
support
need
one
patient
transfer
intens
care
unit
die
icu
discharg
icu
next
month
conclus
age
import
risk
factor
patient
admit
icu
although
patient
classifi
lowveri
low
risk
patient
clinic
unstabl
cardiac
repercuss
need
constant
monitor
patient
younger
less
comorbid
better
physiolog
condit
may
underestim
pesi
score
studi
highlight
import
individu
clinic
evalu
earli
therapi
low
rate
complic
patient
submit
thrombolyt
therapi
introduct
complex
factor
icu
survivor
health
literaci
socioeconom
statu
social
environ
may
predict
advers
outcom
follow
hospit
discharg
well
studi
object
hypothes
medicaid
insur
proxi
individu
low
socioeconom
statu
would
associ
increas
hospit
readmiss
rate
follow
hospit
discharg
method
perform
two
center
observ
studi
patient
treat
medic
surgic
intens
care
unit
boston
massachusett
studi
patient
age
year
receiv
critic
care
surviv
hospit
exposur
interest
medicaid
insur
statu
primari
outcom
unplan
hospit
readmiss
adjust
odd
ratio
estim
multivari
logist
regress
model
inclus
covari
term
gender
race
deyocharlson
index
type
surgic
vs
medic
sepsi
acut
organ
failur
area
depriv
index
proxi
area
socioeconom
statu
social
environ
age
restrict
cubic
spline
function
subset
admit
spauld
rehabilit
hospit
follow
hospit
discharg
n
evalu
associ
medicaid
insur
statu
rehabilit
hospit
length
stay
util
neg
binomi
regress
model
result
cohort
patient
male
nonwhit
surgic
cohort
sepsi
mean
age
year
medicaid
insur
present
medicaid
insur
significantli
younger
frequent
nonwhit
higher
sepsi
acut
lung
injuri
rate
unplan
readmiss
rate
discharg
care
facil
postdischarg
mortal
patient
medicaid
insur
patient
without
medicaid
insur
robust
predictor
hospit
readmiss
remain
follow
multivari
adjust
patient
medicaid
insur
adjust
readmiss
ci
p
rel
patient
without
medicaid
insur
patient
medicaid
insur
adjust
discharg
care
facil
ci
p
rel
patient
without
medicaid
insur
final
patient
medicaid
insur
compar
without
medicaid
insur
expect
fold
time
greater
rehabilit
hospit
length
stay
adjust
irr
ci
p
conclus
critic
ill
survivor
individu
socioeconom
statu
reflect
medicaid
insur
robust
predictor
hospit
readmiss
placement
care
facil
rehabilit
length
stay
dispar
icu
survivor
outcom
like
multifactori
involv
individu
acut
ill
hospit
posthospit
neighborhoodlevel
factor
alter
optimum
post
icu
recoveri
introduct
prolong
hospit
stay
prior
admiss
intens
care
unit
shown
independ
associ
poorer
outcom
even
hour
delay
transfer
emerg
depart
intens
care
worsen
outcom
may
relat
ongo
deterior
physiolog
function
hospit
potenti
influenc
process
diseas
state
culmin
admiss
critic
care
investig
whether
common
ill
sever
score
eg
acut
physiolog
chronic
health
evalu
ii
apach
ii
intens
care
nation
audit
research
centr
icnarc
significantli
differ
patient
admit
prolong
ward
stay
describ
mortal
icu
hospit
length
stay
said
patient
order
elucid
predictor
outcom
object
show
higher
length
stay
icu
admiss
independ
predictor
outcom
identifi
whether
icu
score
system
predict
outcom
popul
identifi
whether
serum
albumin
surrog
marker
frailti
eg
creatinin
help
predict
outcom
method
retrospect
analysi
prospect
collect
data
admiss
icnarc
databas
bed
adult
critic
care
unit
univers
associ
london
major
trauma
centr
twoyear
period
januari
decemb
demograph
data
apach
ii
icnarc
score
icu
mortal
length
stay
ward
preced
icu
within
icu
overal
hospit
length
stay
collect
data
analyz
use
anova
test
accord
preced
ward
length
stay
result
n
mean
apach
score
admiss
sd
p
anova
compar
length
icu
stay
day
p
anova
compar
across
ward
lo
group
p
anova
compar
serum
albumin
across
ward
lo
day
vs
day
non
signific
across
group
conclus
prolong
preicu
hospit
admiss
associ
longer
icu
hospit
admiss
gener
higher
icu
mortal
score
serum
albumin
predict
outcom
refer
goldhil
dr
mcnarri
af
hadjianastassi
vg
tekki
pp
longer
patient
hospit
intens
care
admiss
higher
mortal
intens
care
med
oct
higgin
tl
mcgee
wt
steingrub
js
rapoport
j
lemeshow
tere
earli
indic
prolong
intens
care
unit
stay
impact
ill
sever
physician
staf
preintens
care
unit
length
stay
crit
care
med
jan
chalfin
db
trzeciak
likourezo
baumann
bm
delling
rp
delay
studi
group
impact
delay
transfer
critic
ill
patient
emerg
depart
intens
care
unit
crit
care
med
jun
introduct
histor
cohort
studi
patient
receiv
extracorpor
membran
oxygen
ecmo
icu
region
hospit
object
compar
clinic
outcom
inhous
ecmo
patient
interhospit
retriev
ecmo
patient
method
primari
outcom
icu
mortal
rate
inhous
interhospit
retriev
ecmo
patient
mannwhitney
u
test
fisher
exact
test
use
comparison
continu
categor
variabl
respect
pvalu
repres
statist
signific
result
patient
receiv
ecmo
among
patient
vvecmo
vaecmo
complet
data
analysi
overal
mortal
rate
mean
acut
physiolog
chronic
health
evalu
apach
ii
score
inhous
ecmo
vs
interhospit
retriev
ecmo
p
patient
receiv
ecmo
respiratori
support
vvecmo
n
mean
respiratori
extracorpor
membran
oxygen
surviv
predict
resp
score
vs
p
icu
mortal
vs
p
significantli
differ
inhous
retriev
case
predict
hospit
surviv
resp
score
risk
class
ii
score
patient
receiv
ecmo
circulatori
support
vaecmo
n
mean
surviv
venoarterialecmo
save
score
vs
p
icu
mortal
vs
p
significantli
differ
inhous
retriev
case
predict
hospit
surviv
save
score
risk
class
iv
score
class
iii
score
respect
inhous
ecmo
patient
higher
proport
noninfect
aetiolog
vvecmo
resp
score
postmi
cariogen
shock
vaecmo
observ
condit
poorer
prognosi
lower
revers
may
account
poorer
respsav
score
though
statist
insignific
higher
predict
observ
mortal
conclus
find
show
statist
signific
differ
icu
mortal
rate
inhous
retriev
ecmo
group
interhospit
ecmo
retriev
feasibl
develop
resp
score
save
score
system
provid
tool
monitor
perform
comparison
ecmo
centr
worldwid
refer
schmidt
et
al
surviv
extracorpor
membran
oxygen
sever
acut
respiratori
failur
respiratori
extracorpor
membran
oxygen
surviv
predict
resp
score
j
respir
crit
care
med
vol
iss
pp
schmidt
et
al
predict
surviv
ecmo
refractori
cardiogen
shock
surviv
venoarterialecmo
save
score
european
heart
journal
first
publish
onlin
june
grant
acknowledg
none
introduct
outcom
critic
ill
patient
regard
prognosi
mani
background
effect
risk
factor
age
popul
chronic
diseas
may
also
result
increas
number
patient
intens
care
unit
icu
clinic
result
reveal
need
outcom
examin
guidanc
effect
use
icu
object
aim
studi
evalu
mortal
among
patient
turkish
icu
regard
present
studi
analyz
apach
ii
databas
critic
ill
patient
secondari
tertiari
referr
hospit
icu
turkey
method
studi
period
clinic
data
collect
concurr
patient
contain
demograph
detail
diagnost
categori
lead
icu
admiss
apach
ii
score
follow
icu
admiss
patient
follow
icu
stay
equat
coeffici
apach
ii
suppli
apach
medic
system
mortal
intens
care
unit
analyz
accord
apach
ii
score
attempt
perform
icu
stay
also
record
result
patient
enrol
studi
patient
year
old
male
mean
apach
ii
score
icu
mortal
rate
mechan
ventil
determin
perform
attempt
icu
ratio
ratio
central
venou
catheter
found
ratio
system
infect
antibiot
administr
respect
conclus
present
studi
patient
hospit
icu
ministri
univers
privat
hospit
analyz
turkey
earli
identif
patient
risk
admiss
discharg
icu
may
allow
prevent
physiolog
abnorm
contribut
apach
ii
score
wide
differ
outcom
patient
admit
differ
icu
use
risk
adjust
method
introduct
grow
interest
longterm
effect
critic
care
form
investigatorl
clinic
research
group
around
world
work
aim
standard
core
outcom
measur
instrument
random
clinic
trial
ongo
whether
outcom
measur
reflect
domain
valu
patient
import
issu
miss
exist
scale
unclear
commonli
use
tool
like
unspecif
object
develop
valid
questionnair
patientreport
outcom
measur
prom
critic
care
method
qualit
phase
former
icupati
interview
semistructur
way
provid
detail
inform
symptom
difficulti
area
everyday
life
patient
recruit
posticu
clinic
sahlgrenska
univers
hospit
cover
urban
rural
area
interview
record
transcrib
issu
categor
hypothes
domain
cognit
executivefatigu
physic
health
pain
mental
health
daili
activ
sleep
fooddrinksmok
sexual
hearingvisualdysphagia
intestin
urinari
problem
return
workfinanci
situat
search
literatur
commonli
use
assess
tool
addit
issu
includ
issu
rephras
question
care
taken
maintain
one
conceptu
entiti
per
question
recal
period
usual
last
month
adequ
scale
frequenc
intens
durat
use
question
valid
facetofac
anoth
set
former
icupati
nonicutr
control
make
sure
word
easili
understood
neither
confus
upset
result
questionnair
contain
question
current
test
pilot
studi
patient
recruit
six
month
three
year
discharg
icu
control
match
age
gender
questionnair
sent
mail
invit
letter
follow
phone
call
return
prestamp
envelop
return
questionnair
scan
data
digit
import
spss
addit
clinic
data
ad
comparison
control
item
reduct
follow
result
icuspecif
prom
questionnair
conclus
patientcentr
icuspecif
questionnair
avail
longterm
followup
posticu
clinic
postal
document
patient
return
hospit
provid
inform
make
suitabl
largescal
studi
refer
brussel
roundtabl
particip
intens
care
med
needham
pronovost
et
al
intens
care
med
lind
h
ac
dunberg
g
et
al
br
j
cancer
grant
acknowledg
introduct
approxim
oesophagogasterectomi
perform
year
year
surviv
day
mortal
secondari
analysi
icnarc
data
shown
median
length
stay
day
readmiss
rate
conduct
retrospect
review
post
oesophagogastrectomi
icu
admiss
hospit
jan
part
qualiti
improv
project
reduc
morbid
length
stay
lo
object
analys
electron
record
chest
xray
everi
oesophagogastrectomi
order
compar
lo
patient
characterist
identifi
factor
affect
lo
unit
morbid
method
analys
electron
case
record
open
minim
access
oesophagogastrectomi
patient
data
gather
age
gender
analges
method
pain
score
analgesia
failur
vasopressor
use
highest
arteri
lactat
within
h
unit
lo
readmiss
rate
result
patient
identifi
male
median
age
patient
combin
epidur
paravertebr
analgesia
epidur
alon
paravertebr
alon
median
pain
score
epidur
failur
rate
disconnect
never
effect
vasopressor
use
patient
median
base
excess
median
lactat
unit
lo
rang
day
median
day
combin
collaps
atelectasi
identifi
patient
review
cxr
one
apic
pneumothorax
conclus
epidur
disconnect
rate
high
contribut
longer
unit
lo
nation
averag
higher
pain
score
introduc
train
packag
epidur
care
nurs
encourag
use
tunnel
epidur
combin
paravertebr
cathet
incid
cxr
chang
surgeri
cohort
studi
previous
larg
proport
patient
radiolog
appar
collaps
even
consolid
arriv
icu
may
contribut
develop
pneumonia
set
analgesia
imperfect
cpap
rel
contraind
due
oesophag
anastomosi
encourag
longer
period
recoveri
lung
toilet
recruit
manoeuvr
end
onelung
ventil
refer
bartel
h
stein
hj
siewert
jr
preoper
risk
analysi
postop
mortal
oesophagectomi
resect
oesophag
cancer
br
j
surg
park
dp
welch
ca
harrison
da
et
al
outcom
follow
oesophagectomi
patient
oesophag
cancer
secondari
analysi
icnarc
case
mix
programm
databas
critic
care
grant
acknowledg
help
mr
lympani
support
depart
introduct
placement
tracheostomi
commonli
thought
allow
secur
manag
airway
facilit
wean
mechan
ventil
howev
current
literatur
suggest
tracheostomi
impact
surviv
unselect
icu
patient
transfer
mortal
icu
ward
moreov
mani
circumst
tracheostomi
place
patient
end
live
littl
hope
meaning
recoveri
object
describ
main
characterist
outcom
tracheostom
patient
discharg
icu
ward
public
hospit
method
retrospect
descript
studi
conduct
analyz
data
electron
medic
record
set
four
adult
medicalsurg
icu
bed
tertiari
care
public
hospit
southern
brazil
data
adult
subject
underw
tracheostomi
part
icu
manag
subsequ
transfer
ward
obtain
individu
die
icu
first
admiss
exclud
demograph
data
diagnos
admiss
comorbid
durat
mechan
ventil
icu
length
stay
endoflif
decis
mortal
record
result
januari
decemb
subject
receiv
tracheostomi
thirtytwo
die
initi
icu
admiss
therefor
exclud
analysi
remain
individu
twentyeight
die
four
readmit
icu
within
hour
discharg
mean
age
year
male
mean
apach
ii
score
point
chronic
neurolog
disord
cancer
main
comorbid
respect
common
diagnosi
sepsi
neurolog
emerg
stroke
intracerebr
hemorrhag
mening
length
icu
stay
day
durat
mechan
ventil
day
lifesustain
treatment
withheld
withdrawn
twentyf
deced
seven
subject
die
posterior
hospit
institut
period
record
conclus
tracheostomi
may
repres
burden
icu
discharg
requir
high
resourc
use
low
surviv
rate
indic
tracheostomi
cautiou
effort
made
recogn
patient
might
clearli
benefit
techniqu
avoid
unnecessari
unwant
prolong
mechan
ventil
decis
make
icu
import
impact
futur
care
need
knowledg
characterist
outcom
may
assist
identifi
intervent
reduc
need
tracheostomi
improv
outcom
introduct
readmiss
intens
care
hospit
admiss
shown
associ
higher
risk
mortal
object
determin
readmiss
rate
ten
year
period
subsequ
analys
effect
may
mortal
length
icu
stay
whether
readmiss
icu
requir
higher
level
care
method
retrospect
analysi
electron
patient
inform
system
admiss
patient
year
old
exclud
data
collect
includ
mean
age
mean
stay
proport
ventil
patient
patient
commenc
rrt
unit
mortal
hospit
mortal
mrsa
statu
two
patient
group
compar
patient
readmit
icu
within
hospit
admiss
group
patient
readmit
group
result
patient
identifi
period
group
group
mean
age
group
compar
group
mean
stay
day
day
respect
conclus
patient
readmit
icu
hospit
stay
significantli
increas
risk
die
hospit
icu
mrsa
like
detect
patient
readmit
icu
work
carri
investig
patient
readmit
thoroughli
aim
identifi
patient
risk
readmiss
strategi
prevent
readmiss
improv
discharg
plan
refer
patient
readmit
intens
care
unit
hospit
clinic
featur
outcom
chen
lm
et
al
critic
care
medicin
nov
volum
critic
ill
patient
readmit
intens
care
learn
metnitz
pgh
et
al
intens
care
medicin
feb
volum
pp
introduct
pancreat
common
precipit
critic
ill
intens
care
admiss
mortal
pancreat
overal
sever
pancreat
mortal
risk
mulitfactori
high
risk
comorbid
elderli
develop
sir
progress
pancreat
necrosi
sought
look
pancreat
admiss
icu
year
period
identifi
averag
demograph
differ
survivor
non
survivor
object
identifi
patient
admit
icu
primari
diagnosi
acut
pancreat
compar
predict
demograph
featur
system
inflammatori
respons
survivor
non
survivor
hypothesis
requir
intens
care
manag
sever
pancreat
death
like
occur
begin
icu
stay
due
overwhelm
organ
failur
surviv
initi
insult
hypothesis
may
surviv
hospit
discharg
although
length
hospit
stay
would
prolong
sought
test
theori
patient
group
method
retrospect
audit
patient
admit
icu
glasgow
victoria
infirmari
southern
gener
queen
elizabeth
univers
hospit
patient
identifi
wardwatch
via
search
apach
ii
diagnosi
includ
pancreat
data
collect
patient
profil
wardwatch
trakcar
ci
result
patient
identifi
admiss
diagnosi
pancreat
patient
admit
give
incid
icu
admiss
result
demonstr
data
present
mean
confid
interv
pvalu
unpair
ttest
applic
conclus
could
predict
pancreat
diagnosi
older
male
popul
icu
like
result
concomit
problem
alcohol
abus
west
scotland
patient
higher
normal
apacheii
score
predict
mortal
compar
unit
averag
sir
criteria
met
look
averag
data
henc
like
admiss
icu
compar
survivor
nonsurvivor
survivor
significantli
like
younger
lower
apacheii
score
predict
mortal
differ
length
stay
group
degre
derang
sir
criteria
refer
young
thompson
sever
acut
pancreat
cont
ed
anaesthesia
crit
care
introduct
fluid
resuscit
key
part
patient
manag
cardiac
surgeri
intraven
iv
fluid
use
replac
lost
circul
volum
maintain
adequ
perfus
vital
organ
volum
given
patient
vari
greatli
past
accept
practic
greater
volum
fluid
patient
given
better
chanc
surviv
howev
recent
literatur
show
fluid
overload
could
possibl
lead
wors
outcom
suggest
clinician
cautiou
prescrib
fluid
object
determin
associ
iv
fluid
administr
fa
patient
outcom
patient
cardiothorac
intens
care
unit
method
retrospect
observ
analysi
conduct
patient
admit
cardiothorac
critic
care
unit
ccu
papworth
hospit
patient
data
extract
ccu
electron
databas
patient
miss
data
exclud
lead
final
patient
cohort
use
studi
paramet
includ
iv
fa
surviv
need
prolong
ccu
stay
defin
h
need
prolong
ventil
pv
defin
h
need
parenter
nutrit
pn
aki
score
collect
patient
split
evenli
four
quartil
determin
daili
iv
fa
rel
risk
rr
confid
interv
ci
calcul
advers
patient
outcom
compar
quartil
quartil
quartil
quartil
result
patient
identifi
initi
exclud
incomplet
data
n
total
patient
found
elig
studi
patient
quartil
contain
individu
statist
signific
associ
found
high
fa
advers
patient
outcom
patient
compar
patient
mortal
rr
ci
need
prolong
stay
rr
ci
need
pv
rr
ci
need
pn
rr
ci
aki
score
rr
ci
maximum
aki
score
rr
ci
result
keep
find
conclus
high
fa
associ
increas
mortal
morbid
poorest
patient
outcom
consist
observ
compar
across
complic
cautiou
prescrib
iv
fluid
may
help
improv
patient
outcom
critic
care
refer
pradeep
et
al
high
volum
intraven
fluid
cardiac
surgeri
associ
increas
mortal
hsr
proceed
intens
care
cardiovascular
anesthesia
lee
j
et
al
associ
fluid
balanc
surviv
critic
ill
patient
journal
intern
medicin
grant
acknowledg
na
introduct
lactat
prognost
biomark
use
commonli
intens
care
detect
tissu
hypoxia
lactat
clearanc
shown
associ
improv
outcom
patient
sepsi
cardiac
arrest
whether
elev
lactat
primari
clearanc
ie
secondari
hyperlactataemia
sh
associ
outcom
critic
ill
patient
remain
unknown
object
hypothes
sh
earli
marker
icu
mortal
would
independ
associ
mortal
order
test
hypothesi
perform
retrospect
observ
studi
assess
relationship
sh
mortal
method
retrospect
analysi
multiparamet
intellig
monitor
intens
care
iii
mimiciii
databas
perform
mimiciii
open
access
anonymis
databas
compris
intens
care
admiss
adult
patient
demonstr
initi
lactat
clearanc
lc
mmoll
mmoll
includ
sh
defin
rise
lactat
mmoll
follow
initi
lc
univari
multivari
logist
regress
analysi
use
test
associ
sh
mortal
result
total
patient
includ
show
sh
remaind
belong
lc
group
averag
age
admiss
year
male
frequent
comorbid
includ
hypertens
diabet
mellitu
congest
cardiac
failur
median
time
initi
lc
hour
delay
sh
death
hour
mortal
rate
sh
group
versu
lc
group
sh
associ
mortal
unadjust
analysi
ci
p
multivari
adjust
patient
demograph
comorbid
diseas
new
organ
dysfunct
laboratori
data
sh
remain
independ
associ
mortal
ci
p
conclus
preliminari
studi
secondari
hyperlactataemia
associ
mortal
critic
ill
patient
associ
remain
robust
multivari
adjust
secondari
hyperlactataemia
may
serv
earli
signal
deterior
critic
ill
patient
futur
studi
assess
addit
therapeut
option
patient
secondari
hyperlactataemia
icu
refer
nguyen
hb
et
al
earli
lactat
clearanc
associ
improv
outcom
sever
sepsi
septic
shock
critic
care
medicin
aug
donnino
mw
et
al
initi
lactat
lactat
chang
postcardiac
arrest
multicent
valid
studi
critic
care
medicin
aug
liver
transplant
lt
made
hospit
universitario
de
santiago
de
compostela
spain
period
lt
perform
spain
case
accord
spanish
liver
transplant
registri
reth
review
comparison
cumul
surviv
rate
base
lt
indic
year
experi
materi
method
retrospect
descript
studi
lt
case
perform
hospit
universitario
de
santiago
de
compostela
spain
base
local
lt
registr
result
lt
hepatoren
requir
retransplant
media
ltyear
femal
mean
age
year
oldblood
group
posit
posit
frequent
lt
indic
group
liver
cirrhosi
lc
case
tumor
case
fulmin
liver
failur
flf
case
retranspl
rlt
casesin
lc
group
frequent
alcoholrel
arc
hepat
viru
c
cirrhosi
hvc
primari
biliari
cirrhosi
pbc
cumul
surviv
rate
year
arc
hcv
pbc
group
frequent
indic
hepatocarcinoma
hc
neuroendocrin
tumor
net
klatskin
tumor
kt
cumul
surviv
rate
year
hc
net
kt
flf
group
autoimmun
toxic
idiopat
ati
hepat
b
viru
hbv
posttraumat
pt
global
cumul
surviv
rate
year
total
group
rlt
group
hepat
arteri
thrombosi
hat
primari
allograft
dysfunct
pad
recurr
underli
diseas
rud
global
cumul
surviv
rate
year
conclus
liver
chirrosi
frequent
indic
toward
lt
follow
tumor
hepatocarcinoma
predomin
fulmin
liver
failur
cumul
surviv
rate
global
similar
one
found
transplant
program
liver
cirrhosi
group
alcoholrel
cirrhosi
frequent
better
outcom
well
hepatocarcinoma
int
tumor
group
autoimmunetoxicidiopat
frequent
fulmin
liver
failur
group
best
outcom
lt
indic
though
poor
outcom
retranspl
group
lead
care
select
case
get
better
surviv
ratio
introduct
patient
spinal
cord
injuri
sci
stay
neuro
icu
long
time
object
survey
reason
sci
patient
stay
longer
nicu
outcom
method
local
databas
wardwatch
use
search
collect
data
patient
admit
sci
result
admiss
nicu
case
relat
spinal
injuri
consid
spinal
cord
injuri
admiss
relat
trauma
patient
readmit
hospit
increas
trend
admiss
nicu
data
show
averag
length
number
day
patient
stay
day
spinal
patient
day
guidelin
provis
intens
care
servic
recommend
discharg
critic
care
ward
must
within
hour
decis
consult
data
show
hour
delay
discharg
nicu
ward
mainli
caus
shortag
ward
bed
follow
delay
ward
sci
patient
requir
advanc
cardiac
respiratori
organ
support
neurolog
support
patient
tracheostomi
patient
qualifi
sci
studi
call
injur
spinal
cord
pressur
evalu
iscop
intraspin
pressur
measur
relat
traumat
spinal
cord
injuri
requir
patient
spinal
monitor
pressur
least
day
patient
outcom
improv
die
patient
remain
unchang
hospit
patient
outcom
discharg
live
die
conclus
though
mani
sci
patient
admit
unit
compar
patient
sci
patient
stay
longer
day
averag
three
main
reason
identifi
stay
longer
one
iscop
research
one
depend
advanc
organ
support
lastli
delay
discharg
shortag
ward
bed
delay
discharg
could
indic
hospit
need
increas
bed
capac
patient
outcom
appear
encourag
improv
outcom
audit
necessari
see
chang
refer
guidelin
provis
intens
care
servic
http
wwwicsacukicshomepagelatestnewsguidelinesfortheprovisionofintensivecareservic
access
april
phang
papadopoulo
intraspin
pressur
monitor
patient
spinal
cord
injuri
reveal
differ
intradur
compart
injur
spinal
cord
pressur
evalu
iscop
studi
neurocrit
care
dec
doi
introduct
risk
medic
error
high
intens
care
medicin
error
healthcar
may
occur
due
unintend
act
omiss
error
omiss
insidi
difficult
identifi
group
previous
develop
valid
new
tool
real
time
random
safeti
audit
spanish
aleatorio
de
seguridad
en
tiempo
real
aastr
effect
detect
remedi
error
omiss
real
time
object
purpos
studi
investig
aastr
impact
structur
process
outcom
indic
multicent
studi
method
prospect
studi
conduct
period
month
two
adult
patient
icu
safeti
round
conduct
three
day
week
ascertain
safeti
measur
group
block
round
patient
measur
random
impact
safeti
tool
analys
indic
structur
cultur
safeti
healthcar
protocol
process
improv
proport
relat
tool
applic
ipraastr
outcom
mortal
averag
stay
rate
catheterrel
bacteremia
rate
ventilatorassoci
pneumonia
vap
result
patientsday
analyz
structur
indic
aastr
associ
increas
climat
secur
creation
modif
protocol
sedationanalgesia
wean
process
indic
measur
ipraastr
seven
mesur
ipraastr
three
quarter
analyz
six
mesur
show
progress
decreas
ipr
studi
period
nurs
workload
patient
sever
day
analysi
independ
associ
higher
ipraastr
half
block
variabl
outcom
indic
aastr
associ
signific
decreas
rate
nav
conclus
aastr
associ
improv
structur
process
outcom
indic
tool
also
improv
care
process
adher
clinic
practic
guidelin
prove
use
situat
high
care
load
patient
sever
diseas
refer
olona
mc
alceaga
r
jc
corral
e
villar
jm
sirgo
g
feasibl
util
use
real
time
random
safeti
audit
adult
icu
patient
multicentr
studi
intens
care
med
jun
grant
acknowledg
support
grant
fondo
de
sanitaria
institut
health
carlo
iii
spain
fi
grant
project
introduct
emerg
laparotomi
associ
high
risk
mortal
morbid
lead
signific
financi
expenditur
nh
recent
studi
emerg
laparotomi
pathway
qualiti
improv
care
elpquic
program
shown
set
sequenti
intervent
potenti
improv
clinic
outcom
howev
relat
cost
save
remain
unknown
object
econom
evalu
aim
evalu
cost
costeffect
clinic
pathway
patient
undergo
emerg
laparotomi
compar
histor
cohort
receiv
standard
care
method
consecut
patient
control
group
compar
patient
direct
predefin
pathway
assess
cost
costeffect
two
decis
model
construct
first
model
took
hospit
manag
perspect
second
model
took
societ
perspect
evalu
lifetim
cost
qualiti
adjust
life
year
result
one
time
implement
cost
train
supervis
purchas
equip
pharmaceut
expect
howev
cost
offset
treat
patient
mainli
due
reduc
lo
lower
complic
rate
longterm
model
show
intervent
effect
month
lead
lower
cost
societi
cost
save
increment
costeffect
ratio
mean
new
pathway
domin
strategi
recommend
decis
maker
conclus
bundl
pathway
improv
clinic
care
patient
undergo
emerg
laparotomi
shown
reduc
mortal
seem
costeffect
potenti
improv
clinic
outcom
lower
cost
societi
decis
maker
need
adopt
longterm
vision
prepar
make
one
invest
lower
futur
cost
refer
huddart
peden
cj
swart
et
al
use
pathway
qualiti
improv
care
bundl
reduc
mortal
emerg
laparotomi
br
j
surg
introduct
delay
admiss
emerg
depart
ed
intens
care
unit
icu
associ
increas
icuhospit
mortal
length
stay
total
cost
howev
littl
data
support
use
particular
time
frame
indic
qualiti
care
object
aim
investig
relationship
time
ed
icu
mortal
tertiari
univers
affili
hospit
method
conduct
retrospect
studi
patient
admit
includ
patient
admit
directli
ed
base
upon
administr
registri
transfer
hospit
includ
administr
passag
ed
admiss
emerg
surgeri
exclud
primari
outcom
icu
mortal
secondari
outcom
includ
nosocomi
infect
ventil
time
hospit
mortal
statist
analysi
includ
univari
multivari
logist
regress
result
includ
admiss
patient
mean
sapsii
level
icu
mortal
n
mean
age
time
admiss
male
patient
admit
due
medic
condit
trauma
need
emerg
surgeri
mean
time
ed
hour
skew
distribut
left
significantli
signific
decreas
ed
time
five
year
period
p
hour
compar
univari
analysi
found
associ
time
ed
icu
mortal
p
result
alter
adjust
sapsii
age
gender
trauma
acut
kidney
injuri
year
admiss
relev
also
associ
icu
mortal
excess
hour
emerg
depart
final
associ
time
spent
ed
hospit
mortal
p
ventil
time
p
nosocomi
infect
p
conclus
unnecessari
time
spent
ed
potenti
advers
affect
care
overwhelm
crucial
ed
resourc
singlecent
retrospect
studi
find
associ
absolut
time
spent
ed
icu
mortal
recommend
clinic
relev
specif
time
frame
meanwhil
patient
transfer
icu
emerg
depart
soon
possibl
research
need
develop
potenti
qualiti
indic
refer
chalfin
db
et
al
impact
delay
transfer
critic
ill
patient
emerg
depart
intens
care
unit
crit
care
med
cardoso
lt
et
al
impact
delay
admiss
intens
care
unit
mortal
critic
ill
patient
cohort
studi
critic
care
grant
acknowledg
grant
support
object
sever
studi
demonstr
decreas
mortal
mechan
protect
ventil
low
tidal
volum
ml
per
kilogram
predict
bodi
weight
patient
acut
respiratori
distress
syndrom
ard
also
icu
patient
without
criteria
pulmonari
injuri
aim
studi
evalu
util
daili
checklist
appli
patient
mechan
ventil
mv
admit
icu
well
identifi
factor
influenc
achiev
goal
keep
tidal
volum
ml
per
kilogram
predict
bodi
weight
method
prospect
studi
includ
patient
admit
icu
fourmonth
studi
period
dailybas
regist
implement
icu
patient
mv
morn
afternoon
night
shift
analys
degre
complianc
checklist
well
influenc
achiev
goal
tidal
volum
follow
factor
height
sex
type
mv
continu
mandatori
ventilationcmv
pressur
control
ventilationpcv
bilevel
posit
airway
pressurebipap
synchron
intermittentmandatori
ventilationsimv
pressur
support
ventilationpsv
gaseou
exchang
relat
pulmonari
mechan
plateau
pressur
result
regist
measur
morn
shift
afternoon
night
shift
patient
mv
either
ard
without
criteria
pulmonari
injuri
patient
develop
ventil
induc
lung
injuri
vili
percentag
measur
outsid
establish
goal
tidal
volum
ci
without
differ
shift
averag
tidal
volum
ml
rang
correspond
ml
per
kilogram
predict
bodi
weight
ic
univari
analysi
factor
associ
outsid
goal
tidal
volum
femal
sex
height
pressur
support
ventilationpsv
opposit
mandatori
mode
influenc
shift
work
relat
plateau
pressur
multivari
logist
regress
analysi
show
factor
independ
associ
outsid
goal
tidal
volum
femal
sex
pressur
support
ventilationpsv
conclus
almost
icu
patient
mv
goal
low
tidal
volum
achiev
especi
femal
patient
pressur
support
ventil
establish
daili
checklist
patient
vm
feasibl
could
influenc
low
frequenc
vili
patient
ard
also
without
criteria
pulmonari
injuri
introduct
foster
safeti
cultur
one
import
landmark
come
provid
qualiti
assist
intens
care
unit
icu
detect
analysi
incid
advers
event
affect
patient
cornerston
develop
program
protocol
lead
safe
health
assist
high
standard
qualiti
object
know
natur
casuistri
underli
element
advers
event
ae
rate
seriou
accord
protocol
advers
event
report
establish
unit
method
notifi
ea
reach
patient
analys
advers
event
report
system
aer
establish
heart
surgeri
intens
care
unit
hsicu
januari
januari
among
rate
seriou
caus
patient
temporari
perman
damag
extend
hospit
compromis
live
need
surgeri
order
save
live
contribut
caus
demis
aer
rate
fi
accord
catalogu
nation
coordin
council
medic
error
report
prevent
nccmerp
result
ae
rate
seriou
notifi
among
rate
h
categori
incid
compromis
patient
life
need
care
keep
aliv
rate
categori
incid
contribut
caus
patient
demis
last
relat
surgeri
complic
need
medic
attent
major
discharg
ordinari
ward
hospit
relev
differ
far
urgenc
hospit
clinic
profil
assist
need
moment
ae
ae
equip
avail
resourc
point
contribut
factor
case
relat
format
train
case
due
element
relat
patient
case
element
relat
perform
frequent
seriou
safeti
issu
surgeri
complic
damag
relat
invas
procedur
three
relat
handl
breath
devic
two
reaction
blood
transfus
accord
profession
advic
ae
deem
avoid
conclus
ae
rate
seriou
common
featur
avoid
relat
format
train
techniqu
use
assist
beyond
case
death
seriou
ae
involv
extens
stay
hospit
rise
morbid
mortal
rate
accord
intervent
factor
capabl
improv
format
train
profession
involv
heal
process
compulsori
refer
merino
p
et
al
advers
event
spanish
intens
care
unit
syrec
studi
int
qual
health
care
apr
grant
acknowledg
none
introduct
welldefin
brief
help
improv
exchang
inform
among
profession
shift
chang
strengthen
safeti
cultur
object
gener
promot
safeti
cultur
icu
hgb
motril
specif
encourag
commun
interprofession
team
diminish
appear
advers
effect
ea
implement
use
safeti
brief
increas
patient
safeti
sinc
daili
meet
held
morn
shift
among
medic
nurs
profession
among
nurs
shift
exchang
inform
commun
regard
patient
admit
assess
risk
occurr
ae
patient
method
descript
brief
protocol
design
icu
wich
bed
total
incom
personnel
make
interprofession
team
doctor
nurs
assistantsin
total
ea
report
deriv
care
clinic
procedur
result
accid
patien
medic
equip
rest
due
causesa
work
group
creat
develop
promot
safeti
cultur
novemb
implement
secur
brief
perform
consensu
nurs
profession
variabl
enter
checklist
yesno
three
time
day
morn
afternoon
night
mechan
ventil
vasoact
drug
fasten
wean
pressur
ulcer
drain
revis
infus
rate
review
alarm
reposit
mobil
endotrach
tube
nasogastr
tube
urin
probe
wristband
mandatori
measur
pneumonia
zero
program
includ
ambu
review
aspir
strict
hand
hygien
handl
air
headboard
posit
check
neumotaponamiento
pressur
chlorhexidin
mouthwash
result
regul
exchang
inform
among
professionalsth
number
ea
report
decreas
sinc
introduct
use
new
brief
protocolbrief
accept
staff
complet
checklist
success
conclus
reduc
number
advers
effect
half
thu
demonstr
effect
protocol
also
import
accept
almost
staff
data
show
simpl
easi
carri
data
sensit
staff
import
inform
patient
safeti
think
work
help
unit
grant
acknowledg
icu
stafffor
make
work
possibl
introduct
rapid
respons
system
rr
may
slightli
reduc
cardiac
arrest
hospit
rr
effer
limb
rapid
respons
team
rrt
affer
limb
process
time
detect
activ
rr
activ
mostli
hoursday
daysweek
multidisciplinari
team
middleincom
countri
unlik
eu
usa
person
resourc
limit
rrt
call
common
work
hour
australian
object
daytim
activ
rrt
may
reduc
cardiac
arrest
rate
method
octob
inha
univers
hospit
rapid
respons
team
inhart
organ
activ
inhart
consist
three
doctor
two
pulmonologist
one
cardiologist
one
nurs
experienc
intens
care
unit
activ
time
pm
collect
number
hospit
discharg
cardiac
arrest
event
cae
retrospect
year
inhart
prospect
octob
februari
inhart
cae
per
discharg
compar
inhart
nonparametr
test
perform
result
mean
cae
per
discharg
inhart
inhart
p
cae
reduc
inhart
conclus
despit
shortterm
oper
daytim
activ
rrt
reduc
cardiac
arrest
event
longterm
applic
rrt
would
amelior
cardiac
arrest
improv
patient
safeti
gener
hospit
refer
jone
epidemiolog
adult
rapid
respons
team
patient
australia
anesth
intens
care
grant
acknowledg
inha
univers
research
grant
introduct
patient
safeti
icu
prevent
injuri
harm
aris
result
process
care
rather
result
underli
diseas
process
incid
medic
error
advers
event
icu
surprisingli
system
improv
patient
safeti
checklist
effect
implement
within
recept
posit
safeti
climat
posit
safeti
climat
associ
measur
decreas
error
object
evalu
safeti
climat
across
critic
care
unit
within
aneurin
bevan
univers
health
board
abuhb
method
conduct
anonym
onlin
survey
across
staff
critic
care
within
abuhb
survey
consist
question
valid
agenc
healthcar
research
qualiti
part
unit
state
depart
health
question
regard
staff
incid
report
behaviour
ran
survey
month
aim
get
return
rate
staff
work
across
site
result
receiv
respons
complet
survey
across
multidisciplinari
team
eighti
eight
percent
rate
overal
patient
safeti
good
excel
survey
report
support
environ
peopl
work
well
togeth
team
treat
respect
gener
patient
safeti
sacrif
get
work
done
pressur
take
shortcut
speed
work
rate
crisi
mode
precipit
inabl
discharg
wardabl
patient
rather
lack
staff
unit
full
staff
would
gener
discuss
advers
incid
amongst
inform
mani
case
implement
solut
follow
discuss
feedback
result
advers
event
report
highlight
defici
staff
feel
receiv
similarli
staff
feel
adequ
inform
error
happen
unit
conclus
whilst
result
indic
posit
work
environ
area
improv
specif
feedback
follow
advers
event
design
nurs
attend
morbid
mortal
meet
subsequ
public
patient
safeti
bulletin
improv
feedback
nurs
staff
go
instig
design
patient
safeti
board
publicis
patient
safeti
event
result
chang
practic
littl
current
publish
regard
uk
icu
safeti
survey
allow
benchmark
result
author
feel
uk
icu
consid
collect
public
data
refer
ic
ficm
guidelin
provis
intens
care
servic
valentin
schiffing
steyrer
j
et
al
safeti
climat
reduc
medic
dislodg
error
routin
intens
care
practic
intens
care
medicin
introduct
clinic
safeti
becom
one
side
qualiti
standard
side
ethic
oblig
daili
work
intens
care
unit
icu
establish
standard
protocol
appropri
train
area
safeti
becom
must
come
develop
also
profession
categori
involv
process
object
analysi
incid
advers
event
iae
report
establish
report
protocol
rpiae
heart
surgeri
intens
care
unit
hsicu
method
clinic
safeti
group
intens
care
servic
respons
design
rpiae
creat
januari
thu
rpiae
introduc
hsicu
march
methodolog
review
advers
event
ae
detect
everi
singl
patient
look
unit
march
octob
nonintent
damag
caus
consequ
medic
attent
receiv
nonrel
evolut
eventu
complic
initi
ill
inform
gather
excel
data
base
statist
analysi
perform
spss
epidat
program
result
ae
report
patient
male
admit
hospit
result
ae
discharg
patient
pass
away
report
nurs
staff
doctor
took
place
intens
care
unit
morn
shift
unit
hold
occup
ae
affect
patient
way
need
monitor
andor
intervent
order
check
damag
caus
compromis
patient
life
contribut
caus
demis
patient
doubtlessli
avoid
origin
unpluggingremov
accessesprobescatheterssensorstub
origin
handl
breath
devic
mechan
ventil
case
lack
train
format
direct
effect
iae
mean
durat
hospit
stay
ae
day
statist
standard
deviat
ssd
mean
durat
hospitalis
day
ssd
mean
stay
intens
care
unit
day
ssd
p
conclus
major
ae
deem
evit
neither
import
effect
evolut
patient
extend
patient
stay
icu
longer
stay
icu
relat
bigger
incid
ae
p
format
train
key
element
order
avoid
ae
part
measur
current
establish
icu
order
avoid
iae
refer
merino
p
et
al
advers
event
spanish
intens
care
unit
syrec
studi
int
qual
health
care
apr
grant
acknowledg
none
introduct
medic
error
common
critic
ill
patient
potenti
advers
affect
patient
safeti
whilst
advers
event
includ
caus
medic
direct
relationship
patient
outcom
potenti
clinic
impact
individu
medic
error
remain
less
clear
moreov
complex
critic
ill
patient
care
mean
frequent
optimis
medic
requir
ensur
effect
therapi
current
clinic
impact
grade
medic
error
optimis
remain
subject
clinic
practic
research
methodolog
object
identifi
reliabl
clinic
impact
grade
health
profession
profess
interrat
ii
within
profess
intrarat
common
prescrib
error
optimis
critic
care
patient
iii
identifi
repres
clinic
impact
grade
exampl
method
repres
medic
error
optimis
case
protect
uk
studi
sent
electron
purpos
sampl
healthcar
profession
icu
consult
specialist
pharmacist
specialist
nurs
uk
site
rater
grade
error
optimis
case
sever
clinic
impact
use
categor
scale
minor
moder
sever
life
threateningsav
clinic
impact
interrat
reliabl
test
use
linear
mix
model
intrarat
reliabl
test
use
intraclass
correl
icc
twoway
random
effect
model
use
absolut
agreement
result
major
error
optimis
modal
clinic
sever
grade
moder
higher
error
case
doctor
grade
clinic
impact
significantli
lower
pharmacist
p
nurs
p
nurs
significantli
higher
pharmacist
p
optimis
case
doctor
grade
clinic
impact
significantli
lower
nurs
pharmacist
p
respect
excel
intrareli
icc
grade
pharmacist
p
doctor
p
fair
good
nurs
p
optimis
error
respect
conclus
one
hundr
common
prescrib
error
optimis
modal
clinic
impact
grade
record
potenti
applic
clinic
practic
research
interprofession
variabl
highlight
import
multidisciplinari
perspect
assess
medic
error
optimis
clinic
practic
research
refer
rothschild
jm
et
al
crit
care
med
mania
e
et
al
br
j
clin
pharmacol
garrousteorgea
et
al
j
resp
crit
care
med
shulman
r
et
al
j
crit
care
grant
acknowledg
support
sheffield
hospit
chariti
regist
chariti
number
introduct
advers
event
ae
frequent
patient
admit
intens
care
unit
icu
differ
caus
object
determin
incid
characterist
result
advers
event
critic
ill
patient
requir
mechan
ventil
mv
method
observ
prospect
singlecent
studi
conduct
medicalsurg
icu
period
month
patient
requir
mv
hour
variabl
studi
demograph
data
extub
unschedul
sever
obstruct
airway
cardiac
arrest
atelectasi
loss
medic
devic
septic
shock
durat
mv
icu
hospit
stay
icu
hospit
mortal
statist
analysi
descript
bivari
chi
tstudent
multivari
logist
regress
analysi
result
patient
includ
apach
ii
score
age
year
bodi
mass
index
total
sofa
day
pt
male
renal
replac
therapi
durat
icu
stay
hospit
stay
day
durat
mv
day
cardiac
arrest
septic
shock
airway
obstruct
unschedul
extub
loss
medic
devic
icu
mortal
hospit
mortal
total
incid
ae
predict
factor
associ
hospit
mortal
apach
ii
score
ci
septic
shock
ci
airway
obstruct
ci
unschedul
extub
ci
loss
medic
devic
ci
conclus
occurr
ae
critic
ill
patient
high
strategi
reduc
incid
advers
event
may
eventu
improv
outcom
patient
introduct
sepsi
surviv
rate
improv
recent
year
becom
import
ass
longterm
outcom
order
align
treatment
import
patient
qualiti
life
qol
import
patientreport
outcom
pro
commonli
use
endpoint
clinic
studi
howev
frequent
use
instrument
eg
develop
without
input
intens
care
survivor
may
thu
lack
valid
popul
qualiti
life
domain
matter
sepsi
survivor
yet
elicit
object
identif
domain
qualiti
life
sepsi
survivor
accord
percept
prioriti
method
openend
facetofac
telephon
interview
conduct
sepsi
survivor
interdisciplinari
icu
german
univers
hospit
interview
transcrib
verbatim
fix
set
transcript
rule
analyz
qualit
interpret
phenomenolog
analysi
ipa
approach
code
subcod
appli
data
codebook
develop
second
experienc
research
unfamiliar
data
evalu
codebook
differ
solv
discuss
code
cluster
domain
evalu
import
stakehold
survivor
rel
survivor
intens
care
physician
nurs
psychologist
rehabilit
physician
delphi
process
result
fifteen
particip
femal
male
mean
age
year
rang
year
mean
time
onset
sepsi
month
rang
month
mean
interview
durat
minut
rang
minut
final
codebook
compris
code
subcod
data
satur
alreadi
interview
initi
agreement
two
research
codebook
could
improv
minor
chang
core
domain
qualiti
life
could
identifi
relev
domain
sepsi
survivor
qualiti
life
reintegr
normal
live
survivor
report
qualiti
life
depend
much
could
particip
everyday
life
less
singl
persist
physic
psycholog
deficit
domain
includ
abil
walk
fatigu
famili
partnership
selfpercept
control
one
life
conclus
studi
highlight
domain
import
qualiti
life
sepsi
survivor
assess
survivor
percept
identifi
domain
partli
assess
commonli
use
qualiti
life
instrument
reintegr
import
domain
patient
perspect
novel
concept
context
qualiti
life
sepsi
domain
help
improv
qualiti
life
questionnair
provid
patientrelev
outcom
measur
grant
acknowledg
feder
ministri
educ
research
bmbf
germani
grant
number
introduct
intercost
chest
drain
icd
insert
rel
common
procedur
associ
signific
complic
includ
bleed
organ
perfor
indic
insert
includ
manag
hemothorax
pneumothorax
pleural
effus
triangl
safeti
to
often
quot
site
appropri
icd
insert
includ
trauma
patient
atl
space
delin
later
border
pectorali
major
later
border
latismu
dorsi
line
intercost
space
base
axillaintercost
space
although
ultrasound
us
guidanc
recommend
aid
insert
use
far
establish
practic
landmark
techniqu
to
still
wide
practic
object
establish
safeti
profil
to
use
us
delin
underli
anatomi
includ
posit
intercost
vessel
method
consecut
patient
gener
icu
underw
bilater
us
examin
to
posit
liver
spleen
heart
respect
to
note
doppler
ultrasound
use
identifi
intercost
vessel
within
to
result
overal
heart
liver
spleen
visibl
patient
within
to
percentag
increas
intub
ventil
patient
popul
intercost
vessel
visibl
minor
patient
conclus
british
thorac
societi
nation
patient
safeti
agenc
uk
recommend
ultrasound
insert
drain
fluid
studi
found
to
misnom
expos
patient
risk
underli
organ
perfor
especi
patient
intub
ventil
therefor
safe
practic
abandon
routin
use
realtim
us
guid
icd
insert
recommend
improv
procedur
safeti
refer
havelock
teoh
r
law
et
al
pleural
procedur
thorac
ultrasound
bt
pleural
diseas
guidelin
thorax
suppl
nation
patient
safeti
agenc
rapid
respons
report
chest
drain
risk
associ
insert
chest
drain
http
wwwnrlsnpsanhsukresourcespatientsafetytopicsmedicaldeviceequip
introduct
sever
sepsi
septic
shock
still
common
caus
death
icu
extracorpor
blood
purif
therapi
could
provid
benefit
reduct
inflammatori
mediat
bacteri
endotoxin
object
studi
immunomoud
effect
polymyxinb
hemoperfus
pmx
sever
sepsissept
shock
method
adult
patient
sever
sepsissept
shock
intens
care
unit
icu
king
chulalongkorn
memori
hospit
test
endotoxin
assay
patient
blood
endotoxin
level
random
two
group
pmx
hemoperfus
group
standard
treatment
group
pmx
hemoperfus
done
two
consecut
day
pmx
hemoperfus
group
data
hemodynam
paramet
sequenti
organ
failur
assess
sofa
score
blood
sampl
collect
first
three
day
enrol
primari
outcom
leukocyt
express
hladr
chemotaxi
function
blood
endotoxin
level
day
enrol
secondari
outcom
surviv
apach
ii
score
chang
sofa
score
cv
sofa
score
result
enrol
particip
studi
patient
group
age
apach
ii
score
endotoxin
level
compar
two
group
percent
chang
eaa
vs
pmx
group
control
group
respect
apach
ii
total
sofa
score
vs
vs
pmx
group
control
group
respect
cv
sofa
score
vs
pmx
group
control
group
respect
trend
increas
hladr
express
pmx
group
chang
control
grouphladr
express
day
pmx
group
significantli
higher
control
group
vs
p
surviv
rate
compar
two
group
conclus
pmx
hemoperfus
seem
improv
hemodynam
instabl
improv
immunoparalysi
statu
sever
sepsissept
shock
patient
introduct
sepsi
induc
rapid
proteolysi
earli
exercis
desir
prevent
loss
muscl
mass
known
whether
earli
intervent
safe
critic
ill
patient
sepsi
exercis
may
also
act
recruit
microcircul
object
investig
effect
minut
electr
muscl
stimul
passiv
movement
major
muscl
group
microcircul
patient
first
hour
sepsi
method
chang
tissu
oxygen
assess
baselin
immedi
post
exercis
use
near
infrar
oxygen
devic
thenar
emin
assess
percentag
oxygen
muscl
percentag
muscl
oxygen
extract
rate
moer
baselin
hyperaem
condit
b
orthogon
polar
spectral
imag
devic
place
sublingu
measur
microvascular
flow
index
capillari
densiti
microcircul
result
patient
complet
trial
signific
effect
post
exercis
hyperaemia
p
improv
capillari
densiti
p
advers
effect
conclus
earli
exercis
appear
benefici
effect
critic
ill
patient
tissu
oxygen
improv
evid
recruit
microcircul
refer
kayambu
g
boot
r
paratz
j
prospect
randomis
control
trial
investig
function
physiolog
outcom
follow
earli
rehabilit
sepsi
iperform
trial
protocol
articl
bmc
anesthesiolog
press
oct
grant
acknowledg
intens
care
foundat
australia
introduct
gener
vasodil
nonrespond
hypotens
present
half
death
case
due
septicaemia
methylen
blue
could
use
valuabl
complement
refractori
hypotens
treatment
septic
shock
object
aim
studi
determin
effect
methylen
blue
contributori
treatment
patient
method
control
random
doubl
blind
clinic
trial
perform
patient
divid
two
group
group
receiv
singl
dose
methylen
blue
calcul
mgkg
per
bodi
weight
dilut
cc
dextros
infus
min
c
group
control
receiv
cc
dextros
infus
min
basal
measur
studi
variabl
taken
mbp
lactat
base
deficit
central
venou
satur
delta
prior
blue
methylen
administr
everi
hour
afterward
mbp
mmhg
without
vasopressor
hour
pass
shock
began
data
total
noradrenalin
dose
mg
length
stay
mechan
ventil
length
mortal
record
result
mbp
increas
progress
first
hour
methylen
blue
infus
group
c
group
p
steadili
hour
follow
noradrenalin
dose
decreas
first
hour
group
c
group
p
lactat
clearanc
first
hour
group
contrast
c
group
clearanc
p
mortal
icu
discharg
group
c
group
p
without
variat
day
conclus
methylen
blue
effect
contributori
septic
shock
treatment
note
abstract
previous
publish
avail
includ
complet
record
abstract
confer
refer
edmund
kwok
daniel
h
use
methylen
blue
sepsi
systemat
review
journal
intens
care
medicin
alderton
w
cooper
c
knowl
g
nitric
oxid
synthas
structur
function
inhibit
biochem
j
lopez
v
aguilar
arzapalo
barrada
l
escalant
gongoro
j
cetina
methylen
blue
effect
contributori
treatment
patient
septic
shock
critic
care
suppl
grant
acknowledg
hospit
agustin
introduct
clinic
practic
lp
adsorb
use
method
extracorpor
detoxif
remov
excess
lp
blood
patient
sepsi
recent
year
evid
abil
hemosorpt
columnsto
elimin
cytokin
inflammatori
mediat
trigger
cascad
reaction
irrevers
patholog
chang
organ
tissu
patient
object
studi
elimin
proinflammatori
cytokin
blood
septic
patient
hemosorpt
procedurebi
use
lp
adsorb
alteco
method
studi
includ
patient
confirm
gramneg
sepsi
sorption
procedur
implement
alteco
column
sweden
blood
serum
sampleswer
taken
immedi
procedur
column
lavag
taken
well
sampl
store
c
valu
il
il
il
il
il
serum
lavag
measur
elisa
result
baselin
level
serum
proinflammatori
cytokin
significantli
increas
median
pgml
pgml
pgml
rang
pgml
level
increas
pgml
signific
differ
level
cytokin
chang
individu
hemosorpt
procedur
unambigu
correl
show
clear
depend
baselin
level
number
procedur
perform
concentr
median
interleukin
blood
serum
obtain
hemosorpt
pgmlfor
pgml
pgml
pgml
analysi
result
patient
divid
two
group
moder
high
valu
pgml
ultrahigh
valu
pgml
hemosorpt
procedur
first
group
patient
hemosorpt
procedur
show
signific
chang
concentr
second
group
show
tendenc
decreas
level
serum
studi
ofalteco
lpsadsorb
eluat
sorb
cytokin
found
significantli
high
level
increas
serum
extracorpor
detoxif
procedur
conclus
result
indic
applic
lpsabsorb
alteco
patient
sepsi
significantli
affect
free
cytokin
level
system
circul
reduct
il
observ
patient
moder
increas
cytokin
concentr
higher
pg
ml
presenc
signific
amount
il
alteco
lpsadsorb
eluat
may
indic
presenc
blood
patient
sepsi
relat
form
cytokin
capabl
dissoci
adsorpt
adsorb
filter
lpsalteco
refer
kulabukhov
v
v
acta
anaesthesiol
scand
p
introduct
septic
shock
induc
gramneg
bacteria
infect
seriou
condit
intens
care
unit
icu
endotoxin
play
import
role
pathogenesi
oxiri
filter
polyacrylonitril
haemofiltr
membran
treat
polyethyleneimin
provid
posit
charg
surfac
enhanc
absorpt
endotoxin
cytokin
object
case
seri
determin
oxiri
haemodiafiltr
could
improv
haemodynam
statu
patient
gramneg
bacteria
relat
septic
shock
method
patient
admit
region
icu
intraabdomin
sepsi
requir
intervent
develop
sever
septic
shock
requir
inotrop
support
acut
renal
failur
requir
renal
support
assign
receiv
oxiri
haemodiafiltr
hour
match
patient
similar
patholog
sever
receiv
ordinari
haemodiafiltr
acut
renal
failur
identifi
comparison
primari
outcom
percentag
reduct
inotrop
dose
within
hour
start
renal
replac
therapi
calcul
accord
equival
noradrenalin
dose
ughr
second
outcom
includ
durat
mv
durat
crrt
icu
length
stay
icu
mortal
result
three
patient
assign
receiv
oxiri
haemodiafiltr
five
match
patient
identifi
comparison
icu
mortal
patient
receiv
oxiri
haemodiafiltr
compar
patient
ordinari
haemodiafiltr
patient
receiv
oxiri
haemodiafiltr
shown
rapid
revers
inotrop
dose
compar
control
effect
becam
obviou
hour
treatment
hr
drop
oxiri
group
drop
control
group
hr
drop
oxiri
group
drop
control
group
hr
drop
oxiri
group
drop
control
group
hr
drop
oxiri
group
drop
control
group
differ
group
term
durat
mv
day
oxiri
group
vs
day
control
group
durat
crrt
day
oxiri
group
vs
day
control
group
icu
length
stay
day
oxiri
group
vs
day
control
group
conclus
oxiri
haemodiafiltr
shown
rapid
revers
shock
lower
mortal
patient
intraabdomin
sepsi
septic
shock
differ
term
durat
mv
durat
crrt
icu
length
stay
refer
et
al
high
volum
haemofiltr
new
haemofiltr
membran
enhanc
adsorpt
properti
septic
pig
nephrol
dial
transplant
pp
grant
acknowledg
nil
introduct
direct
hemoperfus
polymyxinbimmobil
fiber
column
pmxdhp
success
use
treat
patient
septic
shock
object
aim
studi
report
clinic
experi
pmxdhp
septic
shock
patient
singl
center
identifi
subgroup
patient
may
benefit
treatment
method
juli
march
perform
case
pmxdhp
septic
shock
sever
acut
respiratori
distress
syndrom
ard
patient
among
septic
shock
patient
requir
vasopressor
lactic
acid
level
mgdl
fluid
resuscit
analyz
result
perform
case
pmxdph
treatment
septic
shock
patient
two
session
pmxdph
perform
patient
median
age
year
old
iqr
male
pmxdhp
treatment
start
median
sofa
score
iqr
median
lactic
acid
level
mgdl
iqr
median
inotrop
score
iqr
major
infect
focu
intraabdomin
patient
treat
due
respiratori
tract
infect
mortal
mortal
sofa
score
pmxdhp
treatment
day
infect
site
sourc
control
lactic
acid
level
associ
mortal
coxregress
analysi
show
signific
associ
sofa
score
ci
p
infect
site
ci
p
overal
surviv
conclus
pmxdhp
applic
septic
shock
patient
could
consid
adjunct
therapi
introduct
recent
decad
studi
report
treatment
polymyxin
bimmobil
hemoperfus
cartridg
may
benefici
effect
hemodynam
mortal
patient
sever
sepsi
septic
shock
prematur
cartridg
clot
common
problem
polymyxin
b
hemoperfus
may
decreas
therapeut
efficaci
increas
cost
therapi
howev
excess
anticoagul
patient
sever
dissemin
intravascular
coagul
intraabdomin
infect
patient
oper
may
increas
risk
bleed
current
nafamostat
mesil
use
dominantli
japan
experi
use
heparin
anticoagul
polymyxin
b
hemoperfus
therapi
countri
less
need
investig
object
aim
investig
effect
safeti
heparin
dose
score
protocol
anticoagul
polymyxin
bimmobil
cartridg
hemoperfus
method
retrospect
studi
icu
nation
taiwan
univers
hospit
medic
record
polymyxin
b
hemoperfus
septic
shock
patient
octob
februari
review
heparin
dose
score
modifi
instruct
heparin
dose
toray
industri
inc
primari
aim
investig
complet
rate
session
hemoperfus
without
prematur
cartridg
clot
event
signific
bleed
secondari
aim
investig
effect
polymyxin
b
hemoperfus
hemodynam
diseas
sever
score
result
among
enrol
patient
session
polymyxin
bimmobil
hemoperfus
administ
complet
rate
session
hemoperfus
one
case
prematur
cartridg
clot
hemoperfus
time
minut
document
signific
bleed
surgic
patient
mean
time
initi
hemoperfus
hour
oper
mortal
enrol
patient
signific
hemodynam
improv
reduct
diseas
sever
score
note
polymyxin
b
hemoperfus
conclus
result
support
heparin
dose
score
protocol
provid
effect
safe
anticoagul
polymyxin
b
hemoperfus
septic
shock
patient
refer
mitaka
c
tomita
polymyxin
bimmobil
fiber
column
hemoperfus
therapi
septic
shock
shock
cruz
dn
antonelli
fumag
r
foltran
f
brienza
n
donati
malcangi
v
petrini
f
volta
g
pallavicini
fmb
et
al
earli
use
polymyxin
b
hemoperfus
abdomin
septic
shock
eupha
random
control
trial
jama
grant
acknowledg
support
part
research
grant
nation
taiwan
univers
hospit
introduct
argatroban
arg
synthet
direct
thrombin
inhibitor
effect
free
fibrin
clot
bound
thrombin
approv
hit
arg
hepat
metabol
halflif
elimin
pharmacokinet
arg
depend
renal
function
anticoagul
effect
declin
within
hour
object
aim
studi
investig
arg
anticoagul
pmb
hemoperfus
septic
patient
thrombocytopenia
possibl
relat
hit
prevent
circuit
clot
method
septemb
octob
five
septic
patient
thrombocytopenia
need
hemoperfus
pmb
enrol
nine
hemoperfus
session
perform
entri
criteria
sever
sepsi
septic
shock
requir
pmb
hemoperfus
thrombocitopenia
exclus
criteria
seriou
liver
dysfunct
recent
surgic
oper
h
recent
head
trauma
cerebr
bleed
day
hemorrhag
diseas
patient
requir
pmb
hemoperfus
follow
standard
protocol
recommend
estor
patient
receiv
arg
dose
mcgkg
singl
bolu
inject
min
begin
treatment
monitor
anticoagul
achiev
system
aptt
thromboelastographi
assess
teg
begin
hemoperfus
session
h
h
h
start
treatment
teg
perform
identifi
r
valu
use
routin
evalu
anticoagul
regimen
clinic
set
compar
aptt
valu
anticoagul
target
achiev
aptt
valu
time
refer
valu
result
patient
receiv
two
hemoperfus
session
except
one
patient
die
prematur
media
aptt
media
tegr
time
conclus
arg
load
dose
mcgkg
demonstr
effect
maintain
cartridg
patenc
pmb
hemoperfus
cartridg
clot
event
occur
aptt
test
demonstr
adequ
anticoagul
contrast
tegr
time
show
greater
variabl
valu
sever
patient
anticoagul
report
aptt
sampl
suggest
lower
arg
dose
could
suffici
ensur
adequ
anticoagul
nevertheless
advers
event
record
durat
arg
anticoagul
effect
appear
longer
describ
pharmaceut
compani
alway
exceed
hour
investig
necessari
introduc
arg
clinic
practic
anticoagul
pmb
hemoperfus
refer
pt
murray
et
al
kidney
intern
link
et
al
crit
care
med
introduct
recent
clinic
studi
shown
reduct
toxic
level
cytokin
blood
use
new
extracorpor
sorbent
cytosorb
cytosorb
could
use
regain
control
complic
inflammatori
condit
patient
sepsi
septic
shock
object
aim
observ
studi
evalu
cours
patient
septic
shock
admit
icu
treat
new
sorbent
cytosorb
primari
outcom
influenc
new
sorbent
hemodynam
evalu
mean
arteri
pressur
map
vasopressor
need
wherea
secondari
outcom
improv
inflammatori
condit
renal
function
studi
procalcitonin
pct
creatinin
method
enrol
patient
f
sever
sepsi
septic
shock
patient
data
report
tabl
median
lower
upper
quartil
patient
nonrespond
standard
care
treatment
sepsissept
shock
therefor
cytosorb
use
adjunct
therapi
combin
continu
renal
replac
therapi
crrt
order
control
cytokin
storm
improv
hemodynam
stabil
patient
instal
seri
connect
dialys
crrt
circuit
h
clinic
paramet
collect
end
cytosorb
treatment
result
treat
patient
surviv
treatment
overal
improv
map
mmhg
rapid
reduct
inotrop
need
noradrenalin
decreas
dopamin
ykgmin
moreov
markedli
decreas
pct
level
ngdl
improv
renal
function
thank
combin
cytosorb
crrt
fact
creatinin
decreas
mg
nonsurvivor
map
hard
stabil
decreas
mmhg
aggrav
overal
patient
condit
conclus
preliminari
data
indic
time
use
cytosorb
combin
standard
therapi
could
benefit
improv
hemodynam
help
rapid
stabil
patient
result
promis
show
cytosorb
might
help
mani
condit
organ
dysfunct
howev
vivo
studi
need
confirm
result
note
abstract
previous
publish
avail
includ
complet
record
abstract
confer
refer
schadler
et
al
critic
care
suppl
laddomada
doronzio
balicco
b
case
seri
patient
sever
sepsi
septic
shock
treat
new
extracorpor
sorbent
critic
care
suppl
introduct
platelet
play
pivot
role
host
immun
respons
antiplatelet
therapi
associ
benefici
outcom
sepsi
antiplatelet
therapi
may
therefor
besid
prevent
cardiovascular
diseas
also
affect
inflammatori
process
outcom
infect
theoret
modul
prostaglandin
product
adenosin
metabol
attenu
platelet
reactiv
may
account
object
evalu
effect
clinic
relev
dose
combin
antiplatelet
therapi
innat
immun
respons
human
model
system
inflamm
evalu
put
mechan
immunomodul
antiplatelet
agent
method
perform
parallel
random
control
studi
healthi
male
volunt
random
seven
day
treatment
cours
either
placebo
p
placebo
acetylsalicyl
acid
asa
pa
ticagrelor
asa
ta
clopidogrel
asa
ca
n
per
group
seventh
day
system
inflammatori
respons
elicit
intraven
administr
bolu
ngkg
purifi
e
coli
endotoxin
follow
ngkgh
hour
subject
evalu
plasma
level
cytokin
prostaglandin
adenosin
measur
platelet
reactiv
endotoxemia
result
treatment
asa
result
profound
augment
plasma
level
proinflammatori
cytokin
endotoxemia
fig
affect
antiinflammatori
cytokin
although
addit
ticagrelor
clopidogrel
attenu
asainduc
increas
antagonist
affect
concentr
proinflammatori
cytokin
fig
differ
cytokin
respons
ticagrelor
clopidogreltr
subject
treatment
asa
lower
plasma
level
thromboxan
plasma
adenosin
increas
endotoxemia
without
differ
group
platelet
reactiv
reduc
ticagrelor
clopidogrel
treat
subject
without
correl
cytokin
respons
conclus
seven
day
cours
low
dose
asa
result
profoundli
enhanc
proinflammatori
immun
respons
vivo
model
system
inflamm
human
although
addit
ticagrelor
clopidogrel
significantli
attenu
respons
ticagrelor
clopidogrel
affect
respons
refer
de
stoppelaar
sf
van
veer
c
van
der
poll
tthe
role
platelet
sepsi
thromb
haemost
thoma
mr
outteridg
sn
ajjan
r
phoenix
f
sangha
gk
faulkner
ecob
r
judg
hm
khan
h
west
le
dockrel
dh
sabro
storey
rf
platelet
inhibitor
reduc
system
inflamm
prothrombot
effect
experiment
human
model
arterioscl
thromb
vasc
biol
grant
acknowledg
work
support
unrestrict
grant
astrazeneca
introduct
sepsi
induc
cardiomyopathi
complic
sever
sepsi
character
left
ventricular
dilat
depress
eject
fraction
recent
metaanalysi
suggest
mortal
depend
heart
hyperkinet
howev
crucial
mechan
sepsi
induc
cardiomyopathi
treatment
still
unknown
report
telomer
length
invers
correl
sever
heart
failur
infecti
diseas
addit
telomer
dysfunct
decreas
mitochondri
function
affect
downstream
gene
express
cell
energi
regul
peroxisom
proliferatoractiv
receptor
gamma
coactiv
suggest
dysfunct
axi
reduc
mitochondri
function
result
develop
heart
failur
betablock
possibl
improv
morbid
mortal
sepsi
regul
sympathet
nerv
system
metabol
carvedilol
antioxid
properti
wide
use
patient
heart
failur
present
studi
conduct
investig
therapeut
potenti
carvedilol
improv
prognosi
preclin
model
sever
infect
murin
cecal
ligat
punctur
clp
model
induc
periton
method
clp
procedur
perform
use
week
male
mice
oper
mice
divid
beta
blocker
group
bb
control
group
ct
mgkg
carvedilol
normal
salin
administ
everi
day
group
isol
left
ventricl
heart
obtain
blood
sampl
surviv
individu
postop
day
estim
surviv
rate
cardiac
function
echocardiographi
blood
pressur
measur
indirect
tailcuff
method
telomer
length
heart
tissu
white
blood
cell
evalu
quantit
fluoresc
situ
hybrid
qfish
analysi
result
kaplanmei
analysi
show
day
mortal
reduc
bb
group
day
surgeri
bb
group
reduc
heart
rate
bb
vs
bpm
ct
p
signific
differ
mean
arteri
pressur
vs
mmhg
p
bb
group
also
improv
cardiac
function
ee
vs
p
lvef
vs
p
lvedv
vs
p
compar
ct
group
qfish
analysi
reveal
telomer
length
white
blood
cell
significantli
longer
bb
group
vs
p
telomer
fluoresc
unit
tfu
kb
quantit
pcr
analysi
reveal
bb
show
higher
express
telomeras
revers
transcriptas
tert
promot
mitochondri
biogenesi
lower
express
heart
tissu
compar
ct
group
conclus
carvedilol
improv
sepsisinduc
cardiomyopathi
attenu
telomer
shorten
regul
gene
express
energi
metabol
reduc
mortal
result
sepsi
corticu
trial
hydrocortison
therapi
improv
outcom
among
patient
septic
shock
onset
within
hour
although
shorten
durat
vasopressor
depend
studi
investig
role
hydrocortison
therapi
earli
phase
sepsi
combin
hyperfluid
therapi
purpos
examin
protect
role
corticoid
hyperfluid
therapi
microcirculatori
dysfunct
progress
earli
phase
sepsi
method
adult
wistar
rat
g
gener
anesthesia
submit
sepsi
iv
ml
e
coli
hour
intervent
start
minut
sepsi
induct
sbh
group
n
treat
basalfluid
reposit
iv
ml
salinekgh
shh
group
n
treat
hyperfluid
therapi
iv
ml
salinekgdur
h
maintain
basal
fluid
sbh
cort
group
n
treat
similar
sbh
howev
treat
hydrocortison
iv
mgkg
dilut
ml
milliq
water
fluid
therapi
shh
cort
group
n
treat
hydrocortison
hyperfluid
therapi
microcircul
mesenteri
monitor
intravit
microscopi
first
hour
sepsi
microcircul
renal
cortex
area
liver
monitor
sidestream
dark
field
imag
sdf
videomicroscopi
hour
sepsi
result
intravit
monitor
show
sepsi
treat
basalfluid
therapi
sbh
import
microcirculatori
dysfunct
includ
intens
leucocyt
adhes
transmigr
lead
vessel
congest
focal
hemorrhag
alter
decreas
group
even
though
one
treat
hyperfluid
shh
hydrocortison
associ
shh
cort
result
lesser
leucocyt
adhes
transmigr
group
treat
hydrocortison
basalfluid
sbh
cort
interestingli
combin
hh
cort
therapi
determin
lowest
leucocyt
adhes
wherea
hh
therapi
alon
lower
leucocyt
transmigr
sdf
monitor
reveal
sepsi
treat
basalfluid
therapi
sbh
greater
microcirculatori
dysfunct
liver
kidney
present
numer
area
heterogen
hh
corticoid
alon
combin
seem
minim
sepsi
effect
microcircul
howev
histolog
biochem
studi
need
better
elucid
find
overal
data
demonstr
hyper
fluid
therapi
corticoid
therapi
alon
combin
given
earli
phase
sepsi
might
bring
potenti
benefit
control
exacerb
inflammatori
respons
sepsi
grant
acknowledg
fapesp
introduct
sepsi
still
repres
major
health
issu
persist
high
mortal
rate
critic
ill
patient
organ
occur
frequent
sepsi
relat
magnitud
inflammatori
respons
erythropoietin
epo
emerg
major
tissu
protect
cytokin
set
object
determin
effect
epo
inflammatori
state
oxid
stress
organ
analyz
function
benefit
epo
heart
vessel
model
sepsi
method
sepsi
induc
cecal
ligat
punctur
clp
perform
rat
sham
abdomin
surgeri
epo
uikg
inject
intraperiton
time
surgeri
group
anim
allow
follow
index
analyz
surviv
anim
invas
blood
pressur
bp
lactat
rate
heart
function
cytokin
profil
use
plasma
organ
heart
kidney
lung
liver
brain
rtpcr
hour
surgeri
oxid
stress
assess
use
dhe
result
discuss
surviv
h
onset
surgeri
sham
clp
clpepo
rat
p
respect
whole
inflammatori
respons
pro
antiinflammatori
cytokin
prevent
epo
organ
plasma
see
figur
henc
increas
cytokin
clpepo
heart
lower
observ
clp
one
p
respect
protein
level
inflammatori
marker
increas
clp
heart
compar
sham
wherea
differ
seen
sham
clpepo
rat
p
less
oxid
stress
clpepo
heart
compar
sham
clp
group
p
hour
onset
sepsi
regard
function
indic
epo
prevent
systol
dysfunct
complet
prevent
tachycardia
p
decreas
bp
p
conclus
sepsi
rat
epo
prevent
inflammatori
respons
oxid
stress
organ
plasma
refer
rabuel
mebazaa
intens
care
medicin
walden
et
al
critic
care
rittirsch
et
al
natur
protocol
introduct
extracorpor
therapi
consid
option
modul
cytokin
level
circul
system
inflammatori
syndrom
technolog
base
high
cutoff
hco
membran
larger
pores
effect
clearanc
middl
molecul
promis
object
aim
studi
conduct
vitro
experi
order
compar
av
highflux
haemofilt
hco
filter
freseniu
medic
care
bad
homburg
germani
regard
cytokin
elimin
method
experi
x
ml
human
plasma
spike
dialyz
av
filter
filter
experi
conduct
use
two
freseniu
haemodialysi
machin
plasma
dialys
flow
mlmin
sampl
clearanc
measur
taken
min
siev
coeffici
determin
filtrat
flow
plasma
flow
experi
carri
triplic
cytokin
quantifi
elisa
result
result
show
effici
remov
filter
larger
cytokin
remov
filter
clearanc
rate
mlmin
respect
show
much
higher
clearanc
rate
av
conclus
compar
highflux
dialyz
hco
filter
offer
significantli
higher
remov
rate
middl
molecul
cytokin
target
molecul
similar
molar
mass
therefor
hco
filter
prefer
extracorpor
therapi
support
treatment
system
inflammatori
syndrom
refer
mathieu
page
charleser
ber
davi
hayislayman
bernard
allaouchich
thoma
remov
middlemolecular
weight
molecul
high
cutoff
continu
hemodialysi
asa
annual
meet
octob
new
orlean
mathieu
page
charleser
ber
davi
hayislayman
bernard
allaouchich
thoma
clinic
toler
continu
hemodialysi
high
cutoff
membran
asa
annual
meet
octob
new
orlean
grant
acknowledg
work
support
govern
lower
austria
within
project
id
